-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GQfqHHtZILNMVScKlRTgdRN9qU0mKLPRDQV5SnzWuWlICNWILVpv6HkLVvfxRYNI wOxAn4dP0PNQqV+UKChDAw== 0000950103-07-002929.txt : 20071204 0000950103-07-002929.hdr.sgml : 20071204 20071204164410 ACCESSION NUMBER: 0000950103-07-002929 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20071128 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20071204 DATE AS OF CHANGE: 20071204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: E TRADE FINANCIAL CORP CENTRAL INDEX KEY: 0001015780 STANDARD INDUSTRIAL CLASSIFICATION: SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035] IRS NUMBER: 942844166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11921 FILM NUMBER: 071284201 BUSINESS ADDRESS: STREET 1: 135 E. 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 6503316000 MAIL ADDRESS: STREET 1: 135 E. 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: E TRADE GROUP INC DATE OF NAME CHANGE: 19960531 8-K 1 dp07754_8k.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 28, 2007
 

E*TRADE FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
1-11921
94-2844166
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
135 East 57th St, New York, NY
 
10222
(Address of principal executive offices)
 
(Zip Code)
 
 
 
Registrant’s telephone number, including area code: (646) 521 4300
 
N/A
 
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 
 
Item 1.01. Entry into a Material Definitive Agreement.
 
On November 29, 2007, E*TRADE Financial Corporation, a Delaware corporation (the “Company”), entered into a Master Investment and Securities Purchase Agreement (the “Citadel Investment Agreement”), by and between the Company and Wingate Capital Ltd., a Cayman Islands company and affiliate of Citadel Limited Partnership (“Citadel”).  In addition, on November 29, 2007, the Company entered into a Securities Purchase Agreement (the “BlackRock Purchase Agreement”) with certain affiliates of BlackRock, Inc. (the “BlackRock Investors”).  The Citadel Investment Agreement and the BlackRock Purchase Agreement provide for, among other things, (i) the issuance to Citadel of $1,650,000,000 in aggregate principal amount of 12.5% Springing Lien Notes due November 30, 2017 (the “Springing Lien Notes”), (ii) the exchange of approximately $186,000,000 of the Company’s senior unsecured notes held by affiliates of Citadel for $186,000,000 in aggregate principal amount of Springing Lien Notes, (iii) the issuance to the BlackRock Investors of $100,000,000 in aggregate principal amount of Springing Lien Notes, (iv) the issuance to Citadel or its affiliates and the BlackRock Investors of an aggregate of 19.99 % of the Company’s outstanding common stock, par value $0.01 per share (the “Common Stock”), measured as of immediately prior to entry into the Citadel Investment Agreement and the BlackRock Purchase Agreement, and (v) the sale (the “ABS Sale”) by E*TRADE Bank and E*TRADE Global Asset Management, Inc. of their respective asset backed securities portfolios to an affiliate of Citadel for approximately $800,000,000, subject to certain adjustments.  Aggregate proceeds to the Company from the transactions contemplated by the Citadel Investment Agreement, the BlackRock Purchase Agreement and the ABS Sale will be approximately $2,550,000,000 in cash.
 
Pursuant to the Citadel Investment Agreement, on November 29, 2007, the Company issued to Citadel $1,686,000,000 in aggregate principal amount of Springing Lien Notes and 10,000,000 shares of Common Stock, representing approximately 2.36% of the Company’s outstanding Common Stock prior to such issuance.  Pursuant to the BlackRock Purchase Agreement, on November 29, 2007, the Company issued to the BlackRock Investors $100,000,000 in aggregate principal amount of Springing Lien Notes and 4,840,430 shares of Common Stock, representing approximately 1.14% of the Company’s outstanding Common Stock prior to such issuance.  Immediately following the closing of the issuance of the Springing Lien Notes, the Company contributed $1,550,000,000 to the equity of E*TRADE Bank.  The ABS Sale was consummated immediately following such contribution.  The aggregate gross proceeds to the Company of the issuances completed on November 29 and the ABS Sale were approximately $2,400,000,000 in cash.  The Company also paid Citadel and BlackRock an aggregate commitment fee of $50,000,000 in connection with the transactions.
 
In addition, upon the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to the issuance of Common Stock pursuant to the Citadel Investment Agreement, the Company will issue additional shares of Common Stock to Citadel, such that Citadel will own approximately 9.9% of the Company’s outstanding Common Stock.  Subsequent to the expiration or termination of the HSR Act waiting period, upon receipt of an acceptance and approval (“OTS Approval”) by the Office of Thrift Supervision (“OTS”) of a rebuttal of control submission to be filed by Citadel, and the satisfaction of certain other customary closing conditions, the Company will issue (the “Final Closing”) to Citadel an aggregate principal amount of $150,000,000 of Springing Lien Notes and additional shares of Common Stock, such that the aggregate number of shares issued to Citadel under the Citadel Investment Agreement will be approximately 18.8% of the Company’s outstanding Common Stock measured as of immediately prior to entry into the Citadel Investment Agreement, and the aggregate number of shares owned by Citadel immediately following the Final Closing will be approximately 18.1% of the Company’s outstanding Common Stock measured as of immediately following the Final Closing (including shares of Common Stock beneficially owned prior to entry into the Citadel Investment Agreement).  Citadel has the right to assign to third parties all or a portion of the Springing Lien Notes and Common Stock issuable at the Final Closing, subject to certain conditions.
 
Effective as of the Final Closing or at such time as the HSR Act waiting period has expired or terminated and OTS Approval has been obtained, the Company’s Board of Directors will be expanded by one member and the Board of Directors will appoint a nominee of Citadel as a Class III member.  Citadel’s nominee must be reasonably acceptable to the nominating and corporate governance committee of the Board of Directors (which will not unreasonably withhold its consent).  Citadel’s right to nominate a director to the Board of Directors will terminate
 

 
when Citadel no longer owns shares of Common Stock representing at least 5% of the Common Stock then outstanding.
 
The Citadel Investment Agreement contains representations, warranties, covenants and indemnities by the Company and Citadel customary for a transaction of this nature, as well as certain put and call rights relating to the Springing Lien Notes and certain covenants regarding post-closing conduct of the Company.
 
The Company and Citadel entered into a Registration Rights Agreement, dated as of November 29, 2007 (the “Registration Rights Agreement”) containing customary terms and conditions providing for the registration of the Springing Lien Notes and Common Stock issued to Citadel pursuant to the Citadel Investment Agreement.
 
In addition, the Company, E*TRADE Securities LLC and Citadel Derivatives Group LLC (“CDG”), entered into an Equities and Options Order Handling Agreement (the “Order Handling Agreement”) dated as of November 29, 2007 pursuant to which the Company has committed to route substantially all of its customer orders in exchange-listed options and 40% of its customer orders in Regulation NMS Securities to CDG for order handling and execution for a term of three years.  Order execution by CDG will be subject to execution quality standards.  The agreement provides for liquidated damages if the Company breaches its commitments to route covered orders through CDG, and if the agreement is terminated prior to expiration, other than by the Company due to material breach by CDG.  Either the Company or CDG may terminate the services agreement in the event of certain changes in control of the Company or CDG.
 
On November 29, 2007, in connection with entering into the Citadel Investment Agreement, the Company and American Stock Transfer & Trust Company, as rights agent, entered into the First Amendment to the Rights Agreement (the “Rights Agreement Amendment”).  The Rights Agreement Amendment modifies the Company’s Rights Agreement, dated as of July 9, 2001 (the “Rights Agreement”), to provide, among other things, that the issuance of rights under the Rights Agreement will not be triggered as a result of the transactions contemplated by the Citadel Investment Agreement, including the issuance of any shares of Common Stock to Citadel or its affiliates pursuant to the Investment Agreement.
 
* * * * * *
 
The description of the terms of the Citadel Investment Agreement, the BlackRock Purchase Agreement, the ABS Purchase Agreement, the Registration Rights Agreement and the Rights Agreement Amendment, contained in this Item 1.01 is a summary and does not purport to be complete, and is qualified in its entirety by reference to the copies of the Citadel Investment Agreement, the BlackRock Purchase Agreement, the ABS Purchase Agreement, the Registration Rights Agreement and the Rights Agreement Amendment, attached hereto as Exhibits 10.1, 10.2, 10.3, 4.1 and 4.3, respectively, each of which is incorporated herein by reference.
 
Item 1.02. Termination of a Material Definitive Agreement
 
On November 29, 2007, in connection with the Transactions contemplated in the Citadel Investment Agreement and the BlackRock Purchase Agreement, the Company terminated the Credit Agreement dated as of September 19, 2005 among the Company, the Lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent and Morgan Stanley Senior Funding Inc. as Syndication Agent, which had provided for a $250 million revolving credit facility for the Company.  Pursuant to the Citadel Investment Agreement, the Company has undertaken to use all commercially reasonable efforts to secure a replacement facility as promptly as practicable.
 
Item 2.03.  Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
In connection with the issuance of the Springing Lien Notes, the Company and The Bank of New York, as trustee, entered into the Springing Lien Notes Indenture dated November 29, 2007 (the “Indenture”).  Under the Indenture, the Company may issue up to $1,936,000,000 (plus capitalized interest, if any) aggregate principal amount of Springing Lien Notes.  A copy of the Indenture is filed herewith as Exhibit 4.2.
 
The Springing Lien Notes bear interest at the rate of 12.5% per annum and will mature on November 30, 2017.  Interest on the Springing Lien Notes is payable in cash on May 31 and November 30 of each year beginning on May
 

 
31, 2008, provided, however, that the Company may capitalize interest payable on interest payment dates occurring on or before May 31, 2010 under certain circumstances.
 
The Company may redeem the Springing Lien Notes beginning on November 30, 2012 for redemption prices set forth in the Indenture.  In addition, prior to such date, the Company may redeem a portion of the outstanding principal amount of Springing Lien Notes using a portion of the net cash proceeds of certain equity offerings.  Upon a change of control, as defined in the Indenture, the Company may be required to make an offer to purchase the Springing Lien Notes at a purchase price equal to 101% of the principal amount of the Springing Lien Notes on the date of purchase, plus accrued interest.  Furthermore, prior to the eighteen-month anniversary of the Final Closing, the Company may redeem all (but not less than all) of the outstanding principal amount of Springing Lien Notes, at a premium set forth in the Indenture, in connection with the Company entering into a definitive agreement to consummate a change of control transaction.
 
The Springing Lien Notes are general senior obligations of the Company and are not guaranteed by the subsidiaries through which the Company currently conducts substantially all of its operations.  The Springing Lien Notes rank equal in right of payment with all of the Company’s existing and future unsubordinated indebtedness, and rank senior in right of payment to all of the Company’s existing and future subordinated indebtedness.  The Indenture will require the Company to secure the Springing Lien Notes in the future, up to the maximum amount of indebtedness as would not require any of the Company’s existing senior notes due 2011, 2013 or 2015 becoming secured equally and ratably with the Springing Lien Notes, on the property and assets of the Company and certain of its subsidiaries as set forth in the Indenture.  The Company will also be required to cause its restricted subsidiaries to guarantee the notes on the date on which the Company is first required to secure the Springing Lien Notes or on the date on which such restricted subsidiaries guarantee other indebtedness of the Company.
 
The Indenture contains several restrictive covenants that are substantially similar to those contained in the indentures governing the Company's existing senior notes due 2011, 2013 and 2015, including, but not limited to the following:  (i) limitations on incurrence of additional indebtedness and issuances of preferred stock, (ii) limitations on restricted payments, (iii) limitations on distributions from regulated subsidiaries and restricted subsidiaries, (iv) limitations on the issuance or sale of capital stock of regulated subsidiaries and restricted subsidiaries, (v) limitations on transactions with affiliates, (vi) limitations on asset sales and sale-leaseback transactions, (vii) future subsidiary guarantees and (viii) limitations on liens, subject in each case to certain exceptions.  The Indenture also contains a covenant requiring certain bank regulated subsidiaries to be “well capitalized” under applicable regulatory standards.
 
The Indenture contains customary terms that upon certain events of default occurring and continuing, either the trustee or the holders of not less than 25% in aggregate principal amount of the Springing Lien Notes then outstanding may declare the principal of the Springing Lien Notes and any accrued and unpaid interest through the date of such declaration immediately due and payable.  In the case of certain events of bankruptcy or insolvency relating to Company or any of its significant subsidiaries, the principal amount of the Springing Lien Notes together with any accrued and unpaid interest through the occurrence of such event shall automatically become and be immediately due and payable.
 
This description of the Springing Lien Notes and the related indenture are hereby incorporated by reference in Item 1.01.  The description of the Indenture and the Springing Lien Notes is a summary and does not purport to be complete, and is qualified in its entirety by reference to the copy of the Indenture (including the form of Springing Lien Note), attached hereto as Exhibit 4.2, which is incorporated herein by reference.
 
Item 3.02. Unregistered Sales of Equity Securities.
 
The information set forth in Item 1.01 hereof is incorporated herein by reference.
 
The issuance and sale of the Springing Lien Notes and the Common Stock pursuant to the Citadel Investment Agreement and the BlackRock Investment Agreement is exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of the Securities Act of 1933 and/or Regulation D promulgated under the Securities Act of 1933.  Each purchaser of the Springing Lien Notes and the Common Stock has represented to the Company that it is an “accredited investor” as defined in Regulation D and that the Springing Lien Notes and the Common Stock are
 

 
being acquired for investment.  The Company has not engaged in general solicitation or advertising with regard to the issuance and sale of the Springing Lien Notes and the Common Stock and has not offered securities to the public in connection with this issuance and sale.
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On November 29, 2007, the Company announced that Mitchell H. Caplan has stepped down from his position as Chief Executive Officer of the Company as of November 28.  At that time, the Company also announced that Mr. Caplan will remain with the Company in an advisory capacity and will remain a member of the Board of Directors.  The Board of Directors appointed R. Jarrett Lilien, President of the Company, as acting Chief Executive Officer.
 
In addition, on November 28, 2007, the Board of Directors elected Donald H. Layton to the Board of Directors and designated Mr. Layton as Chairman of the Board of Directors.  As Chairman, Mr. Layton will be eligible to receive an annualized fee of $1 million, in lieu of other Board fees.  In connection with his appointment as Chairman, he received 118,934 restricted stock awards and 321,419 stock options, which have a one-year vesting schedule.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.

Exhibit No.
 
Description
4.1 
 
Registration Rights Agreement, dated as of November 29, 2007, by and between Wingate Capital Ltd. and E*TRADE Financial Corporation.
     
4.2 
 
Indenture, dated November 29, 2007 between E*TRADE Financial Corporation as Issuer and The Bank of New York, as Trustee (includes form of note).
     
4.3 
 
First Amendment to Rights Agreement, dated November 29, 2007, by and between E*TRADE Financial Corporation and American Stock Transfer & Trust Company, as rights agent.
     
10.1
 
Master Investment and Securities Purchase Agreement, dated as of November 29, 2007, by and between E*TRADE Financial Corporation and Wingate Capital Ltd.
     
10.2
 
Securities Purchase Agreement, dated November 29, 2007 among E*TRADE Financial Corporation, Investment Partners (A), LLC and the additional investors party thereto.
     
10.3
 
ABS Purchase Agreement, dated as of November 29, 2007, by and among E*TRADE Financial Corporation, E*TRADE Bank, E*TRADE Global Asset Management, Inc. and Citadel Equity Fund Ltd.
     
99.1
 
Press Release, dated November 29, 2007
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
E*TRADE FINANCIAL CORPORATION
 
       
       
 
By:
/s/ Arlen W. Gelbard  
    Name:
Arlen W. Gelbard
 
    Title:
Chief Administrative Officer
and General Counsel
 

 
Dated: December 4, 2007
 

 
Exhibit Index
 
Exhibit No.
 
Description
4.1 
 
Registration Rights Agreement, dated as of November 29, 2007, by and between Wingate Capital Ltd. and E*TRADE Financial Corporation.
     
4.2 
 
Indenture, dated November 29, 2007 between E*TRADE Financial Corporation as Issuer and The Bank of New York, as Trustee (includes form of note).
     
4.3 
 
First Amendment to Rights Agreement, dated November 29, 2007, by and between E*TRADE Financial Corporation and American Stock Transfer & Trust Company, as rights agent.
     
10.1
 
Master Investment and Securities Purchase Agreement, dated as of November 29, 2007, by and between E*TRADE Financial Corporation and Wingate Capital Ltd.
     
10.2
 
Securities Purchase Agreement, dated November 29, 2007 among E*TRADE Financial Corporation, Investment Partners (A), LLC and the additional investors party thereto.
     
10.3
 
ABS Purchase Agreement, dated as of November 29, 2007, by and among E*TRADE Financial Corporation, E*TRADE Bank, E*TRADE Global Asset Management, Inc. and Citadel Equity Fund Ltd.
     
99.1
 
Press Release, dated November 29, 2007
 
 
 

EX-4.1 2 dp07754_ex0401.htm

Exhibit 4.1
 
EXECUTION VERSION
 
 

 

 
REGISTRATION RIGHTS AGREEMENT
 
By and Between
 
WINGATE CAPITAL LTD.
 
and
 
E*TRADE FINANCIAL CORPORATION
 



 
 
Table of Contents
   
Page
ARTICLE I
DEFINITIONS
1
Section 1.1.
Certain Defined Terms
1
Section 1.2.
Terms Generally
4
     
ARTICLE II
REGISTRATION RIGHTS
5
Section 2.1.
Shelf Registration
5
Section 2.2.
Demand Registrations
6
Section 2.3.
Piggyback Registrations
8
Section 2.4.
Lock-Up Agreements; Restrictions on the Company
9
Section 2.5.
Registration Procedures
9
Section 2.6.
Indemnification.
15
Section 2.7.
Rule 144; Rule 144A
17
Section 2.8.
Underwritten Registrations
18
Section 2.9.
Registration Expenses
18
Section 2.10.
Other Agreements
19
Section 2.11.
Securities Held by the Company or its Subsidiaries
19
     
ARTICLE III
MISCELLANEOUS
19
Section 3.1.
Conflicting Agreements
19
Section 3.2.
Termination
19
Section 3.3.
Amendment and Waiver
19
Section 3.4.
Severability
19
Section 3.5.
Entire Agreement
19
Section 3.6.
Successors and Assigns
20
Section 3.7.
Counterparts; Execution by Facsimile Signature
20
Section 3.8.
Remedies
20
Section 3.9.
Notices
20
Section 3.10.
Governing Law; Consent to Jurisdiction
21
 


REGISTRATION RIGHTS AGREEMENT
 
REGISTRATION RIGHTS AGREEMENT dated as of November 29, 2007, by and between Wingate Capital Ltd. (“Purchaser”) and E*TRADE Financial Corporation, a Delaware corporation (the “Company”).
 
WHEREAS, the Company and Purchaser have entered into a Master Investment and Securities Purchase Agreement, dated as of November 29, 2007 (as amended, supplemented, restated or otherwise modified from time to time, the “Investment Agreement”), pursuant to and subject to the terms and conditions of which, among other things, the Company has agreed to issue the Purchased Common Stock (as such term is defined in the Investment Agreement) and the Springing Lien Notes (as such term is defined in the Investment Agreement) (the Notes); and
 
WHEREAS, pursuant to the Investment Agreement, the Company has agreed to provide to Purchaser certain rights as set forth herein.
 
NOW, THEREFORE, in consideration of the premises and of the mutual covenants and obligations hereinafter set forth, the parties hereto hereby agree as follows:
 
ARTICLE I
 
DEFINITIONS
 
Section 1.1.     Certain Defined Terms.  As used herein, the following terms shall have the following meanings:
 
Action” means any legal, administrative, regulatory or other suit, action, claim, audit, assessment, arbitration or other proceeding, investigation or inquiry.
 
Affiliate” shall mean, with respect to any Person, any other Person which directly or indirectly controls or is controlled by or is under common control with such Person. As used in this definition, “control”(including its correlative meanings, “controlled by” and “under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise). To the extent that any such term is used in relation to or in connection with any statute and the definition of such term in such statute is broader or different, then, in such context, such term shall have the meaning set forth in such statute.
 
Agreement” means this Registration Rights Agreement as it may be amended, supplemented, restated or modified from time to time.
 
Beneficial Ownership” by a Person of any securities includes ownership by any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares (i) voting power which includes the power to vote, or to direct the voting of, such security; and/or (ii) investment power which includes the power to dispose, or to direct the disposition, of such security; and shall otherwise be interpreted in accordance with the term
 

 
“beneficial ownership” as defined in Rule 13d-3 adopted by the SEC under the Exchange Act; provided , that for purposes of determining Beneficial Ownership, in no event will Purchaser be deemed to Beneficially Own any securities which it has the right to acquire pursuant to this Agreement unless, and then only to the extent that, Purchaser shall have actually exercised such right. The term “Beneficially Own” shall have a correlative meaning.
 
Business Day” means any day, other than a Saturday, Sunday or a day on which banking institutions in New York, New York are authorized or obligated to close.
 
Capital Stock” means, with respect to any Person at any time, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) of capital stock, partnership interests (whether general or limited) or equivalent ownership interests in or issued by such Person.
 
Common Stockshall mean the shares of common stock, par value $0.01 per share, of the Company.
 
Covered Securities” means any shares of Purchased Common Stock and any Notes.
 
Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the SEC from time to time thereunder.
 
Form S-3 means such form under the Securities Act as is in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.
 
Governmental Entity” shall mean any court, administrative agency or commission or other governmental authority or instrumentality, whether federal, state, local or foreign and any applicable industry self-regulatory organization.
 
Holders” means Purchaser and any Transferee of Registrable Securities.
 
Holders’ Representative” means Purchaser or any other Holder designated by Purchaser as a Holders’ Representative.
 
Indenture means the Indenture, dated as of November 29, 2007, between the Company and The Bank of New York, as trustee (the “Trustee”), pursuant to which the Notes are to be issued, as such Indenture is amended, modified or supplemented from time to time in accordance with the terms thereof.
 
Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of the Registrable Securities.
 
Law” means any statute, law, code, ordinance, rule or regulation of any Governmental Entity.
 

 
Other Securities” means shares of Capital Stock of the Company which are contractually entitled to registration rights or which the Company is registering pursuant to a registration statement covered by Section 2.3.
 
Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint stock company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any group (within the meaning of Section 13(d)(3) of the Exchange Act) comprised of two or more of the foregoing.
 
Prospectus” means the prospectus included in any Registration Statement (including a prospectus that discloses information previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement, any Issuer Free Writing Prospectus related thereto, and all other amendments and supplements to such prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such prospectus.
 
Registrable Securities” means the Covered Securities and any securities which may be issued or distributed in respect thereof by way of stock dividend or stock split or other distribution, recapitalization or reclassification. As to any particular Registrable Securities, such Registrable Securities shall cease to be Registrable Securities when (i) a registration statement with respect to the sale by the Holder thereof shall have been declared effective under the Securities Act and such securities shall have been disposed of in accordance with such registration statement, (ii) they shall have been distributed to the public in accordance with Rule 144 or they could be sold pursuant to Rule 144(k) without volume limitation or other restrictions on transfer thereunder or (iii) they shall have ceased to be outstanding.
 
Registration Statement” means any registration statement of the Company under the Securities Act which permits the public offering of any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such registration statement, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.
 
Rule 144” means Rule 144 under the Securities Act.
 
SEC” means the United States Securities and Exchange Commission.
 
Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated by the SEC from time to time thereunder.
 
Selling Holder” means each Holder of Registrable Securities included in a registration pursuant to Article II.
 
Shelf Registration Statement” means a Registration Statement of the Company filed with the SEC on either (a) Form S-3 (or any successor form or other appropriate form under the Securities Act) or (b) if the Company is not permitted to file a Registration Statement on Form S-
 

 
3, an evergreen Registration Statement on Form S-1 (or any successor form or other appropriate form under the Securities Act), in each case for an offering to be made on a continuous or delayed basis pursuant to Rule 415 under the Securities Act covering Registrable Securities. To the extent the Company is a well-known seasoned issuer (as defined in Rule 405 under the Securities Act), a “Shelf Registration Statement” shall be deemed to refer to an automatic shelf registration statement (as defined in Rule 405 under the Securities Act) (an “automatic shelf registration statement”) on Form S-3.
 
Subsidiary” shall mean, with respect to any Person, any other Person of which 50% or more of the shares of the voting securities or other voting interests are owned or controlled, or the ability to select or elect 50% or more of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries, or by such first Person and one or more of its Subsidiaries.
 
TIA means the Trust Indenture Act of 1939, as in effect on the date the Indenture is qualified under that act.
 
Transfer” means, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition.
 
Transferee” means any of (i) the transferee of all or any portion of the Registrable Securities held by Purchaser or (ii) the subsequent transferee of all or any portion of the Registrable Securities held by any Transferee; provided, that no Transferee shall be entitled to any benefits of a Transferee hereunder unless such Transferee executes and delivers to the Company an instrument substantially in the form provided as Exhibit A attached hereto.
 
Section 1.2.  Terms Generally.  The definitions in Section 1.1 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”, unless the context expressly provides otherwise. All references herein to Sections, paragraphs, subparagraphs, clauses, Exhibits or Schedules shall be deemed references to Sections, paragraphs, subparagraphs or clauses of, or Exhibits or Schedules to this Agreement, unless the context requires otherwise. Unless otherwise expressly defined, terms defined in this Agreement have the same meanings when used in any Exhibit or Schedule hereto. Unless otherwise specified, the words “this Agreement”, “herein”, “hereof”, “hereto” and “hereunder” and other words of similar import refer to this Agreement as a whole (including the Schedules and Exhibits) and not to any particular provision of this Agreement. The term “or” is not exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”. Unless expressly stated otherwise, any Law defined or referred to herein means such Law as from time to time amended, modified or supplemented, including by succession of comparable successor Laws and references to all attachments thereto and instruments incorporated therein. References to a Person are also to its permitted successors and assigns. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the
 

 
meaning or interpretation of this Agreement.
 
ARTICLE II
 
REGISTRATION RIGHTS
 
Section 2.1.            Shelf Registration.  Within 10 days following the filing by the Company with the SEC of its Annual Report on Form 10-K for calendar year 2007, the Company shall file with the SEC a Shelf Registration Statement relating to the offer and sale of all of the Registrable Securities by the Holders from time to time in accordance with the methods of distribution elected by such Holders and set forth in the Shelf Registration Statement and shall use its reasonable best efforts to cause such Shelf Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof.
 
(a)           The Company shall use its reasonable best efforts to keep such Shelf Registration Statement continuously effective under the Securities Act in order to permit the Prospectus forming a part thereof to be usable by Holders until the earlier of (i) the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but in no event prior to the applicable period referred to in Section 4(3) of the Securities Act and Rule 174 thereunder) and (ii) the date as of which each of the Holders is permitted to sell its Registrable Securities without Registration pursuant to Rule 144(k) under the Securities Act without volume limitation or other restrictions on transfer thereunder (such period of effectiveness, the “Shelf Period”). Subject to Section 2.1(c), the Company shall not be deemed to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily takes any action or omits to take any action that would result in Holders of Registrable Securities covered thereby not being able to offer and sell any Registrable Securities pursuant to such Shelf Registration Statement during the Shelf Period, unless such action or omission is required by applicable Law. The Company shall use its commercially reasonable best efforts to remain a well-known seasoned issuer (as defined in Rule 405 under the Securities Act) and to not become an ineligible issuer (as defined in Rule 405 under the Securities Act) during the Shelf Period.
 
(b)           The Company shall be entitled to postpone (but not more than once in any 6-month period), for a reasonable period of time not in excess of 60 days, the filing or initial effectiveness of, or suspend the use of, a Shelf Registration Statement if the Company delivers to the Holders’ Representative a certificate signed by both the Chief Executive Officer and Chief Financial Officer of the Company certifying that, in the good faith judgment of the Board of Directors of the Company, such registration, offering or use would reasonably be expected to materially adversely affect or materially interfere with any bona fide material financing of the Company or any material transaction under consideration by the Company or would require the disclosure of information that has not been, and is not otherwise required to be, disclosed to the public, the premature disclosure of which would materially adversely affect the Company. Such certificate shall contain, if requested by the Holders’ Representative (and subject to their entering into a customary confidentiality obligation as to such information), a reasonably detailed statement of the reasons for such postponement or suspension and an approximation of the anticipated delay.
 

 
(c)           If any of the Registrable Securities to be sold pursuant to a Shelf Registration Statement are to be sold in a firm commitment underwritten offering, and the managing underwriter(s) of such underwritten offering advise the Holders in writing that it is their good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering, together with any Other Securities proposed to be included by holders thereof which are entitled to include securities in such Registration Statement, exceeds the total number or dollar amount of such securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all such Other Securities, then there shall be included in such firm commitment underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows:
 
(i)           first, the Registrable Securities for which inclusion in such underwritten offering requested by the Holders, pro rata (if applicable), based on the number of Registrable Securities Beneficially Owned by each such Holder; and
 
(ii)           second, among any holders of Other Securities, pro rata, based on the number of Other Securities Beneficially Owned by each such holder of Other Securities.
 
(d)           The Holders’ Representative shall have the right to notify the Company that it has determined that the Shelf Registration Statement be abandoned or withdrawn, in which event the Company shall promptly abandon or withdraw such Shelf Registration Statementand the Holders’ Representative shall promptly reimburse the Company for all Registration Expenses incurred by the Company in connection with such abandoned or withdrawn registration statement.
 
Section 2.2.             Demand Registrations.  (a) If, following the six (6) month anniversary of the date hereof, the Company is unable to file, cause to be effective or maintain the effectiveness of a Shelf Registration Statement as required under Section 2.1, the Holders’ Representative shall have the right by delivering a written notice to the Company (a “Demand Notice”) to require the Company to, pursuant to the terms of this Agreement, register under and in accordance with the provisions of the Securities Act the number of Registrable Securities Beneficially Owned by any Holders and requested by such Demand Notice to be so registered (a “Demand Registration”); provided, however, that a Demand Notice may only be made if the sale of the Registrable Securities requested to be registered in a Demand Notice is reasonably expected to result in aggregate gross cash proceeds in excess of $50,000,000 (without regard to any underwriting discount or commission). A Demand Notice shall also specify the expected method or methods of disposition of the applicable Registrable Securities. Following receipt of a Demand Notice, the Company shall use its reasonable best efforts to file, as promptly as reasonably practicable, but not later than 60days after receipt by the Company of such Demand Notice (subject to paragraph (e) of this Section 2.2), a Registration Statement relating to the offer and sale of the Registrable Securities requested to be included therein by the Holders thereof in accordance with the methods of distribution elected by such Holders (a “Demand Registration Statement”) and shall use its reasonable best efforts to cause such Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof.
 

 
(b)           If any of the Registrable Securities to be registered pursuant to a Demand Registration are to be sold in a firm commitment underwritten offering, and the managing underwriter(s) of such underwritten offering advise the Holders in writing that it is their good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering, together with any Other Securities proposed to be included by holders thereof which are entitled to include securities in such Registration Statement, exceeds the total number or dollar amount of such securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all such Other Securities, then there shall be included in such firm commitment underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows:
 
(i)           first, among the Holders of the Registrable Securities set forth in the Demand Notice, pro rata (if applicable), based on the number of Registrable Securities Beneficially Owned by each such Holder;
 
(ii)           second, among the Holders of Registrable Securities exercising piggyback registration rights under Section 2.3 with respect to such Demand Registration; and
 
(iii)           third, among any holders of Other Securities, pro rata, based on the number of Other Securities Beneficially Owned by each such holder of Other Securities.
 
(c)           In the event of a Demand Registration, the Company shall be required to maintain the continuous effectiveness of the applicable Registration Statement for a period of at least 180 days after the effective date thereof or such shorter period in which all Registrable Securities included in such Registration Statement have actually been sold.
 
(d)           The Company shall be obligated to effect only two (2) Demand Registrations pursuant to this Section 2.2; provided, however, in case the Company shall receive from the Holders’ Representative a Demand Notice requesting that the Company effect a registration on Form S-3 (provided that the Company is eligible to effect such registration on Form S-3 at such time), the Company shall be obligated to effect any such Demand Registration without regard to the number of Demand Registrations made.
 
(e)           The Company shall be entitled to postpone (but not more than once in any 6-month period), for a reasonable period of time not in excess of 60 days, the filing or initial effectiveness of, or suspend the use of, a Demand Registration Statement if the Company delivers to the Holders’ Representative a certificate signed by both the Chief Executive Officer and Chief Financial Officer of the Company certifying that, in the good faith judgment of the Board of Directors of the Company, such registration, offering or use would reasonably be expected to materially adversely affect or materially interfere with any bona fide material financing of the Company or any material transaction under consideration by the Company or would require the disclosure of information that has not been, and is not otherwise required to be, disclosed to the public, the premature disclosure of which would materially adversely affect the Company.  Such certificate shall contain, if requested by the Holders’ Representative (and
 

 
subject to their entering into a customary confidentiality obligation as to such information), a statement of the reasons for such postponement or suspension and an approximation of the anticipated delay.
 
(f)           The Holders’ Representative shall have the right to notify the Company that it has determined that the Registration Statement relating to a Demand Registration be abandoned or withdrawn, in which event the Company shall promptly abandon or withdraw such Registration Statementand the Holders’ Representative shall promptly reimburse the Company for all Registration Expenses incurred by the Company in connection with such abandoned or withdrawn registration statement.
 
Section 2.3.            Piggyback Registrations.  (a) If, other than pursuant to Section 2.1, the Company proposes or is required to file a registration statement under the Securities Act with respect to an offering of Common Stock, any other of its equity securities or securities convertible into or exchangeable or exercisable for any of its equity securities, whether or not for sale for its own account (other than a registration statement (i) on Form S-4, Form S-8 or any successor forms thereto or (ii) filed solely in connection with any employee benefit or dividend reinvestment plan), then the Company shall give prompt written notice of such proposed filing at least 30 days before the anticipated filing date (the “Piggyback Notice”) to the Holders. The Piggyback Notice shall offer the Holders the opportunity to include in such registration statement the number of Registrable Securities (for purposes of this Section 2.3, “Registrable Securities” shall be deemed to mean solely securities of the same type as those proposed to be offered by the Company for its own account) as they may request (a “PiggybackRegistration”). Subject to Section 2.3(b) hereof, the Company shall include in each such Piggyback Registration all Registrable Securities with respect to which the Company has received written requests for inclusion therein within 15 days after notice has been given to the Holders. The Holders shall be permitted to withdraw all or part of the Registrable Securities from a Piggyback Registration at any time at least 2 Business Days prior to the effective date of the Registration Statement relating to such Piggyback Registration. The Company shall be required to maintain the effectiveness of the Registration Statement for a Piggyback Registration for a period of 180 days after the effective date thereof or such shorter period in which all Registrable Securities included in such Registration Statement have actually been sold.  If the Company shall determine for any reason not to proceed with the registration that is the subject of the Piggyback Notice, the Company shall give notice to the Holders and thereupon shall be relieved of its obligation to register any Registrable Securities in connection with the Piggyback Registration relating to such registration, but shall not be relieved of its obligation for Registration Expenses with respect to such registration.
 
(b)           If any of the securities to be registered pursuant to the registration giving rise to the Holders’ rights under this Section 2.3 are to be sold in an underwritten offering, the Holders shall be permitted to include all Registrable Securities requested to be included in such registration in such offering on the same terms and conditions as any other shares of Capital Stock, if any, of the Company included therein; provided, however, that if such offering involves a firm commitment underwritten offering and the managing underwriter(s) of such underwritten offering advise the Company in writing that it is their good faith opinion that the total amount of Registrable Securities requested to be so included, together with all Other Securities that the Company and any other Persons having rights to participate in such registration intend to include
 

 
in such offering, exceeds the total number or dollar amount of such securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all Other Securities, then there shall be included in such firm commitment underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows:
 
(i)           first, all Other Securities being sold by the Company;
 
(ii)           second, all Registrable Securities requested to be included by the Holders, pro rata (if applicable), based on the number of Registrable Securities Beneficially Owned by each such Holder; and
 
(iii)           third, among any other holders of Other Securities requesting such registration, pro rata, based on the number of Other Securities Beneficially Owned by each such holder of Other Securities.
 
Section 2.4.            Lock-Up Agreements; Restrictions on the Company. ( a) Each Holder agrees, in connection with any underwritten offering made pursuant to a Registration Statement filed pursuant to this Article II in which such Holder has elected to include Registrable Securities, or which underwritten offering is being effected by the Company for its own account, if requested (pursuant to a written notice) by the managing underwriter(s) not to effect any public sale or distribution of any common equity securities of the Company (or securities convertible into or exchangeable or exercisable for such common equity securities) (except as part of such underwritten offering) during the period commencing 7 days prior to and continuing for not more than 90 days (or such shorter period as the managing underwriter(s) may permit) after the date of the Prospectus (or Prospectus supplement if the offering is made pursuant to a “shelf” registration) pursuant to which such underwritten offering shall be made; provided, that the Holders shall only be so bound so long as and to the extent that any other stockholder having registration rights with respect to the securities of the Company is similarly bound.
 
(b)           In connection with any underwritten offering made pursuant to a Registration Statement filed pursuant to this Article II, the Company will not effect any public sale or distribution of any common equity securities of the Company (or securities convertible into or exchangeable or exercisable for such common equity securities) for its own account (other than (x) a registration statement (i) on Form S-4, Form S-8 or any successor forms thereto or (ii) filed solely in connection with an exchange offer or any employee benefit or dividend reinvestment plan or (y) pursuant to such underwritten offering), during the period commencing 7 days prior to and continuing for not more than 90 days (or such shorter period as the managing underwriter(s) may permit) after the date of the Prospectus (or Prospectus supplement if the offering is made pursuant to a “shelf” registration) pursuant to which such underwritten offering shall be made.
 
Section 2.5.            Registration Procedures.  If and whenever the Company is required to use its reasonable best efforts to effect the registration of any Registrable Securities under the Securities Act as provided in Article II, the Company shall effect such registration to permit the
 

 
sale of such Registrable Securities in accordance with the intended method or methods of disposition thereof, and pursuant thereto the Company shall cooperate in the sale of the securities and shall, as expeditiously as possible:
 
(a)           Prepare and file with the SEC a Registration Statement or Registration Statements on such form which shall be available for the sale of the Registrable Securities by the Holders or the Company in accordance with the intended method or methods of distribution thereof, and use its reasonable best efforts to cause such Registration Statement to become effective and to remain effective as provided herein; provided, however, that before filing a Registration Statement or Prospectus (including any Issuer Free Writing Prospectus related thereto) or any amendments or supplements thereto (including documents that would be incorporated or deemed to be incorporated therein by reference), the Company shall furnish or otherwise make available to the Selling Holders, their counsel and the managing underwriter(s), if any, copies of all such documents proposed to be filed, which documents will be subject to the reasonable review and comment of such counsel, and such other documents reasonably requested by such counsel, including any comment letter from the SEC, and, if requested by such counsel, provide such counsel reasonable opportunity to participate in the preparation of such Registration Statement and each Prospectus included therein (including any Issuer Free Writing Prospectus related thereto) and such other opportunities to conduct a reasonable investigation within the meaning of the Securities Act, including reasonable access to the Company’s books and records, officers, accountants and other advisors. The Company shall not file any such Registration Statement or Prospectus (including any Issuer Free Writing Prospectus related thereto) or any amendments or supplements thereto (including such documents that, upon filing, would be incorporated or deemed to be incorporated by reference therein) with respect to any registration pursuant to Section 2.1 or 2.2 to which the Holders’ Representative, its counsel, or the managing underwriter(s), if any, shall reasonably object, in writing, on a timely basis, unless, in the opinion of the Company, such filing is necessary to comply with applicable Law.
 
(b)           Prepare and file with the SEC such amendments and post-effective amendments to each Registration Statement as may be necessary to keep such Registration Statement continuously effective during the period provided herein and comply in all material respects with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement, and cause the related Prospectus to be supplemented by any Prospectus supplement or Issuer Free Writing Prospectus as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of the securities coveredby such Registration Statement, and as so supplemented to be filed pursuant to Rule 424 (or any similar provisions then in force) under the Securities Act.
 
(c)           Notify each Selling Holder and the managing underwriter(s), if any, promptly, and (if requested by any such Person) confirm such notice in writing, (i) when a Prospectus or any Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment has been filed, and, with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the SEC or any other Governmental Entity for amendments or supplements to a Registration Statement or related Prospectus or Issuer Free Writing Prospectus or for additional information, (iii) of the issuance by the SEC of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iv) if at any time the representations and
 

 
warranties of the Company contained in any agreement (including any underwriting agreement contemplated by Section 2.5(p) below) cease to be true and correct, (v) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose, and (vi) of the happening of any event that makes any statement made in such Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference or any Issuer Free Writing Prospectus related thereto untrue in any material respect or that requires the making of any changes in such Registration Statement, Prospectus, documents or Issuer Free Writing Prospectus so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, not misleading, and that in the case of any Prospectus or Issuer Free Writing Prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
(d)           Use its reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement, or the lifting of any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction at the reasonably earliest practical date.
 
(e)           If requested by the managing underwriter(s), if any, or the Holders of a majority of the Registrable Securities being sold in connection with an underwritten offering, promptly include in a Prospectus supplement, post-effective amendment or Issuer Free Writing Prospectus such information as the managing underwriter(s), if any, or such Holders may reasonably request in order to permit the intended method of distribution of such securities and make all required filings of such Prospectus supplement, such post-effective amendment or Issuer Free Writing Prospectus as soon as practicable after the Company has received such request.
 
(f)           Furnish or make available to each Selling Holder, and each managing underwriter, if any, without charge, such number of conformed copies of the Registration Statement and each post-effective amendment thereto, including financial statements (but excluding schedules, all documents incorporated or deemed to be incorporated therein by reference, and all exhibits, unless requested in writing by such Holder, counsel or managing underwriter(s)), and such other documents, as such Holders or such managing underwriter(s) may reasonably request, and upon request a copy of any and all transmittal letters or other correspondence to or received from, the SEC or any other Governmental Entity relating to such offering.
 
(g)           Deliver to each Selling Holder, and the managing underwriter(s), if any, without charge, as many copies of the Prospectus or Prospectuses (including each form of Prospectus and any Issuer Free Writing Prospectus related to any such Prospectuses) and each amendment or supplement thereto as such Persons may reasonably request in connection with the distribution of the Registrable Securities; and the Company, subject to the last paragraph of this Section 2.5, hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the Selling Holders and the managing underwriter(s), if any, in
 

 
connection with the offering and sale of the Registrable Securities covered by such Prospectus and any such amendment or supplement thereto.
 
(h)           Prior to any public offering of Registrable Securities, use its reasonable best efforts to register or qualify or cooperate with the Selling Holders, the managing underwriter(s), if any, and their respective counsel in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities or “Blue Sky” laws of such jurisdictions within the United States as any seller or managing underwriter(s) reasonably requests in writing and to keep each such registration or qualification (or exemption therefrom) effective during the period such Registration Statement is required to be kept effective and to take any other action that may be necessary or advisable to enable such Selling Holders to consummate the disposition of such Registrable Securities in such jurisdiction; provided, however, that the Company will not be required to (i) qualify generally to do business in any jurisdiction where it is not then so qualified or (ii) take any action that would subject it to general service of process in any such jurisdiction where it is not then so subject.
 
(i)           Cooperate with the Selling Holders and the managing underwriter(s), if any, to facilitate the timely preparation and delivery of certificates (not bearing any legends) representing Registrable Securities to be sold after receiving written representations from each Selling Holder that the Registrable Securities represented by the certificates so delivered by such Selling Holder will be transferred in accordance with the Registration Statement, and enable such Registrable Securities to be in such denominations and registered in such names as the managing underwriter(s), if any, or the Selling Holders may request at least 2 Business Days prior to any sale of Registrable Securities.
 
(j)           Use its reasonable best efforts to cause the Registrable Securities covered by the Registration Statement to be registered with or approved by such other Governmental Entities within the United States, except as may be required solely as a consequence of the nature of such Selling Holder’s business, in which case the Company will cooperate in all reasonable respects with the filing of such Registration Statement and the granting of such approvals, as may be necessary to enable the seller or sellers thereof or the managing underwriter(s), if any, to consummate the disposition of such Registrable Securities.
 
(k)           Upon the occurrence of any event contemplated by Section 2.5(c)(ii), (c)(iii), (c)(iv), (c)(v) or (c)(vi) above, prepare a supplement or post-effective amendment to the Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference or an Issuer Free Writing Prospectus related thereto, or file any other required document so that, as thereafter delivered to the Selling Holders, such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
 
(l)           Prior to the effective date of the Registration Statement relating to the Registrable Securities, provide a CUSIP number for the Registrable Securities and, if such Registrable Securities are Notes, provide the Trustee under the Indenture with certificates for the Notes that are in a form eligible for deposit with The Depository Trust Company.
 

 
(m)          Provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement from and after a date not later than the effective date of such Registration Statement.
 
(n)           If the applicable Registrable Securities are Notes, cause the Indenture to be qualified under the TIA not later than the effective date of the Registration Statement relating to the Registrable Securities, and, in connection therewith, reasonably cooperate with the Trustee and the Selling Holders to effect such changes to the Indenture as may be required for such Indenture to be so qualified in accordance with the terms of the TIA; and execute and use its reasonable best efforts to cause the Trustee thereunder to execute all documents that may be required to effect such changes and all other forms and documents required to be filed with the SEC to enable such Indenture to be so qualified in a timely manner.  In the event that such qualification would require the appointment of a new trustee under the Indenture, the Company shall appoint a new trustee thereunder pursuant to the applicable provisions of the Indenture.
 
(o)           Use its reasonable best efforts to cause all shares of Purchased Common Stock covered by such Registration Statement to be authorized to be listed on each national securities exchange, if any, on which similar securities issued by the Company are then listed.
 
(p)           Enter into such agreements (including an underwriting agreement in form, scope and substance as is customary in underwritten offerings) and take all such other actions reasonably requested by the Holders of a majority of the Registrable Securities being sold in connection therewith or by the managing underwriter(s), if any, to expedite or facilitate the disposition of such Registrable Securities, and in connection therewith, whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration, (i) make such representations and warranties to the Selling Holders and the managing underwriter(s), if any, with respect to the business of the Company and its subsidiaries, and the Registration Statement, Prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made by issuers in underwritten offerings, and, if true, confirm the same if and when requested, (ii) use its reasonable best efforts to furnish to the Selling Holders of such Registrable Securities opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriter(s), if any, and counsels to the Selling Holders of the Registrable Securities), addressed to each Selling Holder of Registrable Securities and each of the managing underwriter(s), if any, covering the matters customarily covered in opinions requested in underwritten offerings and such other matters as may be reasonably requested by such counsel and managing underwriter(s), (iii) use its reasonable best efforts to obtain “cold comfort” letters and updates thereof from the independent certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any Subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) who have certified the financial statements included in such Registration Statement, addressed to each Selling Holder of Registrable Securities (unless such accountants shall be prohibited from so addressing such letters by applicable standards of the accounting profession) and each of the managing underwriter(s), if any, such letters to be in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with underwritten offerings, (iv) if an underwriting agreement is
 

 
entered into, the same shall contain indemnification provisions and procedures substantially to the effect set forth in Section 2.6 hereof with respect to all parties to be indemnified pursuant to said Section except as otherwise agreed by the Holders of a majority of the Registrable Securities being sold in connection therewith and the managing underwriter(s) and (v) deliver such documents and certificates as may be reasonably requested by the Holders of a majority of the Registrable Securities being sold in connection therewith, their counsel and the managing underwriter(s), if any, to evidence the continued validity of the representations and warranties made pursuant to clause (i) above and to evidence compliance with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company. The above shall be done at each closing under such underwriting or similar agreement, or as and to the extent required thereunder.
 
(q)           Upon execution of a customary confidentiality agreement, make available for inspection by a representative of the Selling Holders, the managing underwriter(s), if any, and any attorneys or accountants retained by such Selling Holders or managing underwriter(s), at the offices where normally kept, during reasonable business hours, financial and other records, pertinent corporate documents and properties of the Company and its Subsidiaries, and cause the officers, directors and employees of the Company and its Subsidiaries to supply all information in each case reasonably requested by any such representative, managing underwriter(s), attorney or accountant in connection with such Registration Statement.
 
(r)           Cause its officers to use their reasonable best efforts to support the marketing of the Registrable Securities covered by the Registration Statement (including, without limitation, by participation in “road shows”) taking into account the Company’s business needs.
 
(s)           Otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC and any applicable national securities exchange, and make available to its security holders, as soon as reasonably practicable (but not more than 18 months) after the effective date of the registration statement, an earnings statement which shall satisfy the provisions of Section 11(a) of the Securities Act.
 
The Company may require each Selling Holder to furnish to the Company in writing such information required in connection with such registration regarding such Selling Holder and the distribution of such Registrable Securities as the Company may, from time to time, reasonably request in writing and the Company may exclude from such registration the Registrable Securities of any Selling Holder who unreasonably fails to furnish such information within a reasonable time after receiving such request.
 
Each Selling Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 2.5(c)(ii), (c)(iii), (c)(iv), (c)(v) or (c)(vi) hereof, such Holder will forthwith discontinue disposition of such Registrable Securities covered by such Registration Statement or Prospectus until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 2.5(k) hereof, or until it is advised in writing by the Company that the use of the applicable Prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus; provided, however, that the Company shall
 

 
extend the time periods under Section 2.2 and Section 2.3 with respect to the length of time that the effectiveness of a Registration Statement must be maintained by the amount of time the Holder is required to discontinue disposition of such securities.
 
Section 2.6.            Indemnification.
 
(a)           Indemnification by the Company.  The Company shall indemnify and hold harmless, to the fullest extent permitted by Law, each Selling Holder whose Registrable Securities are covered by a Registration Statement or Prospectus, the officers, directors, partners (limited and general), members, managers, shareholders, accountants, attorneys, agents and employees of each of them, each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) each such Selling Holder and the officers, directors, partners (limited and general), members, managers, shareholders, accountants, attorneys, agents and employees of each such controlling person, each underwriter (including any Holder that is deemed to be an underwriter pursuant to any SEC comments or policies), if any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Holder Indemnitees”), from and against any and all losses, claims, damages, liabilities, expenses (including, without limitation, costs of preparation and reasonable attorneys’ fees and any other reasonable fees or expenses incurred by such party in connection with any investigation or Action), judgments, fines, penalties, charges and amounts paid in settlement (collectively, “Losses”), as incurred, arising out of or based upon any untrue statement (or alleged untrue statement) of a material fact contained in any applicable Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto) or any other offering circular, amendment of or supplement to any of the foregoing or other document incident to any such registration, qualification, or compliance, or based on any omission (or alleged omission) to state therein (in the case of a final or preliminary Prospectus, in light of the circumstances under which they were made) a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by the Company of the Securities Act or of the Exchange Act in connection with any such registration, qualification, or compliance; provided, that the Company will not be liable to a Selling Holder or underwriter in any such case to the extent that any such Loss arises out of or is based on any untrue statement or omission by such Selling Holder or underwriter, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto), offering circular, amendment of or supplement to any of the foregoing or other document in reliance upon and in conformity with written information furnished to the Company by such Selling Holder or underwriter specifically for inclusion in such document. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of any Holder Indemnitee or any other Holder and shall survive the transfer of such securities. The foregoing indemnity agreement is in addition to any liability that the Company may otherwise have to each Holder Indemnitee.
 
(b)           Indemnification by Selling Holders.  In connection with any Registration Statement in which a Selling Holder is participating by registering Registrable Securities, such Selling Holder shall furnish to the Company in writing such information as the Company
 

 
reasonably requests specifically for use in connection with any Registration Statement or Prospectus and agrees to indemnify and hold harmless, to the fullest extent permitted by Law, severally and not jointly, the Company, the officers and directors of the Company, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Company, and each underwriter, if any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Company Indemnitees”), from and against all Losses, as incurred, arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto) or any other offering circular or any amendment of or supplement to any of the foregoing or any other document incident to such registration, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a final or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case solely to the extent that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto), offering circular, or any amendment of or supplement to any of the foregoing or other document in reliance upon and in conformity with written information furnished to the Company by such Selling Holder expressly for inclusion in such document; and provided, however, that the liability of each Selling Holder hereunder shall be limited to the net proceeds received by such Selling Holder from the sale of Registrable Securities covered by such Registration Statement.
 
(c)           Conduct of Indemnification Proceedings.  If any Person shall be entitled to indemnity hereunder (an “indemnified party”), such indemnified party shall give prompt notice to the party from which such indemnity is sought (the “indemnifying party”) of any claim or of the commencement of any Action with respect to which such indemnified party seeks indemnification or contribution pursuant hereto; provided, however, that the delay or failure to so notify the indemnifying party shall not relieve the indemnifying party from any obligation or liability except to the extent that the indemnifying party has been actually prejudiced by such delay or failure. The indemnifying party shall have the right, exercisable by giving written notice to an indemnified party promptly after the receipt of written notice from such indemnified party of such claim or Action, to assume, at the indemnifying party’s expense, the defense of any such Action, with counsel reasonably satisfactory to such indemnified party; provided, however, that an indemnified party shall have the right to employ separate counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless: (i) the indemnifying party agrees to pay such fees and expenses; (ii) the indemnifying party fails promptly to assume, or in the event of a conflict of interest cannot assume, the defense of such Action or fails to employ counsel reasonably satisfactory to such indemnified party, in which case the indemnified party shall also have the right to employ counsel and to assume the defense of such Action; or (iii) in the indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist in respect of such Action; provided, further, however, that the indemnifying party shall not, in connection with any one such Action or separate but substantially similar or related Actions in the same jurisdiction, arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one firm of attorneys (together
 

 
with appropriate local counsel) at any time for all of the indemnified parties, or for fees and expenses that are not reasonable. Whether or not such defense is assumed by the indemnifying party, such indemnified party will not be subject to any liability for any settlement made without its consent (but such consent will not be unreasonably withheld or delayed). The indemnifying party shall not consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by all claimants or plaintiffs to such indemnified party of a release, in form and substance reasonably satisfactory to the indemnified party, from all liability in respect of such claim or litigation.
 
(d)           Contribution.  (i) If the indemnification provided for in this Section 2.6 is unavailable to an indemnified party in respect of any Losses (other than in accordance with its terms), then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and such indemnified party, on the other hand, in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such indemnifying party, on the one hand, and indemnified party, on the other hand, shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been taken by, or relates to information supplied by, such indemnifying party or indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent any such action, statement or omission.
 
(ii) The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 2.6(d) were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding anything to the contrary contained in this Section 2.6(d), an indemnifying party that is a Selling Holder shall not be required to contribute any amount in excess of the amount by which the net proceeds from the sale of the Registrable Securities sold by such indemnifying party exceeds the amount of any damages that such indemnifying party has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
 
Section 2.7.            Rule 144; Rule 144A.  The Company covenants that it will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Holder, make publicly available other information so long as necessary to permit sales pursuant to Rule 144 or 144A under the Securities Act), and it will take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or 144A or Regulation S under the Securities Act, as such Rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder a written statement as to whether it has complied with such
 

 
requirements and, if not, the specifics thereof.
 
Section 2.8.            Underwritten Registrations.  (b) If any offering of Registrable Securities pursuant to a Shelf Registration Statement or any Demand Registration is an underwritten offering, the Holders’ Representative shall have the right to select the investment banker or investment bankers and managers to administer the offering, subject to approval by the Company, not to be unreasonably withheld. The Company shall have the right to select the investment banker or investment bankers and managers to administer any incidental or piggyback registration.
 
(b)           No Person may participate in any underwritten registration hereunder unless such Person (i) agrees to sell the Registrable Securities or Other Securities it desires to have covered by the registration on the basis provided in any underwriting arrangements in customary form and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements, provided that such Person shall not be required to make any representations or warranties other than those related to title and ownership of shares and as to the accuracy and completeness of statements made in a Registration Statement, Prospectus, offering circular, or other document in reliance upon and in conformity with written information furnished to the Company or the managing underwriter(s) by such Person and provided further, that such Person’s liability in respect of such representations and warranties shall not exceed such Person’s net proceeds from the offering.
 
Section 2.9.            Registration Expenses.  The Company shall pay all reasonable fees and expenses incident to the performance of or compliance with its obligations under this Article II, including (i) all registration and filing fees (including fees and expenses (A) with respect to filings required to be made with all applicable securities exchanges and/or the National Association of Securities Dealers, Inc. and (B) of compliance with securities or Blue Sky laws including any fees and disbursements of counsel for the underwriter(s) in connection with Blue Sky qualifications of the Registrable Securities pursuant to Section 2.5(h)), (ii) printing expenses (including expenses of printing certificates for Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing Prospectuses if the printing of Prospectuses is requested by the managing underwriter(s), if any, or by the Holders of a majority of the Registrable Securities included in any Registration Statement), (iii) messenger, telephone and delivery expenses of the Company, (iv) fees and disbursements of counsel for the Company, (v) expenses of the Company incurred in connection with any road show, (vi) fees and disbursements of all independent certified public accountants (including, without limitation, the expenses of any “cold comfort” letters required by this Agreement) and any other persons, including special experts retained by the Company, and (vii) fees and disbursements of one counsel for the Selling Holders, in an amount not to exceed $20,000 for each registration.  For the avoidance of doubt, the Company shall bear all of its internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit, the fees and expenses incurred in connection with the listing of the securities to be registered on any securities exchange on which similar securities issued by the Company are then listed and rating agency fees and the fees and expenses of any Person, including special experts, retained by the Company.
 

 
Section 2.10.             Other Agreements.  The Company covenants and agrees that, so long as any Holder holds any Registrable Securities in respect of which any registration rights provided for in this Article II remain in effect, the Company will not, directly or indirectly, grant to any Person or agree to or otherwise become obligated in respect of (a) rights of registration in the nature or substantially in the nature of those set forth in this Article II that would have priority over the Registrable Securities with respect to the inclusion of such securities in any registration or (b) rights of registration in the nature or substantially in the nature of those set forth in this Article II that would be pari passu with the Registrable Securities with respect to the inclusion of such securities in any registration, without the prior written consent of the Holders’ Representative.
 
Section 2.11.             Securities Held by the Company or its Subsidiaries.  Whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, in the event that the Company or any of its Subsidiaries holds Registrable Securities, such Registrable Securities shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage.
 
ARTICLE III
 
MISCELLANEOUS
 
Section 3.1.            Conflicting Agreements.  Each party represents and warrants that it has not granted and is not a party to any proxy, voting trust or other agreement that is inconsistent with or conflicts with any provision of this Agreement.
 
Section 3.2.             Termination.  This Agreement shall terminate upon the later of the expiration of the Shelf Period and such time as there are no Registrable Securities, except for the provisions of Sections 2.7, 2.8, 2.10 and this Article III, which shall survive such termination.
 
Section 3.3.             Amendment and Waiver.  This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company and Purchaser (or, in the case of an amendment at any time when Purchaser is not the sole Holder, signed on behalf of each of (i) the Company and (ii) the Holders of a majority of the aggregate number of Registrable Securities then held by all Holders). Any party hereto may waive any right of such party hereunder by an instrument in writing signed by such party and delivered to the other parties (or, in the case of a waiver of any rights of the Holders at any time when Purchaser is not the sole Holder, by an instrument in writing signed by the Holders of a majority of the aggregate number of Registrable Securities then held by all Holders and delivered to the Company and the Holders’ Representative). The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such party thereafter to enforce each and every provision of this Agreement in accordance with its terms.
 
Section 3.4.               Severability.  If any provision of this Agreement shall be declared by any court of competent jurisdiction to be illegal, void or unenforceable, all other provisions of this Agreement shall not be affected and shall remain in full force and effect.
 
Section 3.5.              Entire Agreement.  Except as otherwise expressly set forth herein, this
 

 
Agreement and the Investment Agreement, together with the several agreements and other documents and instruments referred to herein or therein or annexed hereto or thereto, embody the complete agreement and understanding among the parties hereto with respect to the subject matter hereof and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, that may have related to the subject matter hereof in any way.
 
Section 3.6.              Successors and Assigns.  Neither this Agreement nor any right or obligation hereunder is assignable in whole or in part by any party without the prior written consent of the other party hereto, provided that Purchaser may transfer its rights and obligations hereunder (in whole or in part) to any Transferee (and any Transferee may transfer such rights and obligations to any subsequent Transferee) without the prior written consent of the Company. Any such assignment shall be effective upon receipt by the Company of (x) written notice from the transferring Holder stating the name and address of any Transferee and identifying the number of shares of Registrable Securities with respect to which the rights under this Agreement are being transferred and the nature of the rights so transferred and (y) a written agreement in substantially the form attached as Exhibit A hereto from such Transferee to be bound by the applicable terms of this Agreement.
 
Section 3.7.              Counterparts; Execution by Facsimile Signature.  This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s).
 
Section 3.8.              Remedies.  (a) Each party hereto acknowledges that monetary damages would not be an adequate remedy in the event that any of the covenants or agreements in this Agreement is not performed in accordance with its terms, and it is therefore agreed that, in addition to and without limiting any other remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach or threatened breach and enforcing specifically the terms and provisions hereof. Each party hereto agrees not to oppose the granting of such relief in the event a court determines that such a breach has occurred, and to waive any requirement for the securing or posting of any bond in connection with such remedy.
 
(b)           All rights, powers and remedies provided under this Agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof by any party shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party.
 
Section 3.9.           Notices.  All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next Business Day or (iii) one Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the addresses set forth below or such other address or facsimile number as a party may from time to time specify by notice to the other parties hereto:
 
 

 
 
If to the Company:
   
 
E*TRADE Financial Corporation
 
671 N. Glebe Road
 
Arlington, VA 22203
 
Attention:  Arlen W. Gelbard, Esq.
 
                  Chief Administrative Officer & General Counsel
 
Fax:  (703) 236-7223
   
 
with a copy (which shall not constitute notice) to:
   
 
Davis Polk & Wardwell
450 Lexington Avenue
New York, NY 10017
 
 
Attention:  Daniel G. Kelly, Jr., Esq.
             John G. Amorosi, Esq.
 
Fax:  (212) 450-3800
   
 
If to Purchaser:
   
 
Wingate Capital Ltd.
c/o Citadel Limited Partnership
131 South Dearborn Street
Chicago, IL 60603
   
 
Attention:  Adam Cooper, Esq.
 
Fax:  (312) 267-7444
   
 
with a copy (which shall not constitute notice) to:
   
 
Fried, Frank, Harris, Shriver & Jacobson LLP
 
One New York Plaza
 
New York, NY 10004
   
 
Attention:  Robert C. Schwenkel, Esq.
             David N. Shine, Esq.
 
Fax: (212) 859-4000
   
Section 3.10.           Governing Law; Consent to Jurisdiction.  (a) This Agreement shall be governed in all respects by the laws of the State of New York.
 
(b)           Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of any Federal or state court located in the Borough of Manhattan in the City of New York, New York in the event any dispute arises out of this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from
 

 
any such court and (iii) agrees that it will not bring any action relating to this Agreement in any court other than a Federal or state court located in the Borough of Manhattan in the City of New York, New York.
 
(c)           Each of the parties hereto hereby irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation to this Agreement and for any counterclaim therein.
 


 
IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date first written above.
 

  E*TRADE FINANCIAL CORPORATION  
       
   
By: 
 /s/ Robert J. Lilien  
     
Name: Robert J. Lilien
 
     
Title: President and COO
 


 
WINGATE CAPITAL LTD.
By: Citadel Limited Partnership, Portfolio Manager
By: Citadel Investment Group, L.L.C., its General Partner
 
       
   
By: 
 /s/ Adam Cooper  
     
Name: Adam Cooper
 
     
Title: Senior Managing Director and General Counsel
 
 
 

 
 

 
 
[Registration Rights Agreement Signature Page]
 




EXHIBIT A
JOINDER
 
By execution of this Joinder, the undersigned agrees to become a party to that certain Registration Rights Agreement, dated as of November 29, 2007 (the “Agreement”), by and between E*TRADE Financial Corporation and Wingate Capital Ltd. By execution of this Joinder, the undersigned shall have all the rights and shall observe all the obligations of a Holder (as defined in the Agreement) contained in the Agreement.
 
Name:
_______________________   ___
       
   
   
Address for Notices:
   
With Copies to:
 
         
         
         
         
         
         
         
Signature:
_____________________________   _ 
     
Date:
 
     
           
 




      
        
      
           


EX-4.2 3 dp07754_ex0402.htm
 
Exhibit 4.2
 
 
 
E*TRADE Financial Corporation

as Issuer


And


The Bank of New York

as Trustee




Indenture




Dated as of November 29, 2007


 

12.5% Springing Lien Notes Due 2017
 
 

 
TABLE OF CONTENTS
 
ARTICLE I  DEFINITIONS AND INCORPORATION BY REFERENCE
1
Section 1.01.  Definitions
1
Section 1.02.  Incorporation by Reference of Trust Indenture Act
24
Section 1.03.  Rules of Construction
24
 
 
ARTICLE II  THE NOTES
24
Section 2.01.  Form, Dating and Denominations
24
Section 2.02.  Execution and Authentication
25
Section 2.03.  Registrar, Paying Agent and Authenticating Agent; Paying Agent to Hold Money in Trust
25
Section 2.04.  Replacement Notes
26
Section 2.05.  Outstanding Notes
26
Section 2.06.  Temporary Notes
27
Section 2.07.  Cancellation
27
Section 2.08.  CUSIP and CINS Numbers
27
Section 2.09.  Registration, Transfer and Exchange
27
Section 2.10.  Restrictions on Transfer and Exchange
29
Section 2.11.  Special Transfer Provisions
29
 
 
ARTICLE III  REDEMPTION, OFFER TO PURCHASE
32
Section 3.01.  Optional Redemption
32
Section 3.02.  Redemption in Connection with a Change of Control
32
Section 3.03.  Redemption with Proceeds of Public Equity Offering
32
Section 3.04.  Method and Effect of Redemption
32
 
 
ARTICLE IV  COVENANTS
33
Section 4.01.  Payment of Notes
33
Section 4.02.  Maintenance of Office or Agency
34
Section 4.03.  Limitation on Indebtedness and Issuances of Preferred Stock
34
Section 4.04.  Limitation on Restricted Payments.
36
Section 4.05.  Limitation on Dividends and Other Payment Restrictions Affecting Restricted Subsidiaries or Regulated Subsidiaries
39
Section 4.06.  Limitation on the Issuance and Sale of Capital Stock of Restricted Subsidiaries or Regulated Subsidiaries
41
Section 4.07.  Future Subsidiary Guarantees
41
Section 4.08.  Limitation on Transactions with Shareholders and Affiliates
42
Section 4.09.  Limitation on Liens
43
Section 4.10.  Limitation on Sale-leaseback Transactions
44
Section 4.11.  Limitation on Asset Sales
45
Section 4.12.  Repurchase of Notes Upon a Change of Control
46
Section 4.13.  Limitation on Lines of Business
46
Section 4.14.  Effectiveness of Covenants
46
Section 4.15.  SEC Reports and Reports to Holders
47
Section 4.16.  Payments of Taxes and Other Claims
47
Section 4.17.  Compliance Certificates
47
Section 4.18.  Waiver of Stay, Extension or Usury Laws
48
Section 4.19.  Maintenance Covenants
48
Section 4.20.  Springing Lien
48
 
-i-

 
 
 
ARTICLE V  CONSOLIDATION, MERGER OR SALE OF ASSETS
49
Section 5.01.  Consolidation, Merger and Sale of Assets
49
Section 5.02.  Successor Substituted
50
 
 
ARTICLE VI  EVENTS OF DEFAULT AND REMEDIES
51
Section 6.01.  Events of Default
51
Section 6.02.  Acceleration
53
Section 6.03.  Control by Majority
53
Section 6.04.  Limitation on Suits
53
Section 6.05.  Rights of Holders to Receive Payment
54
Section 6.06.  Collection Suit by Trustee
54
Section 6.07.  Trustee May File Proofs of Claim
54
Section 6.08.  Priorities
54
Section 6.09.  Undertaking for Costs
55
Section 6.10.  Restoration of Rights and Remedies
55
Section 6.11.  Rights and Remedies Cumulative
55
Section 6.12.  Delay or Omission Not Waiver
55
 
 
ARTICLE VII  THE TRUSTEE
55
Section 7.01.  General
55
Section 7.02.  Certain Rights of Trustee
56
Section 7.03.  Individual Rights of Trustee
57
Section 7.04.  Trustee’s Disclaimer
57
Section 7.05.  Notice of Default
58
Section 7.06.  Reports by Trustee to Holders
58
Section 7.07.  Compensation and Indemnity
58
Section 7.08.  Replacement of Trustee
58
Section 7.09.  Successor Trustee by Merger
59
Section 7.10.  Eligibility
59
Section 7.11.  Money Held in Trust
60
 
 
ARTICLE VIII  DEFEASANCE AND DISCHARGE
60
Section 8.01.  Discharge of Company’s Obligations
60
Section 8.02.  Legal Defeasance
61
Section 8.03.  Covenant Defeasance
61
Section 8.04.  Application of Trust Money
62
Section 8.05.  Repayment to Company
62
Section 8.06.  Reinstatement
62
 
 
ARTICLE IX  AMENDMENTS, SUPPLEMENTS AND WAIVERS
62
Section 9.01.  Amendments Without Consent of Holders
62
Section 9.02.  Amendments with Consent of Holders
63
Section 9.03.  Effect of Consent
64
Section 9.04.  Trustee’s Rights and Obligations
64
Section 9.05.  Conformity with Trust Indenture Act
65
Section 9.06.  Payments for Consents
65
 
 
ARTICLE X  GUARANTEES
65
Section 10.01.  Guarantees
65
Section 10.02.  Limitation on Subsidiary Guarantor Liability
66
 
-ii-

 
Section 10.03.  Execution and Delivery of the Guarantee
66
Section 10.04.  Guarantors May Consolidate, etc., on Certain Terms
66
Section 10.05.  Releases Following Certain Events
67
 
 
ARTICLE XI  MISCELLANEOUS
67
Section 11.01.  Trust Indenture Act of 1939
67
Section 11.02.  Noteholder Communications; Noteholder Actions
67
Section 11.03.  Notices
68
Section 11.04.  Certificate and Opinion as to Conditions Precedent
69
Section 11.05.  Statements Required in Certificate or Opinion
69
Section 11.06.  Payment Date Other Than a Business Day
69
Section 11.07.  Governing Law
70
Section 11.08.  No Adverse Interpretation of Other Agreements
70
Section 11.09.  Successors
70
Section 11.10.  Duplicate Originals
70
Section 11.11.  Separability
70
Section 11.12.  Table of Contents and Headings
70
Section 11.13.  No Liability of Directors, Officers, Employees, Incorporators, Members and Stockholders
70
Section 11.14.  Waiver of Jury Trial
70
Section 11.15.  Force Majeure
70
 
 
ARTICLE XII  COLLATERAL DOCUMENTS AND SECURITY
70
Section 12.01.  Appointment of Collateral Agent
71
Section 12.02.  Collateral Documents
71
Section 12.03.  Application of Proceeds of Collateral
71
Section 12.04.  Release of Collateral
71
Section 12.05.  Certain TIA Requirements
72
Section 12.06.  Release of Note Liens
72
 
Exhibit A – Form of Note
Exhibit B – Form of Supplemental Indenture
Exhibit C – DTC Legend
Exhibit D – Restricted Notes Legend
Exhibit E – Form of Certificate to be delivered in connection with transfers pursuant to Rule 144A
Exhibit F – Form of Certificate to be delivered in connection with transfers pursuant to Regulation S
Exhibit G – Form of Certificate to be delivered in connection with transfers to Institutional Accredited Investors
Exhibit H – Form of Certificate of Acquiring Institutional Accredited Investors.
 
 

 
-iii-

 
INDENTURE, dated as of November 29, 2007, between E*TRADE Financial Corporation, a Delaware corporation, as the Company and The Bank of New York, a New York banking corporation, as Trustee.
 
RECITALS
 
The Company has duly authorized the execution and delivery of the Indenture to provide for the issuance of up to $1,936,000,000 (plus any Capitalized Interest) aggregate principal amount of the Company’s 12.5% Springing Lien Notes due 2017 (the “Notes”). All things necessary to make the Indenture a valid agreement of the Company, in accordance with its terms, have been done, and the Company has done all things necessary to make the Notes, when executed by the Company and authenticated and delivered by the Trustee and duly issued by the Company, the valid obligations of the Company as hereinafter provided.
 
This Indenture is subject to, and will be governed by, the provisions of the Trust Indenture Act that are required to be a part of and govern indentures qualified under the Trust Indenture Act.
 
THIS INDENTURE WITNESSETH
 
For and in consideration of the premises and the purchase of the Notes by the Holders thereof, the parties hereto covenant and agree, for the equal and proportionate benefit of all Holders, as follows:
 
ARTICLE I
 
DEFINITIONS AND INCORPORATION BY REFERENCE
 
Section 1.01. Definitions
 
2011 Notes” means 8% Senior Notes due 2011 issued by the Company pursuant to the 2011 Notes Indenture, together with any exchange notes issued therefor.
 
2011 Notes Indenture” means the indenture dated as of June 8, 2004, between the Company and The Bank of New York, as trustee, as amended or supplemented from time to time.
 
2013 Notes” means 7 3/8% Senior Notes due 2013 issued by the Company pursuant to the 2013 Notes Indenture, together with any exchange notes issued therefor.
 
2013 Notes Indenture” means the indenture dated as of September 19, 2005 between the Company and The Bank of New York, as trustee, as amended or supplemented from time to time.
 
2015 Notes” means 7 7/8% Senior Notes due 2015 issued by the Company pursuant to the 2015 Notes Indenture, together with any exchange notes issued therefor.
 
2015 Notes Indenture” means the indenture dated as of November 22, 2005 between the Company and The Bank of New York, as trustee, as amended or supplemented from time to time.
 
Acquired Indebtedness” means Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary or Indebtedness of a Restricted Subsidiary assumed in connection with an Asset Acquisition by such Restricted Subsidiary; provided such Indebtedness was not Incurred in connection with or in contemplation of such Person becoming a Restricted Subsidiary or such Asset Acquisition.
 
-1-

 
Additional Notes” means any notes issued under the Indenture pursuant to the terms of the Investment Agreement in an aggregate principal amount not to exceed $150,000,000, having the same terms in all respects as the Original Notes except that interest will accrue on the Additional Notes from their date of their issuance.
 
Adjusted Consolidated Net Income” means, for any period, the aggregate net income (or loss) of the Company and its Restricted Subsidiaries and Regulated Subsidiaries for such period determined in conformity with GAAP; provided that the following items shall be excluded in computing Adjusted Consolidated Net Income (without duplication):
 
(1)           the net income (or loss) of any Person that is not a Restricted Subsidiary or Regulated Subsidiary, except that the Company’s equity in the net income of any such Person for such period (to the extent not otherwise excluded pursuant to clauses (2) through (6) below) will be included up to the aggregate amount of cash actually distributed by such Person during such period to the Company or to its Restricted Subsidiaries or Regulated Subsidiaries (less minority interest therein) as a dividend or other distribution;
 
(2)           the net income (or loss) of any Person accrued prior to the date it becomes a Restricted Subsidiary or Regulated Subsidiary or is merged into or consolidated with the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries or all or substantially all of the property and assets of such Person are acquired by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries;
 
(3)           the net income of any Restricted Subsidiary to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary;
 
(4)           the net income of any Regulated Subsidiary (x) to the extent that the declaration or payment of dividends or similar distributions by such Regulated Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement or instrument with a Person, other than such Regulated Subsidiaries applicable regulatory authorities, or any judgment or decree applicable to such Regulated Subsidiary (y) other than to the extent that such Regulated Subsidiary reasonably believes, in good faith, that such net income could be distributed, declared or paid as a dividend or similar distribution without causing such Regulated Subsidiary to fail to be at least “adequately capitalized” as defined in the regulations of applicable regulatory authorities, or to meet minimum capital requirements imposed by applicable regulatory authorities;
 
(5)           any gains or losses (on an after-tax basis) attributable to Asset Sales or Regulated Sales;
 
(6)           solely for purposes of calculating the amount of Restricted Payments that may be made pursuant to clause (c) of Section 4.04, any amount paid or accrued as dividends on Preferred Stock of the Company owned by Persons other than the Company and any of its Restricted Subsidiaries and Regulated Subsidiaries;
 
(7)           all extraordinary gains and, solely for purposes of calculating the Consolidated Fixed Charge Coverage Ratio, extraordinary losses;
 
(8)           the cumulative effect of changes in accounting principles; and
 
-2-

 
(9)           the net after-tax effect of impairment charges related to goodwill and other intangible assets.
 
Affiliate” means, as applied to any Person, any other Person directly or indirectly controlling, controlled by, or under direct or indirect common control with, such Person. For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.  Notwithstanding the foregoing, in no event will Citadel be deemed to be an Affiliate of the Company.
 
Agent Member” means a member of, or a participant in, the Depositary.
 
Asset Acquisition” means (1) an investment by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries in any other Person pursuant to which such Person shall become a Restricted Subsidiary or a Regulated Subsidiary or shall be merged into or consolidated with the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries; provided that such Person’s primary business is a Related Business or (2) an acquisition by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of the property and assets of any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries that constitute substantially all of a division or line of business of such Person that is a Related Business.
 
Asset Sale” means any sale, transfer or other disposition (including by way of merger, consolidation or Sale-Leaseback Transaction) in one transaction or a series of related transactions by the Company or any of its Restricted Subsidiaries to any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of:
 
(1)           all or any of the Capital Stock of any Restricted Subsidiary;
 
(2)           all or substantially all of the property and assets of an operating unit or business of the Company or any of its Restricted Subsidiaries; or
 
(3)           any other property and assets (other than the Capital Stock or other Investment in an Unrestricted Subsidiary) of the Company or any of its Restricted Subsidiaries outside the ordinary course of business of the Company or such Restricted Subsidiary,
 
and, in each case, that is not governed by the provisions of the Indenture applicable to mergers, consolidations and sales of assets of the Company; provided that “Asset Sale” shall not include:
 
(A)           sales or other dispositions of Investment Securities, inventory, receivables and other current assets;
 
(B)           sales, transfers or other dispositions of assets constituting a Permitted Investment or Restricted Payment permitted to be made under Section 4.04;
 
(C)           sales, transfers or other dispositions of assets with a Fair Market Value not in excess of $2.5 million in any transaction or series of related transactions;
 
(D)           any sale, transfer, assignment or other disposition of any property equipment that has become damaged, worn out, obsolete or otherwise unsuitable for use in connection with the business of the Company or its Restricted Subsidiaries;
 
-3-

 
(E)           an issuance of Capital Stock by a Restricted Subsidiary or the sale, transfer or other disposition by the Company or a Restricted Subsidiary of the Capital Stock of a Restricted Subsidiary or Regulated Subsidiary, in each case to the Company, a Wholly Owned Restricted Subsidiary or a Wholly Owned Regulated Subsidiary; or
 
(F)           Permitted Liens, or foreclosure on assets as a result of Liens permitted under Section 4.09.
 
Authenticating Agent” refers to a Person engaged to authenticate the Notes in the stead of the Trustee.
 
Average Life” means, at any date of determination with respect to any debt security, the quotient obtained by dividing (1) the sum of the products of (a) the number of years from such date of determination to the dates of each successive scheduled principal payment of such debt security and (b) the amount of such principal payment by (2) the sum of all such principal payments.
 
Bank Regulated Subsidiary” means (i) ETB Holdings, Inc. (provided that such entity is a savings and loan holding company, as defined under the Home Owners’ Loan Act, as amended, or a bank holding company, as defined under the Bank Holding Company Act, as amended, but in no event shall such entity mean, or include, the Company), (ii) any direct or indirect insured depository institution subsidiary of the Company that is regulated by foreign, federal or state banking regulators, including, without limitation, the OTS and the FDIC or (iii) any Subsidiary of a Bank Regulated Subsidiary all of the Common Stock of which is owned by such Bank Regulated Subsidiary and the sole purpose of which is to issue trust preferred or similar securities where the proceeds of the sale of such securities are invested in such Bank Regulated Subsidiary and where such proceeds would be treated as Tier I capital were such Bank Regulated Subsidiary a bank holding company regulated by the Board of Governors of the Federal Reserve System.
 
Board of Directors” means, with respect to any Person, the Board of Directors of such Person or any duly authorized committee of such Board of Directors, or any other group performing comparable functions.
 
Broker Dealer Regulated Subsidiary” means any direct or indirect subsidiary of the Company that is registered as a broker dealer pursuant to Section 15 of the Exchange Act or that is regulated as a broker dealer or underwriter under any foreign securities law.
 
Business Day” means any day except a Saturday, Sunday or other day on which commercial banks in New York City or in the city where the Corporate Trust Office of the Trustee is located are authorized by law to close.
 
Capital Stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) in equity of such Person, whether outstanding on the Closing Date or issued thereafter, including, without limitation, all Common Stock and Preferred Stock.
 
Capitalized Interest” is defined in Paragraph 1(b) of the reverse of the Notes.
 
Capitalized Lease” means, as applied to any Person, any lease of any property (whether real, personal or mixed) of which the discounted present value of the rental obligations of such Person as lessee, in conformity with GAAP, is required to be capitalized on the balance sheet of such Person.
 
-4-

 
Capitalized Lease Obligations” means the discounted present value of the rental obligations under a Capitalized Lease.
 
Certificated Note” means a Note in registered individual form without interest coupons.
 
Change of Control” means such time as:
 
(1)           a “person” or “group” (within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act), becomes the ultimate “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) of more than 50% of either (a) the total voting power of the Voting Stock of the Company on a fully diluted basis or (b) the economic value of the equity of the Company; or
 
(2)           individuals who on the Closing Date constitute the Board of Directors (together with any new directors whose election by the Board of Directors or whose nomination by the Board of Directors for election by the Company’s stockholders was approved by a vote of at least a majority of the members of the Board of Directors then in office who either were members of the Board of Directors on the Closing Date or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the members of the Board of Directors then in office;
 
(3)           the adoption of a plan of liquidation of the Company;
 
(4)           a voluntary sale, conveyance, exchange or transfer of all or substantially all of the property and assets of the Company and its Subsidiaries on a consolidated basis in one transaction or a series of related transactions; or
 
(5)           the consummation of any merger or business combination if, after such transaction, holders of the Company’s Voting Stock before the transaction do not hold a majority of the voting power of the Company’s Voting Stock immediately after the transaction.
 
Change of Control Agreement” means a definitive agreement the consummation of which will result in a Change of Control.
 
Citadel” means Citadel Limited Partnership and/or any of its Affiliates.
 
Closing Date” means November 29, 2007, the date on which the Notes are originally issued.
 
Collateral” means all property (whether tangible or intangible, real or personal), assets and Capital Stock of the Company and its Subsidiaries in which a security interest is granted as provided in Section 4.20, excluding, however, the Excluded Collateral.
 
Collateral Agent” means the Person appointed as such in accordance with the terms of Section 12.01
 
Collateral Documents” means each and every agreement, document and instrument executed by the Company or any of its Subsidiaries for purposes of giving effect to the provisions of Section 4.20, including the Intercreditor Agreement.
 
Common Stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) of such Person’s equity, other than
 
-5-

 
Preferred Stock of such Person, whether outstanding on the Closing Date or issued thereafter, including, without limitation, all series and classes of such common stock.
 
Company” means the party named as such in the first paragraph of the Indenture or any successor obligor under the Indenture and the Notes pursuant to Article 5.
 
Consolidated EBITDA” means, for any period, Adjusted Consolidated Net Income for such period plus, to the extent such amount was deducted in calculating such Adjusted Consolidated Net Income:
 
(1)       Consolidated Interest Expense;
 
(2)       income taxes;
 
(3)       depreciation expense;
 
(4)       amortization expense; and
 
(5)       all other non-cash items reducing Adjusted Consolidated Net Income (other than items that will require cash payments and for which an accrual or reserve is, or is required by GAAP to be, made), less all non-cash items increasing Adjusted Consolidated Net Income, all as determined on a consolidated basis for the Company, its Restricted Subsidiaries and its Regulated Subsidiaries in conformity with GAAP;
 
provided that, if any Restricted Subsidiary or Regulated Subsidiary is not a Wholly Owned Restricted Subsidiary, or Wholly Owned Regulated Subsidiary, as the case may be, Consolidated EBITDA shall be reduced (to the extent not otherwise reduced in accordance with GAAP) by an amount equal to (A) the amount of the Adjusted Consolidated Net Income attributable to such Restricted Subsidiary or Regulated Subsidiary multiplied by (B) the percentage of Common Stock of such Restricted Subsidiary or Regulated Subsidiary not owned on the last day of such period by the Company or any of its Restricted Subsidiaries or any of its Wholly Owned Regulated Subsidiaries.
 
Consolidated Fixed Charge Coverage Ratio” means, with respect to any Person, the ratio of Consolidated EBITDA of such Person during the most recent four full fiscal quarters (the “Four Quarter Period”), for which financial statements are available, ending on or prior to the date of the transaction giving rise to the need to calculate the Consolidated Fixed Charge Coverage Ratio (the “Transaction Date”), to Consolidated Fixed Charges of such Person for the Four Quarter Period. In addition to and without limitation of the foregoing, for purposes of this definition, Consolidated EBITDA and Consolidated Fixed Charges shall be calculated after giving effect on a pro forma basis for the period of such calculation to:
 
(1)           the incurrence or repayment of any Indebtedness of such Person or any of its Restricted Subsidiaries or Regulated Subsidiaries (and the application of the proceeds thereof) giving rise to the need to make such calculation and any incurrence or repayment of other Indebtedness (and the application of the proceeds thereof), other than the incurrence or repayment of Indebtedness in the ordinary course of business for working capital purposes pursuant to working capital facilities, occurring during the Four Quarter Period or at any time subsequent to the last day of the Four Quarter Period and on or prior to the Transaction Date, as if such incurrence or repayment, as the case may be (and the application of the proceeds thereof), occurred on the first day of the Four Quarter Period; and
 
-6-

 
(2)           any Asset Sales or Asset Acquisitions (including, without limitation, any Asset Acquisition giving rise to the need to make such calculation as a result of such Person or one of its Restricted Subsidiaries or Regulated Subsidiaries (including any Person who becomes a Restricted Subsidiary or Regulated Subsidiaries as a result of the Asset Acquisition) incurring, assuming or otherwise being liable for Acquired Indebtedness and also including any Consolidated EBITDA attributable to the assets which are the subject of the Asset Acquisition or Asset Sale during the Four Quarter Period) occurring during the Four Quarter Period or at any time subsequent to the last day of the Four Quarter Period and on or prior to the Transaction Date, as if such Asset Sale or Asset Acquisition (including the incurrence, assumption or liability for any such Acquired Indebtedness) occurred on the first day of the Four Quarter Period.
 
If such Person or any of its Restricted Subsidiaries or Regulated Subsidiaries directly or indirectly guarantees Indebtedness of a third Person, the preceding sentence shall give effect to the incurrence of such guaranteed Indebtedness as if such Person or any Restricted Subsidiary of such Person had directly incurred or otherwise assumed such guaranteed Indebtedness. Furthermore, in calculating “Consolidated Fixed Charges”:
 
(3)           interest on outstanding Indebtedness determined on a fluctuating basis as of the Transaction Date and which will continue to be so determined thereafter shall be deemed to have accrued at a fixed rate per annum equal to the rate of interest on such Indebtedness in effect on the Transaction Date;
 
(4)           if interest on any Indebtedness actually incurred on the Transaction Date may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a eurocurrency interbank offered rate, or other rates, then the interest rate in effect on the Transaction Date will be deemed to have been in effect during the Four Quarter Period; and
 
(5)           notwithstanding clause (1) above, interest on Indebtedness determined on a fluctuating basis, to the extent such interest is covered by agreements relating to Interest Swap Obligations, shall be deemed to accrue at the rate per annum resulting after giving effect to the operation of such agreements.
 
Consolidated Fixed Charges” means, with respect to any Person for any period, the sum, without duplication, of (1) Consolidated Interest Expense, plus (2) the product of (A) the amount of all dividend payments on any series of Preferred Stock of such Person (other than (x) dividends paid in Qualified Capital Stock and (y) dividends on the Preferred Stock, the net proceeds of which will be used for the Distribution, to the extent they are paid in kind or accrete, except to the extent they constitute Disqualified Capital Stock) paid, accrued or scheduled to be paid or accrued during such period times (B) a fraction, the numerator of which is one and the denominator of which is one minus the then current effective consolidated federal, state and local tax rate of such Person, expressed as a decimal.
 
Consolidated Interest Expense” means, for any period, the aggregate amount of interest in respect of Indebtedness (including, without limitation, amortization of original issue discount on any Indebtedness and the interest portion of any deferred payment obligation of the type described under clause (4) of the definition of “Indebtedness”, calculated in accordance with the effective interest method of accounting; all commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptance financing; Indebtedness that is Guaranteed or secured by the Company, any of its Restricted Subsidiaries, or any of its Regulated Subsidiaries), and all but the principal component of rentals in respect of Capitalized Lease Obligations paid, accrued or scheduled to be paid or to be accrued by the Company, its Restricted Subsidiaries and its Regulated Subsidiaries during such period; excluding, however, (1) any amount of such interest of any Restricted Subsidiary or Regulated Subsidiary if the net
 
-7-

 
income of such Restricted Subsidiary or Regulated Subsidiary is excluded in the calculation of Adjusted Consolidated Net Income pursuant to clause (3) or (4) of the definition thereof (but only in the same proportion as the net income of such Restricted Subsidiary or Regulated Subsidiary is excluded from the calculation of Adjusted Consolidated Net Income pursuant to clause (3) or (4) of the definition thereof) and (2) any premiums, fees and expenses (and any amortization thereof) payable in connection with the offering of the Notes, the 2015 Notes, the 2013 Notes and the 2011 Notes, all as determined on a consolidated basis (without taking into account Unrestricted Subsidiaries) in conformity with GAAP, and (3) interest payments on trust preferred or similar securities issued by a Regulated Subsidiary to the extent the proceeds of the sale of such securities are invested in a Regulated Subsidiary.
 
Consolidated Net Worth” means, at any date of determination, stockholders’ equity as set forth on the most recently available quarterly or annual consolidated balance sheet of the Company and its Restricted Subsidiaries and Regulated Subsidiaries (which shall be as of a date not more than 90 days prior to the date of such computation, and which shall not take into account Unrestricted Subsidiaries), plus, to the extent not included, any Preferred Stock of the Company, less any amounts attributable to Disqualified Stock or any equity security convertible into or exchangeable for Indebtedness, the cost of treasury stock and the principal amount of any promissory notes receivable from the sale of the Capital Stock of the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries, each item to be determined in conformity with GAAP (excluding the effects of foreign currency exchange adjustments under Financial Accounting Standards Board Statement of Financial Accounting Standards No. 52).
 
Corporate Trust Office” means the principal office of the Trustee at which at any time its corporate trust business shall be administered, which office at the date hereof is located at 101 Barclay Street, Floor 8 West, New York, New York 10286, Attention:  Corporate Trust Administration, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).
 
Credit Facility” means a credit facility of, or Guaranteed by, the Company and used by the Company, its Restricted Subsidiaries or its Regulated Subsidiaries for working capital and other general corporate purposes together with the related documents (including, without limitation, any guarantee agreements and security documents), as such agreements may be amended (including any amendment and restatement), supplemented, replaced or otherwise modified from time to time.
 
Default” means any event that is, or after notice or passage of time or both would be, an Event of Default.
 
Depositary” means the depositary of each Global Note, which will initially be DTC.
 
Disqualified Stock” means any class or series of Capital Stock of any Person that by its terms or otherwise is (1) required to be redeemed prior to a date that is 123 days following the Stated Maturity of the Notes, (2) redeemable at the option of the holder of such class or series of Capital Stock at any time prior to the Stated Maturity of the Notes or (3) convertible into or exchangeable for Capital Stock referred to in clause (1) or (2) above or Indebtedness having a scheduled maturity prior to the Stated Maturity of the Notes; provided that any Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to repurchase or redeem such Capital Stock upon the occurrence of an “asset sale” or “change of control” occurring prior to the Stated Maturity of the Notes shall not constitute Disqualified Stock if the “asset sale” or “change of control” provisions applicable to such Capital Stock are no more favorable to the holders of such Capital Stock than the provisions contained in Section 4.11 and Section 4.12 and such Capital Stock specifically provides that such Person will not repurchase or redeem any such stock pursuant to such provision prior to the
 
-8-

 
Company’s repurchase of such Notes as are required to be repurchased pursuant to Section 4.11 and Section 4.12.
 
Domestic Subsidiary” means any Restricted Subsidiary of the Company with total assets as determined under GAAP of at least $100,000, as set forth on the most recently available quarterly or annual consolidated balance sheet of such Restricted Subsidiary other than a Restricted Subsidiary that is (1) a Foreign Subsidiary or (2) a Subsidiary of any such Foreign Subsidiary.
 
DTC” means The Depository Trust Company, a New York corporation, and its successors.
 
DTC Legend” means the legend set forth in Exhibit C.
 
Event of Default” has the meaning assigned to such term in Section 6.01.
 
Exchange Act” means the Securities Exchange Act of 1934, as amended.
 
Excluded Collateral” means those assets of the Company and its Subsidiaries as to which (a) (i) Citadel, if Citadel holds a majority in principal amount of outstanding Notes or (ii) the Company’s Board of Directors if Citadel does not hold a majority in principal amount of outstanding Notes, as applicable, shall have determined in good faith that the costs of obtaining a security interest are unreasonably excessive in relation to the benefits to the Holders of the security afforded thereby (which determination shall be delivered to the Trustee or a collateral agent appointed by the trustee to maintain possession of any stock certificates, promissory notes or other instruments delivered to it under the Collateral Documents) or (b) the grant of security interest (x) is prohibited by or requires approval under the applicable law, regulation or rule including those of self-regulatory organizations, or (y) is prohibited by a contractual arrangement existing on the Closing Date or any contractual arrangement entered into after the Closing Date and approved by the Holders of a majority in principal amount of outstanding Notes.
 
Fair Market Value” means the price that would be paid in an arm’s-length transaction between an informed and willing seller under no compulsion to sell and an informed and willing buyer under no compulsion to buy which, if determined by the Board of Directors as evidenced by a Board Resolution, shall be conclusively determined.
 
FDIC” means the Federal Deposit Insurance Corporation.
 
Final Closing” is defined in the Investment Agreement.
 
Foreign Subsidiary” means any Subsidiary of the Company that is an entity which is a controlled foreign corporation under Section 957 of the Internal Revenue Code or any subsidiary that is otherwise organized under the laws of a jurisdiction other than the United States, any state thereof, or the District of Columbia.
 
GAAP” means generally accepted accounting principles in the United States of America as in effect as of the Closing Date, including, without limitation, those set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as approved by a significant segment of the accounting profession. All ratios and computations contained or referred to in the Indenture shall be computed in conformity with GAAP applied on a consistent basis, except that calculations made for purposes of determining compliance with the terms of the covenants and with other provisions of the Indenture shall be made without giving effect to (1) the amortization of any expenses incurred in connection with the offering of
 
-9-

 
the Notes, the 2015 Notes, the 2013 Notes and the 2011 Notes and (2) except as otherwise provided, the amortization or writedown of any amounts required or permitted by Accounting Principles Board Opinion Nos. 16 and 17 and Statement of Financial Accounting Standards No. 142.
 
Global Note” means a Note in registered global form without interest coupons.
 
Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (1) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services (unless such purchase arrangements are on arm’s-length terms and are entered into in the ordinary course of business), to take-or-pay, or to maintain financial statement conditions or otherwise) or (2) entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); provided that the term “Guarantee” shall not include endorsements for collection or deposit in the ordinary course of business, letters of credit issued by a Bank Regulated Subsidiary in the ordinary course of its business or STAMP or other signature guarantees made by a Regulated Subsidiary in the ordinary course of its business. The term “Guarantee” used as a verb has a corresponding meaning.
 
Hedging Obligations” means, with respect to any Person, the obligations of such person under (i) currency exchange, interest rate, commodity, credit or equity swap, forward or futures agreements, currency exchange, interest rate, commodity, credit or equity cap agreements, currency exchange, interest rate, commodity, credit or equity collar agreements, or currency exchange, interest rate, commodity, credit or equity puts or calls, and (ii) other agreements or arrangements designed to protect such Person, directly or indirectly, against fluctuations in currency exchange, interest rate, commodity or equity prices.
 
IAI Global Note” means a Note bearing the Restricted Note Legend and deposited with or on behalf of and registered in the name of the Depositary or its nominee that will be issued in a denomination equal to the outstanding principal amount of the Notes sold to Institutional Accredited Investors.
 
Incur” means, with respect to any Indebtedness, to incur, create, issue, assume, Guarantee or otherwise become liable for or with respect to, or become responsible for, the payment of, contingently or otherwise, such Indebtedness; provided that (1) any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary will be deemed to be incurred by such Restricted Subsidiary at the time it becomes a Restricted Subsidiary and (2) neither the accrual of interest nor the accretion of original issue discount shall be considered an Incurrence of Indebtedness.
 
Indebtedness” means, with respect to any Person at any date of determination (without duplication):
 
(1)           all indebtedness of such Person for borrowed money;
 
(2)           all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments;
 
(3)           all obligations of such Person in respect of letters of credit or other similar instruments (including reimbursement obligations with respect thereto, but excluding letters of credit issued by such Person and excluding obligations with respect to letters of credit (including trade letters of credit) securing obligations (other than obligations described in (1) or (2) above or (5), (6) or (7)
 
-10-

 
below) entered into in the ordinary course of business of such Person to the extent such letters of credit are not drawn upon or, if drawn upon, to the extent such drawing is reimbursed no later than the third Business Day following receipt by such Person of a demand for reimbursement);
 
(4)           all obligations of such Person to pay the deferred and unpaid purchase price of property or services, which purchase price is recorded as a liability under GAAP and due more than six months after the date of placing such property in service or taking delivery and title thereto or the completion of such services, except Trade Payables;
 
(5)           all Capitalized Lease Obligations;
 
(6)           all Indebtedness of other Persons secured by a Lien on any asset of such Person, whether or not such Indebtedness is assumed by such Person; provided that the amount of such Indebtedness shall be the lesser of (A) the Fair Market Value of such asset at such date of determination and (B) the amount of such Indebtedness;
 
(7)           all Indebtedness of other Persons Guaranteed by such Person to the extent such Indebtedness is Guaranteed by such Person;
 
(8)           Acquired Indebtedness;
 
(9)           to the extent not otherwise included in this definition, net obligations under Hedging Obligations (other than Hedging Obligations not entered into for speculative investment purposes and designed to protect the Company or its Restricted Subsidiaries or Regulated Subsidiaries against fluctuations in commodity prices, equity prices, foreign currency exchange rates or interest rates and that do not increase the Indebtedness of the obligor outstanding at any time other than as a result of fluctuations in commodity prices, foreign currency exchange rates or interest rates or by reason of fees, indemnities and compensation payable thereunder); and
 
(10)                      all obligations to redeem or repurchase Preferred Stock issued by such Person, other than PIK Preferred Stock,
 
provided that Indebtedness shall not include:

(A)           obligations arising from products and services offered by Bank Regulated Subsidiaries or Broker Dealer Regulated Subsidiaries in the ordinary course including, but not limited to, deposits, CDs, prepaid forward contracts, swaps, exchangeable debt securities, foreign currency purchases or sales and letters of credit;
 
(B)           indebtedness or other obligations incurred in the ordinary course arising from margin lending, Stock Loan activities or foreign currency settlement obligations of a Broker Dealer Regulated Subsidiary;
 
(C)           indebtedness of the Company or any Restricted Subsidiary represented by letters of credit for the account of the Company or such Restricted Subsidiary, as the case may be, in order to provide security for workers’ compensation claims, payment obligations in connection with self-insurance or similar requirements in the ordinary course of business;
 
(D)           Purchase Money Indebtedness of the Company or any Restricted Subsidiary not to exceed at any one time outstanding 5% of Consolidated Net Worth;
 
-11-

 
(E)           indebtedness arising from agreements of the Company or a Restricted Subsidiary providing for indemnification, adjustment of purchase price or similar obligations, in each case, incurred or assumed in connection with the disposition of any business, assets or a Subsidiary, other than Guarantees of Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition;
 
(F)           indebtedness Incurred by Professional Path, Inc. in the ordinary course of its proprietary trading activities in an amount not to exceed at any one time outstanding of $5 million;
 
(G)           advances from the Federal Home Loan Bank, Federal Reserve Bank (or similar institution), repurchase and reverse repurchase agreements relating to Investment Securities, medium term notes, treasury tax and loan balances, special direct investment balances, bank notes, commercial paper, term investment option balances, brokered certificates of deposit, dollar rolls, and fed funds purchased, in each case incurred in the ordinary course of a Regulated Subsidiary’s business;
 
(H)           Indebtedness Incurred by a Regulated Subsidiary and Guaranteed by the Company (i)(A) the proceeds of which are used to satisfy applicable minimum capital requirements imposed by applicable regulatory authorities of such Regulated Subsidiary and (B) where the provision of such Guarantee by the Company is required by the applicable regulatory authority or (ii) where the provision of such Guarantee by the Company is required by a bank, clearing house or other market participant in connection with the ordinary course of a Broker Dealer Regulated Subsidiary’s business. The amount of Indebtedness of any Person at any date shall be the outstanding balance at such date of all unconditional obligations as described above and, with respect to contingent obligations, the maximum liability upon the occurrence of the contingency giving rise to the obligation, provided
 
(a)           that the amount outstanding at any time of any Indebtedness issued with original issue discount is the face amount of such Indebtedness less the remaining unamortized portion of the original issue discount of such Indebtedness at such time as determined in conformity with GAAP,
 
(b)           that money borrowed and set aside at the time of the Incurrence of any Indebtedness in order to prefund the payment of the interest on such Indebtedness shall not be deemed to be “Indebtedness” so long as such money is held to secure the payment of such interest and
 
(c)           that Indebtedness shall not include:
 
(1)           any liability for federal, state, local or other taxes;
 

(2)           performance, surety or appeal bonds provided in the ordinary course of business; or
 
(3)           agreements providing for indemnification, adjustment of purchase price or similar obligations, or Guarantees or letters of credit, surety bonds or performance bonds securing any obligations of the Company or any of its Restricted Subsidiaries pursuant to such agreements, in any case Incurred in connection with the disposition of any business, assets or Restricted Subsidiary (other than Guarantees of Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or Restricted Subsidiary for the purpose of financing such acquisition), so long as the principal amount does
 
-12-

 
not to exceed the gross proceeds actually received by the Company or any Restricted Subsidiary in connection with such disposition.
 
Indenture” means this indenture, as amended or supplemented from time to time.
 
Indentures” means this Indenture, the 2015 Notes Indenture, the 2013 Notes Indenture and the 2011 Notes Indenture.
 
“Institutional Accredited Investor” means an institution that is an “accredited investor” as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act, who is not also a QIB.
 
Insurance Regulated Subsidiary” means any Subsidiary which conducts an insurance business such that it is regulated by any supervisory agency, state insurance department other state, federal or foreign insurance regulatory body or the National Association of Insurance Commissioners.
 
Intercreditor Agreement” mean an intercreditor agreement among the Company, the Collateral Agent and the representative under the Credit Facility, in form and substance reasonably satisfactory to Citadel, if Citadel holds a majority in principal amount of outstanding Notes and, otherwise, in all instances in the form agreed upon by the Company and the representative under the Credit Facility, which Intercreditor Agreement, among other things may contain (a) provisions permitting the holders of the first priority liens, without the consent of the Holders, to change, waive, modify or vary the Collateral Documents or release Collateral and (b) waivers of certain rights of the Holders in bankruptcy or insolvency procedures.
 
interest”, in respect of the Notes, unless the context otherwise requires, refers to interest and Additional Interest, if any.
 
Interest Payment Date” means May 31 and November 30 of each year commencing on May 31, 2008.
 
Interest Swap Obligations” means the obligations of any Person pursuant to any arrangement with any other Person, whereby, directly or indirectly, such Person is entitled to receive from time to time periodic payments calculated by applying either a floating or a fixed rate of interest on a stated notional amount in exchange for periodic payments made by such other Person calculated by applying a fixed or a floating rate of interest on the same notional amount and shall include, without limitation, interest rate swaps, caps, floors, collars and similar agreements.
 
Investment” in any Person means any direct or indirect advance, loan or other extension of credit (including, without limitation, by way of Guarantee or similar arrangement; but excluding Investment Securities, advances to customers or suppliers in the ordinary course of business that are, in conformity with GAAP, recorded as accounts receivable, prepaid expenses or deposits on the balance sheet of the Company or its Restricted Subsidiaries and endorsements for collection or deposit arising in the ordinary course of business) or capital contribution to (by means of any transfer of cash or other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Capital Stock, bonds, notes, debentures or other similar instruments issued by, such Person and shall include (1) the designation of a Restricted Subsidiary as an Unrestricted Subsidiary or as a Regulated Subsidiary and (2) the retention of the Capital Stock (or any other Investment) by the Company or any of its Restricted Subsidiaries, of (or in) any Person that has ceased to be a Restricted Subsidiary, including without limitation, by reason of any transaction permitted by clause (3) or (4) of Section 4.06. For purposes of the definition of “Unrestricted Subsidiary” and Section 4.04, (a) the amount of or a reduction in an Investment shall be equal to the Fair Market Value thereof at the time such Investment is made or
 
-13-

 
reduced and (b) in the event the Company or a Restricted Subsidiary makes an Investment by transferring assets to any Person and as part of such transaction receives Net Cash Proceeds, the amount of such Investment shall be the Fair Market Value of the assets less the amount of Net Cash Proceeds so received, provided the Net Cash Proceeds are applied in accordance with clause (A) or (B) of Section 4.11.
 
Investment Agreement” means the Master Investment and Securities Purchase Agreement, dated as of the date of this Indenture, between the Company and Citadel.
 
Investment Grade Status” shall occur when the Notes receive a rating of “BBB-” or higher from S&P or a rating of “Baa3” or higher from Moody’s.
 
Investment Securities” means marketable securities of a Person (other than an Affiliate or joint venture of the Company or any Restricted Subsidiary or any Regulated Subsidiary), mortgages, credit card and other loan receivables, futures contracts on marketable securities, interest rates and foreign currencies used for the hedging of marketable securities, mortgages or credit card and other loan receivables purchased, borrowed, sold, loaned or pledged by such Person in the ordinary course of its business.
 
Issue Date” means the date on which the Original Notes are originally issued under the Indenture.
 
Lien” means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including, without limitation, any conditional sale or other title retention agreement or lease in the nature thereof or any agreement to give any security interest).
 
Moody’s” means Moody’s Investors Service, Inc. and its successors.
 
Net Cash Proceeds” means:
 
(1)           with respect to any Asset Sale or Regulated Sale, the proceeds of such Asset Sale or Regulated Sale in the form of cash or cash equivalents, including payments in respect of deferred payment obligations (to the extent corresponding to the principal, but not interest, component thereof) when received in the form of cash or cash equivalents and proceeds from the conversion of other property received when converted to cash or cash equivalents, net of
 
(A)           brokerage commissions and other fees and expenses (including attorney’s fees, accountants’ fees, underwriters’, placement agents’ and other investment bankers’ fees, commissions and consultant fees) related to such Asset Sale or Regulated Sale;
 
(B)           provisions for all taxes (whether or not such taxes will actually be paid or are payable) as a result of such Asset Sale or Regulated Sale without regard to the consolidated results of operations of the Company and its Restricted Subsidiaries, taken as a whole, together with any actual distributions to shareholders of the type contemplated under clause (b)(9) under Section 4.04 with respect to the taxable income relating to such Asset Sale or Regulated Sale;
 
(C)           payments made to repay Indebtedness or any other obligation outstanding at the time of such Asset Sale or Regulated Sale that either (x) is secured by a Lien on the property or assets sold or (y) is required to be paid as a result of such sale and
 
(D)           appropriate amounts to be provided by the Company, any Restricted Subsidiary or any Regulated Subsidiary as a reserve against any liabilities associated with
 
-14-

 
such Asset Sale or Regulated Sale, including, without limitation, pension and other post-employment benefit liabilities, liabilities related to environmental matters and liabilities under any indemnification obligations associated with such Asset Sale or Regulated Sale, all as determined in conformity with GAAP; and
 
(2)           with respect to any issuance or sale of Capital Stock, the proceeds of such issuance or sale in the form of cash or cash equivalents, including payments in respect of deferred payment obligations (to the extent corresponding to the principal, but not interest, component thereof) when received in the form of cash or cash equivalents and proceeds from the conversion of other property received when converted to cash or cash equivalents, net of attorney’s fees, accountants’ fees, underwriters’ or placement agents’ fees, discounts or commissions and brokerage, consultant and other fees incurred in connection with such issuance or sale and net of taxes paid or payable as a result thereof.
 
Note Guarantee” means any Guarantee of the obligations of the Company under the Indenture and the Notes by any Subsidiary Guarantor.
 
Note Lien” means all Liens that secure the obligations under the Notes and the Subsidiary Guarantees.
 
Notes” has the meaning assigned to such term in the Recitals.
 
Obligations” means any principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities payable under the documentation governing any Indebtedness.
 
Offer to Purchase” means an offer to purchase Notes by the Company from the Holders commenced by mailing a notice to the Trustee and each Holder stating:
 
(1)           the covenant pursuant to which the offer is being made and that all Notes validly tendered will be accepted for payment on a pro rata basis;
 
(2)           the purchase price and the date of purchase (which shall be a Business Day no earlier than 30 days nor later than 60 days from the date such notice is mailed) (the “Payment Date”);
 
(3)           that any Note not tendered will continue to accrue interest pursuant to its terms;
 
(4)           that, unless the Company defaults in the payment of the purchase price, any Note accepted for payment pursuant to the Offer to Purchase shall cease to accrue interest on and after the Payment Date;
 
(5)           that Holders electing to have a Note purchased pursuant to the Offer to Purchase will be required to surrender the Note, together with the form entitled “Option of the Holder to Elect Purchase” on the reverse side of the Note completed, to the Paying Agent at the address specified in the notice prior to the close of business on the Business Day immediately preceding the Payment Date;
 
(6)           that Holders will be entitled to withdraw their election if the Paying Agent receives, not later than the close of business on the third Business Day immediately preceding the Payment Date, a telegram, facsimile transmission or letter setting forth the name of such
 
-15-

 
Holder, the principal amount of Notes delivered for purchase and a statement that such Holder is withdrawing his election to have such Notes purchased; and
 
(7)           that Holders whose Notes are being purchased only in part will be issued new Notes equal in principal amount to the unpurchased portion of the Notes surrendered; provided that each Note purchased and each new Note issued shall be in a principal amount of $1,000 or multiples of $1,000.
 
On the Payment Date, the Company shall (a) accept for payment on a pro rata basis Notes or portions thereof tendered pursuant to an Offer to Purchase; (b) deposit with the Paying Agent money sufficient to pay the purchase price of all Notes or portions thereof so accepted; and (c) deliver, or cause to be delivered, to the Trustee all Notes or portions thereof so accepted together with an Officers’ Certificate specifying the Notes or portions thereof accepted for payment by the Company. The Paying Agent shall promptly mail to the Holders of Notes so accepted payment in an amount equal to the purchase price, and the Trustee shall promptly authenticate and mail to such Holders a new Note equal in principal amount to any unpurchased portion of the Note surrendered; provided that each Note purchased and each new Note issued shall be in a principal amount of $1,000 or multiples of $1,000. The Company will publicly announce the results of an Offer to Purchase as soon as practicable after the Payment Date. The Trustee shall act as the Paying Agent for an Offer to Purchase. The Company will comply with Rule 14e-l under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws and regulations are applicable, if the Company is required to repurchase Notes pursuant to an Offer to Purchase.
 
Officer” means the chairman of the Board of Directors, the president or chief executive officer, any vice president, the chief financial officer, the treasurer or any assistant treasurer, or the secretary or any assistant secretary, of the Company.
 
Officers’ Certificate” means a certificate signed in the name of the Company (i) by the chairman of the Board of Directors, the president or chief executive officer or a vice president and (ii) by the chief financial officer, the treasurer or any assistant treasurer or the secretary or any assistant secretary.
 
Opinion of Counsel” means an opinion from legal counsel that meets the requirements of the Indenture.
 
Original Notes” means the Notes, in an aggregate principal amount not to exceed $1,786,000,000 (plus any Capitalized Interest), issued on the Issue Date and any Notes issued in replacement thereof.
 
OTS” means the Office of Thrift Supervision.
 
Outstanding Convertible Notes” means 6.00% convertible subordinated notes due February 2007, issued by the Company pursuant to the indenture dated February 1, 2000, outstanding on the Closing Date.
 
Paying Agent” refers to a Person engaged to perform the obligations of the Trustee in respect of payments made or funds held hereunder in respect of the Notes.
 
Permitted Investment” means:
 
(1)           an Investment in the Company or a Restricted Subsidiary or a Regulated Subsidiary or a Person which will, upon the making of such Investment, become a Restricted
 
-16-

 
Subsidiary or Regulated Subsidiary or be merged or consolidated with or into or transfer or convey all or substantially all its assets to, the Company or a Restricted Subsidiary or Regulated Subsidiary; provided that such person’s primary business is a Related Business on the date of such Investment;
 
(2)           Temporary Cash Investments and Investment Securities;
 
(3)           payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses in accordance with GAAP;
 
(4)           stock, obligations or securities received in satisfaction of judgments;
 
(5)           an Investment in an Unrestricted Subsidiary consisting solely of an Investment in another Unrestricted Subsidiary;
 
(6)           Hedging Obligations not entered into for speculative investment purposes and designed to protect the Company or its Restricted Subsidiaries or Regulated Subsidiaries against fluctuations in commodity prices, securities prices, foreign currency exchange rates or interest rates; and
 
(7)           any Investment made as a result of the receipt of non-cash consideration from an Asset Sale that was made pursuant to and in compliance with Section 4.11.
 
Permitted Liens” means:
 
(1)           Liens for taxes, assessments, governmental charges or claims that are not yet due or that are being contested in good faith by appropriate legal proceedings promptly instituted and diligently conducted and for which a reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made;
 
(2)           statutory and common law Liens of landlords and carriers, warehousemen, mechanics, suppliers, materialmen, repairmen or other similar Liens (including a lender’s unexercised rights of set-off) arising in the ordinary course of business and with respect to amounts not yet delinquent or being contested in good faith by appropriate legal proceedings promptly instituted and diligently conducted and for which a reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made;
 
(3)           Liens incurred or deposits made in the ordinary course of business in connection with workers’ compensation, unemployment insurance and other types of social security;
 
(4)           Liens incurred or deposits made to secure the performance of tenders, bids, leases, statutory or regulatory obligations, bankers’ acceptances, surety and appeal bonds, government contracts, performance and return-of-money bonds and other obligations of a similar nature incurred in the ordinary course of business (exclusive of obligations for the payment of borrowed money);
 
(5)           easements, rights-of-way, municipal and zoning ordinances and similar charges, encumbrances, title defects or other irregularities that do not materially interfere with the ordinary course of business of the Company or any of its Restricted Subsidiaries;
 
-17-

 
(6)           leases or subleases granted to others that do not materially interfere with the ordinary course of business of the Company and its Restricted Subsidiaries, taken as a whole;
 
(7)           Liens encumbering property or assets under construction arising from progress or partial payments by a customer of the Company or its Restricted Subsidiaries relating to such property or assets;
 
(8)           any interest or title of a lessor in the property subject to any Capitalized Lease or operating lease;
 
(9)           Liens arising from filing Uniform Commercial Code financing statements regarding leases;
 
(10)         Liens on property of, or on shares of Capital Stock or Indebtedness of, any Person existing at the time such Person becomes, or becomes a part of, any Restricted Subsidiary; provided that such Liens do not extend to or cover any property or assets of the Company or any Restricted Subsidiary other than the property or assets acquired;
 
(11)          Liens in favor of the Company or any Restricted Subsidiary;
 
(12)          Liens arising from the rendering of a final judgment or order against the Company or any Restricted Subsidiary that does not give rise to an Event of Default;
 
(13)          Liens securing reimbursement obligations with respect to letters of credit that encumber documents and other property relating to such letters of credit and the products and proceeds thereof;
 
(14)          Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods;
 
(15)           Liens encumbering customary initial deposits and margin deposits, and other Liens that are within the general parameters customary in the industry and incurred in the ordinary course of business, in each case, securing Indebtedness under Hedging Obligations not entered into for speculative investment purposes and designed to protect the Company or any of its Restricted Subsidiaries from fluctuations in interest rates, currencies or the price of commodities or securities;
 
(16)            Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business in accordance with the past practices of the Company and its Restricted Subsidiaries prior to the Closing Date;
 
(17)            Liens on shares of Capital Stock of any Unrestricted Subsidiary to secure Indebtedness of such Unrestricted Subsidiary; and
 
(18)            Liens on or sales of receivables or mortgages in the ordinary course of business of the Company and its Subsidiaries.
 
-18-

 
Person” means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.
 
PIK Preferred Stock” means Preferred Stock the terms of which do not permit the declaration or payment of any dividend or other distribution thereon or with respect thereto, or the redemption or conversion thereof, in each such case prior to the payment in full of the Company’s obligations under the Notes.
 
Preferred Stock” of any Person means any Capital Stock of such Person that has preferential rights to any other Capital Stock of such Person with respect to dividends or redemptions or upon liquidation.
 
“Purchase Money Indebtedness” means indebtedness (1) incurred to finance the cost (including the cost of improvement or construction and fees and expenses related to the acquisition) of real or personal property acquired after the Closing Date, provided that (a) the amount of such indebtedness does not exceed 100% of such cost, and (b) such indebtedness is incurred prior to, at the time of, or within twelve months after the later of the acquisition, the completion of construction or the commencement of full operation of such property; or (2) issued in exchange for, or the net proceeds of which are used to refinance or refund, then outstanding Purchase Money Indebtedness and any refinancings or refundings thereof in accordance with Section 4.03(a)(3).  The term “Indebtedness” for purposes of Section 4.03(a)(3) and clauses (4) and (6) of the second paragraph of Section 4.09, shall be deemed to include “Purchase Money Indebtedness.”
 
Puttable Notes” means Notes held by Purchaser (as defined in the Investment Agreement) or any of its affiliates which are subject to put rights pursuant to Section 4.16 of the Investment Agreement.
 
QIB” means a “qualified institutional buyer” (as defined in Rule 144A).
 
QIB Global Note” means a Note offered in reliance on Rule 144A.
 
Register” has the meaning assigned to such term in Section 2.09.
 
Registrar” means a Person engaged to maintain the Register.
 
Regular Record Date” for the interest payable on any Interest Payment Date means the May 15 or November 15 (whether or not a Business Day) next preceding such Interest Payment Date.
 
Regulated Sale” means any sale, transfer or other disposition (including by way of merger, consolidation or Sale-Leaseback Transaction) in one transaction or a series of related transactions by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries to any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of:
 
(1)           all or any of the Common Stock of any Regulated Subsidiary that constitutes a Significant Subsidiary, or
 
(2)           all or substantially all of the property and assets of an operating unit or business of any Regulated Subsidiary that constitutes a Significant Subsidiary,
 
in each case, that is not governed by the provisions of the Indenture applicable to mergers, consolidations and sales of assets of the Company; provided that “Regulated Sale” shall not include an issuance, sale,
 
-19-

 
transfer or other disposition of Capital Stock by a Regulated Subsidiary to the Company, a Wholly Owned Restricted Subsidiary or a Wholly Owned Regulated Subsidiary.

Regulated Subsidiary” means a Broker Dealer Regulated Subsidiary, a Bank Regulated Subsidiary or an Insurance Regulated Subsidiary or any other Subsidiary subject to minimum capital requirements or other similar material regulatory requirements imposed by applicable regulatory authorities.
 
Regulation S” means Regulation S under the Securities Act.
 
Regulation S Global Note” means a Note offered in offshore transactions in reliance on Regulation S.
 
Related Business” means any financial services business which is the same as or ancillary or complementary to any business of the Company and its Restricted Subsidiaries and Regulated Subsidiaries that is being conducted on the Closing Date, including, but not limited to, activities under Section 4(k) of the Bank Holding Company Act, as amended, or Section 10 of the Home Owners’ Loan Act, as amended, broker-dealer services, insurance, investment advisory services, specialist and other market making activities, trust services, underwriting and the creation of and offers and sales of interests in mutual funds.
 
Replacement Assets” means, on any date, property or assets (other than current assets) of a nature or type or that are used in a business (or an Investment in a company having property or assets of a nature or type, or engaged in a business) similar or related to the nature or type of the property and assets of, or the business of, the Company and its Restricted Subsidiaries existing on such date.
 
Resale Restriction Termination Date” means for any Transfer Restricted Note (or beneficial interest therein), that is (a) not a Regulation S Global Note (or Certificated Note issued in respect thereof pursuant to this Indenture), two years (or such other period specified in Rule 144(k) under the Securities Act) from the Issue Date and (b) a Regulation S Global Note (or Certificated Note issued in respect thereof pursuant to this Indenture), the date on or after the 40th consecutive day beginning on and including the later of (i) the day on which any Notes represented thereby are offered to persons other than distributors (as defined in Regulation S) pursuant to Regulation S and (ii) the issue date for such Notes.
 
Responsible Officer” shall mean, when used with respect to the Trustee, any officer within the corporate trust department of the Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.
 
Restricted Notes Legend” means the legend set forth on Exhibit D hereto.
 
Restricted Subsidiary” means any Subsidiary of the Company other than an Unrestricted Subsidiary, or a Regulated Subsidiary.
 
Rule 144A” means Rule 144A under the Securities Act.
 
Sale-Leaseback Transaction” means, with respect to any Person, an arrangement whereby such Person sells or transfers property and then or thereafter leases such property or any substantial part thereof which such Person intends to use for substantially the same purpose or purposes as the property sold or
 
-20-

 
transferred, provided that for purposes of this definition, “property” shall not include Investment Securities.
 
S&P” means Standard & Poor’s Ratings Group, a division of The McGraw-Hill Companies, and its successors.
 
Secured Indebtedness Cap” means, on any date, an amount equal to 1.0 times the Consolidated EBITDA of the Company for the most recently ended Four Quarter Period for which financial statements are available immediately preceding such date. For purposes of making the computation referred to above, Consolidated EBITDA shall be calculated after giving effect on a pro forma basis for the period of such calculation to any Asset Sales or Asset Acquisitions (including, without limitation, any Asset Acquisition giving rise to the need to make such calculation as a result of such Person or one of its Restricted Subsidiaries or Regulated Subsidiaries (including any Person who becomes a Restricted Subsidiary or Regulated Subsidiary as a result of the Asset Acquisition) incurring, assuming or otherwise being liable for Acquired Indebtedness and also including any Consolidated EBITDA attributable to the assets which are the subject of the Asset Acquisition or Asset Sale during the Four Quarter Period) occurring during the Four Quarter Period or at any time subsequent to the last day of the Four Quarter Period and on or prior to the date of such calculation, as if such Asset Sale or Asset Acquisition (including the incurrence, assumption or liability for any such Acquired Indebtedness) occurred on the first day of the Four Quarter Period.
 
Securities Act” means the Securities Act of 1933, as amended.
 
Significant Subsidiary” means, at any date of determination, any Restricted Subsidiary that, together with its Subsidiaries, (1) for the most recent fiscal year of the Company, accounted for more than 10% of the consolidated revenues of the Company and its Restricted Subsidiaries or (2) as of the end of such fiscal year, was the owner of more than 10% of the consolidated assets of the Company and its Restricted Subsidiaries, all as set forth on the most recently available consolidated financial statements of the Company for such fiscal year.
 
Stated Maturity” means, (1) with respect to any debt security, the date specified in such debt security as the fixed date on which the final installment of principal of such debt security is due and payable and (2) with respect to any scheduled installment of principal of or interest on any debt security, the date specified in such debt security as the fixed date on which such installment is due and payable.
 
Stock Loan” means a “Loan” as used in the Master Securities Loan Agreement published from time to time by the Bond Market Association.
 
Subsidiary” means, with respect to any Person, any corporation, association or other business entity of which more than 50% of the voting power of the outstanding Voting Stock is owned, directly or indirectly, by such Person and one or more other Subsidiaries of such Person.
 
Subsidiary Guarantor” means any Domestic Subsidiary which provides a Note Guarantee of the Company’s obligations under the Indenture and the Notes pursuant to Section 4.07.
 
Temporary Cash Investment” means any of the following:
 
(1)           direct obligations of the United States of America or any agency thereof or obligations fully and unconditionally guaranteed by the United States of America or any agency thereof, in each case maturing within one year unless such obligations are deposited by the
 
-21-

 
Company (x) to defease any Indebtedness or (y) in a collateral or escrow account or similar arrangement to prefund the payment of interest on any indebtedness;
 
(2)           demand deposits, time deposit accounts, bankers acceptances, certificates of deposit and money market deposits maturing within 180 days of the date of acquisition thereof issued by a bank or trust company which is organized under the laws of the United States of America, any state thereof or any foreign country recognized by the United States of America, and which bank or trust company (i) has capital, surplus and undivided profits aggregating in excess of $100 million (or the foreign currency equivalent thereof) and has outstanding debt which is rated “A” (or such similar equivalent rating) or higher by at least one nationally recognized statistical rating organization (as defined in Rule 436 under the Securities Act) or (ii) is a money market fund sponsored by a registered broker dealer or mutual fund distributor;
 
(3)           repurchase obligations with a term of not more than 30 days for underlying securities of the types described in clause (1) above entered into with a bank or trust company meeting the qualifications described in clause (2) above;
 
(4)           commercial paper, maturing not more than one year after the date of acquisition, issued by a corporation (other than an Affiliate of the Company) organized and in existence under the laws of the United States of America, any state thereof or any foreign country recognized by the United States of America with a rating at the time as of which any investment therein is made of “P- 1” (or higher) according to Moody’s or “A l” (or higher) according to S&P;
 
(5)           securities with maturities of six months or less from the date of acquisition issued or fully and unconditionally guaranteed by any state, commonwealth or territory of the United States of America, or by any political subdivision or taxing authority thereof, and rated at least “A” by S&P or Moody’s; and
 
(6)           any mutual fund that has at least 95% of its assets continuously invested in investments of the types described in clauses (1) through (5) above.
 
Trade Payables” means, with respect to any Person, any accounts payable or any other indebtedness or monetary obligation to trade creditors created, assumed or Guaranteed by such Person or any of its Subsidiaries arising in the ordinary course of business in connection with the acquisition of goods or services.
 
Transaction Date” means, with respect to the Incurrence of any Indebtedness, the date such Indebtedness is to be Incurred and, with respect to any Restricted Payment, the date such Restricted Payment is to be made.
 
Transfer Restricted Notes” means Notes that bear or are required to bear the Restricted Notes Legend.
 
Trigger Date” means the earlier of (a) the first date on which the Company is allowed to grant Liens to secure Indebtedness in excess of $300,000,000 under the 2011 Notes without granting equal and ratable security to the noteholders of the 2015 Notes, 2013 Notes and/or 2011 Notes and (b) the date of the redemption of the 2011 Notes.
 
Trustee” means the party named as such in the first paragraph of the Indenture or any successor trustee under the Indenture pursuant to Article 7.
 
-22-

 
Trust Indenture Act” means the Trust Indenture Act of 1939, as amended.
 
Unrestricted Subsidiary” means (1) any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors in the manner provided below; and (2) any Subsidiary of an Unrestricted Subsidiary. The Board of Directors may designate any Restricted Subsidiary or Regulated Subsidiary (including any newly acquired or newly formed Subsidiary of the Company) to be an Unrestricted Subsidiary unless such Subsidiary owns any Capital Stock of, or owns or holds any Lien on any property of, the Company or any Restricted Subsidiary; provided that (A) any Guarantee by the Company or any Restricted Subsidiary of any Indebtedness of the Subsidiary being so designated shall be deemed an “Incurrence” of such Indebtedness and an “Investment” by the Company or such Restricted Subsidiary (or both, if applicable) at the time of such designation; (B) either (I) the Subsidiary to be so designated has total assets of $1,000 or less or (II) if such Subsidiary has assets greater than $1,000, such designation would be permitted under Section 4.04 and (C) if applicable, the Incurrence of Indebtedness and the Investment referred to in clause (A) of this proviso would be permitted under the Section 4.03 and Section 4.04. The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that (a) no Default or Event of Default shall have occurred and be continuing at the time of or after giving effect to such designation and (b) all Liens and Indebtedness of such Unrestricted Subsidiary outstanding immediately after such designation would, if Incurred at such time, have been permitted to be Incurred (and shall be deemed to have been Incurred) for all purposes of the Indenture. Any such designation by the Board of Directors shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the Board Resolution giving effect to such designation and an Officers’ Certificate certifying that such designation complied with the foregoing provisions.
 
U.S. Government Obligations” means securities that are (1) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or (2) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America, which, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to the Stated Maturity of the Notes, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment of interest on or principal of the U.S. Government Obligation evidenced by such depository receipt.
 
Voting Stock” means with respect to any Person, Capital Stock of any class or kind ordinarily having the power to vote for the election of directors, managers or other voting members of the governing body of such Person.
 
Well Capitalized” means “well capitalized” within the meaning of 12 U.S.C. §1831o, as determined by a particular Bank Regulated Subsidiary’s appropriate federal banking agency, but in no event less than the amount required in a capital directive or other capital requirement by a federal banking agency.
 
Wholly Owned” means, with respect to any Subsidiary of any Person, the ownership all of the outstanding Capital Stock of such Subsidiary by such Person or one or more Wholly Owned Subsidiaries of such Person.
 
-23-

 
Section 1.02.    Incorporation by Reference of Trust Indenture Act.  Whenever this Indenture refers to a provision of the Trust Indenture Act of 1939, as amended (the “TIA”), the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings:
 
“indenture securities” means the Notes;
 
“indenture security holder” means a Holder or a Noteholder;
 
“indenture to be qualified” means this Indenture;
 
“indenture trustee” or “institutional trustee” means the Trustee; and
 
“obligor” on the indenture securities means the Company or any other obligor on the Notes.
 
All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by a rule of the Commission and not otherwise defined herein have the meanings assigned to them therein.
 
Section 1.03.           Rules of Construction.  Unless the context otherwise requires:
 
(a)           a term has the meaning assigned to it;
 
(b)           an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;
 
(c)           “or” is not exclusive;
 
(d)           words in the singular include the plural, and words in the plural include the singular;
 
(e)           provisions apply to successive events and transactions;
 
(f)           “herein,” “hereof” and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision;
 
(g)           all ratios and computations based on GAAP contained in this Indenture shall be computed in accordance with the definition of GAAP set forth in Section 1.01; and
 
(h)           all references to Sections or Articles refer to Sections or Articles of this Indenture unless otherwise indicated.
 
ARTICLE II
 
THE NOTES
 
Section 2.01.      Form, Dating and Denominations.  The Notes and the Trustee’s certificate of authentication will be substantially in the form attached as Exhibit A.  The terms and provisions contained in the form of the Notes annexed as Exhibit A constitute, and are hereby expressly made, a part of the Indenture.  The Notes may have notations, legends or endorsements required by law, rules of or agreements with national securities exchanges to which the Company is subject, or usage.  Each Note will be dated the date of its authentication.  The Notes will be issuable in denominations  of $1,000 in
 
-24-

 
principal amount and any multiple of $1,000 in excess thereof.
 
Section 2.02.      Execution and Authentication.
 
(a)           An Officer shall execute the Notes for the Company by facsimile or manual signature in the name and on behalf of the Company.  If an Officer whose signature is on a Note no longer holds that office at the time the Note is authenticated, the Note will still be valid.
 
(b)           A Note will not be valid until the Trustee manually signs the certificate of authentication on the Note, with the signature conclusive evidence that the Note has been authenticated under the Indenture.
 
(c)           At any time and from time to time after the execution and delivery of the Indenture, the Company may deliver Notes executed by the Company to the Trustee for authentication.  The Trustee will authenticate and deliver Original Notes for original issue in the aggregate principal amount not to exceed $1,786,000,000 (plus any Capitalized Interest) and Additional Notes in the aggregate principal amount not to exceed $150,000,000 (plus any Capitalized Interest) upon receipt by the Trustee of an Officers’ Certificate specifying:
 
 
(i)
the amount of Notes to be authenticated and the date on which the Notes are to be authenticated;
 
 
(ii)
whether the Notes are to be issued as one or more Global Notes or Certificated Notes; and
 
 
(iii)
other information the Company may determine to include or the Trustee may reasonably request.
 
The Notes shall be issuable only in registered form without coupons and only in denominations of $1,000 in principal amount and any integral multiple thereof. Notwithstanding the foregoing, the Company may not issue and the Trustee may not authenticate Additional Notes unless the Final Closing has occurred.
 
Section 2.03.           Registrar, Paying Agent and Authenticating Agent; Paying Agent to Hold Money in Trust.
 
(a)           The Company may appoint one or more Registrars and one or more Paying Agents, and the Trustee may appoint an Authenticating Agent, in which case each reference in the Indenture to the Trustee in respect of the obligations of the Trustee to be performed by that Agent will be deemed to be references to the Agent.  The Company may act as Registrar or (except for purposes of Article 8) Paying Agent.  In each case the Company and the Trustee will enter into an appropriate agreement with the Agent implementing the provisions of the Indenture relating to the obligations of the Trustee to be performed by the Agent and the related rights.  The Company initially appoints the Trustee as Registrar and Paying Agent.
 
(b)           The Company will require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust for the benefit of the Holders or the Trustee all money held by the Paying Agent for the payment of principal of and interest on the Notes and will promptly notify the Trustee of any default by the Company in making any such payment.  If the Company or any Subsidiary acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund.  The Company at any time may require a
 
-25-

 
Paying Agent to pay all money held by it to the Trustee and account for any funds disbursed, and the Trustee may at any time during the continuance of any payment default, upon written request to a Paying Agent, require the Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed. Upon doing so, the Paying Agent will have no further liability for the money so paid over to the Trustee.
 
Section 2.04.    Replacement Notes.  If a mutilated Note is surrendered to the Trustee or if a Holder claims that its Note has been lost, destroyed or wrongfully taken, the Company will issue and the Trustee will authenticate a replacement Note of like tenor and principal amount and bearing a number not contemporaneously outstanding. Every replacement Note is an additional obligation of the Company and entitled to the benefits of the Indenture; provided that (i) the requirements of Section 8-405 of the Uniform Commercial Code are met, such that the Holder (a) satisfies the Company that such requirements have been met within a reasonable time after such Holder has notice of such loss, destruction or wrongful taking and the Registrar does not register a transfer prior to receiving such notification, (b) makes such request to the Company prior to the Note being acquired by a protected purchaser as defined in Section 8-303 of the Uniform Commercial Code (a “protected purchaser”) and (c) satisfies any other reasonable requirements of the Trustee, and (ii) the requirements of this Section 2.04 are met.  An affidavit of lost certificate and an indemnity bond must be furnished that is sufficient in the judgment of both the Trustee and the Company to protect the Company, the Trustee or any Agent from any loss that any of them may suffer if a Note is replaced.  The Company may charge the Holder for the expenses of the Company and the Trustee in replacing a Note. In case the mutilated, lost, destroyed or wrongfully taken Note has become or is about to become due and payable, the Company in its discretion may pay the Note instead of issuing a replacement Note.
 
Section 2.05.    Outstanding Notes
 
(a)           Notes outstanding at any time are all Notes that have been authenticated by the Trustee except for:
 
 
(i)
Notes cancelled by the Trustee or delivered to it for cancellation;
 
 
(ii)
any Note which has been replaced pursuant to Section 2.04 unless and until the Trustee and the Company receive proof satisfactory to them that the replaced Note is held by a bona fide purchaser; and
 
 
(iii)
on or after the maturity date or any redemption date or date for purchase of the Notes pursuant to an Offer to Purchase, those Notes payable or to be redeemed or purchased on that date for which the Trustee (or Paying Agent, other than the Company or an Affiliate of the Company) holds money sufficient to pay all amounts then due.
 
(b)           A Note does not cease to be outstanding because the Company or one of its Affiliates holds the Note, provided that in determining whether the Holders of the requisite principal amount of the outstanding Notes have given or taken any request, demand, authorization, direction, instruction, notice, consent, waiver or other action hereunder, Notes owned by the Company or any Affiliate of the Company will be disregarded and deemed not to be outstanding, (it being understood that in determining whether the Trustee is protected in relying upon any such request, demand, authorization, direction, notice, consent, waiver or other action, only Notes which the Trustee knows to be so owned will be so disregarded).  Notes so owned which have been pledged in good faith may be regarded as outstanding if the pledgee
 
-26-

 
establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Notes and that the pledgee is not the Company or any Affiliate of the Company.
 
Section 2.06.     Temporary Notes.  Until definitive Notes are ready for delivery, the Company may prepare and the Trustee will authenticate temporary Notes.  Temporary Notes will be substantially in the form of definitive Notes but may have insertions, substitutions, omissions and other variations determined to be appropriate by the Officer executing the temporary Notes, as evidenced by the execution of the temporary Notes.  If temporary Notes are issued, the Company will cause definitive Notes to be prepared without unreasonable delay. After the preparation of definitive Notes, the temporary Notes will be exchangeable for definitive Notes upon surrender of the temporary Notes at the office or agency of the Company designated for the purpose pursuant to Section 4.02, without charge to the Holder.  Upon surrender for cancellation of any temporary Notes the Company will execute and the Trustee will authenticate and deliver in exchange therefor a like principal amount of definitive Notes of authorized denominations.  Until so exchanged, the temporary Notes will be entitled to the same benefits under the Indenture as definitive Notes.
 
Section 2.07.     Cancellation.  The Company at any time may deliver to the Trustee for cancellation any Notes previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and may deliver to the Trustee for cancellation any Notes previously authenticated hereunder which the Company has not issued and sold.  Any Registrar or the Paying Agent will forward to the Trustee any Notes surrendered to it for transfer, exchange or payment.  The Trustee will cancel all Notes surrendered for transfer, exchange, payment or cancellation and dispose of them in accordance with its normal procedures or the written instructions of the Company.  The Company may not issue new Notes to replace Notes it has paid in full or delivered to the Trustee for cancellation.
 
Section 2.08.     CUSIP and CINS Numbers.  The Company in issuing the Notes may use “CUSIP” and “CINS” numbers, and the Trustee will use CUSIP numbers or CINS numbers in notices of redemption or exchange or in Offers to Purchase as a convenience to Holders, the notice to state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of redemption or exchange or Offer to Purchase.  The Company will promptly notify the Trustee in writing of any change in the CUSIP or CINS numbers.
 
Section 2.09.    Registration, Transfer and Exchange.
 
(a)           The Notes will be issued in registered form only, without coupons, and the Company shall cause the Trustee to maintain a register (the “Register”) of the Notes, for registering the record ownership of the Notes by the Holders and transfers and exchanges of the Notes.
 
(b)           (1)           Each Global Note will be registered in the name of the Depositary or its nominee and, so long as DTC is serving as the Depositary thereof, will bear the DTC Legend.
 
(2)           Each Global Note will be delivered to the Trustee as custodian for the Depositary. Transfers of a Global Note (but not a beneficial interest therein) will be limited to transfers thereof in whole, but not in part, to the Depositary, its successors or their respective nominees, except (1) as set forth in Section 2.09(b)(4) and (2) transfers of portions thereof in the form of Certificated Notes may be made upon request of an Agent Member (for itself or on behalf of a beneficial owner) by written notice given to the Trustee by or on behalf of the Depositary in accordance with customary procedures of the Depositary and in compliance with this Section 2.09 and Section 2.10.
 
(3)           Agent Members will have no rights under the Indenture with respect to any Global Note held on their behalf by the Depositary, and the Depositary may be treated by the Company,
 
-27-

 
the Trustee and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, the Depositary or its nominee may grant proxies and otherwise authorize any Person (including any Agent Member and any Person that holds a beneficial interest in a Global Note through an Agent Member) to take any action which a Holder is entitled to take under the Indenture or the Notes, and nothing herein will impair, as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of a holder of any security.
 
(4)           If (x) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for a Global Note and a successor depositary is not appointed by the Company within 90 days of the notice or (y) an Event of Default has occurred and is continuing and the Trustee has received a request from the Depositary, the Trustee will promptly exchange each beneficial interest in the Global Note for one or more Certificated Notes in authorized denominations having an equal aggregate principal amount registered in the name of the owner of such beneficial interest, as identified to the Trustee by the Depositary, and thereupon the Global Note will be deemed canceled.
 
(c)           Each Certificated Note will be registered in the name of the holder thereof or its nominee.
 
(d)           A Holder may transfer a Note (or a beneficial interest therein) to another Person or exchange a Note (or a beneficial interest therein) for another Note or Notes of any authorized denomination by presenting to the Trustee a written request therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other document required by Section 2.10. The Trustee will promptly register any transfer or exchange that meets the requirements of this Section 2.09 by noting the same in the register maintained by the Trustee for the purpose; provided that
 
(x) no transfer or exchange will be effective until it is registered in such register; and

(y) the Trustee will not be required (i) to issue, register the transfer of or exchange any Note for a period of 15 days before a selection of Notes to be redeemed or purchased pursuant to an Offer to Purchase, (ii) to register the transfer of or exchange any Note so selected for redemption or purchase in whole or in part, except, in the case of a partial redemption or purchase, that portion of any Note not being redeemed or purchased, or (iii) if a redemption or a purchase pursuant to an Offer to Purchase is to occur after a Regular Record Date but on or before the corresponding Interest Payment Date, to register the transfer of or exchange any Note on or after the Regular Record Date and before the date of redemption or purchase. Prior to the registration of any transfer, the Company, the Trustee and their agents will treat the Person in whose name the Note is registered as the owner and Holder thereof for all purposes (whether or not the Note is overdue), and will not be affected by notice to the contrary.

From time to time the Company will execute and the Trustee will authenticate additional Notes as necessary in order to permit the registration of a transfer or exchange in accordance with this Section 2.09.
 
No service charge will be imposed in connection with any transfer or exchange of any Note, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than a transfer tax or other similar governmental charge payable upon exchange pursuant to subsection (b)(4)).
 
-28-

 
(e)           (1)          Global Note to Global Note.  If a beneficial interest in a Global Note is transferred or exchanged for a beneficial interest in another Global Note, the Trustee will (x) record a decrease in the principal amount of the Global Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the principal amount of the other Global Note. Any beneficial interest in one Global Note that is transferred to a Person who takes delivery in the form of an interest in another Global Note, or exchanged for an interest in another Global Note, will, upon transfer or exchange, cease to be an interest in such Global Note and become an interest in the other Global Note and, accordingly, will thereafter be subject to all transfer and exchange restrictions, if any, and other procedures applicable to beneficial interests in such other Global Note for as long as it remains such an interest.
 
(2)           Global Note to Certificated Note.  If a beneficial interest in a Global Note is transferred or exchanged for a Certificated Note, the Trustee will (x) record a decrease in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and (y) deliver one or more new Certificated Notes in authorized denominations having an equal aggregate principal amount to the transferee (in the case of a transfer) or the owner of such beneficial interest (in the case of an exchange), registered in the name of such transferee or owner, as applicable.
 
(3)           Certificated Note to Global Note.  If a Certificated Note is transferred or exchanged for a beneficial interest in a Global Note, the Trustee will (x) cancel such Certificated Note, (y) record an increase in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and (z) in the event that such transfer or exchange involves less than the entire principal amount of the canceled Certificated Note, deliver to the Holder thereof one or more new Certificated Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Certificated Note, registered in the name of the Holder thereof.
 
(4)           Certificated Note to Certificated Note.  If a Certificated Note is transferred or exchanged for another Certificated Note, the Trustee will (x) cancel the Certificated Note being transferred or exchanged, (y) deliver one or more new Certificated Notes in authorized denominations having an aggregate principal amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the canceled Certificated Note (in the case of an exchange), registered in the name of such transferee or Holder, as applicable, and (z) if such transfer or exchange involves less than the entire principal amount of the canceled Certificated Note, deliver to the Holder thereof one or more Certificated Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Certificated Note, registered in the name of the Holder thereof.
 
Section 2.10.           Restrictions on Transfer and Exchange.  The transfer or exchange of any Note (or a beneficial interest therein) may only be made in accordance with Section 2.09 and Section 2.11 and, in the case of a Global Note (or a beneficial interest therein), the applicable rules and procedures of the Depositary.  The Trustee shall refuse to register any requested transfer or exchange that does not comply with the preceding sentence.
 
Section 2.11.           Special Transfer Provisions.  Each Note issued pursuant to an exemption from registration under the Securities Act will constitute a Transfer Restricted Note and be required to bear the Restricted Notes Legend until the expiration of the Resale Restriction Termination Date therefor, unless and until such Transfer Restricted Note is transferred or exchanged pursuant to an effective registration statement under the Securities Act.  The following provisions shall apply to the transfer of a Transfer Restricted Note:
 
-29-

 
(a)           Transfers to QIBs.  The following provisions shall apply with respect to the registration of any proposed transfer of a Transfer Restricted Note or a beneficial interest therein (other than pursuant to Regulation S or to an Institutional Accredited Investor):
 
(i)           The Registrar shall register the transfer of a Transfer Restricted Note by a Holder to a QIB if such transfer is being made by a proposed transferor who has provided the Registrar with (a) an appropriately completed certificate of transfer in the form attached to the Note and (b) a letter substantially in the form set forth in Exhibit E hereto.
 
(ii)           If the proposed transferee is an Agent Member and the Transfer Restricted Note to be transferred consists of an interest in the Regulation S Global Note or the IAI Global Note, as the case may be, upon receipt by the Registrar of (x) the items required by paragraph (i) above and (y) instructions given in accordance with the Depositary’s and the Registrar’s procedures therefor, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the QIB Global Note in an amount equal to the principal amount of the beneficial interest in the Regulation S Global Note or the IAI Global Note, as applicable, to be so transferred, and the Registrar shall reflect on its books and records the date and an appropriate decrease in the principal amount of such Regulation S Global Note or IAI Global Note, as applicable.
 
(b)           Transfers Pursuant to Regulation S.  The following provisions shall apply with respect to registration of any proposed transfer of a Transfer Restricted Note or a beneficial interest therein pursuant to Regulation S:
 
(i)           The Registrar shall register any proposed transfer of a Transfer Restricted Note pursuant to Regulation S by a Holder upon receipt of (a) an appropriately completed certificate of transfer in the form attached to the Note and (b) a letter substantially in the form set forth in Exhibit F hereto from the proposed transferor.
 
(ii)           If the proposed transferee is an Agent Member holding a beneficial interest in the QIB Global Note or the IAI Global Note, as the case may be, and the Transfer Restricted Note to be transferred consists of an interest in the QIB Global Note or the IAI Global Note, as the case may be, upon receipt by the Registrar of (x) the letter, if any, required by paragraph (i) above and (y) instructions in accordance with the Depositary’s and the Registrar’s procedures therefor, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the Regulation S Global Note in an amount equal to the principal amount of the beneficial interest in the QIB Global Note or the IAI Global Note, as applicable, to be transferred, and the Registrar shall reflect on its books and records the date and an appropriate decrease in the principal amount of the QIB Global Note or the IAI Global Note, as applicable.
 
(c)           Transfers Pursuant to Registration under Securities Act.  Upon the sale of Notes pursuant to an effective registration under the Securities Act, the Company shall issue an Officers’ Certificate stating that the registration statement with respect to such registration has been declared effective and containing such other information as is required by Section 2.02(c), and, upon receipt of such Officer’s Certificate, the Trustee shall authenticate (i) one or more Global Notes that do not bear the Restricted Notes Legend in an aggregate principal amount equal to the principal amount of the beneficial interests in the Global Notes constituting Transfer Restricted Notes sold pursuant to such registration and (ii) Certificated Notes that do not bear the Restricted Notes Legend in an aggregate principal amount equal to the principal amount of the
 
-30-

 
Certificated Notes constituting Transfer Restricted Notes sold in such registration.  Concurrently with the issuance of such Notes, the Trustee shall cause the aggregate principal amount of the Global Notes constituting Transfer Restricted Notes to be reduced accordingly, and the Trustee shall deliver to the Persons designated by the Holders of Global Notes or Certificated Notes constituting Transfer Restricted Notes so sold the Global Notes or Certificated Notes that do not bear the Restricted Notes Legend issued and authenticated in accordance with the preceding sentence in the appropriate principal amount.
 
(d)           Transfers to Institutional Accredited Investors.  The following provisions shall apply with respect to the registration of any proposed transfer of a Transfer Restricted Note or a beneficial interest therein to an Institutional Accredited Investor:
 
(i)           The Registrar shall register the transfer of an IAI Global Note by a Holder upon receipt of (a) an appropriately completed certificate of transfer in the form attached to the Note, (b) a letter from a transferee to the Registrar in the form of Exhibit G hereto, including the certifications, certificates and Opinion of Counsel required thereby, if applicable and (c) a certificate from the acquiring Institutional Accredited Investor in the form of Exhibit H hereto.
 
(ii)           If the proposed transferee is an Agent Member and the Transfer Restricted Note to be transferred consists of an interest in the Regulation S Global Note or the QIB Global Note, as the case may be, upon receipt by the Registrar of (x) the items required by paragraph (i) above and (y) instructions given in accordance with the Depositary’s and the Registrar’s procedures therefor, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the IAI Global Note in an amount equal to the principal amount of the beneficial interest in the Regulation S Global Note or the QIB Global Note, as applicable, to be so transferred, and the Registrar shall reflect on its books and records the date and an appropriate decrease in the principal amount of the Regulation S Global Note or the QIB Global Note, as applicable.
 
(e)           Restricted Notes Legend.  Upon the transfer, exchange or replacement of Notes not bearing the Restricted Notes Legend, the Registrar shall deliver Notes that do not bear the Restricted Notes Legend.  Upon the transfer, exchange or replacement of Notes bearing the Restricted Notes Legend, the Registrar shall deliver only Notes that bear the Restricted Notes Legend unless there is delivered to the Registrar an Opinion of Counsel reasonably satisfactory to the Company and the Trustee to the effect that neither such legend nor the related restrictions on transfer are required in order to maintain compliance with the provisions of the Securities Act.
 
(f)           General.  By its acceptance of any Note bearing the Restricted Notes Legend, each Holder of such a Note acknowledges the restrictions on transfer of such Note set forth in this Indenture and in the Restricted Notes Legend and agrees that it shall transfer such Note only as provided in this Indenture.  A transfer of a beneficial interest in a Global Note that does not involve an exchange of such interest for a Certificated Note or a beneficial interest in another Global Note shall be subject to compliance with applicable law and the applicable procedures of the Depositary, but is not subject any procedure required by this Indenture.
 
The Registrar shall retain copies of all letters, notices and other written communications received pursuant to this Section 2.11.
 
 
-31-

 
ARTICLE III
 
REDEMPTION, OFFER TO PURCHASE
 
Section 3.01.      Optional Redemption.  At any time and from time to time on or after November 30, 2012, the Company may redeem the Notes, in whole or in part, at a redemption price equal to the percentage of principal amount set forth below plus accrued and unpaid interest to the redemption date.
 
12-month period commencing December 1,
 
Percentage
     
2012
 
112.500%
2013
 
109.375%
2014
 
106.250%
2015
 
103.125%
2016 and thereafter
 
100.000%

Section 3.02.      Redemption in Connection with a Change of Control.  At any time and from time to time prior to the eighteen-month anniversary of the Final Closing (or after the eighteen-month anniversary of the Final Closing, so long as the Company enters into a Change of Control Agreement prior to such eighteen-month anniversary of the Final Closing), the Company may redeem all, but not less than all, Notes in connection with a Change of Control at a redemption price equal to 112.50% of the principal amount plus accrued and unpaid interest.
 
Section 3.03.      Redemption with Proceeds of Public Equity Offering.  At any time and from time to time after May 31, 2008 and prior to November 30, 2012, the Company may redeem Notes with the Net Cash Proceeds received by the Company from one or more sales of its Capital Stock (other than Disqualified Stock) at a redemption price equal to 112.5% of the principal amount plus accrued and unpaid interest, provided that at least 65% of the aggregate principal amount of Notes originally issued on the Closing Date remains outstanding after each such redemption and notice of any such redemption is mailed within 90 days of each such sale of Capital Stock.
 
Section 3.04.      Method and Effect of Redemption
 
(a)           If the Company elects to redeem Notes, it must notify the Trustee of the redemption date and the principal amount of Notes to be redeemed by delivering an Officers’ Certificate not less than 15 days nor more than 90 days before the redemption date.  If fewer than all of the Notes are being redeemed, the Officers’ Certificate must also specify a record date not less than 15 days after the date of the notice of redemption is given to the Trustee and, in the event of a redemption pursuant to Section 3.03, the amount of Notes which are Puttable Notes, and the Trustee will select the Notes for redemption (1) in compliance with the requirements of the principal national securities exchange, if any, on which the Notes are listed, or, (2) if the Notes are not listed on a national securities exchange, by lot or by such other method as the Trustee in its sole discretion shall deem to be fair and appropriate, in each case in denominations of $1,000 principal amount and multiples thereof; provided that in the event of a redemption pursuant to Section 3.03, the Trustee shall apply the redemption price, first, to the redemption of the Puttable Notes, together with the accrued and unpaid interest thereon, pro rata among the Holders thereof, until no Puttable Notes remain outstanding and, second to the redemption of all other outstanding Notes in accordance with clause (1) or (2), as applicable, of this sentence.  The Trustee will notify the Company promptly of the Notes or portions of Notes to be called for redemption. Notice of redemption must be sent by the Company or at the Company’s request, by the Trustee in the
 
 
-32-

 
name and at the expense of the Company, to Holders whose Notes are to be redeemed at least 10 days but not more than 90 days before the redemption date, except where DTC requires a longer period.
 
(b)           The notice of redemption will identify the Notes (including the CUSIP numbers) to be redeemed and will include or state the following:
 
(1)           the redemption date;
 
(2)           the redemption price, including the portion thereof representing any accrued interest;
 
(3)           the place or places where Notes are to be surrendered for redemption;
 
(4)           Notes called for redemption must be so surrendered in order to collect the redemption price;
 
(5)           on the redemption date the redemption price will become due and payable on Notes called for redemption, and interest on Notes called for redemption will cease to accrue on and after the redemption date;
 
(6)           if any Note is redeemed in part, on and after the redemption date, upon surrender of such Note, new Notes equal in principal amount to the unredeemed portion will be issued; and
 
(7)           if any Note contains a CUSIP or CINS number, no representation is being made as to the correctness of the CUSIP or CINS number either as printed on the Notes or as contained in the notice of redemption and that the Holder should rely only on the other identification numbers printed on the Notes.
 
(c)           Once notice of redemption is sent to the Holders, Notes called for redemption become due and payable at the redemption price on the redemption date, and upon surrender of the Notes called for redemption, the Company shall redeem such Notes at the redemption price. Commencing on the redemption date, Notes redeemed will cease to accrue interest. Upon surrender of any Note redeemed in part, the Holder will receive a new Note equal in principal amount to the unredeemed portion of the surrendered Note.
 
ARTICLE IV
 
COVENANTS
 
Section 4.01.      Payment of Notes.  The Company shall pay, or cause to be paid, the principal of, premium, if any, and interest on the Notes of any series on the dates and in the manner provided in the Notes of that series and this Indenture.  An installment of principal, premium, if any, or interest shall be considered paid on the date due if the Trustee or Paying Agent (other than the Company, a Subsidiary of the Company, or any Affiliate of any of them) holds as of 10:00 a.m. (New York City time) on that date money designated for and sufficient to pay the installment.  If the Company or any Subsidiary of the Company or any Affiliate of any of them acts as Paying Agent, an installment of principal, premium, if any, or interest shall be considered paid on the due date if the entity acting as Paying Agent complies with the second sentence of Section 2.03(b).  As provided in Section 6.07, upon any bankruptcy or reorganization procedure relative to the Company, the Trustee shall serve as the Paying Agent, if any, for
 
 
-33-

 
the Notes.
 
The Company shall pay interest on overdue principal and premium, if any, and interest on overdue installments of interest, to the extent lawful, at the rate per annum specified in the Notes.
 
Section 4.02.      Maintenance of Office or Agency.  The Company will maintain in the Borough of Manhattan, The City of New York, an office or agency where Notes of one or more series may be surrendered for registration of transfer or exchange or for presentation for payment and where notices and demands to or upon the Company in respect of the Notes of those series and this Indenture may be served.  The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency.  If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee set forth in Section 11.03.
 
The Company may also from time to time designate one or more other offices or agencies where the Notes of one or more series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in the Borough of Manhattan, The City of New York, for such purposes.  The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency.
 
The Company hereby initially designates the Corporate Trust Office of the Trustee as such office of the Company in accordance with Section 2.03.
 
Section 4.03.      Limitation on Indebtedness and Issuances of Preferred Stock
 
(a)           The Company will not, and will not permit any of its Restricted Subsidiaries to, Incur any Indebtedness, including Disqualified Stock (other than the Notes, any Notes Guarantees, the 2015 Notes, the 2013 Notes, the 2011 Notes and other Indebtedness existing on the Closing Date), and the Company will not permit any Restricted Subsidiary to issue Preferred Stock; provided that the Company or any Subsidiary Guarantor may Incur Indebtedness and any Restricted Subsidiary may Incur Acquired Indebtedness if, after giving effect to the Incurrence of such Indebtedness and the receipt and application of the proceeds therefrom, the Consolidated Fixed Charge Coverage Ratio would be greater than 2.50 to 1.0.
 
Notwithstanding the foregoing, the Company and any Restricted Subsidiary (except as specified below) may Incur each and all of the following:
 
(1)           Indebtedness of the Company under any Credit Facility in an aggregate principal amount at any one time outstanding (with letters of credit being deemed to have a principal amount equal to the maximum potential liability of the Company and its Restricted Subsidiaries thereunder) not to exceed $300 million;
 
(2)           Indebtedness owed (A) to the Company or any Subsidiary Guarantor evidenced by an unsubordinated promissory note or (B) to any Restricted Subsidiary or Regulated Subsidiary; provided that (x) any event which results in any such Restricted Subsidiary or Regulated Subsidiary ceasing to be a Restricted Subsidiary or Regulated Subsidiary or any subsequent transfer of such Indebtedness (other than to the Company or another Restricted Subsidiary or Regulated Subsidiary) shall be deemed, in each case, to constitute an Incurrence of such Indebtedness not permitted by this
 
 
-34-

 
clause (2) and (y) if the Company (or any Subsidiary that is a Subsidiary Guarantor at the time such Indebtedness is Incurred) is the obligor on such Indebtedness, such Indebtedness must be expressly contractually subordinated in right of payment to the Notes, in the case of the Company, or the Note Guarantee, in the case of a Subsidiary Guarantor;
 
(3)           Indebtedness issued in exchange for, or the net proceeds of which are used to refinance or refund, then outstanding Indebtedness (other than Indebtedness outstanding under clause (1), (2) or (4)) and any refinancings thereof in an amount not to exceed the amount so refinanced or refunded (plus premiums, accrued interest, fees and expenses); provided that (a) Indebtedness the proceeds of which are used to refinance or refund the Notes or Indebtedness that is pari passu with, or subordinated in right of payment to, the Notes or a Note Guarantee shall only be permitted under this clause (3) if (x) in case the Notes are refinanced in part or the Indebtedness to be refinanced is pari passu with the Notes or a Note Guarantee, such new Indebtedness, by its terms or by the terms of any agreement or instrument pursuant to which such new Indebtedness is outstanding, is expressly made pari passu with, or subordinate in right of payment to, the remaining Notes or the Note Guarantee, or (y) in case the Indebtedness to be refinanced is subordinated in right of payment to the Notes or a Note Guarantee, such new Indebtedness, by its terms or by the terms of any agreement or instrument pursuant to which such new Indebtedness is issued or remains outstanding, is expressly made subordinate in right of payment to the Notes or the Note Guarantee at least to the extent that the Indebtedness to be refinanced is subordinated to the Notes or the Note Guarantee, (b) such new Indebtedness, determined as of the date of Incurrence of such new Indebtedness, does not mature prior to the Stated Maturity of the Indebtedness to be refinanced or refunded, and the Average Life of such new Indebtedness is at least equal to the remaining Average Life of the Indebtedness to be refinanced or refunded and (c) such new Indebtedness is Incurred by the Company or a Subsidiary Guarantor or by the Restricted Subsidiary that is the obligor on the Indebtedness to be refinanced or refunded;
 
(4)           Indebtedness of the Company, to the extent the net proceeds thereof are promptly (A) used to purchase Notes, 2015 Notes, 2013 Notes or 2011 Notes tendered in an Offer to Purchase made as a result of a Change in Control or (B) deposited to defease the Notes, 2015 Notes, 2013 Notes or 2011 Notes as set forth in Article 8; and
 
(5)           Guarantees of Indebtedness of the Company or of any Restricted Subsidiary by any Restricted Subsidiary provided the Guarantee of such Indebtedness is permitted by and made in accordance with Section 4.07.
 
(b)           Notwithstanding any other provision of this Section 4.03, the maximum amount of Indebtedness that may be Incurred pursuant to this Section 4.03 will not be deemed to be exceeded, with respect to any outstanding Indebtedness due solely to the result of fluctuations in the exchange rates of currencies or due to fluctuations in the value of commodities or securities which underlie such Indebtedness. For the purposes of determining compliance with any restriction on the Incurrence of Indebtedness (x), the U.S dollar equivalent principal amount of any Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was Incurred, in the case of term debt, or first committed, in the case of revolving credit debt and (y) the principal amount of any Indebtedness which is calculated by reference to any underlying security or commodity shall be calculated based on the relevant closing price of such commodity or security on the date such Indebtedness was incurred.
 
(c)           For purposes of determining any particular amount of Indebtedness under this Section 4.03, (x) Indebtedness outstanding under any Credit Facility on the Closing Date shall be treated as Incurred pursuant to clause (1) of the second paragraph of clause (a) of this Section
 
 
-35-

 
4.03, (y) Guarantees, Liens or obligations with respect to letters of credit supporting Indebtedness otherwise included in the determination of such particular amount shall not be included and (z) any Liens granted pursuant to the equal and ratable provisions referred to in Section 4.09 shall not be treated as Indebtedness. For purposes of determining compliance with this Section 4.03, if an item of Indebtedness meets the criteria of more than one of the types of Indebtedness described above (other than Indebtedness referred to in clause (x) of the preceding sentence), including under the first paragraph of part (a), the Company, in its sole discretion, shall classify, and from time to time may reclassify, such item of Indebtedness.
 
(d)           Neither the Company nor any Subsidiary Guarantor will Incur any Indebtedness if such Indebtedness is subordinate in right of payment to any other Indebtedness unless such Indebtedness is also subordinate in right of payment to the Notes or the applicable Note Guarantee to the same extent.
 
(e)           The Company will not permit any Regulated Subsidiary (x) to Incur any Indebtedness the proceeds of which are not invested in the business of such Bank Regulated Subsidiary (or any Subsidiary of such Bank Regulated Subsidiary) or such Broker Dealer Regulated Subsidiary (or any Subsidiary of such Broker Dealer Regulated Subsidiary which is also a Regulated Subsidiary) and (y) to Incur any Indebtedness for the purpose, directly or indirectly, of dividending or distributing the proceeds of such Indebtedness to the Company or any Restricted Subsidiary; except that the Incurrence of Indebtedness by a Regulated Subsidiary that does not comply with (x) or (y) above shall be permitted provided that such Incurrence complies with paragraph (a) of this Section 4.03 as if such paragraph applied to such Regulated Subsidiary.
 
Section 4.04.      Limitation on Restricted Payments.
 
(a)           The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to, directly or indirectly,
 
(i)           declare or pay any dividend or make any distribution on or with respect to its Capital Stock held by Persons other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries (other than (w) dividends or distributions payable solely in shares of its Capital Stock (other than Disqualified Stock) or in options, warrants or other rights to acquire shares of such Capital Stock, (x) pro rata dividends or distributions on Common Stock of Restricted Subsidiaries or Regulated Subsidiaries held by minority stockholders, (y) dividends or distributions on non-voting Preferred Stock the proceeds from the sale of which were invested in the business of such Regulated Subsidiary (or any Subsidiary of such Regulated Subsidiary which is also a Regulated Subsidiary), and (z) pro rata dividends on Preferred Stock of Subsidiaries that are real estate investment trusts, including Highland REIT, Inc., held by minority stockholders;
 
(ii)           purchase, call for redemption or redeem, retire or otherwise acquire for value any shares of Capital Stock of (A) the Company or any Subsidiary Guarantor (including options, warrants or other rights to acquire such shares of Capital Stock) held by any Person (other than the Company, any Restricted Subsidiary or any Regulated Subsidiary) or (B) a Restricted Subsidiary or Subsidiary Guarantor (including options, warrants or other rights to acquire such shares of Capital Stock) held by any Affiliate of the Company (other than the Company or a Wholly Owned Restricted Subsidiary or Wholly Owned Regulated Subsidiary);
 
(iii)           make any voluntary or optional principal payment, or voluntary or optional redemption, repurchase, defeasance, or other acquisition or retirement for value, of Indebtedness
 
 
-36-

 
of the Company that is subordinated in right of payment to the Notes or any Indebtedness of a Subsidiary Guarantor that is subordinated in right of payment to a Note Guarantee; or
 
(iv)           with respect to the Company and any Restricted Subsidiary, make any Investment, other than a Permitted Investment, in any Person, and (b) with respect to any Regulated Subsidiary, make any Investment in an Unrestricted Subsidiary (such payments or any other actions described in clauses (i) through (iv) above being collectively “Restricted Payments”);
 
if, at the time of, and after giving effect to, the proposed Restricted Payment:
 

(A)           a Default or Event of Default shall have occurred and be continuing;
 
(B)           the Company could not Incur at least $1.00 of Indebtedness under the first paragraph of part (a) of Section 4.03;
 
(C)           the subsidiary subject to the Restricted Payment is both a Regulated Subsidiary and a Significant Subsidiary that is not in compliance with applicable regulatory capital or other material requirements of its regulators, such as the OTS or FDIC, or any applicable state, federal or self regulatory organization, or would fail to be in compliance with applicable regulatory requirements as a consequence of the payment; or
 
(D)           the aggregate amount of all Restricted Payments made after the Closing Date shall exceed the sum of:
 
(1)           50% of the aggregate amount of the Adjusted Consolidated Net Income (or, if the Adjusted Consolidated Net Income is a loss, minus 100% of the amount of such loss) accrued on a cumulative basis during the period (taken as one accounting period) beginning on April 1, 2004 and ending on the last day of such fiscal quarter preceding the Transaction Date for which reports have been filed with the SEC or provided to the Trustee, provided that such Adjusted Consolidated Net Income may only be recognized during those quarters for which the Company has filed reports with the SEC to the extent provided in Section 4.15 or has furnished comparable financial information to the Trustee; plus
 
(2)           the aggregate Net Cash Proceeds received by the Company after April 1, 2004 as a capital contribution or from the issuance and sale of its Capital Stock (other than Disqualified Stock or Preferred Stock) to a Person who is not a Subsidiary of the Company, including an issuance or sale permitted by the Indenture of Indebtedness of the Company for cash subsequent to April 1, 2004 upon the conversion of such Indebtedness into Capital Stock (other than Disqualified Stock) of the Company, or from the issuance to a Person who is not a Subsidiary of the Company of any options, warrants or other rights to acquire Capital Stock of the Company (in each case, exclusive of any Disqualified Stock or any options, warrants or other rights that are redeemable at the option of the holder, or are required to be redeemed, prior to the Stated Maturity of the Notes); plus
 
(3)           an amount equal to the net reduction in Investments (other than reductions in Permitted Investments) in any Person resulting from payments of interest on Indebtedness, dividends, repayments of loans or advances, or other transfers of assets, in each case to the Company or any Restricted Subsidiary or Regulated Subsidiary or from the Net Cash Proceeds from the sale of any such Investment (except, in each case, to the extent any such payment or proceeds are included in the calculation of Adjusted Consolidated Net Income), from the release of any Guarantee or from
 
-37-

 
redesignations of Unrestricted Subsidiaries as Restricted Subsidiaries (valued in each case as provided in the definition of “Investments”), not to exceed, in each case, the amount of Investments previously made by the Company or any Restricted Subsidiary or Regulated Subsidiary in such Person or Unrestricted Subsidiary; plus
 
(4)           $100 million.
 
(b)           The foregoing provision shall not be violated by reason of:
 
(1)           the payment of any dividend or redemption of any Capital Stock within 60 days after the related date of declaration or call for redemption if, at said date of declaration or call for redemption, such payment or redemption would comply with the preceding paragraph;
 
(2)           the redemption, repurchase, defeasance or other acquisition or retirement for value of Indebtedness that is subordinated in right of payment to the Notes or any Note Guarantee including premium, if any, and accrued interest, with the proceeds of, or in exchange for, Indebtedness Incurred under clause (3) of the second paragraph of part (a) of Section 4.03;
 
(3)           the repurchase, redemption or other acquisition of Capital Stock of the Company, a Subsidiary Guarantor, a Restricted Subsidiary or a Regulated Subsidiary (or options, warrants or other rights to acquire such Capital Stock) or a dividend on such Capital Stock in exchange for, or out of the proceeds of a capital contribution or a substantially concurrent offering of, shares of Capital Stock (other than Disqualified Stock) of the Company (or options, warrants or other rights to acquire such Capital Stock); provided that such options, warrants or other rights are not redeemable at the option of the holder, or required to be redeemed, in each case other than in connection with a Change of Control of the Company (provided that prior to any such repurchase, redemption or other acquisition in connection with a change of control, the Company has made an Offer to Purchase and purchased all Notes, 2015 Notes, 2013 Notes and 2011 Notes validly tendered for payment in accordance with Section 4.12), prior to the respective Stated Maturity of the Notes, 2015 Notes, 2013 Notes and 2011 Notes;
 
(4)           the making of any principal payment or the repurchase, redemption, retirement, defeasance or other acquisition for value of Indebtedness which is subordinated in right of payment to the Notes or any Note Guarantee in exchange for, or out of the proceeds of a capital contribution or a substantially concurrent offering of, shares of the Capital Stock (other than Disqualified Stock) of the Company (or options, warrants or other rights to acquire such Capital Stock); provided that such options, warrants or other rights are not redeemable at the option of the holder, or required to be redeemed, in each case other than in connection with a Change of Control of the Company (provided that prior to any such repurchase, redemption or other acquisition in connection with a change of control, the Company has made an Offer to Purchase and purchased all Notes, 2015 Notes, 2013 Notes and 2011 Notes validly tendered for payment in accordance with Section 4.12), prior to the respective Stated Maturity of the Notes, 2015 Notes, 2013 Notes and 2011 Notes;
 
(5)           payments or distributions to dissenting stockholders pursuant to applicable law, pursuant to or in connection with a consolidation, merger or transfer of assets of the Company, any Restricted Subsidiary or any Regulated Subsidiary and that, in the case of the Company, comply with the provisions of the Indenture applicable to mergers, consolidations and transfers of all or substantially all of the property and assets of the Company;
 
(6)           Investments acquired as a capital contribution to, or in exchange for, or out of the proceeds of a substantially concurrent offering of, Capital Stock (other than Disqualified Stock) of the Company;
 
 
-38-

 
(7)           the repurchase of Capital Stock deemed to occur upon the exercise of options or warrants if such Capital Stock represents all or a portion of the exercise price thereof;
 
(8)           the repurchase, redemption or other acquisition of the Company’s Capital Stock (or options, warrants or other rights to acquire such Capital Stock) from Persons who are, or were formerly, employees of the Company and their Affiliates, heirs and executors; provided that the aggregate amount of all such repurchases pursuant to this clause (8) shall not exceed $50 million;
 
(9)           the repurchase of Common Stock of the Company, or the declaration or payment of dividends on Common Stock (other than Disqualified Stock) of the Company; provided that the aggregate amount of all such declarations, payments or repurchases pursuant to this clause (9) shall not exceed $100 million in any fiscal year; provided further that at the time of declaration of such dividend or at the time of such repurchase (x) no Default or Event of Default has occurred and is continuing, and (y) the Company is able to Incur at least an additional $1.00 of Indebtedness pursuant to the first paragraph of Section 4.03; or
 
(10)           the repurchase, redemption or other acquisition of the Outstanding Convertible Notes,
 
provided that, except in the case of clause (1), no Default or Event of Default (excluding, in each case, clause (i) of Section 6.01) shall have occurred and be continuing or occur as a consequence of the actions or payments set forth therein.

(c)           Each Restricted Payment permitted pursuant to the preceding paragraph (other than the Restricted Payment referred to in clause (10) thereof, clause (2) thereof, an exchange of Capital Stock for Capital Stock or Indebtedness referred to in clause (3) or (4) thereof, an Investment acquired as a capital contribution or in exchange for Capital Stock referred to in clause (6) thereof, the repurchase of Capital Stock referred to in clause (7) thereof, the repurchase of Common Stock referred to in clause (9) thereof), and the Net Cash Proceeds from any issuance of Capital Stock referred to in clause (3), (4) or (6), shall be included in calculating whether the conditions of clause (D) of the first paragraph of this Section 4.04 have been met with respect to any subsequent Restricted Payments. If the proceeds of an issuance of Capital Stock of the Company are used for the redemption, repurchase or other acquisition of the Notes, or Indebtedness that is pari passu with the Notes or any Note Guarantee, then the Net Cash Proceeds of such issuance shall be included in clause (D) of the first paragraph of this Section 4.04 only to the extent such proceeds are not used for such redemption, repurchase or other acquisition of Indebtedness.
 
(d)           For purposes of determining compliance with this Section 4.04, (x) the amount, if other than in cash, of any Restricted Payment shall be determined in good faith by the Board of Directors, whose determination shall be conclusive and evidenced by a Board Resolution and (y) if a Restricted Payment meets the criteria of more than one of the types of Restricted Payments described in the above clauses, including the first paragraph of this Section 4.04, the Company, in its sole discretion, may order and classify, and from time to time may reclassify, such Restricted Payment if it would have been permitted at the time such Restricted Payment was made and at the time of such reclassification.
 
Section 4.05.      Limitation on Dividends and Other Payment Restrictions Affecting Restricted Subsidiaries or Regulated Subsidiaries.  The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Restricted Subsidiary or
 
 
-39-

 
Regulated Subsidiary (other than any Subsidiary Guarantor) to:
 
(1)           pay dividends or make any other distributions permitted by applicable law on any Capital Stock of such Restricted Subsidiary or Regulated Subsidiary owned by the Company or any other Restricted Subsidiary or Regulated Subsidiary;
 
(2)           pay any Indebtedness owed to the Company or any other Restricted Subsidiary or Regulated Subsidiary;
 
(3)           make loans or advances to the Company or any other Restricted Subsidiary or Regulated Subsidiary; or
 
(4)           transfer any of its property or assets to the Company or any other Restricted Subsidiary or Regulated Subsidiary.
 
The foregoing provisions shall not restrict any encumbrances or restrictions:

(1)           existing on the Closing Date in any Credit Facility, the Indentures or any other agreements in effect on the Closing Date, and any extensions, refinancings, renewals or replacements of such agreements; provided that the encumbrances and restrictions in any such extensions, refinancings, renewals or replacements taken as a whole are no less favorable in any material respect to the Holders than those encumbrances or restrictions that are then in effect and that are being extended, refinanced, renewed or replaced;
 
(2)           existing under or by reason of applicable law including rules and regulations of and agreements with any regulatory authority having jurisdiction over the Company, any Restricted Subsidiary, or any Regulated Subsidiary, including, but not limited to the OTS, the FDIC, the SEC or any self regulatory organization of which such Regulated Subsidiary is a member, or the imposition of conditions or requirements pursuant to the enforcement authority of any such regulatory authority;
 
(3)           existing with respect to any Person or the property or assets of such Person acquired by the Company or any Restricted Subsidiary or Regulated Subsidiary, existing at the time of such acquisition and not incurred in contemplation thereof, which encumbrances or restrictions are not applicable to any Person or the property or assets of any Person other than such Person or the property or assets of such Person so acquired and any extensions, refinancings, renewals or replacements thereof; provided that the encumbrances and restrictions in any such extensions, refinancings, renewals or replacements taken as a whole are no less favorable in any material respect to the Holders than those encumbrances or restrictions that are then in effect and that are being extended, refinanced, renewed or replaced;
 
(4)           in the case of clause (4) of the first paragraph of this Section 4.05:
 
(A)           that restrict in a customary manner the subletting, assignment or transfer of any property or asset that is a lease, license, conveyance or contract or similar property or asset;
 
(B)           existing by virtue of any transfer of, agreement to transfer, option or right with respect to, or Lien on, any property or assets of the Company, any Restricted Subsidiary or any Regulated Subsidiary not otherwise prohibited by the Indenture; or
 
 
-40-

 
(C)           arising or agreed to in the ordinary course of business, not relating to any Indebtedness, and that do not, individually or in the aggregate, detract from the value of property or assets of the Company or any Restricted Subsidiary or Regulated Subsidiary in any manner material to the Company or any Restricted Subsidiary or Regulated Subsidiary taken as a whole; or
 
(5)           with respect to a Restricted Subsidiary or Regulated Subsidiary and imposed pursuant to an agreement that has been entered into for the sale or disposition of all or substantially all of the Capital Stock of, or property and assets of, such Restricted Subsidiary or Regulated Subsidiary.
 
Nothing contained in this Section 4.05 shall prevent the Company, any Restricted Subsidiary or any Regulated Subsidiary from (1) creating, incurring, assuming or suffering to exist any Liens otherwise permitted in Section 4.09 or (2) restricting the sale or other disposition of property or assets of the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries that secure Indebtedness of the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries.
 
Section 4.06.      Limitation on the Issuance and Sale of Capital Stock of Restricted Subsidiaries or Regulated Subsidiaries.  The Company will not sell, and will not permit any Restricted Subsidiary or Regulated Subsidiary, directly or indirectly, to issue or sell, any shares of Capital Stock of a Restricted Subsidiary or Regulated Subsidiary (including options, warrants or other rights to purchase shares of such Capital Stock) except:
 
(1)           (i) with respect to the capital stock of a Restricted Subsidiary, to the Company or a Wholly Owned Restricted Subsidiary or, (ii) in the case of Regulated Subsidiary, to the Company, a Wholly Owned Restricted Subsidiary or a Wholly Owned Regulated Subsidiary;
 
(2)           issuances of director’s qualifying shares or sales to foreign nationals of shares of Capital Stock of foreign Restricted Subsidiaries, to the extent required by applicable law;
 
(3)           if, immediately after giving effect to such issuance or sale, such Restricted Subsidiary would no longer constitute a Restricted Subsidiary and any Investment in such Person remaining after giving effect to such issuance or sale would have been permitted to be made under Section 4.04 if made on the date of such issuance or sale;
 
(4)           (i) sales of Common Stock (including options, warrants or other rights to purchase shares of such Common Stock but excluding Disqualified Stock) of a Restricted Subsidiary or a Regulated Subsidiary by the Company, a Restricted Subsidiary or a Regulated Subsidiary, provided that the Company or such Restricted Subsidiary or Regulated Subsidiary applies the Net Cash Proceeds of any such sale in accordance with clause (A) or (B) of Section 4.11 and (ii) issuances of Preferred Stock of a Restricted Subsidiary if such Restricted Subsidiary would be entitled to Incur such Indebtedness under Section 4.03; or
 
(5)           sales of Capital Stock, other than Common Stock, by a Regulated Subsidiary or a Subsidiary of such Regulated Subsidiary, the proceeds of which are invested in the business of such Regulated Subsidiary.
 
Section 4.07.      Future Subsidiary Guarantees.  The Company will not permit any Restricted Subsidiary or Regulated Subsidiary, directly or indirectly, to Guarantee any Indebtedness (“Guaranteed Indebtedness”) of the Company or any Restricted Subsidiary (other than a Foreign Subsidiary), unless (a) such Restricted Subsidiary or Regulated Subsidiary, to the extent permitted by law, simultaneously
 
 
-41-

 
executes and delivers a supplemental indenture to the Indenture providing for a Guarantee (a “Subsidiary Guarantee”) of payment of the Notes by such Restricted Subsidiary or Regulated Subsidiary and (b) such Restricted Subsidiary or Regulated Subsidiary waives and will not in any manner whatsoever claim or take the benefit or advantage of, any rights of reimbursement, indemnity or subrogation or any other rights against the Company or any other Restricted Subsidiary or Regulated Subsidiary as a result of any payment by such Restricted Subsidiary or Regulated Subsidiary under its Subsidiary Guarantee until the Notes have been paid in full. The obligations of any such future Subsidiary Guarantor will be limited so as not to constitute a fraudulent conveyance under applicable federal or state laws.  In addition, on the Trigger Date, the Company shall cause each of its Restricted Subsidiaries to execute and deliver a Subsidiary Guarantee of payment of the Notes by each such Restricted Subsidiary, to the extent permitted by law.
 
If the Guaranteed Indebtedness is (A) pari passu in right of payment with the Notes or any Note Guarantee, then the Guarantee of such Guaranteed Indebtedness shall be pari passu in right of payment with, or subordinated to, the Subsidiary Guarantee or (B) subordinated in right of payment to the Notes or any Note Guarantee, then the Guarantee of such Guaranteed Indebtedness shall be subordinated in right of payment to the Subsidiary Guarantee at least to the extent that the Guaranteed Indebtedness is subordinated to the Notes or the Notes Guarantee.
 
Notwithstanding the foregoing, any Subsidiary Guarantee by a Restricted Subsidiary or Regulated Subsidiary may provide by its terms that it shall be automatically and unconditionally released and discharged upon any:
 
(1)           sale, exchange or transfer, to any Person not an Affiliate of the Company, of all of the Company’s and each Restricted Subsidiary’s and Regulated Subsidiary’s Capital Stock in, or all or substantially all the assets of, such Restricted Subsidiary or Regulated Subsidiary (which sale, exchange or transfer is not prohibited by the Indenture) or upon the designation of such Restricted Subsidiary or Regulated Subsidiary as an Unrestricted Subsidiary in accordance with the terms of the Indenture; or
 
(2)           the release or discharge of the Guarantee which resulted in the creation of such Subsidiary Guarantee, except a discharge or release by or as a result of payment under such Guarantee.
 
Section 4.08.      Limitation on Transactions with Shareholders and Affiliates.  The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to, directly or indirectly, enter into, renew or extend any transaction (including, without limitation, the purchase, sale, lease or exchange of property or assets, or the rendering of any service) with any Affiliate of the Company or any Affiliates of any Restricted Subsidiary or Regulated Subsidiary, except upon fair and reasonable terms no less favorable to the Company or such Restricted Subsidiary or Regulated Subsidiary than could be obtained, at the time of such transaction or, if such transaction is pursuant to a written agreement, at the time of the execution of the agreement providing therefor, in a comparable arm’s-length transaction with a Person that is not such a holder or an Affiliate.
 
The foregoing limitation does not limit, and shall not apply to:
 
(1)           transactions (A) approved by a majority of the disinterested members of the Board of Directors or (B) for which the Company, a Restricted Subsidiary or a Regulated Subsidiary delivers to the Trustee a written opinion of a nationally recognized investment banking, accounting, valuation or appraisal firm stating that the transaction is fair to the Company or such Restricted Subsidiary or Regulated Subsidiary from a financial point of view;
 
 
-42-

 
(2)           any transaction solely among the Company, its Wholly Owned Restricted Subsidiaries or its Wholly Owned Regulated Subsidiaries or any combination thereof;
 
(3)           the payment of reasonable and customary regular fees to directors of the Company who are not employees of the Company and customary indemnification arrangements entered into by the Company;
 
(4)           any payments or other transactions pursuant to any tax-sharing agreement between the Company and any other Person with which the Company files a consolidated tax return or with which the Company is part of a consolidated group for tax purposes;
 
(5)           any sale of shares of Capital Stock (other than Disqualified Stock) of the Company;
 
(6)           the granting or performance of registration rights under a written agreement and approved by the Board of Directors of the Company, containing customary terms, taken as a whole;
 
(7)           loans to an Affiliate who is an officer, director or employee of the Company, a Restricted Subsidiary or a Regulated Subsidiary by a Regulated Subsidiary in the ordinary course of business in accordance with Sections 7 and 13(k) of the Exchange Act;
 
(8)           deposit, checking, banking and brokerage products and services typically offered to our customers on substantially the same terms and conditions as those offered to our customers, or in the case of a Bank Regulated Subsidiary, as otherwise permitted under Regulation O promulgated by the Board of Governors of under the Federal Reserve System; or
 
(9)           any Permitted Investments or any Restricted Payments not prohibited by Section 4.04.
 
Notwithstanding the foregoing, any transaction or series of related transactions covered by the first paragraph of this Section 4.08 and not covered by clauses (2) through (6) of this paragraph, (a) the aggregate amount of which exceeds $15 million in value, must be approved or determined to be fair in the manner provided for in clause (l)(A) or (B) above and (b) the aggregate amount of which exceeds $25 million in value, must be determined to be fair in the manner provided for in clause (l)(B) above.
 
Section 4.09.      Limitation on Liens.  The Company will not, and will not permit any Restricted Subsidiary to, create, incur, assume or suffer to exist any Lien on any of its assets or properties of any character, or any shares of Capital Stock or Indebtedness of any Restricted Subsidiary, without making effective provision for all of the Notes and all other amounts due under the Indenture to be directly secured equally and ratably with (or, if the obligation or liability to be secured by such Lien is subordinated in right of payment to the Notes, prior to) the obligation or liability secured by such Lien.
 
The foregoing limitation does not apply to:
 
(1)           Liens existing on the Closing Date (other than the Liens securing Indebtedness (including Hedging Obligations with respect thereto) under any Credit Facility);
 
(2)           Liens granted after the Closing Date on any assets or Capital Stock of the Company or its Restricted Subsidiaries created in favor of the Holders;
 
 
-43-

 
(3)           Liens with respect to the assets of a Restricted Subsidiary granted by such Restricted Subsidiary to the Company or a Wholly Owned Restricted Subsidiary or Wholly Owned Regulated Subsidiary to secure Indebtedness owing to the Company or such other Restricted Subsidiary or Regulated Subsidiary;
 
(4)           Liens securing Indebtedness which is Incurred to refinance secured Indebtedness which is permitted to be Incurred under clause (3) of the second paragraph of Section 4.03; provided that such Liens do not extend to or cover any property or assets of the Company or any Restricted Subsidiary or Regulated Subsidiary other than the property or assets securing the Indebtedness being refinanced;
 
(5)           Liens securing Indebtedness (including Hedging Obligations with respect thereto) under any Credit Facility in an aggregate amount not to exceed $300 million;
 
(6)           Liens (including extensions and renewals thereof) upon real or personal property acquired after the Closing Date; provided that (a) any such Lien is created solely for the purpose of securing Indebtedness Incurred, in accordance with Section 4.03, to finance the cost (including the cost of improvement or construction and fees and expenses related to the acquisition) of the item of property or assets subject thereto and such Lien is created prior to, at the time of or within twelve months after the later of the acquisition, the completion of construction or the commencement of full operation of such property, (b) the principal amount of the Indebtedness secured by such Lien does not exceed 100% of such cost and (c) any such Lien shall not extend to or cover any property or assets other than such item of property or assets and any improvements on such item;
 
(7)           Liens on cash set aside at the time of the Incurrence of any Indebtedness, or government securities purchased with such cash, in either case to the extent that such cash or government securities pre-fund the payment of interest on such Indebtedness and are held in a collateral or escrow account or similar arrangement to be applied for such purpose;
 
(8)           Liens incurred by the Company or a Restricted Subsidiary for the benefit of a Regulated Subsidiary in the ordinary course of business including Liens incurred in the Broker Dealer Regulated Subsidiary’s securities business with respect to obligations that do not exceed $200 million at any one time outstanding and that are not incurred in connection with the borrowing of money or the obtaining of advances or credit (other than trade credit in the ordinary course of business); or
 
(9)           Permitted Liens.
 
Section 4.10.      Limitation on Sale-leaseback Transactions.  The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to, enter into any Sale-Leaseback Transaction involving any of its assets or properties whether now owned or hereafter acquired.
 
The foregoing restriction does not apply to any Sale-Leaseback Transaction if:
 
(1)           the lease is for a period, including renewal rights, of not in excess of three years;
 
(2)           the lease secures or relates to industrial revenue or pollution control bonds;
 
 
-44-

 
(3)           the transaction is solely among the Company, its Wholly Owned Restricted Subsidiaries or its Wholly Owned Regulated Subsidiaries or any combination thereof; or
 
(4)           the Company or such Restricted Subsidiary or Regulated Subsidiary, within 12 months after the sale or transfer of any assets or properties is completed, applies an amount not less than the net proceeds received from such sale in accordance with clause (A) or (B) of the third paragraph of Section 4.11.
 
Section 4.11.      Limitation on Asset Sales.  The Company will not, and will not permit any Restricted Subsidiary to, consummate any Asset Sale, unless (1) the consideration received by the Company or such Restricted Subsidiary is at least equal to the Fair Market Value of the assets sold or disposed of and (2) at least 75% of the consideration received consists of (a) cash or Temporary Cash Investments, (b) the assumption of unsubordinated Indebtedness of the Company or any Subsidiary Guarantor or Indebtedness of any other Restricted Subsidiary (in each case, other than Indebtedness owed to the Company), provided that the Company, such Subsidiary Guarantor, such Restricted Subsidiary, as the case may be is irrevocably and unconditionally released from all liability under such Indebtedness or (c) Replacement Assets.
 
The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to consummate any Regulated Sale unless (1) the consideration received by the Company or such Restricted Subsidiary or Regulated Subsidiary is at least equal to the Fair Market Value of the assets sold or disposed of and (2) at least 75% of the consideration received consists of (a) cash or Temporary Cash Investments, (b) the assumption of unsubordinated Indebtedness of the Company or any Subsidiary Guarantor or Indebtedness of any other Restricted Subsidiary or Regulated Subsidiary (in each case, other than Indebtedness owed to the Company), provided that the Company, such Subsidiary Guarantor, such Restricted Subsidiary or such Regulated Subsidiary, as the case may be is irrevocably and unconditionally released from all liability under such Indebtedness or (c) Replacement Assets.
 
If and to the extent that the Net Cash Proceeds received by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries (excluding the first $300 million of Net Cash Proceeds received by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries from Asset Sales and Regulated Sales after the Closing Date) from one or more Asset Sales or Regulated Sales in any period of 12 consecutive months exceed 10% of Consolidated Net Worth (determined as of the date closest to the commencement of such 12 month period for which a consolidated balance sheet of the Company and its Subsidiaries has been filed with the SEC or provided to the Trustee), then the Company shall or shall cause the relevant Restricted Subsidiary or Regulated Subsidiary to:
 
(1)           within twelve months after the date Net Cash Proceeds so received exceed 10% of Consolidated Net Worth,
 
(A)           apply an amount equal to such excess Net Cash Proceeds to permanently repay unsubordinated Indebtedness of the Company or Indebtedness or to redeem or repurchase Capital Stock, otherwise permitted by the Indenture, of any Restricted Subsidiary or Regulated Subsidiary, in each case owing to or owned by a Person other than the Company or any Affiliate of the Company; or
 
(B)           invest an equal amount, or the amount not so applied pursuant to clause (A) (or enter into a definitive agreement committing to so invest within 12 months after the date of such agreement), in Replacement Assets; and
 
 
-45-

 
(2)           apply (no later than the end of the 12-month period referred to in clause (1)) such excess Net Cash Proceeds (to the extent not applied pursuant to clause (1)) as provided in the following paragraphs of this Section 4.11.
 
If and to the extent that the Net Cash Proceeds received by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries from one or more Regulated Sales in any period of 12 consecutive months exceed 10% of Consolidated Net Worth (determined as of the date closest to the commencement of such 12 month period for which a consolidated balance sheet of the Company and its Subsidiaries has been filed with the SEC or provided to the Trustee), then the Company shall or shall cause the relevant Restricted Subsidiary or Regulated Subsidiary to apply (no later than the end of the 12-month period referred to in clause (1)) such excess Net Cash Proceeds (to the extent not applied pursuant to clause (1)) as provided in the following paragraphs of this Section 4.11.
 
The amount of such excess Net Cash Proceeds required to be applied (or to be committed to be applied) during such 12-month period as set forth in clause (1) of the preceding sentence and not applied as so required by the end of such period shall constitute “Excess Proceeds.”
 
If, as of the first day of any calendar month, the aggregate amount of Excess Proceeds not theretofore subject to an Offer to Purchase pursuant to this Section 4.11 totals at least $50 million, the Company must commence, not later than the fifteenth Business Day of such month, and consummate an Offer to Purchase from the Holders (and if required by the terms of any Indebtedness that is pari passu with the Notes (“Pari Passu Indebtedness”), from the holders of such Pari Passu Indebtedness) on a pro rata basis an aggregate principal amount of Notes (and Pari Passu Indebtedness) equal to the Excess Proceeds on such date, at a purchase price equal to 100% of their principal amount, plus, in each case, accrued interest (if any) to the Payment Date.
 
To the extent that the aggregate amount of Notes and Pari Passu Indebtedness so validly tendered and not properly withdrawn pursuant to an Offer to Purchase is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for any other purpose which is permitted by the Indenture.
 
If the aggregate principal amount of Notes surrendered by holders thereof and other Pari Passu Indebtedness surrendered by holders or lenders, collectively, exceeds the amount of Excess Proceeds, the Trustee shall select the Notes and Pari Passu Indebtedness to be purchased on a pro rata basis on the basis of the aggregate principal amount of tendered Notes and Pari Passu Indebtedness. Upon completion of such Offer to Purchase, the amount of Excess Proceeds shall be reset to zero.
 
Section 4.12.      Repurchase of Notes Upon a Change of Control.  The Company must commence, within 30 days of the occurrence of a Change of Control, and consummate an Offer to Purchase for all Notes then outstanding, at a purchase price (a “Change of Control Payment Amount”) equal to 101% of their principal amount, plus accrued interest (if any) to the Payment Date.
 
The Company will not be required to make an Offer to Purchase upon the occurrence of a Change of Control, if a third party makes an offer to purchase the Notes in the manner, at the times and price and otherwise in compliance with the requirements of the Indenture applicable to an Offer to Purchase for a Change of Control and purchases all Notes validly tendered and not withdrawn in such offer to purchase.
 
Section 4.13.      Limitation on Lines of Business.  The Company will not, and will not permit any Restricted Subsidiary or Regulated Subsidiary to, engage in any business other than a Related Business.
 
Section 4.14.     Effectiveness of Covenants.  The covenants set forth in Sections 4.03, 4.04, 4.05,
 
-46-

 
4.06, 4.07, 4.08, 4.10, 4.11, 4.13, 4.15, 4.19 and 4.20 will no longer be in effect upon the Company attaining Investment Grade Status (the “Terminated Covenants”). The Terminated Covenants will not be reinstated regardless of whether the Company’s credit rating is subsequently downgraded from Investment Grade Status.
 
Section 4.15.      SEC Reports and Reports to Holders.  The Company will deliver to the Trustee within 30 days after the filing of the same with the Securities and Exchange Commission, copies of the quarterly and annual reports and of the information, documents and other reports, if any, which the Company is required to file with the Securities and Exchange Commission pursuant to Section 13 or 15(d) of the Exchange Act. Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file with the Securities and Exchange Commission, to the extent permitted, and provide the Trustee and Holders with such annual reports and such information, documents and other reports specified in Sections 13 and 15(d) of the Exchange Act, provided that the Company need not file such reports or other information if, and so long as, it would not be required to do so pursuant to Rule 12h-5 under the Exchange Act. The Company will also comply with the other provisions of the TIA, Section 314(a). Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates).
 
Section 4.16.      Payments of Taxes and Other Claims.
 
[Intentionally Omitted]
 
Section 4.17.      Compliance Certificates.
 
(a)           Officers of the Company must certify, on or before a date not more than 90 days after the end of each fiscal year, that a review has been conducted of the activities of the Company and its Restricted Subsidiaries and Regulated Subsidiaries and the Company’s and its Restricted Subsidiaries’ and its Regulated Subsidiaries’ performance under this Indenture and that, to their knowledge, the Company has fulfilled all obligations hereunder, or, if there has been a default in the fulfillment of any such obligation, specifying each such default and the nature and status thereof. The Company will also be obligated to notify the Trustee of any default or defaults in the performance of any covenants or agreements under the Indenture. Such certificate shall contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the Company as to his or her knowledge of the Company’s compliance with all conditions and covenants under this Indenture. For purposes of this Section 4.17, such compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture. If any of the officers of the Company signing such certificate has knowledge of such a Default or Event of Default, the certificate shall describe any such Default or Event of Default and its status. The first certificate to be delivered pursuant to this Section 4.17(a) shall be for the first fiscal year beginning after the execution of this Indenture.
 
(b)           The Company shall deliver to the Trustee, within 90 days after the end of each fiscal year, beginning with the fiscal year in which this Indenture was executed, a certificate signed by the Company’s independent certified public accountants stating (i) that their audit examination has included a review of the terms of this Indenture and the Notes as they relate to accounting matters, (ii) that they have read the most recent Officers’ Certificate delivered to the Trustee pursuant to paragraph (a) of this Section 4.17 and (iii) whether, in connection with their audit examination, anything came to their attention that caused them to believe that the Company  
 
 
-47-

 
was not in compliance with any of the terms, covenants, provisions or conditions of Article 4 and Section 5.01 of this Indenture as they pertain to accounting matters and, if any Default or Event of Default has come to their attention, specifying the nature and period of existence thereof; provided that such independent certified public accountants shall not be liable in respect of such statement by reason of any failure to obtain knowledge of any such Default or Event of Default that would not be disclosed in the course of an audit examination conducted in accordance with generally accepted auditing standards in effect at the date of such examination. The Company shall not be required to comply with the foregoing clause (b) with respect to any fiscal year if such compliance would be contrary to the recommendations of the American Institute of Certified Public Accountants so long as the Company delivers to the Trustee within 90 days after the end of such fiscal year an Officer’s Certificate stating that such compliance would be so contrary and any facts particular to the Company that may have caused such compliance to be so contrary.
 
Section 4.18.      Waiver of Stay, Extension or Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law or any usury law or other law wherever enacted, now or at any time hereafter in force, or that may affect the covenants or the performance of this Indenture; and (to the extent that it may lawfully do so) the Company hereby expressly waives all benefit or advantage of any such law and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.
 
Section 4.19.      Maintenance Covenants.  The Company shall not permit any Bank Regulated Subsidiary that constitutes a federally insured depositary institution to fail to be at least Well Capitalized for a period of more than 30 consecutive days in any fiscal quarter of the Company.
 
Section 4.20.      Springing Lien.  Promptly following the occurrence of the Trigger Date and from time to time thereafter, the Company shall take such actions as are reasonably necessary and as the Trustee may reasonably request (including delivery of security agreements, pledge agreements, financing statements and other security documents, authorization documents and opinions of counsel) to ensure and confirm that the obligations of the Company under the Notes and of each Subsidiary Guarantor that is a Restricted Subsidiary under any Subsidiary Guarantee (up to a maximum amount of Indebtedness under the Notes that would not result in or require any of the 2011 Notes, the 2013 Notes or the 2015 Notes becoming directly secured equally and ratably with the Notes pursuant to the provisions of the 2011 Notes Indenture, the 2013 Notes Indenture or the 2015 Notes Indenture, as the case may be) are secured by a first priority ((i) junior only to (x) the Liens existing on the Closing Date and (y) Liens securing any Credit Facility in the amount not to exceed $300,000,000 and (ii) otherwise, subject only to Liens permitted by Section 4.09) perfected Lien on (I) the ownership interest of the Company and each such Subsidiary Guarantor in the stock and other equity interests of each Domestic Subsidiary; (II) the ownership interest of the Company and each such Subsidiary Guarantor in the stock and other equity interests of each direct Foreign Subsidiary of the Company and of each Domestic Subsidiary; provided that neither the Company nor any Domestic Subsidiary shall be required to pledge more than 65% of the stock and other equity interest in any Foreign Subsidiary; and (III) all other present and future assets and properties (including, without limitation, accounts receivable, inventory, real property, machinery, equipment, contracts, trademarks, copyrights, patents, license rights, intercompany notes and other investment property, and general intangibles) of the Company and each such Subsidiary Guarantor, except in each of (I), (II) and (III) such property and assets constituting Excluded Collateral.  In furtherance of the foregoing, the Company will, and will cause each Domestic Subsidiary to, execute and deliver to the Trustee (A) from time to time prior to the Trigger Date, such documents as are reasonably necessary and as the Trustee may reasonably request to ensure that the Liens described above on substantially all personal property (other than property described in clause (ii) of the preceding sentence)
 
 
-48-

 
of the Company and its Domestic Subsidiaries will be created and perfected promptly after the Trigger Date; (B) not later than 30 days after the Trigger Date, a mortgage or deed of trust with respect to each parcel of real estate owned by the Company or any Domestic Subsidiary; (C) as soon as reasonably practicable after the Trigger Date, such documentation (including title insurance policies, flood plain certifications and other customary documents) as is reasonably necessary and as the Trustee may reasonably request in connection with the mortgages and deeds of trust described in clause (B) above and (D) as soon as reasonably practicable after the Trigger Date, all documents necessary to create and perfect the Liens described in clause (ii) of the preceding sentence.  The Company agrees that after the Trigger Date it will use, and will cause each applicable Subsidiary to use, commercially reasonable efforts to promptly deliver all items required by clauses (C) and (D) of the preceding sentence.  For the avoidance of doubt, (a) the Company shall not, and shall not permit the Subsidiary Guarantors to, secure Indebtedness under the Notes and the Subsidiary Guarantees in excess of the amount that is permitted to be secured under the provisions of the 2013 Notes Indenture and the 2015 Notes Indenture without granting equal and ratable security to the noteholders of the 2015 Notes, the 2013 Notes and/or the 2011 Notes and (b) at any time the Consolidated EBITDA of the Company for the most recently ended Four Quarter Period exceeds the amount of Indebtedness under the Notes heretofore secured in compliance with this Section 4.20, the Company shall secure the additional amount of Indebtedness under the Notes, such that the aggregate amount of Indebtedness under the Notes secured in compliance with this Section 4.20 equals the amount of the Consolidated EBITDA of the Company for the most recently ended Four Quarter Period.
 
Beyond the exercise of reasonable care in the custody thereof, the Trustee shall have no duty as to any Collateral in its possession or control or in the possession or control of any agent or bailee or any income thereon or as to preservation of rights against prior parties or any other rights pertaining thereto and the Trustee shall not be responsible for filing any financing or continuation statements or recording any documents or instruments in any public office at any time or times or otherwise perfecting or maintaining the perfection of any security interest in the Collateral.  The Trustee shall be deemed to have exercised reasonable care in the custody of the Collateral in its possession if the Collateral is accorded treatment substantially equal to that which it accords its own property and shall not be liable or responsible for any loss or diminution in the value of any of the Collateral, by reason of the act or omission of any carrier, forwarding agency or other agent or bailee selected by the Trustee in good faith. The Trustee shall not be responsible for the existence, genuineness or value of any of the Collateral or for the validity, perfection, priority or enforceability of the Liens in any of the Collateral, whether impaired by operation of law or by reason of any of any action or omission to act on its part hereunder, except to the extent such action or omission constitutes gross negligence, bad faith or willful misconduct on the part of the Trustee, for the validity or sufficiency of the Collateral or any agreement or assignment contained therein, for the validity of the title of the Company to the Collateral, for insuring the Collateral or for the payment of taxes, charges, assessments or Liens upon the Collateral or otherwise as to the maintenance of the Collateral.
 
ARTICLE V
 
CONSOLIDATION, MERGER OR SALE OF ASSETS
 
Section 5.01.      Consolidation, Merger and Sale of Assets.  The Company will not consolidate with, merge with or into, or sell, convey, transfer, lease or otherwise dispose of all or substantially all of its property and assets (as an entirety or substantially an entirety in one transaction or a series of related transactions) to, any Person or permit any Person to merge with or into it unless:
 
(a)           it shall be the continuing Person, or the Person (if other than it) formed by such consolidation or into which it is merged or that acquired or leased such property and assets of (the
 
 
-49-

 
“Surviving Person”) shall be an entity organized and validly existing under the laws of the United States of America or any jurisdiction thereof and shall expressly assume, by a supplemental indenture, executed and delivered to the Trustee, all of the Company’s obligations under the Indenture and the Notes; provided, that if such continuing Person or Person shall not be a corporation, such entity shall organize or have a wholly-owned Subsidiary in the form of a corporation organized and validly existing under the laws of the United States or any jurisdiction thereof, and shall cause such corporation to expressly assume, as a party to the supplemental indenture referenced above, as a co-obligor, each of such continuing Person or Person’s obligations under the Indenture and the Notes;
 
(b)           immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing;
 
(c)           immediately after giving effect to such transaction on a pro forma basis, the Company or the Surviving Person, as the case may be, shall have a Consolidated Net Worth equal to or greater than the Consolidated Net Worth of the Company immediately prior to such transaction;
 
(d)           immediately after giving effect to such transaction on a pro forma basis the Company or the Surviving Person, as the case may be, could Incur at least $1.00 of Indebtedness under the first paragraph of Section 4.03;
 
(e)           it delivers to the Trustee an Officers’ Certificate (attaching the arithmetic computations to demonstrate compliance with clauses (c) and (d)) and Opinion of Counsel, in each case stating that such consolidation, merger or transfer and such supplemental indenture complies with this provision and that all conditions precedent provided for herein relating to such transaction have been complied with; and
 
(f)           each Subsidiary Guarantor, unless such Subsidiary Guarantor is the Person with which the Company has entered into a transaction under this Section 5.01, shall have by amendment to its Note Guarantee confirmed that its Note Guarantee shall apply to the obligations of the Company or the Surviving Person in accordance with the Notes and the Indenture;
 
provided, however, that clauses (c) and (d) above do not apply if, in the good faith determination of the Board of Directors of the Company, whose determination shall be evidenced by a Board Resolution, the principal purpose of such transaction is to change the state of organization or convert the form of organization of the Company to another form, and any such transaction shall not have as one of its purposes the evasion of the foregoing limitations.

Section 5.02.      Successor Substituted.  Upon any consolidation or merger, or any sale, conveyance, transfer, lease or other disposition of all or substantially all of the property and assets of the Company in accordance with Section 5.01 of this Indenture, the successor Person formed by such consolidation or into which the Company is merged or to which such sale, conveyance, transfer, lease or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person had been named as the Company herein; provided that the Company shall not be released from its obligation to pay the principal of, premium, if any, or interest on the Notes in the case of a lease of all or substantially all of its property and assets.
 
 
-50-

 

 
ARTICLE VI
 
EVENTS OF DEFAULT AND REMEDIES
 

Section 6.01.      Events of Default.  Any of the following events shall constitute an “Event of Default” hereunder with respect to Notes of any Series:
 
(a)           default in the payment of principal of (or premium, if any, on) any Note when the same becomes due and payable at maturity, upon acceleration, redemption or otherwise;
 
(b)           default in the payment of interest on any Note when the same becomes due and payable, and such default continues for a period of 30 days;
 
(c)           default in the performance or breach of the provisions of the Indenture applicable to mergers, consolidations and transfers of all or substantially all of the assets of the Company or the failure by the Company to make or consummate an Offer to Purchase in accordance with Section 4.11 or Section 4.12, or the failure of the Company to comply with Section 4.19;
 
(d)           the Company or any Subsidiary Guarantor defaults in the performance of or breaches any other covenant or agreement in the Indenture or under the Notes (other than a default specified in clause (a), (b) or (c) of this Section 6.01) and such default or breach continues for a period of 30 consecutive days after written notice by the Trustee or the Holders of 25% or more in aggregate principal amount of the Notes;
 
(e)           there occurs with respect to any issue or issues of Indebtedness of the Company or any Significant Subsidiary having an outstanding principal amount of $20 million or more in the aggregate for all such issues of all such Persons, whether such Indebtedness now exists or shall hereafter be created, (I) an event of default that has caused the holder thereof to declare such Indebtedness to be due and payable prior to its Stated Maturity and such Indebtedness has not been discharged in full or such acceleration has not been rescinded or annulled within 45 days of such acceleration or (II) the failure to make a principal payment at the final (but not any interim) fixed maturity and such defaulted payment shall not have been made, waived or extended;
 
(f)           any final judgment or order (not covered by insurance), that is non-appealable, for the payment of money in excess of $20 million in the aggregate for all such final judgments or orders against all such Persons (treating any deductibles, self-insurance or retention as not so covered) shall be rendered against the Company or any Significant Subsidiary and shall not be paid or discharged, and there shall be any period of 45 consecutive days following entry of the final judgment or order that causes the aggregate amount for all such final judgments or orders outstanding and not paid or discharged against all such Persons to exceed $20 million during which a stay of enforcement of such final judgment or order, by reason of a pending appeal or otherwise, shall not be in effect;
 
(g)           a court having jurisdiction in the premises enters a decree or order for (A) relief in respect of the Company or any Significant Subsidiary in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, (B) appointment of a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Company or any Significant Subsidiary or for all or substantially all of the property and assets of the Company or any Significant Subsidiary or (C) the winding up or liquidation of the
 
 
-51-

 
affairs of the Company or any Significant Subsidiary and, in each case, such decree or order shall remain unstayed and in effect for a period of 60 consecutive days;
 
(h)           the Company or any Significant Subsidiary (A) commences a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consents to the entry of an order for relief in an involuntary case under any such law, (B) consents to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Company or any Significant Subsidiary or for all or substantially all of the property and assets of the Company or any Significant Subsidiary or (C) effects any general assignment for the benefit of creditors;
 
(i)           failure by any Broker Dealer Regulated Subsidiary that is a Significant Subsidiary to meet the minimum capital requirements imposed by applicable regulatory authorities, and such condition continues for a period of 30 days after the Company or such Broker Dealer Regulated Subsidiary first becomes aware of such failure;
 
(j)           failure by any Bank Regulated Subsidiary that is a Significant Subsidiary to be at least “adequately capitalized,” as defined in regulations of applicable regulatory authorities; provided that an Event of Default under this clause (j) shall not have occurred until (x) 45 days from the time that such Bank Regulated Subsidiary has notice or is deemed to have notice of such failure unless a capital restoration plan has been filed the with OTS within that time (y) the expiration of a 90-day period commencing on the earlier of the date of initial submission of a capital restoration plan to the OTS (unless such capital plan is approved by the OTS before the expiration of such 90-day period or, if the OTS has notified us that it needs additional time to determine whether to approve such capital plan, in which case such 90-day period shall be extended until the OTS determines whether to approve such capital plan, such capital plan is approved by the OTS upon the expiration of such extended period);
 
(k)           if the Company or any Subsidiary that holds Capital Stock of a Broker Dealer Regulated Subsidiary that is a Significant Subsidiary shall become ineligible to hold such Capital Stock by reason of a statutory disqualification or otherwise;
 
(l)           the Commission shall revoke the registration of any Broker Dealer Regulated Subsidiary that is a Significant Subsidiary as a broker-dealer under the Exchange Act or any such Broker Dealer Regulated Subsidiary shall fail to maintain such registration;
 
(m)           the Examining Authority (as defined in Rule 15c3-l) for any Broker Dealer Regulated Subsidiary that is a Significant Subsidiary shall suspend (and shall not reinstate within 10 days) or shall revoke such Broker Dealer Regulated Subsidiary’s status as a member organization thereof;
 
(n)           the occurrence of any event of acceleration in a subordination agreement, as defined in Appendix D to Rule 15c3-l of the Exchange Act, to which the Company or any Broker Dealer Regulated Subsidiary that is a Significant Subsidiary is a party;
 
(o)           any Subsidiary Guarantor that is a Significant Subsidiary repudiates its obligations under its Note Guarantee or, except as permitted by the Indenture, any Note Guarantee is determined to be unenforceable or invalid or shall for any reason cease to be in full force and effect; or
 
 
-52-

 
(p)           any Lien on property or assets with a Fair Market Value in excess of $5,000,000 purported to be created under any Collateral Document shall cease to be, or shall be asserted by the Company or any of its Subsidiaries not to be, a valid and perfected Lien on any Collateral, with the priority required by the applicable Collateral Document, except (i) as a result of the sale or other disposition of the applicable Collateral in a transaction permitted under this Indenture or (ii) as a result of the failure by the Trustee or a collateral agent appointed by the trustee to maintain possession of any stock certificates, promissory notes or other instruments delivered to it under the Collateral Documents.
 
Section 6.02.     Acceleration.  If an Event of Default (other than an Event of Default specified in clause (g) or (h) of Section 6.01 that occurs with respect to the Company or any Subsidiary Guarantor) occurs and is continuing under the Indenture, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes, then outstanding, by written notice to the Company (and to the Trustee if such notice is given by the Holders), may, and the Trustee at the request of such Holders shall, declare the principal of, premium, if any, and accrued interest on the Notes to be immediately due and payable. Upon a declaration of acceleration, such principal of, premium, if any, and accrued interest shall be immediately due and payable. In the event of a declaration of acceleration because an Event of Default set forth in clause (e) of Section 6.01 has occurred and is continuing, such declaration of acceleration shall be automatically rescinded and annulled if the event of default triggering such Event of Default pursuant to clause (e) of Section 6.01 shall be remedied or cured by the Company or the relevant Significant Subsidiary or waived by the holders of the relevant Indebtedness within 60 days after the declaration of acceleration with respect thereto.  If an Event of Default specified in clause (g) or (h) of Section 6.01 occurs with respect to the Company, the principal of, premium, if any, and accrued interest on the Notes then outstanding shall automatically become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder.  The Holders of at least a majority in principal amount of the outstanding Notes by written notice to the Company and to the Trustee, may waive all past defaults and rescind and annul a declaration of acceleration and its consequences if (x) all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of acceleration, have been cured or waived and (y) the rescission would not conflict with any judgment or decree of a court of competent jurisdiction.
 
Section 6.03.      Control by Majority .  With respect to the Notes of any series, the Holders of at least a majority in aggregate principal amount of the outstanding Notes may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee; provided that the Trustee may refuse to follow any direction that conflicts with law or this Indenture, that may involve the Trustee in personal liability, or that the Trustee determines in good faith may be unduly prejudicial to the rights of Holders of Notes not joining in the giving of such direction and may take any other action it deems proper that is not inconsistent with any such direction received from Holders of Notes of that series.
 
Section 6.04.      Limitation on Suits.  A Holder of any Note of any series may not institute any proceeding, judicial or otherwise, with respect to this Indenture or that series of Notes, or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless:
 
(a)           the Holder gives the Trustee written notice of a continuing Event of Default;
 
(b)           the Holders of at least 25% in aggregate principal amount of outstanding Notes make a written request to the Trustee to pursue the remedy;
 
(c)           such Holder or Holders offer the Trustee indemnity satisfactory to the Trustee against any costs, liability or expense;
 
 
-53-

 
(d)           the Trustee does not comply with the request within 60 days after receipt of the request and the offer of indemnity; and
 
(e)           during such 60-day period, the Holders of a majority in aggregate principal amount of the outstanding Notes do not give the Trustee a direction that is inconsistent with the request.
 
For purposes of Section 6.03 of this Indenture and this Section 6.04, the Trustee shall comply with TIA Section 316(a) in making any determination of whether the Holders of the required aggregate principal amount of outstanding Notes of a particular series have concurred in any request or direction of the Trustee to pursue any remedy available to the Trustee or the Holders with respect to this Indenture or the Notes of that series or otherwise under the law.
 
A Holder may not use this Indenture to prejudice the rights of another Holder of Notes of the same series or to obtain a preference or priority over such other Holder (it being understood that the Trustee does not have any affirmative duty to ascertain whether or not such actions or forbearances are unduly prejudicial to such Holders).
 
Section 6.05.       Rights of Holders to Receive Payment.  Notwithstanding any other provision of this Indenture, the right of any Holder of a Note to receive payment of the principal of, premium, if any, or interest on, such Note or to bring suit for the enforcement of any such payment, on or after the due date expressed in the Notes, shall not be impaired or affected without the consent of the Holder.
 
Section 6.06.      Collection Suit by Trustee.  If an Event of Default in payment of principal, premium or interest of any Note specified in clause (a) or (b) of Section 6.01 occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company or any other obligor of that Note for the whole amount of principal, premium, if any, and accrued interest remaining unpaid, together with interest on overdue principal, premium, if any, and, to the extent that payment of such interest is lawful, interest on overdue installments of interest, in each case at the rate specified in such Notes, and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel.
 
Section 6.07.       Trustee May File Proofs of Claim.  The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07) and the Holders allowed in any judicial proceedings relative to the Company (or any other obligor of the Notes), its creditors or its property and shall be entitled and empowered to collect and receive any monies, securities or other property payable or deliverable upon conversion or exchange of the Notes or upon any such claims and to distribute the same, and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07. Nothing herein contained shall be deemed to empower the Trustee to authorize or consent to, or accept or adopt on behalf of any Holder, any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.
 
Section 6.08.       Priorities.  If the Trustee collects any money pursuant to this Article 6, it shall
 
 
-54-

 
pay out the money in the following order:
 
First: to the Trustee for all amounts due under Section 7.07;
 
Second: to Holders for amounts then due and unpaid for principal of, premium, if any, and interest on the Notes in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Notes for principal, premium, if any, and interest, respectively; and
 
Third: to the Company or as a court of competent jurisdiction may direct.
 
The Trustee, upon prior written notice to the Company, may fix a record date and payment date for any payment to Holders pursuant to this Section 6.08.
 
Section 6.09.       Undertaking for Costs.  In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court may require any party litigant in such suit to file an undertaking to pay the costs of the suit, and the court may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.09 does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.05, or a suit by Holders of more than 10% in principal amount of the outstanding Notes of any series.
 
Section 6.10.      Restoration of Rights and Remedies.  If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then, and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holders shall be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Company, Trustee and the Holders shall continue as though no such proceeding had been instituted.
 
Section 6.11.      Rights and Remedies Cumulative.  Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or wrongfully taken Notes in Section 2.04, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.
 
Section 6.12.     Delay or Omission Not Waiver.  No delay or omission of the Trustee or of any Holder to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article 6 or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders, as the case may be.
 
ARTICLE VII
 
THE TRUSTEE
 
Section 7.01.      General.
 
 
-55-

 
(a)           The duties and responsibilities of the Trustee are as provided by the TIA and as set forth herein. Whether or not expressly so provided, every provision of the Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee is subject to this Article.
 
(b)           Except during the continuance of an Event of Default, the Trustee need perform only those duties that are specifically set forth in the Indenture and no others, and no implied covenants or obligations will be read into the Indenture against the Trustee. In case an Event of Default has occurred and is continuing, the Trustee shall exercise those rights and powers vested in it by the Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs.
 
(c)           No provision of the Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act or its own willful misconduct.
 
Section 7.02.      Certain Rights of Trustee.  Subject to TIA Sections 315(a) through (d):
 
(a)           In the absence of bad faith on its part, the Trustee may conclusively rely, and will be protected in acting or refraining from acting, upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper Person.  The Trustee need not investigate any fact or matter stated in the document, but, in the case of any document which is specifically required to be furnished to the Trustee pursuant to any provision hereof, the Trustee shall examine the document to determine whether it conforms to the requirements of the Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). The Trustee, in its discretion, may make further inquiry or investigation into such facts or matters as it sees fit.
 
(b)           Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel conforming to Section 11.05 and the Trustee will not be liable for any action it takes or omits to take in good faith in reliance on the certificate or opinion.
 
(c)           The Trustee may act through its attorneys and agents and will not be responsible for the misconduct or negligence of any agent appointed with due care.
 
(d)           The Trustee will be under no obligation to exercise any of the rights or powers vested in it by the Indenture at the request or direction of any of the Holders, unless such Holders have offered to the Trustee reasonable security or indemnity satisfactory to it against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction.
 
(e)           The Trustee will not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within its rights or powers or for any action it takes or omits to take in accordance with the direction of the Holders in accordance with Section 6.05 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under the Indenture.
 
(f)           The Trustee may consult with counsel of its selection, and the advice of such counsel or any Opinion of Counsel will be full and complete authorization and protection in
 
 
-56-

 
respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.
 
(g)           No provision of the Indenture will require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance of its duties hereunder, or in the exercise of its rights or powers, unless it receives indemnity satisfactory to it against any loss, liability or expense.
 
(h)           The Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities and this Indenture.
 
(i)           The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder;
 
(j)           The Trustee may request that the Company deliver an Officers’ Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any person authorized to sign an Officers’ Certificate, including any person specified as so authorized in any such certificate previously delivered and not superseded; and
 
(k)            In no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.
 
Section 7.03.      Individual Rights of Trustee.  The Trustee, in its individual or any other capacity, may become the owner or pledgee of Notes and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not the Trustee. Any Agent may do the same with like rights. However, the Trustee is subject to TIA Sections 310(b) and 311. For purposes of TIA Section 311(b)(4) and (6):
 
(a)           “cash transaction” means any transaction in which full payment for goods or securities sold is made within seven days after delivery of the goods or securities in currency or in checks or other orders drawn upon banks or bankers and payable upon demand; and
 
(b)           “self-liquidating paper” means any draft, bill of exchange, acceptance or obligation which is made, drawn, negotiated or incurred for the purpose of financing the purchase, processing, manufacturing, shipment, storage or sale of goods, wares or merchandise and which is secured by documents evidencing title to, possession of, or a lien upon, the goods, wares or merchandise or the receivables or proceeds arising from the sale of the goods, wares or merchandise previously constituting the security, provided the security is received by the Trustee simultaneously with the creation of the creditor relationship arising from the making, drawing, negotiating or incurring of the draft, bill of exchange, acceptance or obligation.
 
Section 7.04.      Trustee’s Disclaimer.  The Trustee (i) makes no representation as to the validity or adequacy of the Indenture or the Notes, (ii) is not accountable for the Company’s use or application of
 
 
-57-

 
the proceeds from the Notes and (iii) is not responsible for any statement in the Notes other than its certificate of authentication.
 
Section 7.05.      Notice of Default.  If any Default occurs and is continuing and is known to a Responsible Officer of the Trustee, the Trustee will send notice of the Default to each Holder within 90 days after it occurs, unless the Default has been cured; provided that, except in the case of a default in the payment of the principal of or interest on any Note, the Trustee may withhold the notice if and so long as the board of directors, the executive committee or a trust committee of directors of the Trustee in good faith determines that withholding the notice is in the interest of the Holders. Notice to Holders under this Section will be given in the manner and to the extent provided in TIA Section 313(c).
 
Section 7.06.      Reports by Trustee to Holders.  Within 60 days after each May 15, beginning with May 15, 2008, the Trustee will mail to each Holder, as provided in TIA Section 313(c), a brief report dated as of such May 15, if required by TIA Section 313(a), and file such reports with each stock exchange upon which its Notes are listed and with the Commission as required by TIA Section 313(d).
 
Section 7.07.       Compensation and Indemnity.
 
(a)           The Company will pay the Trustee compensation as agreed upon in writing for its services. The compensation of the Trustee is not limited by any law on compensation of a Trustee of an express trust. The Company will reimburse the Trustee upon request for all reasonable out-of-pocket expenses, disbursements and advances incurred or made by the Trustee, including the reasonable compensation and expenses of the Trustee’s agents and counsel.
 
(b)           The Company will indemnify the Trustee for, and hold it harmless against, any and all loss, liability, damage, claim or expense, including taxes (other than taxes based upon, measured by or determined by the income of the Trustee) incurred by it without negligence or willful misconduct on its part arising out of or in connection with the acceptance or administration of the Indenture and its duties under the Indenture and the Notes, including the costs and expenses of defending itself against any claim (whether asserted by the Company, any Holder or any other Person) or liability and of complying with any process served upon it or any of its officers in connection with the exercise or performance of any of its powers or duties under the Indenture and the Notes.
 
(c)           To secure the Company’s payment obligations in this Section, the Trustee will have a lien prior to the Notes on all money or property held or collected by the Trustee, in its capacity as Trustee, except money or property held in trust to pay principal of, and interest on particular Notes.
 
When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(g) or Section 6.01(h), the expenses (including the reasonable charges and expenses of its counsel) and the compensation for the services are intended to constitute expenses of administration under any applicable Federal or state bankruptcy, insolvency or other similar law.
 
This section shall survive the resignation or removal of the Trustee or the termination of the Indenture.
 
Section 7.08.      Replacement of Trustee.
 
(a)                           (1)           The Trustee may resign at any time by written notice to the Company.
 
 
-58-

 
(2)           The Holders of a majority in principal amount of the outstanding Notes may remove the Trustee by written notice to the Trustee.
 
(3)           If the Trustee is no longer eligible under Section 7.10 or in the circumstances described in TIA Section 310(b), any Holder that satisfies the requirements of TIA Section 310(b) may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.
 
(4)           The Company may remove the Trustee if: (i) the Trustee is no longer eligible under Section 7.10; (ii) the Trustee is adjudged a bankrupt or an insolvent; (iii) a receiver or other public officer takes charge of the Trustee or its property; or (iv) the Trustee becomes incapable of acting.
 
A resignation or removal of the Trustee and appointment of a successor Trustee will become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section.
 
(b)           If the Trustee has been removed by the Holders, Holders of a majority in principal amount of the Notes may appoint a successor Trustee with the consent of the Company. Otherwise, if the Trustee resigns or is removed, or if a vacancy exists in the office of Trustee for any reason, the Company will promptly appoint a successor Trustee. If the successor Trustee does not deliver its written acceptance within 30 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of a majority in principal amount of the outstanding Notes may petition any court of competent jurisdiction at the expense of the Company in the case of the Trustee, for the appointment of a successor Trustee.
 
(c)           Upon delivery by the successor Trustee of a written acceptance of its appointment to the retiring Trustee and to the Company, (i) the retiring Trustee will transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07, (ii) the resignation or removal of the retiring Trustee will become effective, and (iii) the successor Trustee will have all the rights, powers and duties of the Trustee under the Indenture. Upon request of any successor Trustee, the Company will execute any and all instruments for fully and vesting in and confirming to the successor Trustee all such rights, powers and trusts. The Company will give notice of any resignation and any removal of the Trustee and each appointment of a successor Trustee to all Holders, and include in the notice the name of the successor Trustee and the address of its Corporate Trust Office.
 
(d)           Notwithstanding replacement of the Trustee pursuant to this Section, the Company’s obligations under Section 7.07 will continue for the benefit of the retiring Trustee.
 
(e)           The Trustee agrees to give the notices provided for in, and otherwise comply with, TIA Section 310(b).
 
Section 7.09.      Successor Trustee by Merger.  If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation or national banking association, the resulting, surviving or transferee corporation or national banking association without any further act will be the successor Trustee with the same effect as if the successor Trustee had been named as the Trustee in the Indenture.
 
Section 7.10.      Eligibility.  The Indenture must always have a Trustee that satisfies the requirements of TIA Section 310(a) and has a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual report of condition.
 
 
-59-

 
Section 7.11.      Money Held in Trust.  The Trustee will not be liable for interest on any money received by it except as it may agree with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law and except for money held in trust under Article 8.
 
ARTICLE VIII
 
DEFEASANCE AND DISCHARGE
 
Section 8.01.      Discharge of Company’s Obligations.
 
(a)           Subject to paragraph (b), the Company’s obligations under the Notes and the Indenture, and each Subsidiary Guarantor’s obligations under its Note Guarantee, will terminate if:
 
 
(i)
either:
 
(1)           all Notes that have been authenticated and delivered (other than destroyed, lost or stolen Notes that have been replaced, Notes that are paid pursuant to Section 4.01 and Notes for whose payment money or securities have theretofore been deposited in trust and thereafter repaid to the Company pursuant to Section 8.05) have been delivered to the Trustee for cancellation and the Company has paid all sums payable under such Indenture; or
 
(2)           all Notes mature within one year or are to be called for redemption within one year and the Company has irrevocably deposited with the Trustee, as trust funds in trust solely for the benefit of the holders, money or U.S. Government Obligations sufficient, without consideration of any reinvestment of interest, to pay principal, premium, if any, and accrued interest on the Notes to the date of maturity or redemption and all other sums payable under such Indenture;
 
 
(ii)
no Default or Event of Default shall have occurred and be continuing on the date of such deposit and such deposit will not result in a breach or violation of, or constitute a default under such Indenture or any other instrument to which the Company or any Subsidiary Guarantor is a party or by which the Company or any Subsidiary Guarantor is bound;
 
 
(iii)
the Company has delivered irrevocable instructions to the Trustee to apply the deposited money toward the payment of the Notes at maturity or the redemption date, as applicable; and
 
 
(iv)
the Company delivers to the Trustee an Officers’ Certificate and an Opinion of Counsel, in each case stating that all conditions precedent provided for herein relating to the satisfaction and discharge of the Indenture have been complied with.
 
(b)           After satisfying the conditions in clause (a)(i)(1), only the Company’s obligations under Section 7.07 will survive. After satisfying the conditions in clause (a)(i)(2), (a)(ii) and (a)(iii), only the Company’s obligations in Article 2 and Sections 4.01, 4.02, 7.07, 7.08, 8.05 and 8.06 will survive. In either case, the Trustee upon request will acknowledge in writing the discharge of the Company’s obligations under the Notes and the Indenture other than the surviving obligations.
 
 
-60-

 
Section 8.02.      Legal Defeasance.  On the 123rd day following the deposit referred to in clause (1), the Company will be deemed to have paid and will be discharged from its obligations in respect of the Notes and this Indenture, other than its obligations in Article 2 and Sections 4.01, 4.02, 7.07, 7.08, 8.05 and 8.06, and each Subsidiary Guarantor’s obligations under its Note Guarantee will terminate, provided the following conditions have been satisfied:
 
(1)           The Company has irrevocably deposited in trust with the Trustee, as trust funds solely for the benefit of the Holders, money and/or U.S. Government Obligations or a combination thereof sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certificate thereof delivered to the Trustee, without consideration of any reinvestment, to pay principal of, premium, if any, and accrued interest on the Notes to maturity or redemption, as the case may be, provided that any redemption before maturity has been irrevocably provided for under arrangements satisfactory to the Trustee.
 
(2)           Immediately after giving effect to such deposit on a pro forma basis, no Event of Default, or event that after the giving of notice or lapse of time or both would become an Event of Default, shall have occurred and be continuing on the date of such deposit or during the period ending on the 123rd day after the date of such deposit, and such deposit shall not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound.
 
(3)           The Company has delivered to the Trustee:
 
(A)           either (x) an Opinion of Counsel to the effect that Holders will not recognize income, gain or loss for federal income tax purposes as a result of the defeasance and will be subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred, which Opinion of Counsel must be based upon (and accompanied by a copy of) a ruling of the Internal Revenue Service to the same effect unless there has been a charge in applicable federal income tax law after the Closing Date such that a ruling is no longer required or (y) a ruling directed to the Trustee received from the Internal Revenue Service to the same effect as the aforementioned Opinion of Counsel; and
 
(B)           the defeasance trust is not required to register as an investment company under the Investment Company Act of 1940 and, after the passage of 123 days following the deposit, the trust fund will not be subject to the effect of Section 547 of the United States Bankruptcy Code or Section 15 of the New York Debtor and Creditor Law.
 
(4)           The Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, in each case stating that all conditions precedent provided for herein relating to the defeasance have been complied with.
 
Prior to the end of the 123-day period, none of the Company’s obligations under the Indenture will be discharged. Thereafter, the Trustee upon request will acknowledge in writing the discharge of the Company’s obligations under the Notes and the Indenture except for the surviving obligations specified above.
 
Section 8.03.      Covenant Defeasance.  The Company may, subject as provided herein, be released from their respective obligations to comply with, and shall have no liability in respect of any term, condition or limitation, set forth in Sections 4.03, 4.04, 4.05, 4.06, 4.07, 4.08, 4.09, 4.10, 4.11, 4.13, 4.19 and 4.20, clauses (3) and (4) of Section 5.01, clause (c) of Section 6.01 with respect to such clauses
 
 
-61-

 
(3) and (4) of Section 5.01 and Sections 4.11 and 4.19, clause (d) of Section 6.01 with respect to the covenants contained in Sections 4.03, 4.04, 4.05, 4.06, 4.07, 4.08, 4.09, 4.10, 4.11 4.13 and 4.20, and clauses (e) and (f) of Section 6.01 shall not constitute an Event of Default under Section 6.01 (“Covenant Defeasance”) if:
 
 
(i)
The Company has complied with clauses (1), (2), 3(B), and (4) of Section 8.02; and
 
 
(ii)
the Company has delivered to the Trustee an Opinion of Counsel to the effect that the Holders will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income tax on the same amount and in the same manner and at the same times as would otherwise have been the case if such deposit and defeasance had not occurred.
 
Except as specifically stated above, none of the Company’s obligations under the Indenture will be discharged.

Section 8.04.      Application of Trust Money.  Subject to Section 8.05, the Trustee will hold in trust the money or U.S. Government Obligations deposited with it pursuant to Section 8.01, 8.02 or 8.03, and apply the deposited money and the proceeds from deposited U.S. Government Obligations to the payment of principal of and interest on the Notes in accordance with the Notes and the Indenture. Such money and U.S. Government Obligations need not be segregated from other funds except to the extent required by law.
 
Section 8.05.      Repayment to Company.  Subject to Sections 7.07, 8.01, 8.02 and 8.03, the Trustee will promptly pay to the Company upon request any excess money held by the Trustee at any time and thereupon be relieved from all liability with respect to such money. The Trustee will pay to the Company upon request any money held for payment with respect to the Notes that remains unclaimed for two years, provided that before making such payment the Trustee may at the expense of the Company publish once in a newspaper of general circulation in New York City, or send to each Holder entitled to such money, notice that the money remains unclaimed and that after a date specified in the notice (at least 30 days after the date of the publication or notice) any remaining unclaimed balance of money will be repaid to the Company. After payment to the Company, Holders entitled to such money must look solely to the Company for payment, unless applicable law designates another Person, and all liability of the Trustee with respect to such money will cease.
 
Section 8.06.      Reinstatement.  If and for so long as the Trustee is unable to apply any money or U.S. Government Obligations held in trust pursuant to Section 8.01, 8.02 or 8.03 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under the Indenture and the Notes will be reinstated as though no such deposit in trust had been made. If the Company makes any payment of principal of or interest on any Notes because of the reinstatement of its obligations, it will be subrogated to the rights of the Holders of such Notes to receive such payment from the money or U.S. Government Obligations held in trust.
 
ARTICLE IX
 
AMENDMENTS, SUPPLEMENTS AND WAIVERS
 
Section 9.01.      Amendments Without Consent of Holders.  The Company and the Trustee may
 
 
-62-

 
amend or supplement the Indenture or the Notes without notice to or the consent of any Noteholder:
 
(a)           to cure any ambiguity, defect or inconsistency in the Indenture or the Notes, provided that such amendments or supplements shall not, in the good faith opinion of the Board of Directors of the Company as evidenced by a board resolution, adversely affect the interest of the holders in any material respect;
 
(b)           to comply with Section 4.07 or Article 5;
 
(c)           to comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA;
 
(d)           to evidence and provide for the acceptance of an appointment hereunder by a successor Trustee;
 
(e)           make any change that, in the good faith opinion of the Board of Directors as evidenced by a Board Resolution, does not materially and adversely affect the rights of any Holder;
 
(f)           to provide for uncertificated Notes in addition to or in place of certificated Notes;
 
(g)           add Guarantees with respect to the Notes in accordance with the applicable provisions of the Indenture; or
 
(h)           to secure the Notes.
 
Section 9.02.      Amendments with Consent of Holders.
 
(a)           Except as otherwise provided in Section 6.05, Section 9.01 or paragraph (b), the Company and the Trustee may amend the Indenture and the Notes with the consent of the Holders of a majority in aggregate principal amount of the outstanding Notes, and the Holders of a majority in principal amount of the outstanding Notes by written notice to the Trustee may waive future compliance by the Company with any provision of the Indenture or the Notes.
 
(b)           Notwithstanding the provisions of paragraph (a), without the consent of each Holder affected, an amendment or waiver may not:
 
 
(i)
change the Stated Maturity of the principal of, or any installment of interest on, any Note,
 
 
(ii)
reduce the principal amount of, or premium, if any, or interest on, any Note,
 
 
(iii)
change the optional redemption dates or optional redemption prices of the Notes from that stated under the caption “Optional Redemption”,
 
 
(iv)
change the place or currency of payment of principal of, or premium, if any, or interest on, any Note,
 
 
(v)
impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity (or, in the case of a redemption, on or after the Redemption Date) of any Note,
 
 
-63-

 
 
(vi)
waive a default in the payment of principal of, premium, if any, or interest on the Notes or modify any provision of the Indenture relating to modification or amendment thereof,
 
 
(vii)
reduce the above-stated percentage of outstanding notes of such series, the consent of whose holders is necessary to modify or amend the applicable indenture,
 
 
(viii)
release any Subsidiary Guarantor from its Notes Guarantee, except as provided in the Indenture,
 
 
(ix)
increase the amount of Notes issued pursuant to this Indenture above $1,936,000,000 (plus any Capitalized Interest), or
 
 
(x)
reduce the percentage or aggregate principal amount of outstanding Notes the consent of whose Holders is necessary for waiver of compliance with certain provisions of the Indenture or for waiver of certain defaults.
 
(c)           It is not necessary for Noteholders to approve the particular form of any proposed amendment, supplement or waiver, but is sufficient if their consent approves the substance thereof.
 
(d)           An amendment, supplement or waiver under this Section will become effective on receipt by the Trustee of written consents from the Holders of the requisite percentage in principal amount of the outstanding Notes. After an amendment, supplement or waiver under this Section becomes effective, the Company will send to the Holders affected thereby a notice briefly describing the amendment, supplement or waiver. The Company will send supplemental indentures to Holders upon request. Any failure of the Company to send such notice, or any defect therein, will not, however, in any way impair or affect the validity of any such supplemental indenture or waiver.
 
Section 9.03.      Effect of Consent.
 
(a)           After an amendment, supplement or waiver becomes effective, it will bind every Holder unless it is of the type requiring the consent of each Holder affected. If the amendment, supplement or waiver is of the type requiring the consent of each Holder affected, the amendment, supplement or waiver will bind each Holder that has consented to it and every subsequent Holder of a Note that evidences the same debt as the Note of the consenting Holder.
 
(b)           If an amendment, supplement or waiver changes the terms of a Note, the Trustee may require the Holder to deliver it to the Trustee so that the Trustee may place an appropriate notation of the changed terms on the Note and return it to the Holder, or exchange it for a new Note that reflects the changed terms. The Trustee may also place an appropriate notation on any Note thereafter authenticated. However, the effectiveness of the amendment, supplement or waiver is not affected by any failure to annotate or exchange Notes in this fashion.
 
Section 9.04.      Trustee’s Rights and Obligations. The Trustee shall be provided with, and will be fully protected in conclusively relying upon, an Officer’s Certificate and an Opinion of Counsel stating that the execution of any amendment, supplement or waiver authorized pursuant to this Article is authorized or permitted by the Indenture. If the Trustee has received such an Opinion of Counsel, it shall
 
 
-64-

 
sign the amendment, supplement or waiver so long as the same does not adversely affect the rights of the Trustee. The Trustee may, but is not obligated to, execute any amendment, supplement or waiver that affects the Trustee’s own rights, duties or immunities under the Indenture.
 
Section 9.05.      Conformity with Trust Indenture Act.  Every supplemental indenture executed pursuant to this Article shall conform to the requirements of the TIA.
 
Section 9.06.      Payments for Consents.  Neither the Company nor any of its Subsidiaries or Affiliates may, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of the Indenture or the Notes unless such consideration is offered to be paid or agreed to be paid to all Holders of the Notes that consent, waive or agree to amend such term or provision within the time period set forth in the solicitation documents relating to the consent, waiver or amendment.
 

ARTICLE X
 
GUARANTEES
 
Section 10.01.      Guarantees.  Subject to this Article 10, each of the Guarantors hereby, jointly and severally, unconditionally guarantees to each Holder of a Note and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Notes or the obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any, and interest on the Notes will be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of, premium, if any, and interest on the Notes, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and (b) in the case of any extension of time of payment or renewal of any Notes or any of such other obligations, that the same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately. Each Subsidiary Guarantor agrees that this is a guarantee of payment and not a guarantee of collection.
 
The Guarantors hereby agree that their obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Notes or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Subsidiary Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenant that this Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes and this Indenture or pursuant to Section 10.04.
 
If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or such Holder, this Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect.
 
 
-65-

 
Each Subsidiary Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Subsidiary Guarantor further agrees that, as between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 for the purposes of this Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Guarantee. The Guarantors shall have the right to seek contribution from any non-paying Subsidiary Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Guarantee.
 
Section 10.02.      Limitation on Subsidiary Guarantor Liability.  Each Subsidiary Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the intention of all such parties that the Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that the obligations of such Subsidiary Guarantor under its Guarantee and this Article 10 shall be limited to the maximum amount as will, after giving effect to such maximum amount and all other contingent and fixed liabilities of such Subsidiary Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Subsidiary Guarantor in respect of the obligations of such other Subsidiary Guarantor under this Article 10, result in the obligations of such Subsidiary Guarantor under its Guarantee to not constitute a fraudulent transfer or conveyance.
 
Section 10.03.      Execution and Delivery of the Guarantee.  In the event that the Company is required to cause a Regulated Subsidiary or Restricted Subsidiary to guarantee the Notes pursuant to Section 4.07, the Company shall cause such Subsidiaries to execute supplemental indentures to this Indenture and Guarantees in accordance with Section 4.07 and this Article 10, to the extent applicable.
 
Section 10.04.      Guarantors May Consolidate, etc., on Certain Terms.  No Subsidiary Guarantor may consolidate with or merge with or into (whether or not such Subsidiary Guarantor is the surviving Person) another Person whether or not affiliated with such Subsidiary Guarantor unless:
 
(a)           subject to the other provisions of this Section, the Person formed by or surviving any such consolidation or merger (if other than a Subsidiary Guarantor or the Company) shall be a corporation organized and validly existing under the laws of the United States or any state thereof or the District of Columbia, and unconditionally assumes all the obligations of such Subsidiary Guarantor, pursuant to a supplemental indenture in form and substance reasonably satisfactory to the Trustee, under the Notes, this Indenture, the Registration Rights Agreement and the Guarantee on the terms set forth herein or therein;
 
(b)           immediately after giving effect to such transaction, no Default or Event of Default exists; and
 
(c)           the Company would be permitted, immediately after giving effect to such transaction, to incur at least $1.00 of additional Indebtedness (other than Permitted Indebtedness) pursuant to Section 4.03.
 
 
-66-

 
In case of any such consolidation, merger, sale or conveyance and upon the assumption by the successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the Guarantee endorsed upon the Notes and the due and punctual performance of all of the covenants and conditions of this Indenture to be performed by the Subsidiary Guarantor, such successor Person shall succeed to and be substituted for the Subsidiary Guarantor with the same effect as if it had been named herein as a Subsidiary Guarantor. Such successor Person thereupon may cause to be signed any or all of the Guarantees to be endorsed upon all of the Notes issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee. All the Guarantees so issued shall in all respects have the same legal rank and benefit under this Indenture as the Guarantees theretofore and thereafter issued in accordance with the terms of this Indenture as though all of such Guarantees had been issued at the date of the execution hereof.
 
Except as set forth in Articles Four and Five, and notwithstanding clause (c) above, nothing contained in this Indenture or in any of the Notes shall prevent any consolidation or merger of a Subsidiary Guarantor with or into the Company or another Subsidiary Guarantor, or shall prevent any sale or conveyance of the property of a Subsidiary Guarantor as an entirety or substantially as an entirety to the Company or another Subsidiary Guarantor.
 
Section 10.05. Releases Following Certain Events.  In the event of a (i) sale or other disposition of all of the assets of any Subsidiary Guarantor, by way of merger, consolidation or otherwise, or a sale, exchange or transfer to any Person (other than an Affiliate of the Company) of all of the capital stock of any Subsidiary Guarantor, (ii) the designation of any Subsidiary Guarantor as an Unrestricted Subsidiary or (iii) the defeasance of the Notes in accordance with Section 8.01, in each case in compliance with the terms of this Indenture, then such Subsidiary Guarantor (in the event of a sale, exchange, transfer or other disposition, by way of merger, consolidation or otherwise, of all of the capital stock of such Subsidiary Guarantor) or the corporation acquiring the property (in the event of a sale or other disposition of all or substantially all of the assets of such Subsidiary Guarantor) will be released and relieved of any obligations under its Guarantee and Registration Rights Agreement; provided that, in the case of (i) above, the Net Cash Proceeds of such sale or other disposition are applied in accordance with the applicable provisions of this Indenture, including without limitation Section 4.11.  Upon delivery by the Company to the Trustee of an Officers’ Certificate and an Opinion of Counsel to the effect that such sale or other disposition was made by the Company in accordance with the applicable provisions of this Indenture, including, in the case of a release pursuant to (i) above and Section 4.11, the Trustee shall execute any documents reasonably required in order to evidence the release of any Subsidiary Guarantor from its obligations under its Guarantee.
 
Any Subsidiary Guarantor not released from its obligations under its Guarantee shall remain liable for the full amount of principal of and interest on the Notes and for the other obligations of any Subsidiary Guarantor under this Indenture as provided in this Article 10.
 
ARTICLE XI
 
MISCELLANEOUS
 
Section 11.01.  Trust Indenture Act of 1939.  The Indenture shall incorporate and be governed by the provisions of the TIA that are required to be part of and to govern indentures qualified under the TIA.
 
Section 11.02.  Noteholder Communications; Noteholder Actions.
 
(a)  The rights of Holders to communicate with other Holders with respect to the Indenture or the Notes are as provided by the TIA, and the Company and the Trustee shall
 
-67-

 
comply with the requirements of TIA Sections 312(a) and 312(b).  Neither the Company nor the Trustee will be held accountable by reason of any disclosure of information as to names and addresses of Holders made pursuant to the TIA.
 
(b)          (1) Any request, demand, authorization, direction, notice, consent to amendment, supplement or waiver or other action provided by this Indenture to be given or taken by a Holder (an “act”) may be evidenced by an instrument signed by the Holder delivered to the Trustee.  The fact and date of the execution of the instrument, or the authority of the person executing it, may be proved in any manner that the Trustee deems sufficient.
 
(2)  The Trustee may make reasonable rules for action by or at a meeting of Holders, which will be binding on all the Holders.
 
(c)  Any act by the Holder of any Note binds that Holder and every subsequent Holder of a Note that evidences the same debt as the Note of the acting Holder, even if no notation thereof appears on the Note. Subject to paragraph (d), a Holder may revoke an act as to its Notes, but only if the Trustee receives the notice of revocation before the date the amendment or waiver or other consequence of the act becomes effective.
 
(d)  The Company may, but is not obligated to, fix a record date (which need not be within the time limits otherwise prescribed by TIA Section 316(c)) for the purpose of determining the Holders entitled to act with respect to any amendment or waiver or in any other regard, except that during the continuance of an Event of Default, only the Trustee may set a record date as to notices of default, any declaration or acceleration or any other remedies or other consequences of the Event of Default.  If a record date is fixed, those Persons that were Holders at such record date and only those Persons will be entitled to act, or to revoke any previous act, whether or not those Persons continue to be Holders after the record date.  No act will be valid or effective for more than 90 days after the record date.
 
Section 11.03.  Notices.
 
(a)  Any notice or communication to the Company will be deemed given if in writing (i) when delivered in person or (ii) five days after mailing when mailed by first class mail, or (iii) when sent by facsimile transmission, with transmission confirmed. Notices or communications to a Subsidiary Guarantor will be deemed given if given to the Company.  Any notice to the Trustee will be effective only upon receipt. In each case the notice or communication should be addressed as follows:
 
if to the Company:
E*TRADE Financial Corporation
135 East 57th Street
New York, New York 10022

if to the Trustee:
The Bank of New York
101 Barclay Street, Floor 8W
New York, New York 10286
Attn: Corporate Trust Administration
Fax: 212-815-5707
 
-68-

 
The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.
 
(b)           Except as otherwise expressly provided with respect to published notices, any notice or communication to a Holder will be deemed given when mailed to the Holder at its address as it appears on the Register by first class mail or, as to any Global Note registered in the name of DTC or its nominee, as agreed by the Company, the Trustee and DTC.  Copies of any notice or communication to a Holder, if given by the Company, will be mailed to the Trustee at the same time.  Defect in mailing a notice or communication to any particular Holder will not affect its sufficiency with respect to other Holders.
 
(c)           Where the Indenture provides for notice, the notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and the waiver will be the equivalent of the notice.  Waivers of notice by Holders must be filed with the Trustee, but such filing is not a condition precedent to the validity of any action taken in reliance upon such waivers.
 
Section 11.04.   Certificate and Opinion as to Conditions Precedent.  Upon any request or application by the Company to the Trustee to take any action under the Indenture, the Company will furnish to the Trustee:
 
(a)           an Officers’ Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in the Indenture relating to the proposed action have been complied with; and
 
(b)           an Opinion of Counsel stating that all such conditions precedent have been complied with, except that such Opinion of Counsel need not be provided in connection with the issuance of the Notes.
 
Section 11.05.   Statements Required in Certificate or Opinion.  Each certificate or opinion with respect to compliance with a condition or covenant provided for in the Indenture must include:
 
(a)           a statement that each person signing the certificate or opinion has read the covenant or condition and the related definitions;
 
(b)           a brief statement as to the nature and scope of the examination or investigation upon which the statement or opinion contained in the certificate or opinion is based;
 
(c)           a statement that, in the opinion of each such person, that person has made such examination or investigation as is necessary to enable the person to express an informed opinion as to whether or not such covenant or condition has been complied with; and
 
(d)           a statement as to whether or not, in the opinion of each such person, such condition or covenant has been complied with, provided that an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials with respect to matters of fact.
 
Section 11.06.   Payment Date Other Than a Business Day.  If any payment with respect to a payment of any principal of, premium, if any, or interest on any Note (including any payment to be made on any date fixed for redemption or purchase of any Note) is due on a day which is not a Business Day, then the payment need not be made on such date, but may be made on the next Business Day with the same force and effect as if made on such date, and no interest will accrue for the intervening period.
 
 
-69-

 
Section 11.07.  Governing Law.  The Indenture, including any Note Guaranties, and the Notes shall be governed by, and construed in accordance with, the laws of the State of New York.
 
Section 11.08.  No Adverse Interpretation of Other Agreements.  The Indenture may not be used to interpret another indenture or loan or debt agreement of the Company or any Subsidiary of the Company, and no such indenture or loan or debt agreement may be used to interpret the Indenture.
 
Section 11.09.  Successors.  All agreements of the Company or any Subsidiary Guarantor in the Indenture and the Notes will bind its successors.  All agreements of the Trustee in the Indenture will bind its successor.
 
Section 11.10.  Duplicate Originals.  The parties may sign any number of copies of the Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
 
Section 11.11.  Separability.  In case any provision in the Indenture or in the Notes is invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired thereby.
 
Section 11.12.  Table of Contents and Headings.  The Table of Contents, Cross-Reference Table and headings of the Articles and Sections of the Indenture have been inserted for convenience of reference only, are not to be considered a part of the Indenture and in no way modify or restrict any of the terms and provisions of the Indenture.
 
Section 11.13.  No Liability of Directors, Officers, Employees, Incorporators, Members and Stockholders.  No director, officer, employee, incorporator, member or stockholder of the Company or any Subsidiary Guarantor, as such, will have any liability for any obligations of the Company or such Subsidiary Guarantor under the Notes, any Note Guarantee or the Indenture or for any claim based on, in respect of, or by reason of, such obligations.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.
 
Section 11.14.  Waiver of Jury Trial. EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY.
 
Section 11.15.  Force Majeure.   In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.
 
ARTICLE XII
COLLATERAL DOCUMENTS AND SECURITY
 
Upon securing the Notes in accordance with Section 4.20 hereof, the following provisions shall apply:
 
- 70 -

 
Section 12.01.  Appointment of Collateral Agent.  The Company shall appoint a Collateral Agent which shall be entitled to the protections, immunities and indemnities as provided in a supplemental indenture hereto.
 
Section 12.02.  Collateral Documents.
 
(a)           In order to secure the due and punctual payment of the Notes, the Company and the Subsidiary Guarantors will enter into the Collateral Documents to create the Note Liens on the Collateral in accordance with the terms thereof.  In the event of a conflict between the terms of this Indenture and the Intercreditor Agreement, the Intercreditor Agreement shall control.
 
(b)           Each Holder of a Note, by accepting such Note, (i) agrees to all of the terms and provisions of the Collateral Documents (including, without limitation, the provisions providing for foreclosure and release of Collateral and the automatic amendment or waiver of the Collateral Documents pursuant to the terms of the Intercreditor Agreement) and (ii) authorizes the Trustee and the Collateral Agent to enter into the Intercreditor Agreement and the other Collateral Documents, to bind the Holders on the terms set forth in the Collateral Documents, to perform and observe its obligations under the Collateral Documents and, unless violative of the provisions hereof and thereof, to execute any and all documents, amendments, waivers, consents, releases or other instruments required (or authorized) to be executed by it pursuant to the terms thereof.
 
Section 12.03.  Application of Proceeds of Collateral.  Upon any realization upon the Collateral, the proceeds thereof shall be applied, subject to the terms of the Intercreditor Agreement, in accordance with the Collateral Documents and Section 6.08.
 
Section 12.04.  Release of Collateral.
 
(a)           Each Holder of a Note, by accepting such Note, acknowledges and agrees that the Note Liens will be released automatically and without the need for any further action by any Person (so long as such release is in compliance with the TIA):
 
 
(i)
as to all of the Collateral, upon payment in full of the principal of, and accrued and unpaid interest and premium, if any, on the Notes;
 
 
(ii)
as to all of the Collateral, upon defeasance or discharge of the Notes in accordance with the provisions described under Article VIII;
 
 
(iii)
as to any property or assets constituting Collateral that is sold, transferred or otherwise disposed of by the Company or any of its subsidiaries in a transaction not prohibited by this Indenture, at the time of such sale, transfer or disposition; or
 
 
(iv)
as to any property constituting Collateral that is owned by a Subsidiary Guarantor that has been released from its obligations under its Subsidiary Guarantee in accordance with Section 4.07, concurrently with the release of such Guarantee.
 
(b)           Each Holder of a Note, by accepting such Note, acknowledges that, notwithstanding the provisions set forth in this Section 12.04, the Company and each Subsidiary Guarantor may, without any release or consent by the Trustee or the Collateral Agent, perform a number of activities in the ordinary course in respect of the Collateral to the extent not restricted
 
- 71 -

 
or prohibited by the Collateral Documents and this Indenture, including, without limitation, (i) selling or otherwise disposing of, in any transaction or series of related transactions, any property subject to the Note Liens which has become worn out, defective or obsolete or not used or useful in the business, (ii) abandoning, terminating, canceling, releasing or making alternations in or substitutions of any leases or contracts subject to the Note Liens, (iii) surrendering or modifying any franchise, license or permit subject to the Note Liens which it may own or under which it may be operating; (iv) altering, repairing, replacing, changing the location or position of and adding to its structures, machinery, systems, equipment, fixtures and appurtenances; (v) granting a license of any intellectual property; (vi) selling, transferring or otherwise disposing of inventory in the ordinary course of business; (vii) selling, collecting, liquidating, factoring or otherwise disposing of accounts receivable in the ordinary course of business; (viii) making cash payments (including for the repayment of Indebtedness) from cash that is at any time part of the Collateral in the ordinary course of business that are not otherwise prohibited by this Indenture; and (ix) abandoning any property which is not longer used or useful in the Company's business.  The release of any Collateral from the Note Liens pursuant to the terms of this Indenture and the Collateral Documents shall not be deemed to impair the security under this Indenture in contravention of the provisions hereof if and to the extent that the Collateral is released pursuant to the terms of this Section 12.04.
 
Section 12.05.   Certain TIA Requirements.
 
(a)           To the extent applicable, and in addition to any other requirements under this Indenture, the Company will cause § 313(b) of the TIA (relating to reports) and § 314(d) of the TIA (relating to the release of property or securities from the Note Liens or relating to the substitution for such Note Liens of any property or securities to be subjected to the Note Liens) to be complied with and will furnish to the Trustee, prior to each proposed release of Collateral pursuant to this Indenture and the Collateral Documents, all documents required by § 314(d) of the TIA and an Opinion of Counsel to the effect that the accompanying documents constitute all documents required by § 314(d) of the TIA.
 
(b)           Notwithstanding anything to the contrary in this Section 12.05, the Company will not be required to comply with all or any portion of § 314(d) of the TIA if the Board of Directors of the Company determines, in good faith based on advice of counsel, that, under the terms of § 314(d) of the TIA and/or any interpretation or guidance as to the meaning thereof of the Commission or its staff, including publicly available "no action" letters or exemptive orders, all or any portion of § 314(d) of the TIA is inapplicable to all or any part of the Collateral or the release, deposit or substitution thereof.
 
Section 12.06.   Release of Note Liens.  In the event that the Company delivers an Officers' Certificate certifying that (a) its obligations under this Indenture have been defeased or discharged by complying with the provisions of Article VIII or (b) a Subsidiary Guarantor shall have been released from its obligations under its Subsidiary Guarantee the Note Liens on all property and assets (including any Capital Stock) constituting Collateral (in the case of clause (a)) or the property and assets (including any Capital Stock) constituting Collateral owned by such Subsidiary Guarantor (in the case of clause (b)) shall be released, and the Collateral Agent shall (i) at the Company's expense, promptly execute and deliver such releases, termination statements and other instruments (in recordable form, where appropriate) as the Company or any Subsidiary Guarantor, as applicable, may reasonably request to evidence the termination of such Note Liens and (ii) not be deemed to hold such Note Liens for the benefit of the Trustee and the Holders of Notes.
 
- 72 -

 
SIGNATURES

IN WITNESS WHEREOF, the parties hereto have caused the Indenture to be duly executed as of the date first written above.
 
  E*TRADE FINANCIAL CORPORATION  
       
       
 
By: 
/s/ Robert J. Lilien  
    Name: Robert J. Lilien  
    Title: President & COO  
       
 
 
[12.5% Springing Lien Notes Due 2017 Indenture Signature Page]
 

 
  THE BANK OF NEW YORK, as Trustee  
       
       
 
By: 
/s/ Mary LaGumina  
    Name: Mary LaGumina  
    Title: Vice President  
       
 
 
[12.5% Springing Lien Notes Due 2017 Indenture Signature Page]
 

 
EXHIBIT A

[Insert the DTC Legend, if applicable pursuant to the provisions of the Indenture]

[Insert the Restricted Notes Legend, if applicable pursuant to the provisions of the Indenture]

[FACE OF NOTE]

E*TRADE FINANCIAL CORPORATION

12.5% Springing Lien Notes due 2017

CUSIP No. [_____________]1

$[_______________]

E*TRADE Financial Corporation, a Delaware corporation (the “Company”, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to CEDE& Co., or its registered assigns, the principal sum [of [___________________] DOLLARS ($[_________])] [set forth on the Schedule of Exchange of Notes attached hereto] on November 30, 2017.

Interest Rate: 12.5% per annum.

Interest Payment Dates: May 31 and November 30, commencing May 31, 2008.

Regular Record Dates: May 15, and November 15.

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which will for all purposes have the same effect as if set forth at this place.
 


IN WITNESS WHEREOF, the Company has caused this Note to be signed manually or by facsimile by its duly authorized officers.
 
Date:     E*TRADE FINANCIAL CORPORATION  
           
           
   
 
By: 
   
        Name:  
        Title:  
           
 
 
[12.5% Springing Lien Notes Due 2017– Note Signature Page]
 
A-2

 
(Form of Trustee’s Certificate of Authentication)
 
This is one of the 12.5% Springing Lien Notes due 2017 described in the Indenture referred to in this Note.
 
  THE BANK OF NEW YORK, as Trustee  
       
       
 
By: 
   
    Name:  
    Title: Authorized Signatory  
       
 
 
[12.5% Springing Lien Notes Due 2017– Trustee’s Certificate of Authentication Signature Page]
 
A-3

 
[REVERSE SIDE OF NOTE]

E*TRADE FINANCIAL CORPORATION

12.5% Springing Lien Notes due 2017

1. Principal and Interest.  (a) The Company promises to pay the principal of this Note plus accrued and unpaid interest thereon on November 30, 2017.
 
(b) The Company promises to pay interest in cash on the principal amount of this Note on each interest payment date, as set forth on the face of this Note, at the rate of 12.5% per annum (subject to adjustment as provided below), provided, however, that on any interest payment date occurring on or prior to May 31, 2010, the Company shall have the option to capitalize and to add to the principal amount of the Notes all or a portion of the interest payable on the Notes on such interest payment date and, provided, further, that on any interest payment date occurring after May 31, 2010, all interest on the Notes shall be payable in cash.  The interest so capitalized is referred to herein as “Capitalized Interest” and shall constitute principal amount of the Notes for all purposes of the Notes and the Indenture.
 
(c) Interest will be payable semi-annually (to the holders of record of the Notes at the close of business on May 15 and November 15 immediately preceding the interest payment date) on each interest payment date, commencing May 31, 2008.
 
(d) Interest on this Note will accrue from the most recent date to which interest has been paid on this Note or the Note surrendered in exchange for this Note (or, if there is no existing default in the payment of interest and if this Note is authenticated between a regular record date and the next interest payment date, from such interest payment date) or, if no interest has been paid, from the Issue Date. Interest will be computed in the basis of a 360-day year of twelve 30-day months.
 
(e) The Company will pay interest on overdue principal, premium, if any, and, to the extent lawful, interest at the interest rate borne by the Notes.  Interest not paid when due and any interest on principal, premium or interest not paid when due will be paid to the Persons that are Holders on a special record date, which will be the 15th day preceding the date fixed by the Company for the payment of such interest, whether or not such day is a Business Day.  At least 15 days before a special record date, the Company will send to each Holder and to the Trustee a notice that sets forth the special record date, the payment date and the amount of interest to be paid.
 
2. Indenture. (a) This is one of the Notes issued under an Indenture dated as of November 29, 2007 (as amended from time to time, the “Indenture”), between the Company and The Bank of New York, as Trustee. Capitalized terms used herein are used as defined in the Indenture unless otherwise indicated. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act.  The Notes are subject to all such terms, and Holders are referred to the Indenture and the Trust Indenture Act for a statement of all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture will control.
 
(b) The Notes are general unsecured obligations of the Company, subject to a springing lien under certain circumstances, as provided in the Indenture. The Indenture limits the original aggregate principal amount of the Notes to $1,936,000,000 (plus any Capitalized Interest).
 
3.  Redemption, Repurchase; Discharge Prior to Redemption or Maturity.  This Note is subject to optional and mandatory redemption and may be the subject of an Offer to Purchase, as further described in the Indenture.  There is no sinking fund applicable to this Note.
 
A-4

 
If the Company deposits with the Trustee money or U.S. Government Obligations sufficient to pay the then outstanding principal of, premium, if any, and accrued interest on the Notes to redemption or maturity, the Company may in certain circumstances be discharged from the Indenture and the Notes or may be discharged from certain of its obligations under certain provisions of the Indenture.
 
4. Registered Form; Denominations; Transfer; Exchange.  The Notes are in registered form without coupons in denominations of $1,000 principal amount and any multiple of $1,000 in excess thereof.  A Holder may register the transfer or exchange of Notes in accordance with the Indenture.  The Trustee may require a Holder to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture.  Pursuant to the Indenture, there are certain periods during which the Trustee will not be required to issue, register the transfer of or exchange any Note or certain portions of a Note.
 
5. Defaults and Remedies.  If an Event of Default, as defined in the Indenture, occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the Notes may declare all the Notes to be due and payable.  If a bankruptcy or insolvency default with respect to the Company occurs and is continuing, the Notes automatically become due and payable.  Holders may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may require indemnity satisfactory to it before it enforces the Indenture or the Notes.  Subject to certain limitations, Holders of a majority in principal amount of the Notes then outstanding may direct the Trustee in its exercise of remedies.
 
6. Amendment and Waiver.  Subject to certain exceptions, the Indenture and the Notes may be amended, or default may be waived, with the consent of the Holders of a majority in principal amount of the outstanding Notes. Without notice to or the consent of any Holder, the Company and the Trustee may amend or supplement the Indenture or the Notes to, among other things, cure any ambiguity, defect or inconsistency or make any change that in the good faith opinion of the Board of Directors does not materially and adversely affect the rights of any Holder.
 
7. Authentication.  This Note is not valid until the Trustee (or Authenticating Agent) signs the certificate of authentication on the other side of this Note.
 
8. Governing Law.  This Note shall be governed by, and construed in accordance with, the laws of the State of New York.
 
9. Abbreviations.  Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian) and U/G/M/A/ (= Uniform Gifts to Minors Act).
 
The Company will furnish a copy of the Indenture to any Holder upon written request and without charge.
 
A-5

 
[FORM OF TRANSFER NOTICE]

FOR VALUE RECEIVED the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto
 
 
Insert Taxpayer Identification No.
 
 
 
 
Please print or typewrite name and address including zip code of assignee
 
the within Note and all rights thereunder, hereby irrevocably constituting and appointing:
 
attorney to transfer said Note on the books of the Company with full power of substitution in the premises.
 


A-6

 
 
OPTION OF HOLDER TO ELECT PURCHASE

If you wish to have all of this Note purchased by the Company pursuant to Section 4.11 or Section 4.12 of the Indenture, check the box: 

If you wish to have a portion of this Note purchased by the Company pursuant to Section 4.11 or Section 4.12 of the Indenture, state the amount (in original principal amount) below:

$__________


Date:
 
 

 
Your Signature:  
 
 
(Sign exactly as your name appears on the other side of this Note) 

Signature Guarantee:
 
 
 
A-7


 
SCHEDULE OF EXCHANGES OF NOTES2

The initial outstanding principal amount of this Global Note is $_________.  The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made:

Date of Exchange
 
Amount of decrease in principal amount of this Global Note
 
Amount of increase in principal amount of this Global Note
 
Principal amount of this Global Note following such decrease (or increase)
 
Signature of authorized signatory of Trustee
                 
                 
                 


 
A-8

 
EXHIBIT B

SUPPLEMENTAL INDENTURE

dated as of _________,

among

E*TRADE Financial Corporation

[the Subsidiary Guarantor]

and

[Any existing Subsidiary Guarantors]

And

The Bank of New York,
as Trustee

12.5% Springing Lien Notes due 2017


THIS SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), entered into as of __________, ____, among E*TRADE Financial Corporation, a Delaware corporation (the “Company”), (the “Subsidiary Guarantor”), any existing Subsidiary Guarantors and The Bank of New York, as trustee (the “Trustee”).

RECITALS

WHEREAS, the Company, and the Trustee entered into the Indenture, dated as of November 29, 2007 (the “Indenture”), relating to the Company’s 12.5% Springing Lien Notes due 2017 (the “Notes”);

WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause Restricted Subsidiaries and Regulated Subsidiaries to provide Guarantees in certain circumstances.

AGREEMENT

NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows:

1.  Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.

2.  Each Subsidiary Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.
 
B-1


 
3.  This Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New York.

4.  This Supplemental Indenture may be signed in various counterparts which together will constitute one and the same instrument.

5.  This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.

6.  The Recitals herein are statements of the Company and/or the Guarantors, and the Trustee assumes no responsibility as to the correctness thereof. The Trustee makes no representations as to the validity of this Supplemental Indenture.

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the date first above written.

 
E*TRADE FINANCIAL CORPORATION, as Issuer 
 
       
       
 
By:
   
   
Name:
 
   
Title:
 
       
       
 
THE BANK OF NEW YORK, as Trustee 
 
       
       
 
By:
   
   
Name:
 
   
Title:
 
       
       
 
[Subsidiary Guarantor], as Subsidiary Guarantor 
 
       
       
 
By:
   
   
Name:
 
   
Title:
 
       
       
 
[Any existing Subsidiary Guarantor] 
 
       
       
 
By:
   
   
Name:
 
   
Title:
 
 
 
B-2

 
EXHIBIT C

DTC LEGEND

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN.

TRANSFERS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE.
 
 
C-1

 
EXHIBIT D

RESTRICTED NOTES LEGEND

THIS NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED  (THE “SECURITIES ACT”) AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) (1) TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (3) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), (4) TO AN INSTITUTIONAL ACCREDITED INVESTOR IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, (5) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (BASED UPON AN OPINION OF COUNSEL IF THE COMPANY SO REQUESTS) OR (6) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND (B) IN ACCORDANCE WITH ALL APPLICABLE BLUE SKY LAWS OF THE STATES OF THE UNITED STATES.
 
 
D-1

 
EXHIBIT E

[FORM OF CERTIFICATE TO BE DELIVERED
IN CONNECTION WITH TRANSFERS PURSUANT TO RULE 144A]


E*TRADE Financial Corporation
135 East 57th Street
New York, New York 10022
Facsimile: [_________]
Attention: [_________]

The Bank of New York
101 Barclay Street, Floor 8W
New York, New York 10286
Facsimile: (212) 815-5707
Attention: Corporate Trust Administration

Re:  E*TRADE Financial Corporation (the “Company”) 12.5%  Springing Lien Notes due 2017 (the “Notes”)
 
Ladies and Gentlemen:
 
In connection with our proposed sale of $ _______ aggregate principal amount at maturity of the Notes, we hereby certify that such transfer is being effected pursuant to and in accordance with Rule 144A (“Rule 144A”) under the United States Securities Act of 1933, as amended (the “Securities Act”), and, accordingly, we hereby further certify that the Notes are being transferred to a person that we reasonably believe is purchasing the Notes for its own account, or for one or more accounts with respect to which such person exercises sole investment discretion, and such person and each such account is a “qualified institutional buyer” within the meaning of Rule 144A in a transaction meeting the requirements of Rule 144A and such Notes are being transferred in compliance with any applicable blue sky securities laws of any state of the United States.
 
You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.
 
 
Very truly yours, 
 
 
 
 
 
[Name of Transferor] 
 
       
       
       
 
By:
 
 
   
Authorized Signature
 
 
 
E-1

 
EXHIBIT F
[FORM OF CERTIFICATE TO BE DELIVERED
IN CONNECTION WITH TRANSFERS
PURSUANT TO REGULATION S]

 
E*TRADE Financial Corporation
135 East 57th Street
New York, New York 10022
Facsimile: [_________]
Attention: [_________]

The Bank of New York
101 Barclay Street, Floor 8W
New York, New York 10286
Facsimile: (212) 815-5707
Attention: Corporate Trust Administration

Re:  E*TRADE Financial Corporation (the “Company”) 12.5% Springing Lien Notes due 2017 (the “Notes”)
 
Ladies and Gentlemen:
 
In connection with our proposed sale of $_________ aggregate principal amount of the Notes, we confirm that such sale has been effected pursuant to and in accordance with Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and, accordingly, we represent that:
 
(1)           the offer of the Notes was not made to a person in the United States;
 
(2)           either (a) at the time the buy order was originated, the transferee was outside the United States or we and any person acting on our behalf reasonably believed that the transferee was outside the United States or (b) the transaction was executed in, on or through the facilities of a designated off-shore securities market and neither we nor any person acting on our behalf knows that the transaction has been pre-arranged with a buyer in the United States;
 
(3)           no directed selling efforts have been made in the United States in contravention of the requirements of Rule 903(b) or Rule 904(b) of Regulation S, as applicable; and
 
(4)           the transaction is not part of a plan or scheme to evade the registration requirements of the Securities Act.
 
In addition, if the sale is made during a restricted period and the provisions of Rule 903(b) or Rule 904(b) of Regulation S are applicable thereto, we confirm that such sale has been made in accordance with the applicable provisions of Rule 903(b) or Rule 904(b), as the case may be.
 
The Company and you are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.  Terms used in this certificate have the meanings set forth in Regulation S.
 
F-1

 
 
Very truly yours, 
 
 
 
 
 
[Name of Transferor] 
 
       
       
       
 
By:
 
 
   
Authorized Signature
 

F-2

 
EXHIBIT G

[FORM OF CERTIFICATE TO BE DELIVERED
IN CONNECTION WITH TRANSFERS
TO INSTITUTIONAL ACCREDITED INVESTOR]


E*TRADE Financial Corporation
135 East 57th Street
New York, New York 10022
Facsimile: [_________]
Attention: [_________]

The Bank of New York
101 Barclay Street, Floor 8W
New York, New York 10286
Facsimile: (212) 815-5707
Attention: Corporate Trust Administration

Re:  E*TRADE Financial Corporation (the “Company”) 12.5% Springing Lien Notes due 2017 (the “Notes”)
 
Reference is hereby made to the Indenture, dated as of November 29, 2007 (the “Indenture”) between the Company and Bank of New York, as trustee.  Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture.

We own and propose to transfer the Notes or interest in such Notes in aggregate principal amount at maturity of $___________ in such Notes or interests (the “Transfer”), to  _____________________  (the “Transferee”). 

In connection with the Transfer, we hereby certify that the Transfer is being effected in compliance with the transfer restrictions applicable to beneficial interests in Transfer Restricted Notes and pursuant to and in accordance with the Securities Act and any applicable blue sky securities laws of any state of the United States.  We hereby further certify that such Transfer is being effected to an Institutional Accredited Investor and pursuant to an exemption from the registration requirements of the Securities Act other than Rule 144A, Rule 144, Rule 903 or Rule 904, and we hereby further certify that we have not engaged in any general solicitation within the meaning of Regulation D under the Securities Act and the Transfer complies with the transfer restrictions applicable to beneficial interests in Restricted Transfer Notes and the requirements of the exemption claimed, which certification is supported by (1) a certificate executed by the Transferee in the form of Exhibit H to the Indenture and (2) an Opinion of Counsel provided by us or the Transferee (a copy of which we have attached to this certification), to the effect that such Transfer is in compliance with the Securities Act.  Upon consummation of the proposed transfer in accordance with the terms of the Indenture, the transferred beneficial interest or definitive Note will be subject to the restrictions on transfer enumerated in the Restricted Notes Legend printed on the IAI Global Note and/or the Restricted Transfer Notes and in the Indenture and the Securities Act.

You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.
 
G-1


 
     
 
 
[Insert Name of Transferor]
 
 
 
 
 
 
 
 
   By:
 
 
 
Name:
 
 
Title:
 
 
 
Dated: 
                                          
 
 
 
 
G-2

 
EXHIBIT H

[FORM OF CERTIFICATE TO BE DELIVERED  BY
ACQUIRING INSTITUTIONAL ACCREDITED INVESTOR]


E*TRADE Financial Corporation
135 East 57th Street
New York, New York 10022
Facsimile: [_________]
Attention: [_________]

The Bank of New York
101 Barclay Street, Floor 8W
New York, New York 10286
Facsimile: (212) 815-5707
Attention: Corporate Trust Administration

Re:  E*TRADE Financial Corporation (the “Company”) 12.5% Springing Lien Notes due 2017 (the “Notes”)
 
Reference is hereby made to the Indenture, dated as of November 29, 2007 (the “Indenture”) between the Company and Bank of New York, as trustee.  Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture.

In connection with our proposed purchase of $_________ aggregate principal amount at maturity of the Notes, we confirm that:

1.           We understand that any subsequent transfer of the Notes or any interest therein is subject to certain restrictions and conditions set forth in the Indenture and the undersigned agrees to be bound by, and not to resell, pledge or otherwise transfer the Notes or any interest therein except in compliance with, such restrictions and conditions and the Securities Act of 1933, as amended (the “Securities Act”).

2.           We understand that the offer and sale of the Notes have not been registered under the Securities Act, and that the Notes and any interest therein may not be offered or sold except as permitted in the following sentence.  We agree, on our own behalf and on behalf of any accounts for which we are acting as hereinafter stated, that if we should sell the Notes or any interest therein, we will do so only (A) to the Company or any subsidiary thereof, (B) in accordance with Rule 144A under the Securities Act to a “qualified institutional buyer” (as defined therein), (C) to an institutional “accredited investor” (as defined below) that, prior to such transfer, furnishes (or has furnished on its behalf by a U.S. broker-dealer) to you and to the Company a signed letter substantially in the form of this letter and an Opinion of Counsel in form reasonably acceptable to the Company to the effect that such transfer is in compliance with the Securities Act, (D) outside the United States in accordance with Rule 904 of Regulation S under the Securities Act, (E) pursuant to the provisions of Rule 144(k) under the Securities Act or (F) pursuant to an effective registration statement under the Securities Act, and we further agree to provide to any Person purchasing the definitive Note or beneficial interest in a Global Note from us in a transaction meeting the requirements of clauses (A) through (E) of this paragraph a notice advising such purchaser that resales thereof are restricted as stated herein.
 
H-1


 
3.           We understand that, on any proposed resale of the Notes or beneficial interest therein, we will be required to furnish to you and the Company such certifications, legal opinions and other information as you and the Company may reasonably require to confirm that the proposed sale complies with the foregoing restrictions.  We further understand that the Notes purchased by us will bear a legend to the foregoing effect.

4.           We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act) and have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of our investment in the Notes, and we and any accounts for which we are acting are each able to bear the economic risk of our or its investment.

5.           We are acquiring the Notes or beneficial interest therein purchased by us for our own account or for one or more accounts (each of which is an institutional “accredited investor”) as to each of which we exercise sole investment discretion.

You are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.


     
 
 
[Insert Name of Acquiring Accredited Investor]
 
 
 
 
 
 
 
 
   By:
 
 
 
Name:
 
 
Title:
 
 
 
Dated:
                                           
 
 
 
 
 
 
H-2

EX-4.3 4 dp07754_ex0403.htm
Exhibit 4.3
 
FIRST AMENDMENT TO RIGHTS AGREEMENT

 
This Amendment dated as of November 29, 2007 (this “Amendment”) to the Rights Agreement, dated as of July 9, 2001 (the “Rights Agreement”), between E*TRADE Financial Corporation (formerly known as E*TRADE Group, Inc.), a Delaware corporation (the “Company”), and American Stock Transfer and Trust Company, as Rights Agent (the “Rights Agent”).  Capitalized terms used herein and not defined shall have the meanings specified in the Rights Agreement.
 
WHEREAS, the Company and the Rights Agent are parties to the Rights Agreement;
 
WHEREAS, the Company proposes to enter into a Master Investment and Securities Purchase Agreement, dated as of November 29, 2007 (as amended, supplemented, modified or replaced from time to time, the “Master Investment and Securities Purchase Agreement”), by and between the Company and Wingate Capital Ltd. (“Investor”), a Cayman Islands company, as well as the Ancillary Documents (as such term is defined in the Master Investment and Securities Purchase Agreement, the “Ancillary Documents”), providing for, among other transactions, the purchase by Investor of 12.5% Springing Lien Notes of the Company and shares of the Company’s Common Stock and (the “Securities”) (collectively, the “Transactions”);
 
WHEREAS, Section 27 of the Rights Agreement permits the Company to amend the Rights Agreement on the terms set forth in this Amendment;
 
WHEREAS, the Board of Directors of the Company has determined that the Master Investment and Securities Purchase Agreement, the Ancillary Documents and the terms and conditions set forth therein and the transactions contemplated thereby, including, without limitation, the Transactions, are in the best interests of the Company and its shareholders;
 
WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders to modify the terms of the Rights Agreement to exempt the Master Investment and Securities Purchase Agreement, the Ancillary Documents and all of the transactions contemplated thereby including, without limitation, the Transactions, from the application of the Rights Agreement, and in connection therewith the Company is entering into this Amendment and directing the Rights Agent to enter into this Amendment; and
 
WHEREAS, all acts and things necessary to make this Amendment a valid agreement, enforceable according to its terms have been done and performed, and the execution and delivery of this Amendment by the Company and the Rights Agent have been in all respects duly authorized by the Company and the Rights Agent.
 
NOW, THEREFORE, in consideration of the promises and mutual agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Company and the Rights Agent hereby agree as follows:
 

 
A.           Amendment of Certain Definitions.
 
Section 1 of the Rights Agreement is supplemented to add the following definitions in the appropriate alphabetical locations:
 
“Investor” shall mean Wingate Capital Ltd., a Cayman Islands company.
 
“Transactions” shall have the meaning ascribed to such term in the Master Investment and Securities Purchase Agreement.
 
“Master Investment and Securities Purchase Agreement” shall mean the Master Investment and Securities Purchase Agreement, dated as of November 29, 2007, by and between the Company and Investor, as it may be amended, supplemented, modified or replaced from time to time.
 
“Securities” shall have the meaning ascribed to such term in the Master Investment and Securities Purchase Agreement.
 
The definition of “Acquiring Person” in Section 1 of the Rights Agreement is hereby amended by adding the following sentence at the end thereof as paragraph (d):
 
“(d) notwithstanding anything in this Agreement to the contrary, Investor or any of its Affiliates or Associates shall not be deemed to be an Acquiring Person solely by virtue of (i) the approval, execution and delivery of the Master Investment and Securities Purchase Agreement and the Ancillary Documents, (ii) the consummation of the Transactions or (iii) the purchase of any Securities contemplated in the Master Investment and Securities Purchase Agreement or the Ancillary Documents, or the purchase by Investor or any of its Affiliates or Associates of up to an additional 8,474,989 shares of Common Stock (as adjusted for any stock splits, combinations and the like).”
 
The definition of “Stock Acquisition Date” in Section 1 of the Rights Agreement is hereby amended by adding the following sentence at the end thereof:
 
“Notwithstanding anything in this Agreement to the contrary, a Stock Acquisition Date shall not be deemed to have occurred solely as the result of (i) the approval, execution, delivery or public announcement of the Master Investment and Securities Purchase Agreement or the Ancillary Documents, (ii) the consummation of the Transactions, or (iii) the purchase of any Securities contemplated in the Master Investment and Securities Purchase Agreement or the Ancillary Documents, or the purchase by Investor or any of its Affiliates or Associates of up to an additional
 
2

 
8,474,989 shares of Common Stock (as adjusted for any stock splits, combinations and the like).”
 
B.           Amendment of Section 3.  Section 3(b) of the Rights Agreement is hereby amended and supplemented by adding the following sentence at the end thereof:
 
“Notwithstanding anything in this Agreement to the contrary, a Distribution Date shall not be deemed to have occurred solely as the result of (i) the approval, execution and delivery of the Master Investment and Securities Purchase Agreement and the Ancillary Documents, (ii) the consummation of the Transactions, or (iii) the purchase of any Securities contemplated in the Master Investment and Securities Purchase Agreement or the Ancillary Documents, or the purchase by Investor or any of its Affiliates or Associates of up to an additional 8,474,989 shares of Common Stock (as adjusted for any stock splits, combinations and the like).”
 
Furthermore, Section 3 of the Rights Agreement is amended to add the following sentence at the end thereof as Section 3(e):
 
“(e) Nothing in this Agreement shall be construed to give any holder of Rights or any other Person any legal or equitable rights, remedies or claims under this Agreement by virtue of the execution and delivery of the Master Investment and Securities Purchase Agreement and the Ancillary Documents or by virtue of any of the Transactions or the purchase of any Securities contemplated in the Master Investment and Securities Purchase Agreement or the Ancillary Documents, or the purchase by Investor or any of its Affiliates or Associates of up to an additional 8,474,989 shares of Common Stock (as adjusted for any stock splits, combinations and the like).
 
C.           New Section 35:  Section 35 is hereby added to the Rights Agreement to read in its entirety as follows:
 
“Section 35. The Master Investment and Securities Purchase Agreement; The Ancillary Documents.  Notwithstanding anything contained in this Agreement to the contrary, neither the approval, execution, delivery or public announcement of the Master Investment and Securities Purchase Agreement and the Ancillary Documents nor the consummation of the Transactions or the purchase of any Securities contemplated in the Master Investment and Securities Purchase Agreement or the Ancillary Documents, or the purchase by Investor or any of its Affiliates or Associates of up to an additional 8,474,989 shares of Common Stock (as adjusted for any stock splits, combinations and the like), or the performance by the Company of its obligations thereunder shall cause (a) the Rights to become exercisable, (b) Investor or any of its Affiliates or Associates to be an Acquiring Person, (c) a Stock Acquisition Date to occur or (d) a Distribution Date to occur.”
 
D.           Effect of Amendment.  Except as expressly set forth herein, the Rights Agreement shall not by implication or otherwise be supplemented or amended by virtue of this
 
3

 
Amendment, but shall remain in full force and effect, as amended hereby.  This Amendment shall be construed in accordance with and as a part of the Rights Agreement, and all terms, conditions, representations, warranties, covenants and agreements set forth in the Rights Agreement and each other instrument or agreement referred to therein, except as herein amended, are hereby ratified and confirmed.  To the extent that there is a conflict between the terms and provisions of the Rights Agreement and this Amendment, the terms and provisions of this Amendment shall govern for purposes of the subject matter of this Amendment only.
 
E.           Waiver of Notice.  The Rights Agent and the Company hereby waive any notice requirement with respect to each other under the Rights Agreement, if any, pertaining to the matters covered by this Amendment.
 
F.           Severability.  If any provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, illegal or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be effected, impaired or invalidated.
 
G.           Governing Law.  This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state, except that the rights and obligations of the Rights Agent shall be governed by the law of the State of New York.
 
H.           Counterparts.  This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
 
I.           Effective Date of Amendment.  This Amendment shall be deemed effective as of the date first written above, as if executed on such date.
 
J.           Descriptive Headings.  Descriptive headings appear herein for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof.
 
4

 
 
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first written above.
 

  E*TRADE FINANCIAL CORPORATION
     
   
By: 
 /s/ Robert Jarrett Lilien
     
Name: Robert Jarrett Lilien
     
Title: President


  AMERICAN STOCK TRANSFER & TRUST COMPANY
     
   
By: 
 /s/ Herbert J. Lemmer
     
Name: Herbert J. Lemmer
     
Title: Vice President


5

 
 
EX-10.1 5 dp07754_ex1001.htm
Exhibit 10.1





 

MASTER INVESTMENT AND SECURITIES PURCHASE AGREEMENT
 
By and Between
 
WINGATE CAPITAL LTD.
 
and
 
E*TRADE FINANCIAL CORPORATION
 
Dated as of November 29, 2007
 
 
 
 
 
 
 

 
Table of Contents
 
Page
 
ARTICLE I  
Definitions  
     
Section 1.01.
Definitions
2
Section 1.02.
General Interpretive Principles
7
     
ARTICLE II  
Sale and Purchase of the Securities  
     
Section 2.01.
Initial Closing and Final Closing
7
ARTICLE III  
Representations and Warranties  
     
Section 3.01.
Representations and Warranties of the Company
11
Section 3.02.
Representations and Warranties of Purchaser
23
 
ARTICLE IV  
Additional Agreements of the Parties  
 
Section 4.01.
Taking of Necessary Action
25
Section 4.02.
Financial Statements and Other Reports
25
Section 4.03.
Inspection of Property
25
Section 4.04.
Securities Laws; Legends; Transferability.
26
Section 4.05.
Lost, Stolen, Destroyed or Mutilated Securities
27
Section 4.06.
Regulatory Matters
27
Section 4.07.
Board of Directors
29
Section 4.08.
Confidentiality Agreement; Publicity
30
Section 4.09.
PORTAL and CUSIPs and DTC Eligibility
30
Section 4.10.
NASDAQ
30
Section 4.11.
Replacement of Revolving Credit Facility
30
Section 4.12.
10-K Filing
30
Section 4.13.
Purchaser Acquisition of Additional Common Stock
30
Section 4.14.
Use of Proceeds
31
Section 4.15.
Investment Policy Covenant
31
Section 4.16.
Put Rights
32
Section 4.17.
Call Rights
32
Section 4.18.
Change of Control
33
 
ARTICLE V 
Conditions 
 
Section 5.01.
Conditions of Purchase at Initial Closing
33
Section 5.02.
Conditions of Sale at Initial Closing
35
 
-i-

 
Section 5.03.
Conditions of Purchase at Final Closing
36
Section 5.04.
Conditions of Sale at Final Closing
36
 
ARTICLE VI 
Miscellaneous  
 
Section 6.01.
Survival of Representations and Warranties
37
Section 6.02.
Notices
37
Section 6.03.
Entire Agreement; Third Party Beneficiaries; Amendment
38
Section 6.04.
Termination of Final Closing Obligation
38
Section 6.05.
Counterparts
38
Section 6.06.
Governing Law
38
Section 6.07.
Public Announcements
39
Section 6.08.
Expenses
39
Section 6.09.
Indemnification
39
Section 6.10.
Successors and Assigns
42
Section 6.11.
Remedies; Waiver
42
Section 6.12.
Securities Contract; Qualified Financial Contract
42
Section 6.13.
Consent to Jurisdiction; WAIVER OF JURY TRIAL
43
Section 6.14.
Severability
43
Section 6.15.
Headings
43
Section 6.16.
Aggregation
43
Section 6.17.
Specific Performance
43
Section 6.18.
Arm’s Length Transactions
43
Section 6.19.
No Presumption
43
 
Exhibits
 
A    -   Form of Indenture for Springing Lien Notes (including form of Springing Lien Notes)
 
B    -   Form of Order Handling Agreement
 
B-1  -  Form of Canadian Direct Market Access Agreement
 
C    -   ABS Purchase Agreement
 
D    -   Form of Registration Rights Agreement
 
E    -   Form of Parent Guaranty
 
-ii-

 
MASTER INVESTMENT AGREEMENT
 
MASTER INVESTMENT AND SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 29, 2007, by and between Wingate Capital Ltd. (“Purchaser”), and E*Trade Financial Corporation, a Delaware corporation (the “Company”). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in ARTICLE I.
 
RECITALS:
 
WHEREAS, at the Initial Closing (as defined below) Purchaser has agreed to purchase and the Company has agreed to issue or sell, or to cause one of its Subsidiaries, in the case of clause (d) below, to sell, subject to the terms and conditions of this Agreement:
 
 
(a)
$1,500,152,000 aggregate principal amount of its 12.5% Springing Lien Notes due 2017 (the “Springing Lien Notes”) to be issued at the Initial Closing in accordance with the terms and conditions of the Indenture for the Springing Lien Notes in the form attached hereto as Exhibit A (the “Springing Lien Notes Indenture”);
 
 
(b)
$185,848,000 aggregate principal amount of its Springing Lien Notes in exchange for the Existing Notes Consideration (as defined below);
 
 
(c)
30,741,901 shares of the Company’s common stock, par value $.01 per share (the “Common Stock”), of which 10,000,000 will be issued to Purchaser at the Initial Closing and 20,741,901 will be issued to Purchaser immediately following termination or expiration of any applicable waiting period under the HSR Act with respect to such issuance; and
 
 
(d)
the ABS Assets pursuant to the ABS Purchase Agreement (each as defined below).
 
WHEREAS, at the Initial Closing, (a) Purchaser or an Affiliate of Purchaser, the Company and E*Trade Securities LLC will enter into an Equities and Options Order Handling Agreement in the form attached hereto as Exhibit B to route 40% of the retail “normal market size” or NMS securities order flow and all of the options order flow of the Company, E*Trade Securities LLC and any other affiliate of the Company to Purchaser or its Affiliate for a three-year period, and (b) Purchaser or an Affiliate of Purchaser, and E*Trade Capital Markets LLC will enter into a Canadian Direct Market Access Agreement in the form attached hereto as Exhibit B-1  (such agreements together, the “Order Handling Agreement”);
 
WHEREAS, the OTS has indicated their approval of a notice filed by the Company  pursuant to 12 CFR 563.22(c) with respect to the transfer of the ABS Assets;
 
WHEREAS, the Company has agreed to issue to Purchaser subject to the terms and conditions of this Agreement:
 

 
 
(a)
an additional $150,000,000 aggregate principal amount of its Springing Lien Notes; and
 
 
(b)
an additional 49,125,186 shares of Common Stock (together with the shares of Common Stock issued pursuant to clause (c) of the first WHEREAS clause, the “Purchased Common Stock” and the Purchased Common Stock together with the Springing Lien Notes being issued pursuant to this Agreement, the “Securities”); and
 
WHEREAS, the Company and Purchaser desire to set forth certain agreements herein.
 
NOW THEREFORE, in consideration of the premises and the representations, warranties and agreements herein contained and intending to be legally bound hereby, the parties hereby agree as follows:
 
ARTICLE I
 
Definitions
 
Section 1.01.   Definitions.
 
As used in this Agreement, the following terms shall have the meanings set forth below:
 
ABS Assets” shall mean the Company’s portfolio of asset backed securities listed on Schedule A to the ABS Purchase Agreement.
 
ABS Purchase Agreement” shall mean the purchase agreement to be executed by the Company, E*Trade Bank, E*Trade Global Asset Management, Inc., and Purchaser or its Affiliate at the Initial Closing with respect to the purchase by Purchaser or its Affiliate of the ABS Assets, which shall be in the form attached hereto as Exhibit C.
 
Affiliate” or “affiliate” shall mean, with respect to any Person, any other Person which directly or indirectly controls or is controlled by or is under common control with such Person. As used in this definition, “control” (including its correlative meanings, “controlled by” and “under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise). To the extent that any such term is used in relation to or in connection with any statute and the definition of such term in such statute is broader or different, then, in such context, such term shall have the meaning set forth in such statute.
 
Agreement” shall have the meaning set forth in the preamble hereto.
 
Ancillary Documents” shall mean the Registration Rights Agreement, the ABS Purchase Agreement, the Springing Lien Notes Indenture (including the Springing Lien Notes), and the Order Handling Agreement.
 
Banking Authority” shall have the meaning set forth in Section 3.01(q).
 
-2-

 
Business Day” shall mean any day, other than a Saturday, Sunday or a day on which banking institutions in the City of New York, New York are authorized or obligated by law or executive order to close.
 
Change of Control” shall have the meaning given to such term in the Springing Lien Notes Indenture.
 
Change of Control Agreement” means a definitive agreement the consummation of which will result in a Change of Control.
 
Change of Control Payment Amountshall have the meaning set forth in Section 4.17.
 
CIBC Act” shall mean the Change in Bank Control Act, as amended, 12 U.S.C. §1817(j).
 
Code” shall mean the United States Internal Revenue Code of 1986, as amended.
 
Commitment Fee” shall mean $47,142,857.14.
 
Common Stock” shall have the meaning set forth in the Recitals.
 
Company” shall have the meaning set forth in the preamble hereto.
 
Company Disclosure Schedule” shall have the meaning set forth in Section 3.01.
 
Company Group” shall have the meaning set forth in Section 3.01(k).
 
Company Indemnitees” shall have the meaning set forth in Section 6.09(b).
 
Company Pension Plans” and “Company Plans” shall have the meanings set forth in Section 3.01(k).
 
 “Competitor” shall mean any of the entities listed on Section 1.01 of the Company Disclosure Schedule.
 
Confidentiality Agreement” shall mean that certain Mutual Non-Disclosure Agreement, dated November 12, 2007, between the Company and Citadel Limited Partnership.
 
Deductible” shall have the meaning set forth in Section 6.09(d).
 
DGCL” shall mean the Delaware General Corporation Law.
 
ERISA” shall have the meaning set forth in Section 3.01(k).
 
Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.
 
Existing Notes Accrued Interest” shall mean an amount in cash equal to all accrued and unpaid interest on the notes constituting the Existing Notes Consideration calculated through and including the Initial Closing Date.
 
-3-

 
Existing Notes Consideration” shall mean $185,848,000 in aggregate principal amount of the Company’s (A) 8% senior notes due 2011, (B) 7.875% senior notes due 2015 and/or (C) 7.375% senior notes due 2013, held by Purchaser or one of its Affiliates on the Initial Closing Date.
 
E*Trade Bank” shall mean E*Trade Bank and each of its Subsidiaries.
 
FDIC” shall mean the Federal Deposit Insurance Corporation.
 
Final Cash Consideration” shall mean initially $150,000,000, and shall be reduced in accordance with the provisions of Section 2.01(c)(v).
 
Final Closing” and “Final Closing Date” shall have the meanings set forth in Section 2.01(b).
 
GAAP” shall mean generally accepted accounting principles in the United States of America.
 
Governmental Entity” shall mean any court, administrative agency or commission or other governmental authority or instrumentality, whether federal, state, local or foreign, and any applicable industry self-regulatory organization.
 
HSR Act” shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
 
Indemnified Party” shall have the meaning set forth in Section 6.09(f).
 
Indemnifying Party” shall have the meaning set forth in Section 6.09(f).
 
Initial Closing” and “Initial Closing Date” shall have their meanings set forth in Section 2.01(a).
 
Initial Consideration” shall mean $1,500,152,000.
 
Intellectual Property” shall mean trademarks, service marks, brand names, certification marks, trade dress and other indications of origin, the goodwill associated with the foregoing and registrations in any jurisdiction of, and applications in any jurisdiction to register, the foregoing, including any extension, modification or renewal of any such registration or application; inventions, discoveries and ideas, whether patentable or not, in any jurisdiction; patents, applications for patents (including divisions, continuations, continuations in part and renewal applications), and any renewals, extensions or reissues thereof, in any jurisdiction; nonpublic information, trade secrets and confidential information and rights in any jurisdiction to limit the use or disclosure thereof by any person; writings and other works, whether copyrightable or not, in any jurisdiction; and registrations or applications for registration of copyrights in any jurisdiction, and any renewals or extensions thereof; and any similar intellectual property or proprietary rights.
 
IRS” shall have the meaning set forth in Section 3.01(l).
 
-4-

 
Loan Portfolio Announcement” shall have the meaning set forth in Section 6.07.
 
Loss” shall have the meaning set forth in Section 6.09(a).
 
Material Adverse Effect” shall mean any material adverse effect on (a) the financial condition, results of operations, assets, liabilities or business of the Company and its Subsidiaries taken as a whole (provided, however, that, with respect to this clause (a), a “Material Adverse Effect” shall not be deemed to include any effects to the extent resulting from (i) changes, after the date hereof, in generally accepted accounting principles or regulatory accounting requirements applicable to companies in the industries in which the Company and its Subsidiaries operate, (ii) changes, after the date hereof, in laws, rules or regulations of general applicability or interpretations thereof by Governmental Entities, (iii) actions or omissions of the Company taken with the prior written consent of Purchaser, (iv) changes, after the date hereof, in general economic or market conditions generally affecting the other companies in the industries in which the Company and its Subsidiaries operate, (v) any change in the market price or trading volume of the Common Stock or other securities of the Company after the date hereof (provided that this clause (v) shall not exclude any underlying circumstance, change, event, fact, development or effect which may have caused such change in market price or trading volume), (vi) the failure of the Company to meet any internal or public projections, forecasts or estimates or earnings for any period ending on or after September 30, 2007 (provided that this clause (vi) shall not exclude any underlying circumstance, change, event, fact, development or effect which may have caused such failure to meet projections, forecasts, estimates or earnings), or (vii) changes in global, national or regional political conditions, including the outbreak or escalation of war or acts of terrorism, except, with respect to clauses (i), (ii), (iv) and (vii), to the extent such changes are disproportionately adverse to the financial condition, results of operations, assets, liabilities or business of the Company and its Subsidiaries, taken as a whole, as compared with other companies participating in the applicable industry), (b) the ability of the Company to perform its obligations under this Agreement or the Ancillary Documents or (c) the validity or enforceability of this Agreement or any of the Ancillary Documents or the rights or remedies of Purchaser hereunder and thereunder.
 
NASDAQ” shall mean the Nasdaq Global Market of the Nasdaq Stock Market, Inc.
 
Order Handling Agreement” shall have the meaning set forth in the Recitals.
 
OTS” shall mean the Office of Thrift Supervision.
 
Parent Guaranty” shall mean the Guaranty in the form attached hereto as Exhibit E pursuant to which Citadel Wellington LLC will guaranty, on the terms and conditions set forth therein, certain obligations of Purchaser hereunder and under the Registration Rights Agreement.
 
Permitted Transfer” shall mean any Transfer by Purchaser (i) to an Affiliate; (ii) in the form of a pledge, hypothecation (provided such hypothecation does not require registration under the Securities Act) or encumbrance of such Purchased Common Stock for financing purposes; (iii) to an acquiring or offering Person in a transaction that is a Change of Control (as defined in the Springing Liens Notes Indenture) or a tender offer for more than a majority of the outstanding shares of the Company’s Common Stock, or (iv) with respect to any Purchaser that
 
-5-

 
is an investment fund, any other investment fund with respect to which the sponsor and discretionary investment manager or advisor of such Purchaser or an Affiliate thereof, serves as sponsor and discretionary investment manager or advisor.
 
Person” or “person” shall mean an individual, corporation, association, partnership, group (as such term is used in Section 13(d)(3) of the Exchange Act), trust, joint venture, business trust or unincorporated organization, or a government or any agency or political subdivision thereof.
 
Purchased Common Stock” shall have the meaning set forth in the Recitals.
 
Purchaser” shall have the meaning set forth in the preamble hereto.
 
Purchaser Indemnitees” shall have the meaning set forth in Section 6.09(a).
 
Purchaser Information” shall have the meaning set forth in Section 3.02(f).
 
Purchaser Schedule” shall mean a schedule to this Agreement provided or required to be provided by Purchaser.
 
Recent 10-K” shall have the meaning set forth in Section 3.01.
 
Registration Rights Agreement” shall mean the registration rights agreement to be executed by the Company and Purchaser at the Initial Closing, which shall be in the form attached hereto as Exhibit D.
 
Regulatory Filings” shall have the meaning set forth in Section 3.01(r).
 
Reports” shall have the meaning set forth in Section 3.01(f).
 
Restated Certificate of Incorporation” shall mean the Restated Certificate of Incorporation of the Company as filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q, filed November 7, 2003.
 
Rights Agreement” shall have the meaning set forth in Section 3.01(e).
 
S&LHC Act” shall mean the Savings and Loan Holding Company Act, as amended, 12 U.S.C. §1467a.
 
SEC” shall mean the United States Securities and Exchange Commission.
 
Securities” shall have the meaning set forth in the Recitals.
 
Securities Act” shall mean the Securities Act of 1933, as amended.
 
Springing Lien Notes” shall have the meaning set forth in the Recitals.
 
Springing Lien Notes Indenture” shall have the meaning set forth in the Recitals.
 
-6-

 
Subsidiary” shall mean, with respect to any Person, any other Person of which 50% or more of the shares of the voting securities or other voting interests are owned or controlled, or the ability to select or elect 50% or more of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries, or by such first Person, or by such first Person and one or more of its Subsidiaries.
 
Tax” or “Taxes” shall mean all federal, state, local, and foreign income, excise, gross receipts, gross income, ad valorem, profits, gains, property, capital, sales, transfer, use, payroll, employment, severance, withholding, duties, intangibles, franchise, backup withholding, and other taxes, charges, levies or like assessments together with all penalties and additions to tax and interest thereon.
 
Tax Return” shall mean a report, return or other information (including any amendments) required to be supplied to a governmental entity with respect to Taxes including, where permitted or required, combined or consolidated returns for any group of entities that includes the Company or any of its Subsidiaries.
 
Transactions” shall have the meaning set forth in Section 3.01(c).
 
 “Transfer” shall mean, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer,  assignment, pledge, encumbrance, hypothecation or similar disposition of, and shall include a short sale or the entry into of any other hedging or other derivative transaction that has the effect of materially changing the economic benefits and risks of ownership.
 
Voting Debt” shall have the meaning set forth in Section 3.01(e).
 
Well Capitalized” shall have the meaning set forth in 12 C.F.R. § 565.4(b)(1).
 
Section 1.02.   General Interpretive Principles.  Whenever used in this Agreement, except as otherwise expressly provided or unless the context otherwise requires, any noun or pronoun shall be deemed to include the plural as well as the singular and to cover all genders. The name assigned this Agreement and the section captions used herein are for convenience of reference only and shall not be construed to affect the meaning, construction or effect hereof. Whenever the words “include,” “includes,” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.”  Unless otherwise specified, the terms “hereto,” “hereof,” “herein” and similar terms refer to this Agreement as a whole (including the exhibits, schedules and disclosure statements hereto), and references herein to Articles or Sections refer to Articles or Sections of this Agreement.
 
ARTICLE II
 
Sale and Purchase of the Securities
 
Section 2.01.   Initial Closing and Final Closing.
 
(a)  Initial Closing.
 
-7-


(i)    Subject to the satisfaction or waiver of the conditions set forth in Section 5.01 and Section 5.02 of this Agreement, and in reliance upon the representations and warranties hereinafter set forth, the purchase and sale of:
 
 
(A)
$1,686,000,000 aggregate principal amount of Springing Lien Notes;
 
(B)
10,000,000 shares of the Purchased Common Stock; and
 
(C)
the ABS Assets (the “Initial Closing”)
 
 shall take place at the offices of Fried, Frank, Harris, Shriver & Jacobson LLP, One New York Plaza, New York, NY, concurrently with the execution and delivery of this Agreement by the parties (the date that the Initial Closing occurs, the “Initial Closing Date”).
 
(ii)    At the Initial Closing: (A) the Company will deliver to Purchaser (1) certificates for the shares of Common Stock in the amounts set forth in the Section 2.01(a)(i)(B) registered in the name of Purchaser; (2) $1,686,000,000 of executed Springing Lien Notes which shall be reflected in one or more global notes representing the Springing Lien Notes and held by The Depository Trust Corporation or its nominee (or a custodian on its behalf); (3) an executed copy of the ABS Purchase Agreement, the Registration Rights Agreement, the Springing Lien Notes Indenture and the Order Handling Agreement; (4) the Commitment Fee by wire transfer of immediately available funds to the accounts set forth on Purchaser Schedule 2.01(a); and (5) the Existing Notes Accrued Interest by wire transfer of immediately available funds to the accounts set forth on Purchaser Schedule 2.01(a); (B) Purchaser, in full payment for such shares of the Purchased Common Stock and such Springing Lien Notes, will deliver (1) the Initial Consideration by wire transfer of immediately available funds to the accounts set forth on  Company Disclosure Schedule 2.01(a), and (2) the Existing Notes Consideration; (C) Purchaser will deliver to the Company an executed copy of the Parent Guaranty and an executed counterpart to the Registration Rights Agreement, the ABS Purchase Agreement and the Order Handling Agreement; (D) the Company will contribute the full amount of the Initial Consideration to E*Trade Bank and $50,000,000 of any other consideration received with respect to the Springing Lien Notes sold contemporaneously herewith to any Person other than Purchaser; (E) following delivery to Purchaser of the written certification of the Company’s Chief Financial Officer that the actions contemplated by preceding clause (D) have been completed, E*Trade Bank, E*Trade Global Asset Management, Inc. and Purchaser will consummate the purchase and sale of the ABS Assets pursuant to the ABS Purchase Agreement; and (F) each party shall take or cause to happen such other actions, and shall execute and deliver such other instruments or documents, as shall be required under Section 5.01 and Section 5.02.
 
(iii)    Notwithstanding any other provision of this Agreement, after the Initial Closing Date in consideration, in part, of the payments made by Purchaser at the Initial Closing, Purchaser shall have the right to receive an additional 20,741,901 shares of the Purchased Common Stock, which shares of Purchased Common Stock shall be issued by the Company to Purchaser upon termination or expiration of any applicable waiting periods with respect to such issuance under the HSR Act.   Immediately upon expiration or notice of termination of any such applicable waiting period, the Company shall issue such additional
 
-8-

 
shares to Purchaser registered in the name of Purchaser.   The Company shall not be required to issue such additional shares at any time that there shall be in effect any law, rule or regulation or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits consummation of such issuance.  Notwithstanding the foregoing, in the event Purchaser determines that the issuance of all of such shares of Purchased Common Stock under this Section 2.01(a)(iii) will or may give rise to regulatory concerns for Purchaser or its Affiliates, Purchaser may elect to receive a fewer number of shares of Purchased Common Stock otherwise issuable pursuant to this 2.01(a)(iii), and the number of shares not issued to Purchaser as a result of such election shall be issued to Purchaser at the time shares of Purchased Common Stock are issued to Purchaser pursuant to Section 2.01(b)(i)(A) at the Final Closing or pursuant to Section 2.01(b)(iii), as applicable.   Notwithstanding the foregoing or anything to the contrary herein, until the earlier of the Final Closing or the date shares of Purchased Common Stock are issuable to Purchaser pursuant to Section 2.01(b)(iii), Purchaser shall not have the right to receive any shares of Common Stock to the extent that, after receiving such shares, Purchaser (together with its Affiliates) would beneficially own in excess of 9.90% of the number of shares of Common Stock outstanding immediately after giving effect to such issuance (the “Issuance Limitation”).   For purposes of this Section, beneficial ownership shall be calculated in accordance with Rule 13(d)(3) of the Exchange Act.  By not less than sixty-one (61) days’ prior written notice to the Company, Purchaser may, at its election, increase or decrease the Issuance Limitation to any other percentage not in excess of 9.90% specified in such notice, and the Issuance Limitation shall continue to apply until such sixty-first day (or such later date, as determined by Purchaser, as may be specified in such notice).
 
(iv)    If the Initial Closing is consummated, the conditions to the Initial Closing set forth in Sections  5.01 and 5.02 shall be deemed to have been satisfied or waived, and neither party shall assert the failure of any such condition as the basis for failing to consummate the Final Closing or as the basis for terminating this Agreement.
 
(b)  Final Closing.
 
(i)    On the third Business Day following the satisfaction or waiver (to the extent permitted by applicable law) of the conditions set forth in Section 5.03 and Section 5.04 (other than those conditions that by their nature are to be satisfied at the Final Closing, but subject to the satisfaction or waiver of such conditions) (the “Final Closing” and the date that the Final Closing occurs, the “Final Closing Date”), and in reliance upon the representations and warranties hereinafter set forth and in consideration, in part, of the payments made by the Purchaser at the Final Closing or allocable portions of the payments made by Purchaser at the Initial Closing, the Company will issue:
 
(A) 49,125,186 shares of Purchased Common Stock; and
 
(B) $150,000,000 of Springing Lien Notes.
 
The Final Closing shall take place at the offices of Fried, Frank, Harris, Shriver & Jacobson LLP, One New York Plaza, New York, NY on the Final Closing Date.  Notwithstanding the foregoing or any other provision in this Agreement, the Company shall not be obligated to consummate the Final Closing or any Additional Closing with respect to all or
 
-9-

 
any portion of the $150,000,000 of Springing Lien Notes to the extent that its Chief Financial Officer certifies in writing to the Company and Purchaser that the Company cannot incur all or any portion of such additional indebtedness under the terms of its existing indentures.
 
(ii)    At the Final Closing, (A) the Company will deliver to Purchaser (1) certificates for the shares of Common Stock in the amounts set forth in Section 2.01(b)(i)(A) registered in the name of Purchaser; and (2) $150,000,000 of executed Springing Lien Notes which shall be reflected in one or more global notes representing the Springing Lien Notes and held by The Depository Trust Corporation or its nominee (or a custodian on its behalf); (B) Purchaser, in exchange for such shares of Purchased Common Stock and Springing Lien Notes, will deliver to the Company the Final Cash Consideration by wire transfer of immediately available funds to the accounts set forth on Schedule 2.01; (C) the Company shall contribute all of the Final Cash Consideration on the Final Closing Date to E*Trade Bank, and (D) each party shall take or cause to happen such other actions, and shall execute and deliver such other instruments or documents, as shall be required under Section 5.03 and Section 5.04.
 
(iii)    Notwithstanding any other provision of this Agreement, whether or not the Final Closing is consummated, the shares of Purchased Common Stock contemplated by Section 2.01(b)(i)(A) above shall be issued by the Company to Purchaser immediately following (A) the expiration or termination of any applicable waiting periods under the HSR Act with respect to the issuance of Purchased Common Stock after the Initial Closing and (B) the acceptance by the OTS of a rebuttal of control submission for the proposed Transactions without, unless approved by Purchaser in its sole discretion, the imposition of any Burdensome Condition (subject to the absence of any law, rule or regulation or any order or regulation or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits such sale); provided, however, that in the event Purchaser determines that the issuance of such shares will or may give rise to regulatory concerns for Purchaser or its Affiliates, Purchaser may elect to delay receipt of all or any portion of such shares until Purchaser is reasonably satisfied that receipt of such shares is permitted by regulatory authorities.  The Company shall issue such additional shares to Purchaser registered in the name of Purchaser.
 
(c)  (i)  Notwithstanding Section 2.01(b) above, following the date hereof, Purchaser shall use its commercially reasonable efforts to assign prior to January 15, 2008 in accordance with Section 6.10, and if such right is not exercised prior to January 15, 2008, the Company shall have the right, upon the prior consent of Purchaser (such consent not to be unreasonably withheld), to assign, Purchaser’s right to purchase the Springing Lien Notes to be purchased on the Final Closing Date.  Any such assignment shall only be made in increments of $50,000,000 (or a lesser amount if, as of the Final Closing Date, an amount less than such amount that has not previously been purchased has been assigned).
 
(ii)    The sale of the Springing Lien Notes to an assignee as set forth in Section 2.01(c)(i) shall be an “Additional Closing” and shall occur promptly after such assignment (subject to the absence of any law, rule or regulation or any order or regulation or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits such sale).
 
(iii)    On the date each such Additional Closing occurs (such date, the “Additional Closing Date”), in consideration of the payment made by the assignee on such
 
-10-

 
Additional Closing Date, the Company will issue such assignee for each $50,000,000 (or such lesser amount as permitted by Section 2.01(c)) increment assigned to such assignee, $50,000,000 (or such lesser amount as permitted by Section 2.01(c)) of Springing Lien Notes.
 
(iv)    At each such Additional Closing, (A) the Company will deliver to such assignee $50,000,000 (or such lesser amount as permitted by Section 2.01(c)) of executed Springing Lien Notes, which will be reflected in one or more global notes representing the Springing Lien Notes and held by the Depository Trust Corporation or its nominee (or a custodian on its behalf); (B) such assignee, in exchange for such Springing Lien Notes shall deliver to the Company $50,000,000 (or such lesser amount as permitted by Section 2.01(c)) by wire transfer of immediately available funds to the account specified by the Company; and (C) the Company will contribute the proceeds of such Additional Closing to E*Trade Bank.
 
(v)    Upon the occurrence of an Additional Closing, the amount of Springing Lien Notes to be issued under Section 2.01(b) shall be reduced for the Springing Lien Notes issued under this Section 2.01(c) and the Final Cash Consideration shall be reduced dollar for dollar for any funds received by the Company pursuant to Section 2.01(c)(iv).
 
 
ARTICLE III
 
Representations and Warranties
 
Section 3.01.   Representations and Warranties of the Company.  Except as disclosed in (i) the Company’s 10-K covering the year ended December 31, 2006 (the “Recent 10-K”) and the Reports filed with the SEC by the Company after the Recent 10-K (excluding any risk factor disclosures contained in such documents under the heading “Risk Factors” and any disclosure of risks included in any “forward-looking statements” disclaimer or other statements that are similarly non-specific and are predictive or forward−looking in nature and excluding any exhibits to or referenced in such Reports) or (ii) in the disclosure schedule (the “Company Disclosure Schedule”) delivered by the Company to Purchaser prior to the execution of this Agreement (which schedule sets forth, among other things, items, the disclosure of which is necessary or appropriate, either in response to an express disclosure requirement contained in a provision hereof or as an exception to one or more representations or warranties contained in this Section 3.01, or to one or more of the Company’s covenants; provided, however, that disclosure in any section of such Company Disclosure Schedule shall apply only to the indicated Section of this Agreement except to the extent that it is reasonably apparent that such disclosure is relevant to another Section of this Agreement), the Company represents and warrants to Purchaser, as of the date hereof (or as of such specific date in the case of any representation or warranty expressly made as of a specific date), as follows:
 
(a)           Organization and Good Standing of the Company; Organizational Documents.  The Company is a Delaware corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority and governmental authorizations to own, operate and lease its properties and to carry on its business as it is being conducted on the date of this Agreement.  The Company is duly licensed or qualified as a foreign corporation for the transaction of business and is in good standing under
 
-11-

 
the laws of each other jurisdiction in which it owns or leases properties, or conducts any business, so as to require such qualification, except where the failure to be so licensed or qualified in any such jurisdiction would not reasonably be expected to have a Material Adverse Effect.  True, complete and correct copies of the Company’s restated certificate of incorporation and by-laws, as in effect as of the date of this Agreement, are publicly available on the SEC’s website.
 
(b)  Organization and Good Standing of Subsidiaries.  Each Subsidiary of the Company is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and has all requisite corporate or other organizational power and authority and governmental authorizations to own, operate and lease its properties and to carry on its business as it is now being conducted, and is duly licensed or qualified to do business in each other jurisdiction in which it owns or leases properties, or conducts any business, so as to require such qualification, except where the failure to be so authorized, licensed or qualified in any such jurisdiction, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.  The deposit accounts of E*Trade Bank are insured by the FDIC to the fullest extent permitted by the Federal Deposit Insurance Act and the rules and regulations of the FDIC thereunder, and all premiums and assessments required to be paid in connection therewith have been paid when due.
 
(c)  Authorization; No Conflicts.
 
(i)    The Company and each Subsidiary that is or will be a party to an Ancillary Document have full corporate or other organizational power and authority to execute and deliver this Agreement and the Ancillary Documents to which it is or will be a party and to consummate the transactions contemplated hereby and thereby (the “Transactions”).  The execution, delivery and performance by the Company and each Subsidiary that is or will be a party to an Ancillary Document of this Agreement and each Ancillary Document to which it is or will be  a party and the consummation of the Transactions (including the issuance of the Securities as contemplated by this Agreement) have been duly authorized by the Board of Directors (or equivalent governing body) of the Company or the relevant Subsidiary.  No other corporate or other organizational proceedings on the part of the Company (including approval of the Company’s stockholders), including under the NASDAQ rules and regulations relating to the continued listing of the Common Stock under the Nasdaq, or any Subsidiary are necessary to authorize the execution, delivery and performance by the Company and each Subsidiary that is or will be a party to an Ancillary Document of this Agreement and each Ancillary Document and consummation of the Transactions  (including the issuance of the Securities as contemplated by this Agreement).  This Agreement has been, and at or prior to the Initial Closing or Final Closing, as applicable, each Ancillary Document to which it is a party will be, duly and validly executed and delivered by the Company or its Subsidiaries, as applicable.  This Agreement is, and upon its execution at or prior to the Initial Closing or the Final Closing, as applicable, each Ancillary Document to which it is a party will be, a valid and binding obligation of the Company or its Subsidiaries, as applicable, enforceable against them in accordance with its terms.
 
(ii)    The execution, delivery and performance of this Agreement and the Ancillary Documents to which the Company and/or its Subsidiaries is a party, the consummation by the Company and its Subsidiaries of the Transactions and the compliance by
 
-12-

 
the Company and its Subsidiaries with any of the provisions hereof and thereof will not conflict with, violate or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both would constitute a default) under, or give rise to any rights of any Person other than the parties to this Agreement or the Ancillary Documents or give rise to any obligations of the Company other than under this Agreement and the Ancillary Documents under, or result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration under (x) any provision of the Restated Certificate of Incorporation or By-laws of the Company or the certificate of incorporation, charter, by-laws or other governing instrument of any Subsidiary of the Company that is or will be a party to any Ancillary Agreement or (y) any mortgage, note, indenture, deed of trust, lease, loan agreement, commitment, arrangement, written or oral contract or other agreement or instrument or any permit, concession, grant, franchise, license, judgment, order, decree, ruling, injunction, statute, law, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries or any of their respective properties or assets, other than any such conflict, violation, breach, default, rights, obligations, termination and acceleration under clause (y) (other than with respect to the indentures governing the Company’s outstanding senior notes) that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.
 
(d)  Governmental Consents.  No consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental Entity is required on the part of the Company or any of its Subsidiaries in connection with the execution, delivery and performance by the Company of this Agreement and the Ancillary Documents to which it is or will be a party and the consummation by the Company of the Transactions other than (i) compliance with the applicable requirements of the HSR Act, (ii) compliance with any applicable requirements of the Securities Act, the Exchange Act, and any other applicable foreign or state securities or “blue sky” laws, (iii) filing of notice with the OTS pursuant to 12 CFR 563.22(c) with respect to the transfer of the ABS Assets; (iv) with respect to the Final Closing, the acceptance by the OTS of the rebuttal of control submission referred to in Section 4.06(a), and (v) any consent, approval,  actions or filings the absence of which would not have, or reasonably be expected to have, a material adverse affect on the Company or any of its material Subsidiaries, the Transactions, or the Purchasers or any of their respective Affiliates as a result of the Transactions.
 
(e)  Capitalization.
 
(i)    The authorized capital stock of the Company consists of (i) 600,000,000 shares of Common Stock of which, as of November 29, 2007,  423,749,462 shares were issued and outstanding and (ii) 1,000,000 shares of preferred stock, $0.01 par value, of the Company (the “Preferred Stock”) of which, as of the date hereof, one share is designated Series A Preferred Stock and 500,000 shares are designated Series B Preferred Stock.  As of the date hereof, no shares of Series A Preferred Stock or Series B Preferred Stock are issued and outstanding.  All of the shares of Series B Preferred Stock are reserved for issuance in accordance with the Rights Agreement, dated as of July 9, 2001 between the Company and American Stock Transfer and Trust Company (the “Rights Agreement”), pursuant to which the Company has issued rights to purchase Series B Preferred Stock.  As of the date hereof, the Company held no shares of Common Stock in its treasury.  As of the date hereof, there were 61,188,234 shares of Common Stock reserved for issuance in connection with employee benefit, stock option and dividend reinvestment and stock purchase plans.  All of the issued and
 
-13-

 
outstanding shares of the Company’s capital stock have been duly and validly authorized and issued and are fully paid and nonassessable, and are not subject to preemptive rights.  No bonds, debentures, notes or other indebtedness having the right to vote on any matters on which the stockholders of the Company may vote (“Voting Debt”) are issued and outstanding.  Other than as set forth in this Section 3.01(e)(i) or pursuant to this Agreement, (A) no equity securities or Voting Debt of the Company are or may be required to be issued by reason of any options, warrants, rights to subscribe to, calls or commitments of any character whatsoever, (B) there are outstanding no securities or rights convertible into or exchangeable for any equity securities or Voting Debt of the Company and (C) there are no contracts, commitments, understandings or arrangements by which the Company is bound to issue additional equity securities or Voting Debt or options, warrants or rights to purchase or acquire any additional equity securities or Voting Debt.  The consummation of the Transactions contemplated by this Agreement will not result in the triggering of any anti-dilution adjustment provisions of any security of the Company convertible into equity securities of the Company.  The Springing Lien Notes will rank pari-passu with all other senior indebtedness of the Company.  The Purchased Common Stock, collectively with the Common Stock issued on the date hereof to Persons other than Purchaser, represents 19.99% of the Company’s issued and outstanding shares of Common Stock as of the date of this Agreement, before giving effect to any shares of Common Stock to be issued under this Agreement to Purchaser or such Common Stock issued to such other Persons.
 
(ii)    Except for any directors’ qualifying shares, all of the issued and outstanding shares of capital stock or other equity ownership interests of each Subsidiary of the Company are owned by the Company, directly or indirectly, free and clear of any material liens, pledges, charges and security interests and similar encumbrances, and all of such shares or equity ownership interests have been duly and validly authorized and issued and are fully paid and nonassessable, and are not subject to preemptive rights.  None of the outstanding shares of capital stock or other securities of any Subsidiary were issued in violation of the Securities Act or any other applicable federal state or local law, rule or regulation.  No Subsidiary of the Company has or is bound by any outstanding subscriptions, options, warrants, calls, commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.
 
(f)    Reports; Financial Statements; Controls.
 
(i)    Since January 1, 2005, the Company and each of its Subsidiaries has timely filed all reports, registration statements, proxy statements and other materials, together with any amendments required to be made with respect thereto, that were required to be filed with (i) the SEC under the Securities Act or the Exchange Act, (ii) the OTS, (iii) the Federal Reserve Board, (iv) the FDIC and (v) any other federal, state or foreign Governmental Entity (all such reports and statements are collectively referred to herein as the “Reports”), and have paid all fees and assessments due and payable in connection therewith.  As of their respective dates, the Reports complied in all material respects with all of the statutes and published rules and regulations enforced or promulgated by the regulatory authority with which they were filed and (i) with respect to Reports filed with the SEC, did not as of the date of filing thereof with the SEC contain any untrue statement of a material fact or omit to state any material fact required to
 
-14-

 
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (ii) with respect to all other Reports, were complete and accurate in all material respects as of their respective dates.  There are no facts existing as of the date hereof peculiar to the Company or any of its Subsidiaries that the Company has not disclosed in the Reports or to Purchaser in writing that, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect.  No executive officer of the Company has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act of 2002.
 
(ii)    Each of the consolidated balance sheets, and the related consolidated statements of income, changes in stockholders’ equity and cash flows, included in the Reports filed with the SEC under the Exchange Act (A) have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries, (B) fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates shown and the results of the consolidated operations, changes in stockholders’ equity and cash flows of the Company and its consolidated Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth, subject, in the case of any unaudited financial statements, to normal recurring year-end audit adjustments, (C) complied as to form, as of their respective dates of filing with the SEC, in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto and (D) have been prepared in accordance with GAAP consistently applied during the periods involved, except as otherwise set forth in the notes thereto.
 
(iii)    The books, records, systems, controls, data and information of the Company and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of the Company or its Subsidiaries or accountants (including all means of access thereto and therefrom), except for any non-exclusive ownership and non-direct control that would not reasonably be expected to have a material adverse effect on the system of internal accounting controls described below in this Section 3.01(f)(iii).  The Company (A) has implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the chief executive officer and the chief financial officer of the Company by others within those entities, and (B) has disclosed, based on its most recent evaluation prior to the date hereof, to the Company’s outside auditors and the audit committee of the Company’s Board of Directors (x) any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting.  As of the date hereof, to the knowledge of the Company, there is no reason that its outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, without qualification, when next due.  Since January 1, 2005, (A) neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer, employee, auditor, accountant or
 
-15-

 
representative of the Company or any of its Subsidiaries has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or claim that the Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (B) no attorney representing the Company or any of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by the Company or any of its officers, directors, employees or agents to the Board of Directors of the Company or any committee thereof or to any director or officer of the Company.
 
(g)  Absence of Certain Changes.  Since September 30, 2007 until the date hereof, and except as publicly disclosed by the Company in the Reports filed by it with the SEC and publicly available prior to the date hereof,
 
(i)     the Company and its Subsidiaries have conducted their respective businesses in all material respects in the ordinary course, consistent with prior practice,
 
(ii)     the Company has not made or declared any distribution in cash or in kind to its stockholders or issued or repurchased any shares of its capital stock or other equity interests; and
 
(iii)     no event or events have occurred that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.
 
(h)  No Undisclosed Liabilities, etc.  Neither the Company nor any of its Subsidiaries has any liabilities or obligations of any nature (absolute, accrued, contingent or otherwise) which are not fully reflected or reserved against in the financial statements described in Section 3.01(f), except for liabilities that have arisen since September 30, 2007 in the ordinary and usual course of business and consistent with past practice and that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.
 
(i)  Compliance with Applicable Law.  Each of the Company and its Subsidiaries holds all licenses, franchises, permits and authorizations necessary for the lawful conduct of its business under, and has complied in all material respects and is not in default or violation in any respect of, any law, statute, order, rule, regulation, policy or guideline of any federal, state or local governmental authority applicable to the Company or such Subsidiary, other than such non-compliance, defaults or violations that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.
 
(j)  Legal Proceedings.   Neither the Company nor any of its Subsidiaries is a party to any, and there are no pending, or to the knowledge of the Company, threatened, legal, administrative, arbitral or other proceedings, claims, actions or governmental investigations of any nature against the Company or any of its Subsidiaries or to which any of their assets are subject that, (i) individually or in the aggregate, has had or would reasonably be expected to have
 
-16-

 
a Material Adverse Effect or (ii) relating to or which challenges the validity or propriety of the Transactions.  Neither the Company nor any of its Subsidiaries is subject to any order, judgment or decree of a Governmental Entity that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect, (i) there is no unresolved violation, criticism or exception by any Governmental Entity with respect to any Report or relating to any examinations or inspections of the Company or any of its Subsidiaries and (ii) since January 1, 2005, there has been no formal or informal inquiries by, or disagreements or disputes with, any Governmental Entity with respect to the business, operations, policies or procedures of the Company or any of its Subsidiaries.
 
(k)  ERISA.
 
(i)           All “employee benefit plans,” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that are subject to Title I of ERISA and are currently maintained or maintained since January 1, 2001, by either the Company or any companies which, with the Company, would be deemed to be a single employer under Section 414(b), (c), (m) or (o) of the Code (collectively, the “Company Group”) for the benefit of the Company Group employees, are collectively, for purposes of this Agreement, referred to herein as the “Company Plans.”  All Company Plans that constitute employee “pension plans” as defined in Section 3(2) of ERISA that are subject to Title IV of ERISA are referred to herein as the “Company Pension Plans.”  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect, no non-exempt “prohibited transaction” (as such term is used in Section 406 of ERISA or Section 4975 of the Code), has heretofore occurred with respect to any Company Plan or any Company Pension Plan and, to the knowledge of the Company, no such non-exempt prohibited transaction with respect to any Company Plan or Company Pension Plan shall occur as a result of the execution and delivery of this Agreement or the Ancillary Documents and the consummation of the Transactions.
 
(ii)           The consummation of the transactions contemplated hereby will not result in a material increase in the amount of, or acceleration in the timing of payment or vesting of, any material compensation payable or awarded by the Company or any of its Subsidiaries to any of its or their employees under any employment agreements, plans or programs of the Company or any of its Subsidiaries.
 
(l)  Taxes.  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect:
 
(i)           Each of the Company and its Subsidiaries has duly and timely filed (including all applicable extensions) all Tax Returns required to be filed by it on or prior to the date hereof (all such returns being accurate, true and complete in all material respects), has paid all Taxes due (whether or not shown on any Tax Return) and has duly paid or made provision for the payment of all Taxes that have been incurred or are due or claimed to be due from it by federal, state, foreign or local taxing authorities other than Taxes that are not yet delinquent or are being contested in good faith, have not been finally determined and have been adequately reserved against;
 
-17-

 
(ii)           the federal, state and local income Tax returns of the Company and its Subsidiaries have been examined by the Internal Revenue Service (the “IRS”) and any applicable state and local tax authorities for all years to and including 2003 and any liability with respect thereto has been satisfied or any liability with respect to deficiencies asserted as a result of such examination is covered by reserves that are adequate under GAAP;
 
(iii)          there are no disputes pending, or claims asserted, for Taxes or assessments upon the Company or any of its Subsidiaries for which the Company does not have reserves that are adequate under GAAP;
 
(iv)          each of the Company and its Subsidiaries has withheld and paid all Taxes required to be withheld and paid in connection with amounts paid and owing to any employee, independent contractor, creditor, stockholder or other third party (whether domestic or foreign);
 
(v)           there are no liens for Taxes (other than Taxes not yet due and payable) upon any assets of the Company or any of its Subsidiaries;
 
(vi)          neither the Company nor any of its Subsidiaries is (A) a party to or is bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement exclusively between or among the Company and its Subsidiaries) or (B) has any liability for the Taxes of any Person (other than the Company or any of its Subsidiaries) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or foreign law);
 
(vii)          within the past two years, neither the Company nor any of its Subsidiaries has been a “distributing corporation” or a “controlled corporation” in a distribution intended to qualify under Section 355(a) of the Code;
 
(viii)          neither the Company nor any of its Subsidiaries is required to include in income any adjustment pursuant to Section 481(a) of the Code, no such adjustment has been proposed by the IRS and no pending request for permission to change any accounting method has been submitted by the Company or any of its Subsidiaries; and
 
(ix)            neither the Company nor any of its Subsidiaries has participated in a “listed transaction” within the meaning of Treasury Regulation Section 1.6011-4(b)(2).
 
(m)  Intellectual Property.  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect:
 
(i)           the Company and each of its Subsidiaries owns, or is licensed to use (in each case, free and clear of any claims, liens or encumbrances), all Intellectual Property used in or necessary for the conduct of its business as currently conducted;
 
(ii)           the use of any Intellectual Property by the Company and its Subsidiaries does not, to the knowledge of the Company, infringe on or otherwise violate the rights of any person and is in accordance with any applicable license pursuant to which the Company or any of its Subsidiaries acquired the right to use any Intellectual Property;
 
-18-

 
(iii)          no person is challenging, infringing on or otherwise violating any right of the Company or any of its Subsidiaries with respect to any material Intellectual Property owned by or licensed to the Company or its Subsidiaries;
 
(iv)          to the knowledge of the Company, neither the Company nor any of its Subsidiaries has received any notice of any pending claim with respect to any Intellectual Property used by the Company or any of its Subsidiaries; and
 
(v)           to the knowledge of the Company, no Intellectual Property owned or licensed by the Company or any of its Subsidiaries is being used or enforced in a manner that would be expected to result in the abandonment, cancellation or unenforceability of such Intellectual Property.
 
(n) Environmental Liability.  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect:
 
(i)           there are no legal, administrative, arbitral or other proceedings, claims, actions, causes of action or notices with respect to any environmental, health or safety matters or any private or governmental environmental, health or safety investigations or remediation activities of any nature seeking to impose, or that are reasonably likely to result in, any liability or obligation of the Company or any of its Subsidiaries arising under common law or under any local, state or federal environmental, health or safety statute, regulation or ordinance, including the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, pending or threatened against the Company or any of its Subsidiaries;
 
(ii)           to the knowledge of the Company, there is no reasonable basis for, or circumstances that are reasonably likely to give rise to, any such proceeding, claim, action, investigation or remediation by any Governmental Entity or any third party that would give rise to any liability or obligation on the part of the Company or any of its Subsidiaries; and
 
(iii)          neither the Company nor any of its Subsidiaries is subject to any agreement, order, judgment, decree, letter or memorandum by or with any Governmental Entity or third party imposing any liability or obligation with respect to any of the foregoing.
 
(o)  Mortgage Banking Business.  Except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect, the Company and each of its Subsidiaries has complied with, and all documentation in connection with the origination, processing, underwriting and credit approval of any real estate secured loans originated, purchased or serviced by E*Trade Bank or any of its Subsidiaries has satisfied all applicable federal, state and local laws, rules and regulations with respect to the origination, insuring, purchase, sale, pooling, servicing, subservicing, or filing of claims in connection with such loans, including all laws relating to real estate settlement procedures, consumer credit protection, truth in lending laws, usury limitations, fair housing, transfers of servicing, collection practices, equal credit opportunity and adjustable rate mortgages.
 
(p)  Broker – Dealer.
 
-19-

 
(i)           Section 3.01(p) of the Company Disclosure Schedule sets forth a complete list of all securities exchanges, boards of trade, clearing organizations, trade associations and similar organizations in which the Company holds a membership or has been granted trading privileges and which memberships or trading privileges are material to the Company’s broker-dealer business.  The Company’s Subsidiaries, to the extent required, are members of the Securities Investor Protection Corporation.  The Company is not required to be registered as a futures commission merchant, commodities trading adviser, commodity pool operator or introducing broker under the Commodities Exchange Act or any similar state laws. The Company is not subject to registration under the Investment Company Act of 1940, as amended.
 
(ii)           The Company is duly registered, licensed or qualified as a broker-dealer in each jurisdiction where the conduct of the Company’s business requires such registration, licensing or qualification, and is in compliance with all laws requiring any such registration, licensing or qualification and is not subject to any material liability or disability by reason of the failure to be so registered, licensed or qualified, except where such failure to register, license or qualify or noncompliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
 
(iii)          Except as disclosed on Form BD filed prior to the date of this Agreement or as would not reasonably be expected to have a Material Adverse Effect, neither the Company nor any of its directors, officers, employees or “associated persons” (as defined in the Exchange Act) has been the subject of any disciplinary proceedings or orders of any Governmental Entity arising under applicable laws which would be required to be disclosed on Form BD. Except as set forth in Section 3.01(p) of the Company Disclosure Schedule, no such disciplinary proceeding or order is pending or threatened. Except as disclosed on a Form BD filed prior to the date of this Agreement, neither the Company nor any of its directors, officers, employees or associated persons has been permanently enjoined by the order of any Governmental Entity from engaging or continuing any conduct or practice in connection with any activity or in connection with the purchase or sale of any security. Except as disclosed on Form BD filed prior to the date of this Agreement, neither the Company nor any of its directors, officers, employees or associated persons is or has been ineligible to serve as a broker-dealer or an associated person of a broker-dealer under Section 15(b) of the Exchange Act (including being subject to any “statutory disqualification” as defined in Section 3(a)(39) of the Exchange Act).
 
(q) Regulatory Actions.  Except as set forth in the Company Disclosure Schedule, since January 1, 2005 neither E*Trade Bank nor any its Subsidiaries have received any written communication from any federal or state banking authority (“Banking Authority”) (i) asserting that it is in material violation of any law, (ii) threatening to revoke any of its material permits or licenses, (iii) requiring it (x) to enter into or consent to the issuance of a cease and desist order, written agreement, consent decree, directive, commitment or memorandum of understanding, or (y) to adopt any policy, procedure or resolution of its Board of Directors or similar undertaking, that restricts the conduct of its business, or relates to its capital adequacy, its credit or reserve policies, it management, or the payment of dividends or any other policy or procedure, in either case, that would be material to the conduct of the business or E*Trade Bank or any of its Subsidiaries or (iv) threatening or contemplating revocation or limitation of, or which would
 
-20-

 
have the effect of revoking or limiting,  FDIC deposit insurance, and neither E*Trade Bank nor any of its Subsidiaries has received any written notice from a Banking Authority that it is considering issuing or requiring any of the foregoing.  Since January 1, 2005, each of E*Trade Bank and its Subsidiaries has filed all reports and statements, together with any amendment required to be made with respect thereto, that it was required to file with any Banking Authority, and has paid all fees and assessments due and payable in connection with its business.
 
(r) Company Information.  None of the information to be contained in any document filed with any regulatory agency in connection with the transactions contemplated by this Agreement (the “Regulatory Filings”), in each case, other than Purchaser Information, as to which no representation is made by the Company, will, at the time such filing is made, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they are made, not misleading.
 
(s) State Takeover Laws.  The Company’s Board of Directors has taken all action necessary to render inapplicable to Purchaser the restrictions on “business combinations” set forth in Section 203 of the DGCL and, to the knowledge of the Company, any similar “moratorium,” “control share,” “fair price,” “takeover” or “interested stockholder” law applicable to transactions between Purchaser and the Company taking into account shares of Common Stock issued contemporaneously herewith to Persons other than the Purchaser.
 
(t) Rights Agreement.   The Company has taken all actions necessary to irrevocably amend the Rights Agreement to provide that the rights thereunder will not be triggered as a result of the Transactions or by the acquisition of an additional 8,474,989 shares of Common Stock of the Company after the Initial Closing Date by the Purchaser or any of its Affiliates or Associates, in addition to the shares of Purchased Common Stock issuable pursuant to the terms hereof on or after the Initial Closing Date.
 
(u) Solvency.  Immediately after giving effect to all of the Transactions contemplated by this Agreement, including payment of all related fees and expenses, the Company and each of its Subsidiaries will be Solvent.  For purposes of this Section 3.01, the term “Solvent” with respect to the Company and each of its Subsidiaries means that, as of any date of determination, (a) the amount of the Fair Value and Present Fair Saleable Value of the assets of the Company and each of its Subsidiaries, exceeds as of such date, their respective Stated Liabilities and other Contingent Liabilities on an individual basis; (b) the Company and each of its Subsidiaries will not have, as of such date, an unreasonably small amount of capital for the operation of the business in which each of the Company and its Subsidiaries is engaged as a going concern following such date on an individual basis; and (c) the Company and each of its Subsidiaries will have sufficient assets and cash flow to pay each of their respective Stated Liabilities and other Contingent Liabilities as they mature or otherwise become due on an individual basis.  For purposes of this Section 3.01, the term, “Fair Value” means the amount at which the assets, in their entirety, of the Company or any of its Subsidiaries as the case may be (on an individual basis) would change hands between a willing buyer and a willing seller, within a commercially reasonable period of time, each having reasonable knowledge of the relevant facts, with neither being under any compulsion to act; the term “Present Fair Saleable Value” means the amount that could be obtained by an independent willing seller from an independent
 
-21-

 
willing buyer if the assets of the Company or any of its Subsidiaries as the case may be (on an individual basis) are sold with reasonable promptness under normal selling conditions in a current market, the term “Stated Liabilities” means all known liabilities and recorded liabilities (including Contingent Liabilities that would be recorded in accordance with GAAP consistently applied) of the Company or any of its Subsidiaries as the case may be (on an individual basis) and the term “Contingent Liabilities” means the maximum estimated amount of liability reasonably likely to result from pending litigation, asserted claims and assessments, guaranties, uninsured risks and other contingent liabilities of the Company or any of its Subsidiaries as the case may be (on an individual basis).
 
(v) Status of Securities.  The Securities have been duly authorized by all necessary corporate action.  When issued as contemplated by this Agreement, the Securities will be validly issued, fully paid and nonassessable, will not subject the holders thereof to personal liability and will not be subject to preemptive rights of any other stockholder of the Company.
 
(w) Offering of Securities.  Neither the Company nor any Person acting on its behalf has offered the Securities or any similar securities of the Company for sale to, solicited any offers to buy any of the Securities or any similar securities of the Company from or otherwise approached or negotiated with respect to any of the Securities or any similar securities of the Company with any Person other than Purchaser.  Neither the Company nor any Person acting on its behalf has taken or will take any action (including, without limitation, any offering of any securities of the Company under circumstances which would require the integration of such offering with the offering of any of the Securities under the Securities Act and the rules and regulations of the SEC thereunder) which might subject the offering, issuance or sale of any of the Securities to the registration requirements of the Securities Act.
 
(x) Brokers and Finders.  Neither the Company nor any of its Subsidiaries nor any of their respective officers, directors, employees or agents has utilized any broker, finder, placement agent or financial advisor or incurred any liability for any fees or commissions in connection with any of the Transactions, other than Evercore Partners and JP Morgan, the fees and expenses of which will be paid by the Company.
 
(y) Liquidity.  Pro forma for the Transactions and projected as of December 31, 2007, the Company will have at least $125 million of cash not subject to regulatory limitations.
 
(z) Capital.  Pro forma for the Transactions and projected as of December 31, 2007, the Company’s bank capital position will exceed by at least $200 million the regulatory capital standards to maintain “Well Capitalized” status within the meaning of 12 U.S.C. 1831(o) (as in effect on the date hereof) as determined by E*Trade Bank’s principal federal banking agency or the FDIC, but in no event, less than the amount required in a capital directive from a federal banking agency.
 
 
-22-

 
Section 3.02. Representations and Warranties of Purchaser.  Each Purchaser represents and warrants to, and agrees with, the Company, as of the date hereof and as of each of the Initial Closing Date and the Final Closing Date (or as of such specific date in the case of any representation or warranty expressly made as of a specific date) as follows:
 
(a) Organization.  Purchaser is duly organized, validly existing and in good standing under the laws of the state or country of its jurisdiction of formation and has all requisite power and authority to own, operate and lease its properties and to carry on its business as it is being conducted on the date of this Agreement.
 
(b) Authorization; No Conflicts.
 
(i)           Purchaser has full power and authority to execute and deliver this Agreement and the Ancillary Documents to which it is or will be a party and to consummate the Transactions.  The execution, delivery and performance by Purchaser of this Agreement and each of the Ancillary Documents to which it is or will be a party and the consummation of the Transactions have been duly authorized by all necessary action on behalf of Purchaser.  No other proceedings on the part of Purchaser are necessary to authorize the execution, delivery and performance by Purchaser of this Agreement and each Ancillary Document and consummation of the Transactions.  This Agreement has been, and on or prior to the Initial and Final Closing each Ancillary Document to which it is a party will be, duly and validly executed and delivered by Purchaser.  This Agreement is, and upon its execution at or prior to the Initial and Final Closing each Ancillary Document to which it is or will be a party will be, a valid and binding obligation of Purchaser, enforceable against it in accordance with its terms.
 
(ii)           The execution, delivery and performance of this Agreement and the Ancillary Documents to which it is or will be a party, the consummation by Purchaser of the Transactions and the compliance by Purchaser with any of the provisions hereof and thereof will not conflict with, violate or result in a breach of any provision of, or constitute a default (or an event, which, with notice or lapse of time or both would constitute a default) under, or result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, (A) any provision of the governing documents of Purchaser or (B) any mortgage, note, indenture, deed of trust, lease, loan agreement or other agreement or instrument of Purchaser or any permit, concession, grant, franchise, license, judgment, order, decree, ruling, injunction, statute, law, ordinance, rule or regulation applicable to Purchaser or its properties or assets other than any such conflict, violation, breach, default, termination and acceleration under clause (B) that, individually or in the aggregate, would not reasonably be expected to materially and adversely affect or delay the consummation of the Transactions.
 
(c) Consents and Approvals.  Except for (i) filing of notice with the OTS pursuant to 12 CFR 563.22(c) with respect to the transfer of the ABS Assets; (ii) the applicable requirements of the HSR Act, (iii) with respect to the Final Closing, the acceptance by the OTS of a rebuttal of control submission referred to in Section 4.06(a), and (iv) any consent, approval, action or filing the absence of which would not have, or reasonably be expected to have, a material adverse affect on Purchaser’s ability to consummate the Transactions or the Company, no consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental Entity is required on the part of Purchaser in connection with the execution,
 
-23-

 
delivery and performance by Purchaser of this Agreement and the Ancillary Documents to which it is or will be a party and the consummation by Purchaser of the Transactions.  As of the date hereof, Purchaser has no knowledge of any reason why, solely due to the current business operations of Purchaser and its Affiliates, the acceptance and approval of the rebuttal of control submission referred to in Section 4.06(a) by the OTS should not be obtained.
 
(d) Securities Act.  Purchaser is acquiring the Securities solely for the purpose of investment and not with a view to, or for resale in connection with, any distribution thereof in violation of the Securities Act.  Purchaser (either alone or together with its advisors) has sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of its investment in the Securities and is capable of bearing the economic risks of such investment.
 
(e) Brokers and Finders.  Neither Purchaser nor any of its officers, directors, employees or agents has utilized any broker, finder, placement agent or financial advisor or incurred any liability for any fees or commissions in connection with any of the Transactions.
 
(f) Purchaser Information.  None of the information with respect to Purchaser and its Affiliates or any of their respective officers and directors that is provided to the Company by Purchaser or any of its representatives (collectively, “Purchaser Information”) specifically for inclusion in any of the Regulatory Filings, will, at the time such filing is made, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they are made, not misleading.
 
(g) Legal Proceedings.  Purchaser is not a party to any, and there are no pending, or to the knowledge of Purchaser, threatened, legal, administrative, arbitral or other proceedings, claims, actions or governmental investigations of any nature against Purchaser or any of its Affiliates or to which any of their assets are subject, that as of the date hereof relate to or which challenge the validity of the Transactions.
 
(h) Financing.  Purchaser has, or will have prior to the Initial Closing or Final Closing, as applicable, sufficient cash, available lines of credit or other sources of immediately available funds to enable it to consummate the Initial Closing or Final Closing, as applicable.
 
(i) Current Ownership.  As of the date hereof and prior to giving effect to the Transactions contemplated hereby, except as set forth on Purchaser Schedule 3.02(i), Purchaser and its Affiliates are not owners of record or the “Beneficial Owner” (as such term is defined under Rule 13d-3 of the Exchange Act) of any shares of Common Stock or any interest therein, including any right, swap, derivative or other such arrangement in relation to shares of Common Stock.
 
(j) No Other Representations.  Purchaser is an informed and sophisticated purchaser, and has engaged to the extent it deemed appropriate expert advisors experienced in the evaluation of transactions of the type contemplated hereby.  Purchaser acknowledges that it has not relied upon any express or implied representations or warranties of any nature made by or on behalf of or imputed to the Company, except as expressly set forth in this Agreement or the
 
-24-

 
Ancillary Documents.   Without limiting the generality of the foregoing, Purchaser acknowledges that the Company makes no representation or warranty with respect to (i) any projections, estimates or budgets delivered to or made available to Purchaser of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of the Company and its Subsidiaries or the future business and operations of the Company and its Subsidiaries or (ii) any other information or documents made available to Purchaser or its counsel, accountants or advisors with respect to the Company or its Subsidiaries or their respective businesses or operations, except as expressly set forth in this Agreement, the Ancillary Documents and the schedules hereto and thereto.
 
ARTICLE IV
 
Additional Agreements of the Parties
 
Section 4.01.   Taking of Necessary Action.  Subject to the terms and conditions hereof,  (i) each of the parties hereto agrees to use all reasonable best efforts promptly to take or cause to be taken all action and promptly to do or cause to be done all things necessary, proper or advisable under applicable laws and regulations to consummate and make effective the Transactions, and (ii) each party shall execute and deliver both before and after the Initial Closing and the Final Closing such further certificates, agreements and other documents and take such other actions as the other party may reasonably request to consummate or implement the Transactions or to evidence such events or matters.
 
Section 4.02.   Financial Statements and Other Reports.   The Company covenants that from and after the date hereof, to the extent it has not previously publicly filed such information with the SEC in an annual report on Form 10-K or periodic report on Form 10-Q, it will deliver to Purchaser:
 
(a) within 40 days after the end of each quarterly period (other than the last quarterly period) in each fiscal year, consolidated statements of income, changes in stockholders’ equity and cash flows of the Company and its consolidated Subsidiaries (including the Company Subsidiary) for the period from the beginning of the then current fiscal year to the end of such quarterly period, and a consolidated balance sheet of the Company and its consolidated Subsidiaries (including the Company Subsidiary) as of the end of such quarterly period; and
 
(b) within 75 days after the end of each fiscal year, a consolidated balance sheet of the Company and its consolidated Subsidiaries as of the end of such fiscal year and the related consolidated statements of income, changes in stockholders’ equity and cash flows for such fiscal year, together with the audit report of Deloitte & Touche LLP or other independent public accountants of recognized standing selected by the Company.
 
           The obligations of the Company to deliver the materials described in this Section 4.02 shall continue in full force and effect until such time as Purchaser shall no longer own shares of Common Stock representing at least five percent of the Common Stock then outstanding.
 
Section 4.03.   Inspection of Property.  The Company covenants that it will permit
 
-25-

 
representatives of Purchaser to visit and inspect, at Purchaser’s expense, any of the properties of the Company or its Subsidiaries to examine the corporate books and make copies or extracts therefrom and to discuss the affairs, finances and accounts of the Company and its Subsidiaries with the principal officers of the Company, all upon reasonable notice and at such reasonable times and as often as Purchaser may reasonably request.  Any investigation pursuant to this Section shall be conducted during normal business hours and in such manner as not to interfere unreasonably with the conduct of the business of the Company, and nothing herein shall require the Company or any of its Subsidiaries to disclose any information to the extent (a) that the Company reasonably believes such information to be competitively sensitive proprietary information (except to the extent Purchaser provides reasonable assurances that such information shall not be shared with employees of its or its Affiliates’ competing businesses or otherwise used by the Purchaser or its Affiliates to compete with the Company and its Subsidiaries), (b) prohibited by applicable law or regulation, or (c) that such disclosure would reasonably be expected to cause a violation of any agreement to which the Company or any of its Subsidiaries is a party or would cause a risk of a loss of privilege to the Company or any of its Subsidiaries (provided that the Company shall use reasonable best efforts to make appropriate substitute disclosure arrangements under circumstances where the restrictions in this clause (c) apply).  The provisions of this Section 4.03 shall terminate and no longer be of any effect from and after such time as Purchaser no longer beneficially owns Common Stock representing at least five percent of the Common Stock then outstanding.
 
Section 4.04.   Securities Laws; Legends; Transferability.
 
(a) Purchaser acknowledges and agrees that as of the date hereof the Securities issuable pursuant to this Agreement shall not have been or will not be registered under the Securities Act or the securities laws of any state and that they may be sold or otherwise disposed of only in one or more transactions registered under the Securities Act and, where applicable, such laws or as to which an exemption from the registration requirements of the Securities Act and, where applicable, such laws is available.  Purchaser acknowledges that, except as provided in the Ancillary Documents, Purchaser has no right to require the Company to register the Securities.  Purchaser further acknowledges and agrees that each certificate for the Purchased Common Stock shall bear a legend substantially as set forth in paragraph (b) of this Section 4.04, and each Springing Lien Note shall bear a legend substantially as set forth in the Springing Lien Notes Indenture.
 
(b) Certificates for the Purchased Common Stock shall bear legends in substantially the following form:
 
The securities represented by this Certificate have not
been registered under the Securities Act of 1933, as amended,
and may not be transferred, sold or otherwise disposed of
except while such a registration is in effect under such act and
applicable state securities laws or pursuant to an exemption
from registration under such act or such laws.
 
(c) When issued pursuant hereto, the certificates evidencing the Securities shall also bear any legend required by any applicable state blue sky law.
 
-26-

 
(d) Any holder of the Purchased Common Stock may request the Company to remove any or all of the legends described in this Section 4.04 from the certificates evidencing such Purchased Common Stock by submitting to the Company such certificates, together with an opinion of counsel reasonably satisfactory to the Company to the effect that such legend or legends are no longer required under the Securities Act or applicable state laws, as the case may be.  Any holder of Springing Lien Notes may request the Company to remove legends on the Springing Lien Notes in accordance with the Springing Lien Notes Indenture.
 
(e) Prior to the date six months after the Initial Closing Date, Purchaser will not, without the Company’s prior consent, Transfer any shares of Purchased Common Stock, except for Permitted Transfers to Persons who agree with the Company (other than in the case of Transfers contemplated by clause (iii) of the definition of “Permitted Transfers”) in writing to be bound by the provisions of this Section 4.04(e) and Section 4.04(f) to the same extent as Purchaser.  For the avoidance of doubt, the provisions of this Section 4.04(e) are waivable by the Company in its sole discretion.
 
(f) Notwithstanding anything in this Agreement to the contrary and except for Transfers pursuant to the exercise of rights under the Registration Rights Agreement, in connection with a Change of Control transaction or pursuant to Rule 144 under the Securities Act, Purchaser may not Transfer in excess of  five percent (5%) of the shares of Purchased Common Stock issuable hereunder to any Competitor in a single transaction or series of related transactions without the prior consent of the Company.
 
Section 4.05. Lost, Stolen, Destroyed or Mutilated Securities.  Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of any certificate for any security of the Company and, in the case of loss, theft or destruction, upon delivery of an undertaking by the holder thereof to indemnify the Company (and, if requested by the Company, the delivery of an indemnity bond sufficient in the judgment of the Company to protect the Company from any loss it may suffer if a certificate is replaced), or, in the case of mutilation, upon surrender and cancellation thereof, the Company will issue a new certificate for an equivalent number of shares or another security of like tenor, as the case may be.
 
Section 4.06.   Regulatory Matters.
 
(a) Purchaser and the Company shall use reasonable best efforts to promptly prepare and file all necessary documentation, to effect all applications, notices, petitions and filings (including, without limitation, under the HSR Act, which filing shall be made by Purchaser and the Company within four (4) Business Days following the date of this Agreement), and to obtain as promptly as practicable all permits, consents, approvals and authorizations of all third parties and Governmental Entities, and take all other actions, which are necessary or advisable to consummate the Transactions.  Purchaser and the Company shall, within four (4) Business Days of the date hereof, prepare and deliver to the OTS a rebuttal of control submission in respect of the Transactions that are proposed to be consummated at the Final Closing and seek acceptance and approval of such rebuttal of control submission by the OTS with respect to such Transactions to the effect that Purchaser will not be deemed to control the Company or any of its Subsidiaries for purposes of the CIBC Act or the S&LHC Act as a result of the consummation of the Transactions and shall use reasonable best efforts (including
 
-27-

 
using good faith efforts to respond to all requests for additional information from the OTS as promptly as practicable following each such request) to obtain such acceptance and approval (including, subject to Section 4.06(d), the Purchaser entering into a rebuttal of control agreement with the OTS materially in conformance with the form contained in 12 CFR §574.100 and (subject to Section 4.06(d)) agreeing to such other conditions as required by the OTS to obtain such acceptance and approval and the Company using the proceeds of the Transactions in a manner directed by the OTS).  The Company and Purchaser shall have the right to consult the other, in each case subject to applicable laws relating to the exchange of information, with respect to any filing made with, or written materials submitted to, any third party or any Governmental Entity in connection with the Transactions.  In exercising the foregoing right, each of the parties hereto shall act reasonably and as promptly as practicable.  The parties hereto agree that they will consult with each other with respect to the obtaining of all permits, consents, approvals and authorizations of all third parties and Governmental Entities necessary or advisable to consummate the Transactions and each party will keep the other appraised of the status of matters relating to completion of the Transactions.  Without limiting the generality of the foregoing and subject to applicable law and except as prohibited by the OTS, each of the Purchaser and the Company shall keep the other apprised of the status of matters relating to completion of the Transactions, including promptly furnishing the other with copies of notices or other written communications, and the substance of any material oral communications, between the Purchaser and the Company, as the case may be, or any of their respective Subsidiaries or Affiliates, and the OTS with respect to the Transactions and the rebuttal of control submission referred to in this Section 4.06(a).
 
(b) Purchaser and the Company shall, upon request, furnish each other with all information concerning themselves, their Subsidiaries, directors, officers and stockholders and such other matters as may be reasonably necessary or advisable in connection with any statement, filing, notice or application made by or on behalf of Purchaser, the Company or any of their respective Subsidiaries to any Governmental Entity in connection with the Transactions.
 
(c) Purchaser and the Company shall promptly furnish the other with copies of written communications received by them or their Subsidiaries from, or delivered by any of the foregoing to, any Governmental Entity in respect of the Transactions (other than in respect of information filed or otherwise submitted confidentially to any such Governmental Entity).
 
(d) Notwithstanding anything in this Agreement, including, without limitation, the provisions of Section 4.06(a), in no event will Purchaser or its Affiliates be obligated to:
 
(i)           without limiting Purchaser’s obligation under clause (ii) below, propose or accept any divestiture of any of Purchaser’s or any of its Affiliate’s assets, accept any operational restriction on Purchaser’s or any of its Affiliate’s business, or agree to take any action that limits Purchaser’s or its Affiliate’s commercial practices in any way to obtain any consent, acceptance or approval of any Governmental Entity to consummate the Transactions; or
 
(ii)           propose or agree to accept any term or condition or otherwise modify the terms of this Agreement or the Ancillary Documents, including for the avoidance of doubt the terms or the amount of the Securities to be delivered by the Company under this Agreement, to obtain any consent, acceptance or approval of any Governmental Entity to the
 
-28-

 
consummation of the Transactions if such term, condition or modification would (A) materially adversely affect (with respect to Purchaser or its Affiliates) any term of the Transactions (other than a financial term), or (B) adversely affect (with respect to Purchaser or its Affiliates) any financial term of the Transactions contemplated hereby.
 
(iii)    Any of the foregoing contemplated by clauses (i) and (ii) above shall be a “Burdensome Condition”.
 
(iv)    With regard to any Governmental Entity, neither the Company nor any Company Subsidiary (or any of their respective Affiliates) shall, without Purchaser’s prior written consent, discuss or commit to any Burdensome Condition.
 
Section 4.07.  Board of Directors.
 
(a) Effective as of the date the Company issues (or is obligated to issue) to Purchaser the shares of Purchased Common Stock contemplated by Section 2.01(b)(i)(A)  (whether in connection with the consummation of Final Closing or, absent the consummation of the Final Closing, in accordance with Section 2.01(b)(iii) after satisfaction of the conditions contemplated thereby), the Board of Directors of the Company shall appoint to the Board one  nominee of Purchaser to serve as a Class III director on the Board until the Company’s 2009  annual meeting, provided such nominee shall be reasonably acceptable to the nominating committee of the Company’s Board of Directors (which approval shall not be unreasonably withheld).  Beginning with such annual meeting of the Company’s stockholders or at any meeting of the stockholders of the Company at which the Class III directors of the Board of Directors of the Company are to be elected, or whenever such members of the Board of Directors are to be elected by written consent, the Company will include in the slate of directors recommended for election to Class III by the Board of Directors to the stockholders of the Company one member of the Company’s Board of Directors designated by Purchaser, which nominee shall be reasonably acceptable to the nominating committee of the Company’s Board of Directors (which approval shall not be unreasonably withheld), and will use its reasonable best efforts to take all action necessary (including the solicitation of proxies on such person’s behalf) to ensure such person is elected by the stockholders of the Company as a Class III director of the Company’s Board of Directors.
 
(b) In the event of resignation, death, removal or disqualification of a director nominated by Purchaser in accordance with Section 4.07(a) and subsequently elected to the Company's Board of Directors, Purchaser shall promptly designate a replacement director, which nominee shall be reasonably acceptable to the nominating committee of the Company’s Board of Directors (which approval shall not be unreasonably withheld), and the Company will use its reasonable best efforts to take all action necessary (including the solicitation of proxies on such person’s behalf) to ensure such person is elected by the stockholders of the Company to the Company’s Board of Directors at the next meeting of the Company’s stockholders at which Class III directors are elected.   Any director nominated by Purchaser in accordance with Section 4.07(a) may be removed at any time and from time to time, with or without cause (subject to the bylaws of the Company as in effect from time to time and any requirements of law), in Purchaser’s sole discretion.
 
-29-

 
(c) At such time as Purchaser shall no longer own shares of Common Stock representing at least five percent of the Common Stock then outstanding, this Section 4.07 shall terminate and be of no further force or effect.
 
Section 4.08.   Confidentiality Agreement; Publicity.
 
(a) Effective on the Initial Closing Date, the Purchaser and its Affiliates will be released from their obligations under paragraph 11 of the Confidentiality Agreement and the Confidentiality Agreement will otherwise continue to remain in full force and effect.
 
(b) Notwithstanding anything to the contrary in the Confidentiality Agreement, Purchaser may disclose Proprietary Information (as defined in the Confidentiality Agreement) to prospective debt and equity financing sources for the Transactions contemplated hereby, provided that any such disclosure shall not relieve Purchaser of its obligations with respect to the continued confidentiality of such information pursuant to the Confidentiality Agreement.
 
Section 4.09.   PORTAL and CUSIPs and DTC Eligibility.  The Company will use its reasonable best efforts to (a) permit the Springing Lien Notes issued pursuant to this Agreement to be designated PORTAL securities in accordance with the rules and regulations adopted by the NASD relating to the PORTAL Market as of the Closing or as promptly as practicable thereafter, (b) obtain all necessary Committee on Uniform Securities Identification Procedures numbers (CUSIP numbers) for the Springing Lien Notes issued pursuant to this Agreement required for creating a market in the Springing Lien Notes traded pursuant to Rule 144A under the Securities Act or which are not “restricted securities” for purposes of Rule 144 under the Securities Act and (c) make the Securities issued and sold in accordance with this Agreement eligible for clearance and settlement through the facilities of the Depository Trust Company.
 
Section 4.10.   NASDAQ.   The Company shall use its reasonable best efforts to obtain approval from the NASDAQ for the listing on the NASDAQ of the Purchased Common Stock issued at the Initial Closing and issuable after such date pursuant to the terms and conditions hereof as soon as practicable after the Initial Closing Date, subject to notice of issuance only with respect to shares of Purchased Common Stock issuable after the Initial Closing Date.
 
Section 4.11.   Replacement of Revolving Credit Facility.   The Company shall use its commercially reasonable efforts to obtain, and enter into customary agreements on terms  reasonably satisfactory to Purchaser in its capacity as a holder of Springing Lien Notes with respect to, a replacement for and access to a secured revolving credit facility of up to $300,000,000.
 
Section 4.12.   10-K Filing.   The Company shall, as soon as reasonably practicable but in any event within the period prescribed therefor under the rules and regulations of the SEC, file with the SEC its annual report on Form 10-K (or such successor form prescribed by the SEC) for the year ended December 31, 2007, which filing shall include, for the avoidance of doubt, all material non-public information which the Company has provided to Purchaser in connection with its consideration of this Agreement and the Transactions (to the extent it remains material non-public information at such time).
 
Section 4.13.   Purchaser Acquisition of Additional Common Stock.   From the Initial
 
-30-

 
Closing Date until the earlier of: (a) the date the condition contemplated by Section 5.03(d) has been satisfied, and (b) the date the obligation to consummate the purchase and sale of the Springing Lien Notes at the Final Closing is terminated in accordance with Section 6.04, Purchaser shall not and shall cause its Affiliates not to, purchase any shares of Common Stock in addition to the shares of Common Stock owned as of the date hereof and set forth in Purchaser Schedule 3.02(i), except for the shares of Purchased Common Stock issuable pursuant to this Agreement.
 
Section 4.14.   Use of Proceeds.  Upon receipt of any proceeds from the sales of Securities contemplated by this Agreement, the Company shall immediately contribute the  amount of such cash proceeds contemplated to be contributed by Article II to its intermediate Subsidiary holding company that owns E*Trade Bank, and cause such intermediate Subsidiary holding company to immediately contribute the full amount of such proceeds to E*Trade Bank.
 
Section 4.15.   Investment Policy Covenant.   Notwithstanding anything herein or anywhere else in this Agreement to the contrary, during the period beginning on the Initial Closing Date and ending January 1, 2010 (or such earlier date as the Springing Lien Notes are no longer outstanding), without the prior written consent of Purchaser, the Company will not permit E*Trade Bank to, and shall cause E*Trade Bank not to, purchase for its own account:
 
(a) asset-backed securities, collateralized debt obligations, collateralized loan obligations and similar instruments, including any derivative products based on any of the foregoing,
 
(b) preferred securities and common stock of any Person other than (x) the common stock of the Company or any of its Subsidiaries otherwise permitted to be issued hereunder or (y) the Capital Stock of Federal Home Loan Banks,
 
(c) indebtedness that is, at the time of such purchase, (x) rated lower than “A-” from S&P and “A3” from Moody’s (in each case, with stable outlook) or (y) issued by corporations incorporated in any jurisdiction other than a state of the United States of America or the District of Columbia,
 
(d) (w) any second lien mortgage loan, (x) any mortgage loan with a combined loan to value ratio of greater than 80%, (y) any mortgage loan borrowed by a Person with a FICO score of less than 700 at the time of origination or (z) any mortgage loan that is not a “full documentation loan,” or
 
(e) any home equity lines of credit;
 
provided that:
 
(1)           notwithstanding the foregoing clauses (a) through (e), (1) any purchase or agreement to purchase entered into prior to the date hereof shall be permitted, (2) any purchase of securities issued by Federal National Mortgage Association or Freddie Mac shall be permitted, and (3) none of the restrictions in the foregoing clauses (i) through (v) shall apply during any fiscal quarter of E*Trade Bank immediately following the quarter in which its
 
-31-

 
regulatory capital exceeds the amount of regulatory capital required for it to be Well Capitalized by $500 million;
 
(2)           “purchase for its own account” shall mean purchases of assets subject to E*TRADE Bank’s investment policy and included in an “investment portfolio” (as defined in FASB 115); and
 
(3)           for purposes of clauses (iv) and (v) above, the term “purchase for its own account” shall mean purchases in the secondary market and shall not include purchases of such mortgage loans or equity lines of credit originated by any Affiliate of the Company.
 
Section 4.16.    Put Rights.
 
(a)   If the condition set forth in Section 5.03(d) has not been satisfied prior to January 15, 2008, then Purchaser, upon not less than 15 nor more than 30 days’ prior written notice to the Company and the Trustee (as defined in the Springing Lien Notes Indenture), may require the Company to redeem all, but not less than all, of the Proportionate Percentage as of December 1, 2009 of Springing Lien Notes held by the Purchaser or its Affiliates on December 1, 2009 at a redemption price in cash equal to (i) 115.00% of the principal amount of such Springing Lien Notes plus (ii) accrued and unpaid interest thereon through December 1, 2009.  Upon consummation of such redemption, the Company shall have no further obligation under this Agreement with respect to the shares of Purchased Common Stock that remain unissued as of such date.
 
(b)   This section shall expire and have no further effect if at any time prior to December 1, 2009 the condition set forth in Section 5.03(d) is satisfied and the Purchaser has been issued all of the Purchased Common Stock to be issued by the Company under this Agreement.
 
(c)   “Proportionate Percentage” shall mean, as of any date, the product of (i) $1,750,000,000 less the aggregate principal amount of Springing Lien Notes not held by Purchaser or its Affiliates, multiplied by (ii) a fraction (A) the numerator of which is the Undelivered Common Stock as of such date and (B) the denominator of which is the total number of shares of Purchased Common Stock to be issued under this Agreement.
 
(d)   For the avoidance of doubt, the rights under this Section 4.16 may not be transferred by Purchaser to any subsequent holder of the Springing Lien Notes.
 
Section 4.17.   Call Rights.
 
(a)  If the condition set forth in Section 5.03(d) has not been satisfied prior to May 29, 2008, then at any time following such date, the Company may redeem from Purchaser and its Affiliates all but not less than all of the Proportionate Percentage of Springing Lien Notes held by Purchaser and its Affiliates, upon not less than 15 nor more than 30 days’ prior written notice, at a redemption price in cash equal to (i) 101% of the principal amount of the Springing Lien Notes  redeemed plus (ii) the Call Premium as of, and accrued and unpaid interest if any to, the date of redemption (the “Redemption Date”).  Upon consummation of such redemption, the
 
-32-

 
Company shall have no further obligation under this Agreement with respect to the shares of Purchased Common Stock that remain unissued as of such date.
 
(b) If a Change of Control Agreement is entered into within 18 months of the Redemption Date, then upon consummation of the transactions contemplated by such Change of Control Agreement the Company will make a further payment to Purchaser equal to (x) (A) the per share payment in respect of a share of Common Stock pursuant to such Change of Control Agreement less (B) the Redemption Date Value multiplied by (y) the Undelivered Common Stock as of the Redemption Date.  The payment pursuant to this Section 4.16(b) shall be disregarded if the application of the formula above would yield a negative number.
 
(c) The “Call Premium” means an amount in dollars equal to (x)the Undelivered Common Stock as of the Redemption Date multiplied by (y) the Redemption Date Value.
 
(d) The “Redemption Date Value” means the average of closing prices of the Common Stock on the NASDAQ over the ten trading day period ending the last day prior to the Redemption Date.
 
Section 4.18.   Change of Control.
 
(a) If, prior to the date that all of the shares of Purchased Common Stock issuable to Purchaser pursuant to this Agreement have been issued to Purchaser, a Change of Control occurs or the Company enters into a Change of Control Agreement, then the Company must pay to Purchaser simultaneously with the consummation of any such transaction that would give rise to such Change of Control an amount in cash (a “Change of Control Payment Amount”) equal to the value that would have been payable upon closing of such Change of Control transaction with respect to the Undelivered Common Stock as of the date of the consummation of such Change of Control transaction, which Change of Control Payment Amount is independent of any amounts that Purchaser or its Affiliates may actually receive as a result of such transaction in consideration of Common Stock or Springing Lien Notes owned by Purchaser or its Affiliates as of such date.  Upon Purchaser’s receipt of such payment, the Company shall have no further obligation under this Agreement with respect to the shares of Purchased Common Stock that remain unissued as of such date.
 
(b) “Undelivered Common Stock” means, as of any date, the number of shares of the Company’s Common Stock equal to the difference between (i) 79,867,087 and (ii) the number of shares of Purchased Common Stock issued as of such date.
 
ARTICLE V
 
Conditions
 
Section 5.01.   Conditions of Purchase at Initial Closing.  The obligations of Purchaser to complete the Initial Closing and pay the Initial Consideration are subject to satisfaction or waiver of each of the following conditions precedent by Purchaser:
 
-33-

 
(a)  Representations and Warranties; Covenants.
 
(i)           The representations and warranties of the Company (i) contained in Section 3.01(e)(i) of this Agreement shall be true and correct in all material respects, (ii) contained in Sections 3.01(g)(iii) and 3.01(u) shall be true and correct in all respects and (iii) contained in any other Section of this Agreement and in the Ancillary Documents shall be true and correct (disregarding all qualifications or limitations set forth in such representations and warranties as to “materiality,” “Material Adverse Effect” and words of similar import), except, in the case of clause (iii), where the failure of such representations and warranties to be so true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, in each case on and as of the date of this Agreement or the date of such Ancillary Documents, as the case may be, and on and as of the Initial Closing Date with the same effect as though made on and as of such respective dates (unless any such representation or warranty is made only as of a specific date, in which event such representation or warranty shall be true and correct only as of such specific date); and
 
(ii)           the Company shall have performed all obligations and complied with all covenants required hereunder to be performed by it at or prior to the Initial Closing.
 
(b) Material Adverse Effect.  Except as disclosed in the Company Disclosure Schedule, there shall not have occurred, since the date hereof, any event, circumstance, change or effect that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.
 
(c) Company Certificate.  The Company shall have delivered to Purchaser a certificate, dated the Initial Closing Date, signed by an executive officer of the Company, to the effect that the conditions set forth in Section 5.01(a) and Section 5.01(b) have been satisfied to the best knowledge of the officer executing the same.
 
(d) No Adverse Law, Action or Decision or Injunction.  There shall not be in effect any law, rule or regulation or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits consummation of the Transactions.
 
(e) Regulatory Approvals.
 
(i)           All material permits, consents, authorizations, orders and approvals of, and filings and registrations required under any federal, state or foreign law, rule or regulation for or in connection with the execution and delivery of this Agreement and the Ancillary Documents and the consummation by the parties hereto of the Transactions to take place on the Initial Closing Date contemplated on such parties’ part hereby and thereby shall have been obtained or made, including without limitation, any required foreign competition approvals and all statutory waiting periods thereunder in respect thereof shall have expired.
 
(ii)           The OTS shall have approved or not objected to the notice filed by the Company pursuant to 12 CFR 563.22(c) with respect to the sale of the ABS Assets.
 
(f) Closing Deliveries.  Purchaser shall have received the items to be delivered by the Company pursuant to Section 2.01(a)(ii).
 
-34-

 
(g) ABS Assets.  The purchase of the ABS Assets pursuant to the ABS Purchase Agreement shall be completed immediately after the contribution contemplated by Section 2.01(a)(ii)(D) and Section 4.14 and as part of the Initial Closing.
 
(h) Regulatory Enforcement.  Except as disclosed in the Company Disclosure Schedule, as of the date hereof, neither the OTS nor any other Governmental Entity has (i) initiated an administrative or enforcement investigation or proceeding, or has taken any remedial action, including the imposition of a cease and desist order, against the Company or any of its subsidiaries, directors, officers or employees or (ii) changed the status of any investigation, including without limitation the SEC informal inquiry initiated on October 17, 2007.
 
(i) Legal Opinion.  The Purchaser shall have received, dated the Initial Closing Date and addressed to the Purchaser, an opinion of Davis Polk & Wardwell, outside counsel to the Company, in the form attached hereto as Schedule 5.01(i).
 
(j) Revolving Credit Facility.  The Company’s revolving credit facility shall have been terminated effective prior to the Initial Closing.
 
(k) Simultaneous Closing.  Except for the purchase of the ABS Assets, all transactions to be completed on the Initial Closing Date pursuant to Section 2.01(a) shall be completed simultaneously with the Initial Closing.
 
Section 5.02.   Conditions of Sale at Initial Closing.  The obligation of the Company to issue and sell the Securities and sell the ABS Assets at the Initial Closing as contemplated by Section 2.01(a)(i) is subject to satisfaction or waiver of each of the following conditions precedent:
 
(a) Representations and Warranties; Covenants.  The representations and warranties of Purchaser contained in this Agreement shall be true and correct in all material respects on and as of the date of this Agreement and on and as of the Initial Closing Date with the same effect as though made on and as of such dates (unless any such representation or warranty is made only as of a specific date, in which event such representation or warranty shall be true and correct in all material respects only as of such specific date), and Purchaser shall have performed all obligations and complied with all covenants required hereunder to be performed by it at or prior to the Initial Closing.
 
(b) Purchaser’s Certificate.  An executive officer of Purchaser shall have delivered to the Company a certificate, dated the Initial Closing Date, to the effect that the condition set forth in Section 5.02(a) has been satisfied to the best knowledge of the officer executing the certificate.
 
(c) No Adverse Action or Decision or Injunction.  There shall not be in effect any law, rule or regulation or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits consummation of the Transactions.
 
(d) Closing Deliveries.  The Company shall have received the items to be delivered by Purchaser pursuant to Section 2.01(a)(ii).
 
-35-

 
(e) Purchase of ABS Assets.  The purchase of the ABS Assets pursuant to the ABS Purchase Agreement shall be completed immediately after the contribution contemplated by Section 2.01(a)(ii)(D) and Section 4.14 and as part of the Initial Closing.
 
Section 5.03.   Conditions of Purchase at Final Closing.  The obligations of Purchaser to complete the Final Closing and to pay the Final Cash Consideration at the Final Closing are subject to satisfaction or waiver (to the extent permitted by applicable law) of each of the following conditions precedent by Purchaser:
 
(a) No Adverse Law, Action or Decision or Injunction.  There shall not be in effect any law or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits consummation of the Transactions to be consummated at the Final Closing Date.
 
(b) Antitrust Approvals.  Any applicable waiting period under the HSR Act relating to the issuance of the Purchased Common Stock issued after the Initial Closing Date shall have expired or been terminated.
 
(c) Final Closing Deliveries.  Purchaser shall have received the items to be delivered by the Company pursuant to Section 2.01(b)(ii).
 
(d) OTS Approval.  The OTS shall have accepted a rebuttal of control submission for the proposed Transactions without, unless approved by Purchaser in its sole discretion,  imposition of any Burdensome Condition.
 
(e) Legal Opinion.  The Purchaser shall have received, dated the Final Closing Date and addressed to the Purchaser, an opinion of Davis Polk & Wardwell, outside counsel to the Company, in the form attached hereto as Schedule 5.03(e).
 
Section 5.04.   Conditions of Sale at Final Closing.  The obligation of the Company to issue the shares of Purchased Common Stock listed in Section 2.01(b)(i) (subject to the provisions of Section 2.01(b)(iii)), and the Springing Lien Notes to be issued at the Final Closing is subject to satisfaction or waiver (to the extent permitted by applicable law) of each of the following conditions precedent:
 
(a)  No Adverse Action or Decision or Injunction.  There shall not be in effect any law or any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits consummation of the Transactions to be consummated at the Final Closing.
 
(b) Antitrust Approvals.  Any applicable waiting period under the HSR Act relating to the issuance of the Purchased Common Stock issued after the Initial Closing Date shall have expired or been terminated.
 
(c) Closing Deliveries.  The Company shall have received the items to be delivered by Purchaser pursuant to Section 2.01(b).
 
-36-

 
ARTICLE VI
 
Miscellaneous
 
Section 6.01.   Survival of Representations and Warranties.  All covenants and agreements shall survive the Initial Closing Date and the Final Closing Date until expired in accordance with their terms.   Except for the representations and warranties contained in (i) Section 3.01(a), Section 3.01(b), Section 3.01(c)(i), Section 3.01(e)(i), Section 3.01(v) and Section 3.01(x) and (ii) Section 3.02(a), Section 3.02(b) and Section 3.02(e), which shall survive the Initial Closing and Final Closing until the latest date permitted by law, the representations and warranties made herein or in any Ancillary Documents or in any certificates delivered in connection with the Initial Closing or the Final Closing, as applicable, shall survive the Final Closing for a period of two years and shall then expire.
 
Section 6.02.   Notices.  All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given, if delivered personally, by telecopier or sent by overnight courier as follows:
 
 
(a) If to the Company, to:
   
 
E*TRADE Financial Corporation
671 N. Glebe Road
Arlington, VA 22203
Attention:  Arlen W. Gelbard, Esq.
                  Chief Administrative Officer & General Counsel
Fax:  (703) 236-7223
 
with a copy (which shall not constitute notice) to:
 
Davis Polk & Wardwell
450 Lexington Avenue
New York, NY 10017
Attention:  Daniel G. Kelly, Jr.
                  John D. Amorosi
Fax:  (212) 450-3800
 
(b) If to Purchaser:
 
Wingate Capital Ltd.
c/o Citadel Limited Partnership
131 South Dearborn Street
Chicago, IL 60603
Attention:  Adam Cooper, Esq.
Fax:  (312) 267-7444
 
with a copy (which shall not constitute notice) to:
 
-37-

 
 
Fried, Frank, Harris, Shriver & Jacobson LLP
One New York Plaza
New York, NY 10004
Attention:    Robert C. Schwenkel
       Thomas P. Vartanian
Fax: (212) 859-4000
 
or to such other address or addresses as shall be designated in writing.  All notices shall be effective when received.
 
Section 6.03.    Entire Agreement; Third Party Beneficiaries; Amendment.  This Agreement, the Confidentiality Agreement and the Ancillary Documents and the documents described herein and therein or attached or delivered pursuant hereto or thereto set forth the entire agreement between the parties hereto with respect to the Transactions, and, other than as set forth in Section 4.04(d) and Section 6.09, are not intended to and shall not confer upon any person other than the parties hereto any rights or remedies hereunder.  Any provision of this Agreement may be amended or modified in whole or in part at any time by an agreement in writing between the parties hereto executed in the same manner as this Agreement.  No failure on the part of any party to exercise, and no delay in exercising, any right shall operate as a waiver thereof nor shall any single or partial exercise by any party of any right preclude any other or future exercise thereof or the exercise of any other right.  No investigation by any Purchaser of the Company prior to or after the date hereof shall stop or limit Purchaser from exercising any right hereunder or be deemed to be a waiver of any such right.
 
Section 6.04.   Termination of Final Closing Obligation.  If the purchase and sale of the Springing Lien Notes contemplated to occur at the Final Closing shall not have occurred on or prior to September 30, 2008, then the obligations of the parties to consummate such purchase and sale shall automatically terminate at such date.
 
Section 6.05.   Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed to constitute an original, but all of which together shall constitute one and the same documents.
 
Section 6.06.   Governing Law.  This Agreement shall be governed by, and interpreted in accordance with, the laws of the State of New York.
 
 
 
-38-

 
Section 6.07.   Public Announcements.  Subject to each party’s disclosure obligations imposed by law and notwithstanding any provision to the contrary contained in the Confidentiality Agreement, each of the parties hereto will cooperate with each other in the development and distribution of all news releases and other public information disclosures with respect to this Agreement and any of the Transactions, and no party hereto will make any such news release or public disclosure without first consulting with the other party hereto.  In conjunction with the Company’s and Purchaser’s joint public disclosure of this Agreement and the transactions contemplated hereby (which shall occur no later than 24 hours following the execution of this Agreement), the Company will pre-announce fourth quarter 2007 incremental provisions for the Company’s One-to-Four Family (1st Lien) and Home Equity Loan Portfolios (the “Loan Portfolio Announcement”).
 
Section 6.08.   Expenses.  Upon the occurrence of the Initial Closing, and from time to time afterward in connection with the Transactions contemplated hereby and as requested by the Purchaser, the Company will reimburse the Purchaser for all reasonable, documented, out-of-pocket expenses (including fees and expenses of legal counsel and accounting consultants) incurred by Purchaser in connection with the transactions contemplated by this Agreement and the Ancillary Documents (including Purchaser’s due diligence review of the Company and the negotiation of all definitive documentation entered into in connection with the transactions contemplated by this Agreement) up to a maximum reimbursement of $8,000,000.  If the Initial Closing shall not occur, each party shall bear its own costs and expenses.
 
Section 6.09.   Indemnification.
 
(a) The Company agrees to indemnify and hold harmless Purchaser, each Affiliate of Purchaser and each officer, director, employee, partner, member, shareholder and agent of the Purchaser and their Affiliates in their respective capacities as such (the “Purchaser Indemnitees”), to the fullest extent lawful, from and against any and all actions, suits, claims, proceedings, damages, losses, deficiencies, liabilities, penalties, fines, interest, costs, judgments, amounts paid in settlement (subject to the penultimate sentence of Section 6.09(g) below) and expenses (including, without limitation, the cost and expenses of any litigations, actions, judgments and settlements related thereto, and the reasonable costs and expenses of attorneys and accountants incurred in the investigation or defense thereof or the enforcement of rights hereunder) (collectively, “Loss”) arising out of or resulting from (i) subject to the provisions set forth in Section 6.09(c) and Section 6.09(d), any inaccuracy in or breach of the representations or warranties made by the Company in this Agreement or any Ancillary Document, (ii) any breach of or failure to comply with the covenants and agreements of the Company or any of its Subsidiaries under this Agreement or any Ancillary Document; or (iii) any action, claim, suit, proceeding or investigation by any Governmental Entity, stockholder of the Company or any other Person (other than the Company or any Purchaser Indemnitee) against or involving a Purchaser Indemnitee relating to the execution and delivery of this Agreement and the Ancillary Documents or the performance by the parties of their obligations hereunder and thereunder or the consummation of the Transactions contemplated hereby and thereby, except, with respect to this clause (iii), to the extent it is determined pursuant to a final, non-appealable order of a court with competent jurisdiction that the Purchaser Indemnitees’ liability is based on acts of the Purchaser Indemnitee constituting fraud, gross negligence, willful misconduct or violations of applicable law.
 
-39-

 
(b) Purchaser agrees to indemnify and hold harmless the Company, its Affiliates and each of their respective officers, directors, employees and agents in their respective capacities as such (the “Company Indemnitees”), to the fullest extent lawful (i) subject to the provisions set forth in Section 6.09(e), from and against any and all Losses arising out of or resulting from any inaccuracy in or breach of the representations or warranties made by Purchaser in this Agreement or any Ancillary Document, and (ii) any breach of or failure to comply with the covenants and agreements of Purchaser under this Agreement or any Ancillary Document.
 
(c) For purposes of the indemnity contained in Section 6.09(a)(i), the Material Adverse Effect and other materiality (or correlative meaning) qualifications included in the representations and warranties contained herein shall have no effect on any provisions in this Section 6.09 concerning the indemnities of the Company or Purchaser with respect to such representations and warranties, each of which representations and warranties shall be read as though there were no Material Adverse Effect or other materiality qualification for purposes of such indemnities.
 
(d) Notwithstanding anything to the contrary set forth in this Agreement, except in the case of fraud, the Purchaser Indemnitees shall not make a claim against the Company for indemnification under Section 6.09(a)(i) (not including indemnification for breaches of the representations and warranties made by the Company in Section 3.01)(e)) for Purchaser Losses unless and until the aggregate amount of Purchaser Losses under Section 6.09(a)(i) (not including indemnification for breaches of the representations and warranties made by the Company in Section 3.01(e)) exceeds $100,000,000 (the “Deductible”) and then the Purchaser Indemnitees shall be entitled to indemnification for all Losses in excess of the Deductible. The aggregate amount of Purchaser Losses for which the Company is obligated to indemnify Purchaser in respect of claims under Section 6.09(a)(i) shall not exceed $1,500,000,000 (the “Cap”) (it being acknowledged and agreed that Purchaser shall be responsible for only a pro rata share of the Deductible and shall be subject to a pro rata share of the Cap calculated based on the aggregate amount of Springing Lien Notes issuable to Purchaser under this Agreement in proportion to the Springing Lien Notes issued to Persons other than Purchaser).
 
(e) Notwithstanding anything to the contrary set forth in this Agreement, except in the case of fraud, the Company Indemnitees shall not make a claim against Purchaser for indemnification under Section 6.09(b)(i) for Company Losses unless and until the aggregate amount of Company Losses under Section 6.09(b)(i) exceeds the Deductible and then the Company Indemnitees shall be entitled to indemnification for all Losses in excess of the Deductible.  The aggregate amount of Company Losses for which Purchaser is obligated to indemnify the Company in respect of claims under Section 6.09(b)(i) shall not exceed $1,500,000,000.
 
(f) A party obligated to provide indemnification under this Section 6.09 (an “Indemnifying Party”) shall reimburse the indemnified parties of the other party (the “Indemnified Parties”) for all reasonable out-of-pocket expenses (including attorneys’ fees and disbursements) as they are incurred in connection with investigating, preparing to defend or defending any such action, suit, claim or proceeding (including any inquiry or investigation) whether or not an Indemnified Party is a party thereto.  If an Indemnified Party makes a claim
 
-40-

 
under this Section 6.09 for payment or reimbursement of expenses, such expenses shall be paid or reimbursed promptly upon receipt of appropriate documentation relating thereto even if the Indemnifying Party reserves the right to dispute whether this Agreement requires the payment or reimbursement of such expenses.
 
(g) An Indemnified Party shall give written notice to the Indemnifying Party of any claim with respect to which it seeks indemnification promptly after the discovery by such party of any matters giving rise to a claim for indemnification; provided that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 6.09 unless and to the extent that the Indemnifying Party shall have been materially prejudiced by the failure of such Indemnified Party to so notify such party.  In case any such action, suit, claim or proceeding is brought against an Indemnified Party, the Indemnified Party shall be entitled to hire, at its own expense, separate counsel and participate in the defense thereof unless there are conflicts that make it reasonably necessary for separate counsel to represent the Indemnifying Party and the Indemnified Party, in which case the Indemnifying Party shall pay such expenses; provided, however, that the Indemnifying Party shall be entitled to assume and conduct the defense, unless the Indemnifying Party determines otherwise and following such determination the Indemnified Party assumes responsibility for conducting the defense (in which case the Indemnifying Party shall be liable for any legal or other expenses reasonably incurred by the Indemnified Party in connection with assuming and conducting the defense).  No Indemnifying Party shall be liable for any settlement of any action, suit, claim or proceeding effected without its written consent; provided, however, the Indemnifying Party shall not unreasonably withhold, delay or condition its consent.  The Indemnifying Party further agrees that it will not, without the Indemnified Party’s prior written consent, settle or compromise any claim or consent to entry of any judgment in respect thereof in any pending or threatened action, suit, claim or proceeding in respect of which indemnification may be sought hereunder (whether or not any Indemnified Party is an actual or potential party to such action, suit, claim or proceeding) unless such settlement or compromise includes an unconditional release of each Indemnified Party from all liability arising out of such action, suit, claim or proceeding.
 
(h) The obligations of the Indemnifying Party under this Section 6.09 shall survive the transfer or redemption of the Securities, the Initial Closing, the Final Closing and termination of this Agreement, any Ancillary Document, and the Transactions.  The agreements contained in this Section 6.09 shall be in addition to any other rights of the Indemnified Party against the Indemnifying Party or others, at common law or otherwise.  The Indemnifying Party consents to personal jurisdiction, service and venue in any court in the continental United States in which any claim subject to this Agreement is brought against any Indemnified Party.
 
(i) The amount the Indemnifying Party shall pay to the Indemnified Party with respect to a claim made pursuant to this Section 6.09 shall be an amount equal to the Loss incurred by the Indemnified Party with respect to such claim, after giving effect to any taxes payable by the Indemnified Party on receipt of any indemnification hereunder with respect to such claim and any tax benefit actually realizable (including deductions) by the Indemnified Party with respect to such claim for tax purposes.
 
-41-

 
(j) In addition to and without limitation of any other indemnities in this Agreement, as a protection to the Purchaser against the existence of issued shares or other securities of the Company not disclosed in Section 3.01(e), in the event that, at any time after the Initial Closing, the representation and warranty set forth in the last sentence of Section 3.01(e)(i) is determined not to have been true as of the Initial Closing, the Company shall issue to the Purchaser, at no cost to the Purchaser, an additional amount of Common Stock such that, if such issuance of additional Common Stock had been made under this Agreement, such representation and warranty would have been true and accurate in all respects at the Initial Closing.
 
(k) Notwithstanding anything to the contrary in this Section 6.09, if and to the extent any Ancillary Document provides for indemnification with respect to matters for which indemnity is provided by Section 6.09(a) or Section 6.09(b) of this Agreement, the indemnity provisions of such Ancillary Document shall govern and control.
 
Section 6.10.   Successors and Assigns.  Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the Company’s successors and assigns and Purchaser’s successors and assigns, and no other person; provided, that, subject to applicable law, Purchaser may (prior to or following the Initial Closing or prior to the Final Closing) assign all or any portion of its right to be issued Securities under this Agreement to any proposed transferee (who is not a Competitor) in a transfer in compliance with applicable law that (a) makes substantially similar investment representations to the Company as made by the Purchaser in Section 3.02 and acknowledgements made in Section 4.04(a)-(d), and (b) to the extent such transferee receives shares of Purchased Common Stock, as a condition of such Transfer, shall be bound by restrictions substantially similar to the provisions of Section 4.04(e) and Section 4.04(f) (with the Company as a third party beneficiary of such agreement), but no such assignment shall relieve Purchaser of its obligations hereunder; provided, further, that the Company may not assign any of its rights or delegate any of its duties under this Agreement without the prior consent of Purchaser.    In connection with the purchase by any assignee of Springing Lien Notes pursuant to this Section 6.10, the Company shall, to the extent deliverable, deliver to such assignee a certificate of the Chief Financial Officer of the Company, dated the date of such purchase, certifying that such issuance does not violate the terms and conditions of the Company’s outstanding indebtedness.
 
Section 6.11.   Remedies; Waiver.  To the extent permitted by law, all rights and remedies existing under this Agreement or any Ancillary Documents are cumulative to, and are exclusive of, any rights or remedies otherwise available under applicable law.  No failure on the part of any party to exercise, or delay in exercising, any right hereunder shall be deemed a waiver thereof, nor shall any single or partial exercise preclude any further or other exercise of such or any other right.
 
Section 6.12.   Securities Contract; Qualified Financial Contract.  This Agreement is intended to be a “securities contract” within the meaning of section 741 of title 11 of the United States Code.  This Agreement is intended to be a “qualified financial contract” within the meaning of section 1821(e)(8) of title 12 of the United States Code and the Company agrees to maintain this Agreement and the evidence of authority in its official books and records.
 
-42-

 
Section 6.13.   Consent to Jurisdiction; WAIVER OF JURY TRIAL.  Each of the parties hereto (a) consents to submit itself to the personal jurisdiction of any Federal or state court located in the Borough of Manhattan in the City of New York, New York in the event any dispute arises out of this Agreement, any of the Ancillary Documents or the Transactions, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (c) agrees that it will not bring any action relating to this Agreement, any of the Ancillary Documents or the Transactions in any court other than a Federal or state court located in the Borough of Manhattan in the City of New York, New York.  EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
 
Section 6.14.   Severability.  If any provision of this Agreement is determined to be invalid, illegal, or unenforceable, the remaining provisions of this Agreement shall remain in full force and effect; provided that the economic and legal substance of, any of the Transactions is not affected in any manner materially adverse to any party.  In the event of any such determination, the parties agree to negotiate in good faith to modify this Agreement to fulfill as closely as possible the original intent and purpose hereof.  To the extent permitted by law, the parties hereby to the same extent waive any provision of law that renders any provision hereof prohibited or unenforceable in any respect.
 
Section 6.15.   Headings.  The headings of Articles and Sections contained in this Agreement are for reference purposes only and are not part of this Agreement.
 
Section 6.16.   Aggregation.   For purposes of the rights of Purchaser that are contingent on ownership of Common Stock, under Sections 4.02, 4.03 and 4.07, Purchaser’s ownership of Common Stock then outstanding shall be calculated in the aggregate among Purchaser and its controlled Affiliates.
 
Section 6.17.   Specific Performance.  The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in the United States District Court for the Southern District of New York or any New York State court sitting in New York City, in addition to any other remedy to which they are entitled at law or in equity.
 
Section 6.18.   Arm’s Length Transactions.  This Agreement and the Transactions contemplated hereby have been negotiated and entered into by the parties on an arms-length basis, and the Company expressly acknowledges and agrees that neither Purchaser nor any of its Affiliates is, or has acted in any capacity as, an advisor to the Company in connection with this Agreement or the Transactions contemplated hereby.
 
Section 6.19.   No Presumption.  If any claim is made by a party relating to any conflict, omission or ambiguity in this Agreement or any Ancillary Document, no presumption or burden
 
-43-

 
of proof or persuasion shall be implied by virtue of the fact that this Agreement or any Ancillary Document was prepared by or at the request of a particular party or its counsel.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
-44-

 
IN WITNESS WHEREOF, this Agreement has been executed by the parties hereto or by their respective duly authorized officers, all as of the date first above written.
 
 
E*TRADE FINANCIAL CORPORATION
   
   
 
By:          /s/ R. Jarrett Lilien
 
Name:
R. Jarrett Lilien  
 
Title:
President and COO  
   
   
 
WINGATE CAPITAL LTD.
   
   
 
By:           /s/ Adam Cooper
 
Name:
Adam Cooper  
 
Title:
Senior Managing Director and General Counsel  
   

 
[Investment Agreement Signature Page]
 
 
 

EX-10.2 6 dp07754_ex1002.htm
Exhibit 10.2 
 

 
SECURITIES PURCHASE AGREEMENT
 
This Securities Purchase Agreement (this “Purchase Agreement”) is made as of the 29th day of November, 2007, by and among E*TRADE Financial Corporation (the “Company”), Investment Partners (A), LLC (“IP(A)”) and the additional investors listed on Schedule A hereto.  Each of IP(A) and the investors listed on Schedule A hereto is herein referred to as an “Investor”.

Reference is made to (i) the Master Investment and Securities Purchase Agreement dated as of November 29, 2007 by and between Wingate Capital Ltd. (“Wingate”) and the Company (the “Master Investment Agreement”) and (ii) the Registration Rights Agreement dated as of November 29, 2007 by and between Wingate and the Company (the “Registration Rights Agreement”).  Capitalized terms used but not defined herein have the respective meanings given to such terms in the Master Investment Agreement.

In consideration of the promises and of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investors, intending to be legally bound, hereby agree as follows:

1.  
At the Initial Closing (or as promptly as practicable thereafter in the case of stock certificates): (i) the Company will deliver (A) to IP(A) certificates for 2,420,215 shares of Common Stock and executed Springing Lien Notes in the aggregate principal amount of $50,000,000, (B) to each other Investor certificates for the shares of Common Stock in the applicable amount set forth in Schedule A registered in the name of such Investor and executed Springing Lien Notes in the applicable aggregate principal amount set forth in Schedule A registered in the name of such Investor which shall be reflected in one or more global notes representing the Springing Lien Notes and held by The Depository Trust Corporation or its nominee (or a custodian on its behalf) and (C) a commitment fee to IP(A) of $1,428,572, and a commitment fee to the other Investors in the aggregate amount of $1,428,572; and (ii) each Investor, in full payment for such shares of the Purchased Common Stock and such Springing Lien Notes, will deliver the applicable cash consideration for such securities set forth in Schedule A (or in the case of IP(A), $50,000,000) by wire transfer of immediately available funds to the account designated by the Company.  Notwithstanding the foregoing, as mutually agreed between the Company and each Investor, such Investor’s commitment fee may be netted against the applicable cash consideration payable by such Investor (in which case the Investor shall remit to the Company an amount equal to such cash consideration less such commitment fee).
 
2.  
The Company hereby: (i) makes to the Investors the same representations and warranties made by the Company to Wingate in Section 3.01 of the Master Investment Agreement to the same extent as made by the Company to Wingate
 
 

 
 
(and as if each reference to “this Agreement” in such Section were a reference to this Purchase Agreement and each reference to “Ancillary Document” in such Section were a reference to the Registration Rights Agreement and Indenture only); (ii) agrees, for the benefit of the Investors, to the obligations set forth in Sections 4.01, 4.04(d), 4.05, 4.08 (as if each Investor were a “Purchaser” for purposes of such Section), 4.09 and 4.10 (with respect to the Securities issued to the Investors pursuant to this Purchase Agreement), 4.12 and 4.14 of the Master Investment Agreement and (iii) agrees that the Investors shall be treated as “Purchaser Indemnitees” for purposes of the indemnification provisions in Section 6.09 of the Master Investment Agreement with respect to any misrepresentation, breach of warranty or breach of covenant or obligation under this Purchase Agreement by the Company (it being acknowledged and agreed by the Investors, for the avoidance of doubt, that they shall be responsible for their pro rata share of the Deductible and shall be subject to their pro rata share of the cap provided for in Section 6.09(d) of the Master Investment Agreement, calculated based on the aggregate purchase price payable by the Investors for the Springing Lien Notes pursuant to this Purchase Agreement as a proportion of the aggregate purchase price payable by Purchaser for the Springing Lien Notes issuable to Purchaser pursuant to the Master Investment Agreement).
 
3.  
Each of the Investors hereby: (i) makes to the Company the same representations and warranties made by the Purchaser to the Company in Section 3.02 of the Master Investment Agreement (other than Section 3.02(i)) and the same acknowledgements as made by the Purchaser to the Company in Section 4.04(a), (b) and (c) of the Master Investment Agreement, in each case as if each Investor were a “Purchaser” for purposes of such Sections and to the same extent as made by Purchaser to the Company (and as if each reference to “this Agreement” in such Section were a reference to this Purchase Agreement and each reference to “Ancillary Document” in such Section were a reference to the Registration Rights Agreement and Indenture only); (ii) agrees to the obligation set forth in Section 4.01 of the Master Investment Agreement and (iii) agrees to indemnify the Company Indemnitees with respect to any misrepresentation, breach of warranty or breach of covenant or obligation under this Purchase Agreement by any Investor to the same extent as the indemnity provided by the Purchaser to the Company Indemnitees in Section 6.09(b) of the Master Investment Agreement.
 
4.  
Each Investor hereby acknowledges and agrees that, by its execution of this Purchase Agreement, such Investor shall be deemed to be a party to the Registration Rights Agreement as of the date hereof and shall have all of the rights and observe all of the obligations of a “Holder” (as defined in the Registration Rights Agreement) thereunder.

Sections 6.01, 6.02, 6.03, 6.05, 6.06, and Sections 6.10 through 6.19 (other than Section 6.16), of the Master Investment Agreement shall apply to this Purchase Agreement, mutatis mutandis.
 
 

 
IN WITNESS WHEREOF, the parties hereto have executed this Purchase Agreement on the day and year first above written.
 
 
E*TRADE FINANCIAL CORPORATION  
 
 
 
By:
/s/ Robert J. Simmons  
 
Name:
Robert J. Simmons  
 
Title:
Chief Financial Officer  

 


 
INVESTMENT PARTNERS (A), LLC
BY:       BAA CO-INVESTMENT FUND
(GENPAR), LLC, ITS MANAGER
 
BY:     BLACKROCK ALTERNATIVE
ADVISORS GP HOLDINGS, LLC, ITS SOLE
MEMBER
 
BY:     BLACKROCK FINANCIAL
MANAGEMENT, INC., ITS MANAGING
MEMBER
  
By:
/s/ Bryan K. White  
 
Name: 
Bryan K. White  
 
Title:
Managing Director  
       
       
By:
/s/ Marie M. Bender  
 
Name:
Marie M. Bender  
 
Title: 
Managing Director  

 
BLACKROCK FINANCIAL MANAGEMENT, INC.
in its capacity as Sub-Adviser to, agent for and solely
with respect to the assets of each of the entities listed on Schedule A
  
By:
/s/ Mark Williams  
 
Name:
Mark Williams  
 
Title:  
Managing Director  
 
 

 
EX-10.3 7 dp07754_ex1003.htm
 
Exhibit 10.3
 
EXECUTION VERSION
 
 
ABS Purchase Agreement

This Agreement (this “Agreement”), dated as of November 29, 2007, constitutes the understanding and agreement by and among Citadel Equity Fund Ltd. (“CEFL”), an affiliate of Citadel Limited Partnership (“Citadel”), E*TRADE Bank (the “Bank”), E*TRADE Global Asset Management, Inc. (“ETGAM”, and together with the Bank, the “Sellers”), and E*TRADE Financial Corporation (the “Company”) regarding the acquisition by CEFL of all of the Sellers’ Asset-Backed Securities (“ABS”) portfolio (including CMOs, CDOs and other asset-backed instruments) listed on Schedule A hereto (the “Portfolio”, and each line-item of which is a “Position”).
 
1.           Transfer.  In consideration of the Purchase Price (as hereinafter defined) and the premises set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, effective as of the Initial Closing Date (as defined in the Investment and Securities Purchase Agreement, dated as of November 29, 2007 by and between Wingate Capital Ltd. and the Company (the “Investment Agreement”)) (the “Effective Date”), the Sellers hereby sell, transfer, assign and convey to CEFL, free and clear of all liens, claims, encumbrances or rights of third parties of any kind, all right, title and interest in and to the Portfolio and the Positions and CEFL hereby purchases from the Sellers all right, title and interest in and to, and assumes the obligations of the Sellers in respect of, the Portfolio and Positions, in each case on the terms and subject to the conditions set forth herein (the “Transfer”).
 
2.           Purchase Price.  The “Purchase Price” means (a) eight hundred million dollars ($800,000,000), plus (b) any and all interest which, as of the Effective Date, is accrued and unpaid for the Positions (except with respect to those ABS CDOs and TRUPS CDOs listed on Schedule B hereto) with respect to the periods prior to 12:01 a.m. New York City time on November 18, 2007 (the “Accrued Interest Amount”), less (c) any and all principal and interest payments which, as of the Effective Date, have been received directly or indirectly by the Sellers for the Positions with respect to the periods between 12:01 a.m. New York City time on November 18, 2007 and 12:01 a.m. New York City time on the Effective Date (the “Principal and Interest Amount”).
 
3.           Closing.  Upon the terms and subject to the conditions herein (including, but not limited to, the terms of paragraph 8, regarding the Mechanics of the Transfer of Positions and the Movement of Cash), on the Effective Date, CEFL shall pay, or shall cause to be paid to the Sellers: (a) eight hundred million dollars ($800,000,000) plus, (b) the Estimated Accrued Interest Amount.  These payments shall be made as follows:
 
(i) CEFL shall pay, or shall cause to be paid to the Bank, (a) seven hundred ninety million seven hundred twenty-five thousand six dollars and ninety cents ($790,725,006.90) plus, (b) the Estimated Accrued Interest Amount for the “Bank” Positions which is equal to nine million seven hundred sixty-four thousand seven hundred thirty-eight dollars and sixty-seven cents ($9,764,738.67); and
 

 
(ii) CEFL shall pay, or shall cause to be paid to ETGAM, (a) nine million two hundred seventy-four thousand nine hundred ninety-three dollars and ten cents ($9,274,993.10) plus, (b) the Estimated Accrued Interest Amount for the “ETGAM” Positions which is equal to thirty-three thousand seven hundred thirty-four dollars and forty-four cents ($33,734.44).
 
To the extent that the Effective Date Payment is not made completely in connection with the DVP/RVP settlement process set forth in paragraph 8, then any remaining portions of the Effective Date Payment will be made by wire transfer of immediately available funds to the Bank’s and/or ETGAM’s accounts designated below immediately following the completion of such settlement process.
 
In addition to the foregoing payments, on the Effective Date, the Sellers shall pay, or shall cause to be paid to CEFL, the Estimated Principal and Interest Amount by wire transfer of immediately available funds to an account designated below by CEFL.
 
Estimated Accrued Interest Amount” means $9,798,473.11, which is a good faith estimate by CEFL and the Sellers of the Accrued Interest Amount.  “Estimated Principal and Interest Amount” means $18,035,093.85, which is a good faith estimate by CEFL and the Sellers of the Principal and Interest Amount received or likely to be received by the Sellers.  “Effective Date Payment” means eight hundred million dollars ($800,000,000) plus, (x) the Estimated Accrued Interest Amount less (y) the Estimated Principal and Interest Amount.
 
 
4.
Purchase Price Adjustment.
 
(a)           Purchase Price Adjustment Statement.  Within thirty (30) days after the Effective Date, the Sellers shall prepare and deliver to CEFL a statement of the Principal and Interest Amount, which statement shall separately identify “Bank” Positions and “ETGAM” Positions.  Within forty-five (45) days after the Effective Date, CEFL shall prepare and deliver to the Sellers a statement of the Accrued Interest Amount and the Principal and Interest Amount, which statement shall separately identify “Bank” Positions and “ETGAM” Positions (which may include adjustments to the Principal and Interest Amount provided by the Sellers if such adjustments are necessary to correct the information) as of the Effective Date for purposes of calculating the adjustment to the Effective Date Payment (the “Purchase Price Adjustment Statement”).    CEFL shall have reasonable access to any documents, schedules or work papers of the Sellers related to the Principal and Interest Amount.
 
(b)           Review.  The Sellers shall have fifteen (15) days after delivery of the Purchase Price Adjustment Statement to review the Purchase Price Adjustment Statement.  If the Sellers fail to deliver to CEFL a written objection to the Purchase Price Adjustment Statement within such fifteen (15) day period, the Purchase Price Adjustment Statement shall be deemed to be agreed to by the Sellers and will be final and binding upon the parties.  If the Sellers  disagree with the determination of the adjustment to the Effective Date Payment under the Purchase Price Adjustment Statement, the Sellers must notify CEFL in writing of such disagreement within such fifteen (15) day period, which notice shall describe the nature of any such disagreement in reasonable detail, identify the specific items involved and the dollar amount of each such disagreement and provide reasonable supporting documentation for each such disagreement.  
 
2

 
During the fifteen (15) day period of its review, the Sellers shall have reasonable access to any documents, schedules or work papers used in the preparation of the Purchase Price Adjustment Statement.
 
(c)           Dispute Resolution.  The Sellers and CEFL agree to negotiate in good faith to resolve any such disagreement and any resolution agreed to in writing by the Sellers and CEFL shall be final and binding upon the parties.  If the Sellers and CEFL are unable to resolve all disagreements properly identified by the Sellers pursuant to Section 4(c) hereof within twenty (20) days after delivery to CEFL of written notice of such disagreement, then the disputed matters shall be referred for final determination to arbitration.  The Sellers and CEFL shall jointly select an arbiter from an accounting firm of national standing that is not the independent auditor of either the Sellers or CEFL (or their respective affiliates); if the Sellers and CEFL are unable to select such an arbiter within five (5) days after the end of such twenty (20) day period, the American Arbitration Association shall make such selection.  The person so selected shall be referred to herein as the “Arbitrator”.  The Arbitrator shall deliver to the Sellers and CEFL, as promptly as practicable after its appointment and in any event within thirty (30) days after its appointment, a written report setting forth the resolution of any such disagreement determined in accordance with the terms herein.  Such report shall be final and binding upon the Sellers and CEFL.  The fees, expenses and costs of the Arbitrator shall be borne equally by the Sellers and CEFL.
 
(d)           The “Final Accrued Interest Amount” and the “Final Principal and Interest Amount” means the Accrued Interest Amount (with respect to “Bank” Positions and “ETGAM” Positions) and the Principal and Interest Amount (with respect to “Bank” Positions and “ETGAM” Positions) respectively, each as either (a) set forth in the Purchase Price Adjustment Statement (if the Sellers do not object within the fifteen (15) day period), (b) mutually agreed upon by the Sellers and CEFL or (c) finally determined by the Arbitrator.
 
(e)           Purchase Price Adjustment.  In the event that the Estimated Principal and Interest Amount (with respect to “Bank” Positions and/or “ETGAM” Positions, as the case may be) is greater than the Final Principal and Interest Amount (with respect to “Bank” Positions and/or “ETGAM” Positions, as the case may be), CEFL shall pay the applicable Seller an amount equal to the difference between the applicable Estimated Principal and Interest Amount and the applicable Final Principal and Interest Amount in accordance with Section 4 hereof.  In the event that the applicable Final Principal and Interest Amount is greater than the applicable Estimated Principal and Interest Amount, the applicable Seller shall pay CEFL an amount equal to the difference between the applicable Final Principal and Interest Amount and the applicable Estimated Principal and Interest Amount in accordance with Section 4 hereof.  In the event that the applicable Estimated Accrued Interest Amount is greater than the applicable Final Accrued Interest Amount, the applicable Seller shall pay CEFL an amount equal to the difference between the applicable Estimated Accrued Interest Amount and the applicable Final Accrued Interest Amount in accordance with Section 4 hereof.  In the event that the applicable Final Accrued Interest Amount is greater than the applicable Estimated Accrued Interest Amount, CEFL shall pay the applicable Seller an amount equal to the difference between the applicable Final Accrued Interest Amount and the applicable Estimated Accrued Interest Amount in accordance with Section 4 hereof.
 
3

 
(f)           Payment.  Any adjustment to the Effective Date Payment shall be paid by the Sellers or CEFL, as applicable, by wire transfer of immediately available funds to an account designated by the party receiving such payment within five (5) Business Days (as hereinafter defined) after the final determination of the adjustment to the Effective Date Payment. “Business Day” means a day other than a Saturday, a Sunday or any other day on which commercial banks in the State of New York are authorized or obligated to be closed.
 
5.           Post-Closing Principal and Interest Payments.  Any and all principal and interest payments received by the Sellers or its affiliates for the Positions after 12:01 a.m. New York City time on the Effective Date shall be held in trust thereby and shall be paid promptly by the Sellers to CEFL, by wire transfer of immediately available funds to an account designated by CEFL within five (5) Business Days after CEFL receives notice from the Sellers of such principal and interest payments.
 
6.           Portfolio.  The Portfolio consists of the Positions listed by CUSIP, original size, and/or size as of the end of September, 2007, on Schedule A.  Each of the Sellers and the Company represents and warrants (a) that Schedule A accurately reflects the Positions in all respects set forth therein (e.g., the CUSIP, Original Face Amount, September 30 Face Amount, nature of exposure, and the like), (b) that there are no Over-The-Counter (OTC) derivative or forward positions contained within the Portfolio (including, but not limited to, credit default swaps), (c) that no novations or assignments are necessary to vest CEFL with full right, title and interest in the Positions, (d) that there are no short positions contained within the Portfolio, and (e) that the Positions will be delivered to CEFL by the Sellers free and clear of any liens, pledges and other encumbrances.
 
7.           Trade Breaks.  If Citadel identifies any “trade breaks” (such as errors in the instrument, CUSIP,  nature of exposure (such as short rather than long), Original or Current Face Amount, or the like) resulting in differences in the composition of any Position being transferred from the information set forth in Schedule A, the Sellers and the Company shall, at CEFL’s election, (a) take such action as may be necessary to conform such Position to the information set forth in Schedule A, and to place CEFL in the position it would have been in had the Position been as represented (such as by replacing the Position with a conforming Position) or (b) pay CEFL the greater of the difference between the fair market value that the Position would have had if the Position had been as identified in Schedule A and the fair market value as actually received on (i) the Effective Date or (ii) the date on which Citadel notifies the Sellers of the trade break, it being understood that Citadel will begin managing the risk associated with each Position as reflected on Schedule A on behalf of CEFL immediately upon the execution of this Agreement.  Notwithstanding the foregoing, Citadel is not entitled to be put in a better financial position than it would have been in had there been no trade break.
 
In the event that the parties have a dispute regarding any claimed trade break, each party may seek resolution of such dispute in accordance with the terms of the Investment Agreement.
 
8.           Mechanics of the Transfer of Positions and the Movement of Cash.  The Sellers, as promptly as practicable, shall take any and all actions necessary to effect the transfer
 
4

 
of the Positions to CEFL on the terms contemplated hereby (including but not limited to executing any documents and instruments reasonably required by CEFL and providing appropriate instructions, and procuring the consent of third parties) via (a) the DTC for DTC-eligible securities or such other custodian as designated by CEFL; (b) physical delivery to CEFL’s designated custodian for non-DTC-eligible securities, or (c) such other acceptable processes as the parties may agree.  The Company and the Sellers, jointly and severally, will hold CEFL harmless from any costs or losses of the Positions incurred as the result of any inability to transfer such Positions on the terms contemplated hereby. The parties will endeavor to settle the transfer of the Positions via the Delivery-Versus-Payment/Receive-Versus-Payment (DVP/RVP) method.  For these settlement purposes only, the parties will agree to dollar values for each Position so that each Position will move versus cash. The parties will make all commercially reasonable efforts to settle these cash versus Position transfers on the Effective Date, but recognize that it may take more than one business day to complete.
 
9.           Cooperation.  The parties will use their reasonable best efforts to cooperate with each other in effectuating this Agreement, including but not limited to executing any necessary instruments and other documents and providing appropriate instructions.  To the extent not already provided, the Sellers will immediately provide CEFL with copies of the most current back office and other files containing details relating to the Positions and will provide them in such file and other format as requested by CEFL.
 
10.           Certain Information.  The Sellers acknowledge that because it desires to sell, transfer, assign and convey to CEFL all of its Positions in the Portfolio, it is possible that CEFL may have information about one or more of the Positions, issuers or reference entities of Positions that is not publicly available and that may be material (“Excluded Information”).  The Sellers acknowledge and agree that it has not requested that Excluded Information be disclosed to it and that Excluded Information is not being disclosed to it.  The Sellers hereby irrevocably and unconditionally waive any right that it may have to the disclosure of any such Excluded Information in connection with this transaction.  The Sellers further agree that CEFL shall not be obligated to refrain from using any such Excluded Information in connection with this transaction, and that the parties shall not have any liability to each other with respect to any such non-disclosure or use of Excluded Information in connection with this transaction or any related transaction.
 
11.           Representations and Warranties of CEFL.  CEFL represents and warrants that (a) it has the power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby, (b) the execution, delivery and performance by it of this Agreement and the consummation by it of the transactions contemplated hereby have been duly authorized, (c) this Agreement, when delivered in accordance with the terms hereof, assuming the due execution and delivery of this Agreement by the Sellers and the Company, shall have been duly executed and delivered by it and shall be a valid and binding obligation of it, enforceable against it in accordance with its terms, except to the extent that enforceability may be subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and to general equitable principles, and (d) no action, consent or approval of, registration or filing with or any other action by any governmental authority, regulatory authority, self-regulatory authority, exchange or clearing
 
5

 
organization or any other third party will be required to be made, taken or obtained by it for the purchase and assumption by, or transfer to, it of the Portfolio pursuant to this Agreement on the terms contained herein, other than those that have already been properly made, taken or obtained by CEFL.
 
12.           Representations and Warranties of the Sellers and the Company.  Each of the Sellers and the Company represents and warrants that (a) it has the power and authority to execute and deliver this Agreement and, to consummate the transactions contemplated hereby, (b) the execution, delivery and performance by it of this Agreement and the consummation by it of the transactions contemplated hereby have been duly authorized, (c) this Agreement, when delivered in accordance with the terms hereof, assuming the due execution and delivery of this Agreement by CEFL, shall have been duly executed and delivered by it and shall be a valid and binding obligation of it, enforceable against it in accordance with its terms, except to the extent that enforceability may be subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and to general equitable principles, (d) the consummation of the Transfer as provided herein will transfer to CEFL all of the right, title and interest in the Positions and the Portfolio free and clear of any liens, claims, encumbrances or rights of third parties of any kind, (e) the Transfer is being made by the Sellers in compliance with all applicable laws and regulations, and (f) no action, consent or approval of, registration or filing with or any other action by any governmental authority, regulatory authority, self-regulatory authority, exchange or clearing organization or any other third party will be required to be made, taken or obtained by it for the sale, transfer, assignment and conveyance by the Sellers of the Portfolio to CEFL pursuant to this Agreement on the terms contained herein, other than those that have already been properly made, taken or obtained by the Sellers or the Company.
 
13.           No Third Party Beneficiaries.  No person other than the parties hereto shall have any rights with respect to the matters contemplated hereby and there are no third party beneficiaries hereto, except for the Citadel Indemnitees (as hereinafter defined) pursuant to Section 14.
 
14.            Indemnity.  (a) The Sellers and the Company, jointly and severally, shall indemnify and defend each of CEFL, Citadel and each of their respective officers, directors, employees, agents and affiliates (the “Citadel Indemnitees”), to the fullest extent lawful, from and against any and all actions, suits, claims, proceedings, damages, losses, deficiencies, liabilities, penalties, fines, interest, costs, damages, judgments, amounts paid in settlement and expenses (including, without limitation, the cost and expenses of any litigations, actions, judgments and settlements related thereto, and the reasonable costs and expenses of attorneys and accountants incurred in the investigation or defense thereof or the enforcement of rights hereunder) (collectively, “Losses”) arising out of or resulting from (i) any breach of any representation or warranty made by the Sellers or the Company under this Agreement, (ii) any breach by the Sellers or the Company of any covenant, obligation or other agreement contained in this Agreement (including, without limitation, Sections 6 and 12 hereof), or (iii) any third party or governmental claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or otherwise relating to the transactions contemplated by this Agreement (including, but not limited to, any such claim, action, suit,
 
6

 
proceeding or investigation initiated by or on behalf of any investors, clients or customers of the Sellers or the Company). Notwithstanding anything to the contrary set forth in this Agreement, (x) except for fraud, the aggregate amount of Losses for which the Company and Sellers are obligated to indemnify the Citadel Indemnitees in respect of claims under Section 14(a)(i) shall not exceed $800,000,000 and (y) CEFL and Citadel agree, prior to asserting any indemnification claims hereunder against the Bank, to use commercially reasonable efforts to seek satisfaction of such indemnification claim from the Company (it being understood that the use of such reasonably commercial efforts shall not waive any rights of CEFL and Citadel against the Bank or limit any obligations and liabilities of the Bank hereunder).
 
(b) CEFL and Citadel jointly and severally, shall indemnify and defend each of the Sellers, the Company and each of their respective officers, directors, employees, agents and affiliates (the “Company Indemnitees”), to the fullest extent lawful, from and against any and all Losses arising out of or resulting from (i) any breach of any representation or warranty made by CEFL under this Agreement or (ii) any breach by CEFL of any covenant, obligation or other agreement contained in this Agreement.  Notwithstanding anything to the contrary set forth in this Agreement, except for fraud, the aggregate amount of Losses for which CEFL and Citadel are obligated to indemnify the Company Indemnitees in respect of claims under Section 14(b)(i) shall not exceed $800,000,000.
 
15.           Securities Contract.  This Agreement is intended to be a “securities contract” within the meaning of section 741 of title 11 of the United States Code.  It is also intended to be a "qualified financial contract" within the meaning of section 1821(e)(8) of title 12 of the United States Code and the Company agrees to maintain this Agreement and the evidence of authority in its official books and records.
 
16.           Choice of Law.  This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be performed within such State without regard to principles of conflict of laws.
 
17.           Notice.  Except as provided elsewhere herein, notices hereunder shall be sent by express courier, e-mail, or hand delivery to the addresses indicated below:
 
Citadel Equity Fund Ltd.
c/o Citadel Limited Partnership
131 South Dearborn Street
Chicago, Illinois 60603
 
with a copy (which shall not constitute notice) to:

Attention:  Legal Department
E-Mail: CitadelAgreementNotice@Citadelgroup.com

Wire instructions:

Bank of New York
 
7

 
ABA: 021000018
Citadel Equity Fund
Account: 8900472545

DTC:

DTC ID:  0775
a/c:  CEFL


E*TRADE Bank
Attn: Back Office Services, 15th Floor
Ballston Tower
671 North Glebe Rd.
Arlington, VA 22203

E*TRADE Global Asset Management, Inc.
Attn: Back Office Services, 15th Floor
Ballston Tower
671 North Glebe Rd.
Arlington, VA 22203

E*TRADE Financial Corporation
671 N. Glebe Road
Arlington, VA 22203
Attention: 
 Arlen W. Gelbard, Esq.
 Chief Administrative Officer & General Counsel
                  
with a copy (which shall not constitute notice) to:

Davis Polk & Wardwell
450 Lexington Avenue
New York, NY 10017
Attention: 
 Daniel G. Kelly, Jr.
 John D. Amorosi
Fax:  (212) 450-3800

Wire instructions:
 
E*TRADE Bank:
ABA # 256072691 
ETRADE BANK
Acct # 1000303
Acct Name: E*TRADE Bank

E*TRADE Global Asset Management, Inc.:
 
8

 
ABA # 256072691 
ETRADE BANK
Acct # 2000020145
Acct Name: ETGAM

DTC:

E*TRADE Bank:
Agent Bank:  48614
Inst. ID:  48614
DTC Part. #:  2225

MidWest ID:  TBCM
Telebank Sub Account:  TBNK
Mortgage Sub Account: ETMG

E*TRADE Global Asset Management, Inc.:
Agent Bank:  48609
Inst. ID:  48609
DTC Part. #:  2226
 
18.            Consent to Jurisdiction; Waiver of Jury Trial.  Any judicial proceeding brought against any party regarding any dispute arising out of this Agreement or any matter related hereto may be brought in the courts of the State of New York, or in the United States District Court for the Southern District of New York, in each case located in the Borough of Manhattan, and, by execution and delivery of this Agreement, each such party accepts the exclusive jurisdiction of such courts solely for such purpose.  Each party hereto hereby agrees that service of any process, summons, notice or document by U.S. registered mail addressed to CEFL, the Sellers or the Company at the addresses listed above or at such other address as each party may provide to the others from time to time, as applicable, shall be effective service of process for any action, suit or proceeding brought against such addressee in any such court.  Each party hereto hereby irrevocably and unconditionally waives any objection to the laying of venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.  Each party hereto agrees that a final judgment relating to it in any such suit, action or proceeding brought in any such court shall be conclusive and binding upon it and may be enforced in any other courts to whose jurisdiction such party is or may be subject, by suit upon each judgment.  EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF SUCH PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF.
 
19.           Severability.  In the event that any provision or portion of this Agreement is determined to be invalid, illegal or unenforceable for any reason, in whole or in part, the
 
9

 
remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by applicable law.
 
20.           Entire Agreement.  This Agreement (including the Exhibits) and the Investment Agreement, constitutes the entire agreement between the parties hereto relating to the subject matter contained herein, and supersedes and replaces all prior writings, discussions and rights relating hereto and thereto; and no obligation of any kind relating hereto is assumed by or implied against any party hereto except for those obligations expressly stated herein.  This Agreement may only be amended by a written instrument signed by the parties hereto.
 
21.           Survival.  The representations and warranties contained in this Agreement shall survive the conclusion of the Transfer.
 
22.           Counterparts.  This Agreement may be executed in counterparts (including by facsimile or similar means of electronic transmission), and any party hereto may execute any such counterpart, each of which when executed and delivered shall be deemed to be an original and all of which counterparts taken together shall constitute but one and the same instrument.
 
*   *   *   *   *
 
10

 
           IN WITNESS WHEREOF, this Agreement has been executed by the parties hereto or by their respective duly authorized officers, all as of the date first above written.
 
 
 
Citadel Equity Fund Ltd.
         
         
  By:   /s/ Adam Cooper  
   
Name: 
Adam Cooper  
   
Title:
Senior Managing Director and General Counsel  

 
 
E*TRADE Bank
         
         
  By:   /s/ Arlen W. Gelbard  
   
Name: 
Arlen W. Gelbard  
   
Title:
President and COO  

 
 
E*TRADE Global Asset Management, Inc.
         
         
  By:   /s/ Michael Hlushak  
   
Name: 
Michael Hlushak  
   
Title:
President and CEO  
 
 
 
E*TRADE Financial Corporation
         
         
  By:   /s/ R. Jarrett Lilien  
   
Name: 
R. Jarrett Lilien  
   
Title:
President and COO  
 
                              
 
 
EX-99.1 8 dp07754_ex9901.htm
 
Exhibit 99.1
 
FOR IMMEDIATE RELEASE

E*TRADE FINANCIAL Media Relations Contact
Citadel Contact
Pam Erickson
Katie Spring
E*TRADE FINANCIAL Corporation
Citadel Investment Group
617-296-6080
312-395-2596
pam.erickson@etrade.com
katie.spring@citadelgroup.com


E*TRADE FINANCIAL Investor Relations Contact
Adam Townsend
E*TRADE FINANCIAL Corporation
703-236-8719
adam.townsend@etrade.com


E*TRADE FINANCIAL ANNOUNCES $2.5 BILLION INVESTMENT LED BY CITADEL

Affiliates of Citadel Purchase E*TRADE’s Entire ABS Portfolio, Including CDOs

Additional Capital Strengthens Balance Sheet

Transaction Accelerates E*TRADE’s Strategic Focus on Core Retail Business

R. Jarrett Lilien Named Acting CEO, Succeeding Mitchell H. Caplan

Donald H. Layton Named Chairman of the Board


New York, November 29, 2007– E*TRADE FINANCIAL Corporation (NASDAQ: ETFC) today announced an agreement that will result in a cash infusion of $2.5 billion.  The transaction, led by affiliates of Citadel Investment Group, includes immediate funding of approximately $2.4 billion with the remaining $150 million expected to fund by January 15, 2008.  The investment fortifies the Company’s balance sheet, allows the Company to focus on its core retail business and provides additional capital to manage credit risk.

E*TRADE also announced that, effective immediately, R. Jarrett Lilien has been named acting Chief Executive Officer of the Company, succeeding Mitchell H. Caplan, who has stepped down from the position of CEO.  Mr. Caplan will serve as an advisor to the Company on transition matters through the end of the year.  Mr. Lilien, who is also a Director of the Company, has been E*TRADE FINANCIAL’s President and Chief Operating Officer, leading the retail business since 2003.  The Company will conduct an executive search for the CEO position, which will include Mr. Lilien and external candidates.

The Company also announced that Donald H. Layton, who has served as a special advisor to the E*TRADE FINANCIAL Board of Directors, will become Chairman of the Board, succeeding George A. Hayter who will remain a Director of the Company.  Mr. Layton retired in 2004 after 29 years at JP Morgan Chase and its predecessors, serving most recently as Vice Chairman, and as a member of its three person Office of the Chairman and its Executive Committee.

“E*TRADE’s core business is strong,” said Mr. Lilien.  “This transaction with Citadel is not only a major vote of confidence from one of the world’s leading financial institutions but also allows us
 

 
to directly address customer concerns and get back to our real business, which is providing industry leading products and services to our customers.”

Mr. Layton said, “E*TRADE FINANCIAL’s Board of Directors, in cooperation with our financial advisors, conducted a thorough and robust review of strategic alternatives.  As part of this process, the Company held discussions with potential strategic and financial partners.  In the end, the Board unanimously concluded that the transaction with Citadel clearly provides the greatest benefits to our shareholders and other constituencies.  The Company now has the financial strength to aggressively compete in the marketplace.”

“With its strong brand, solid business model and fortified balance sheet, we believe E*TRADE is well-positioned to execute on its growth strategy for its core retail business,” said Ken Griffin, Founder and CEO of Citadel Investment Group. “We believe this capital infusion will restore investor and customer confidence in the Company, and will allow the Board and management to continue to grow the business from a position of strength, creating value for all shareholders.”

This transaction removes the assets with the greatest market risk from E*TRADE’s consolidated balance sheet.  Effective today, E*TRADE has divested itself of its $3 billion asset-backed securities (ABS) portfolio, including its ABS collateralized debt obligations (CDOs) and second lien securities.

E*TRADE FINANCIAL, with more than 4.7 million customer accounts worldwide and $227 billion of assets under management as of October 31, is a global financial services leader.  Its retail brokerage business is recognized for its customer service, product innovation and execution speed, and it maintains a “well-capitalized” status by regulatory standards.

MANAGEMENT CHANGES

In addition to his position as acting CEO, Mr. Lilien will retain his seat on the Company’s Board of Directors.  Mr. Lilien joined E*TRADE FINANCIAL in August 1999.  Prior to his election as President and COO in March 2003, Mr. Lilien served as Chief Brokerage Officer and President, E*TRADE Securities LLC.  Mr. Lilien has also served the Company as Managing Director, Asia-Pacific and Latin America.  He spent 10 years as Chief Executive Officer of TIR Holdings, which E*TRADE FINANCIAL acquired in August 1999.  Prior to TIR, he held various positions at Paine Webber and Autranet, a former division of Donaldson, Lufkin & Jenrette, Inc.

“Jarrett is a proven leader who has demonstrated vision and effectiveness in many positions throughout the Company,” said Mr. Hayter.  “We are confident that he is the right person to lead E*TRADE forward as we focus on our core retail business.”

“We value the contributions that Mitch has made to E*TRADE over the past seven years, and the Board thanks him for his dedication and service,” continued Mr. Hayter.  “Mitch played a vital role in reaching this agreement with Citadel, and his passion has helped revolutionize the online financial services industry, positioning E*TRADE as a leader in value, customer service and product innovation.”

“It has been an honor to work with E*TRADE’s employees, management team, Board and customers as we transformed the Company.  I am proud of our accomplishments,” said Mr. Caplan.  “With today’s transaction, I am pleased to pass on our Company as a strong, vibrant leader in financial services.”
 


 
TRANSACTION TERMS

Under the terms of the Citadel transaction, E*TRADE will receive $2.5 billion in cash, of which $2.4 billion will fund today.  The terms include:
 
·
E*TRADE will receive $1.6 billion of capital in exchange for 12.5% senior unsecured notes and common stock.  This includes a contribution of capital by investment funds managed by BlackRock, Inc.
 
·
Citadel has acquired E*TRADE’s entire ABS portfolio, including CDOs, for $800 million in cash.
 
·
Upon final closing, it is expected that Citadel will invest an additional $150 million in exchange for 12.5% senior unsecured notes and common stock.
 
·
The amount of common stock expected to be issued by E*TRADE is approximately 19.99% of current outstanding common stock.
 
·
Citadel will nominate one representative to E*TRADE FINANCIAL’s Board of Directors.

As a result of the sale of the ABS portfolio, E*TRADE will take a charge of $2.2 billion.  The Company also expects to take a provision in the fourth quarter related to its portfolio of home equity loans in excess of the quarter’s expected losses that will result in an ending allowance of over $400 million.

Evercore Partners Inc. and J.P. Morgan Securities Inc. served as financial advisors to E*TRADE.  Davis Polk & Wardwell served as legal advisor to E*TRADE.  Fried Frank Harris Shriver & Jacobson LLP served as legal advisors to Citadel.

E*TRADE will hold an investor call and webcast today at 8:00 a.m. Eastern Time to discuss this morning’s announcement.  To participate in the call, dial 800-683-1525.  International callers should dial 973-872-3197.  All callers should reference conference call ID 9510908.  The call will also be simultaneously webcast on the Company’s web site www.investor.etrade.com.

A replay of the conference call will be available at www.investor.etrade.com.

About E*TRADE FINANCIAL
The E*TRADE FINANCIAL family of companies provides financial services including trading, investing, banking and lending for retail and institutional customers.  Securities products and services are offered by E*TRADE Securities LLC (Member FINRA/SIPC).  Bank and lending products and services are offered by E*TRADE Bank, a Federal savings bank, Member FDIC, or its subsidiaries.

# # #
 
Important Notice
E*TRADE FINANCIAL, E*TRADE and the E*TRADE logo are trademarks or registered trademarks of E*TRADE FINANCIAL Corporation.  The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.  The uncertainties and risks include, but are not limited to, changes in market activity, anticipated increases in the rate of new customer acquisition, the conversion of new visitors to the site to customers, the activity of customers and assets held at the institution, seasonality, macro trends of the economy in general and the residential real estate market, instability in the consumer credit markets and credit trends, rising mortgage interest rates, tighter mortgage lending guidelines across the industry, increased mortgage loan delinquency and default rates, portfolio growth, portfolio seasoning and resolution through collections, sales or charge-offs, the development and enhancement of products and services, competitive pressures (including price competition), system failures, economic and political conditions, changes in consumer behavior and the introduction of competing products having technological and/or other advantages. Further information about these risks and uncertainties can be found in the information included in the annual reports previously filed by E*TRADE FINANCIAL Corporation with the SEC on Form 10-K (including information under the caption "Risk Factors") and quarterly reports on Form 10-Q.
 
 
© 2007 E*TRADE FINANCIAL Corporation. All rights reserved.
 
 


-----END PRIVACY-ENHANCED MESSAGE-----